Inner Banner

Publications

    1. Ambulkar R, Parab S, Vignesh B, Nagargoje V, Janu A, Parikh P, Moiyadi A.(2023) A prospective study to evaluate the use of surveillance venous ultrasonography to detect incidence of deep venous thrombosis following neurosurgical excision of brain tumors. Journal of Neurosciences in Rural Practice.

    2. Budukh A, Pradhan S, Singh VB, Khanna D, Bagal SS, Chakravarti PS, Sharma AN, Vishwakarma RK, Shinde SS, Khargekar NC, Chaturvedi P, Dikshit RP, Shukla VK, Badwe R (2023). Cancer pattern in Varanasi district from Uttar Pradesh state of India, a foundation for cancer control based on the first report of the population-based cancer registry. Indian Journal of Cancer.

    3. Budukh A, Bagal S, Thakur JS, Khanna D, Sancheti S, Banavali S. Pediatric cancer burden in different regions of India: Analysis of published data from 33 population-based Cancer Registries. Indian Pediatrics.

    4. Chavan P, Bhat V, Joshi A, Gupta T, Murthy V, Noronha V, Rathish D, Prabhash K (2023). Salivary IgA as a surrogate biomarker for microbial infections in postoperative patients receiving chemo-radio-therapy for head and neck cancer. Journal of Laboratory Physicians.

    5. D'Silva SZ, Bodade A, Kadam S, Tambe M, Dhanda S, Bagal B, Sengar M, Jain H, Nayak L, Bonda A, Punatar S, Gokarn A, Khattry N, Singh M. Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian Cohort. Indian Journal of Hematology and Blood Transfusion. 39(1):50-56. PMID: 36699439.

    6. Das S, Bagal B, Jain H, Kashyap L, Anbarsan S, Sharma A, Bondili S, Nayak L, Thorat J, Mirgh S, Gokarn A, Punatar S, Sahay A, Epari S, Tembhare P, Shetty P, Khanna N, Goda J, Moiyadi A, Gupta T, Sengar M, Khattry N, Menon H (2023).Demographic, pattern of care and outcomes of primary CNS lymphoma-experience from a tertiary care cancer center in India. Indian Journal of Hematology and Blood Transfusion. 39(1):57-70. PMID: 36699441.

    7. Dash B, Shylasree TS, Rekhi B, Gulia S, Ghosh J, Maheshwari A, Patil A, Sable N, Gupta S (2023). Clinical observations and outcomes in advanced low-grade serous carcinoma of the ovary: Case series from a tertiary cancer center. Indian Journal of Surgical Oncology.

    8. Harankhedkar S, Patkat N(2023). Molecular MRD assessment in acute myeloid leukemias. Indian Journal of Medical and Paediatric Oncology.

    9. Joshi S, Chougle Q, Noronha J, Hawaldar R, Nair N, Vanmali V, Parmar V, Thakkar P, Chitkara G, Shet T, Badwe R. Determinants of pathological complete response to neoadjuvant chemotherapy in breast cancer: A single‑institution experience. Indian Journal of Cancer.

    10. Joshi S, Murali-Nanavati S, Shylasree TS, Hawaldar R, Tripathi S, Sahay A, Noronha J, Jain U, Thomas A, Kowtal P, Vanmali V, Nair N, Parmar V, Badwe RA, Sarin R (2023). Synchronous and Metachronous breast and ovarian cancers: Experience from a single tertiary care cancer centre in India. Indian Journal of Surgical Oncology.

    11. Krishnatry R, Mani S, Manjali JJ, Rane PP, Chatterjee A, Goda JS, Janu A, Sahu A, Gupta T, Jalali R (2023). Institutional patterns of care of diffuse intrinsic pontine glioma. Neurology India. 71(1):72-78.

    12. Kamtalwar S, Mirgh S, More A, Gokarn A, Dhumal S, Sharma P, Lall S, Patkar N, Shetty N, Chatterjee G, Rajpal S, Bhat V, Khattry N, Gupta S (2023). Triple trouble: Disseminated Penicilliosis in a cancer patient with COVID-19. Indian Journal of Medical and Paediatric Oncology.

    13. Kothari B, Parab P, Gulia S, Rath S, Gupta S (2023). Ribociclib-induced delayed dermatological reaction: Case report of a rare adverse effect and review of literature. Indian Journal of Medical and Paediatric Oncology.

    14. Majithia J, Mahajan A, Vaish R, Prakash G, Patwardhan S, Sarin R (2023). Imaging recommendations for diagnosis, staging, and management of hereditary malignancies. Indian Journal of Medical and Paediatric Oncology.

    15. Mohite A, Choudhury S, Purandare N, Agrawal T, Shet T, Agrawal A, Shah S, Puranik A, Rangarajan V (2023). Adenopathy in multiple myeloma: An enigma unravelled by FDG PET. Indian Journal of Hematology and Blood Transfusion.

    16. Nayak P, Sinha S, Goda JS, Sahu A, Joshi K, Choudhry O Roy, Mhatre R, Mummudi N, Agarwal JP (2023). Computerized tomography-based first order tumor texture features in non-small cell lung carcinoma treated with concurrent chemoradiation: A simplistic and potential surrogate imaging marker for survival. Journal of Cancer Research and Therapeutics. 19(2): 366-375.

    17. Patil S, Ambulkar R, Kulkarni A. (2023) Patient safety in intensive care unit: What can we do better? Indian Journal of Critical Care Medicine. 27(3): 163-165.

    18. Poladia P, Chavan P, Mohite R, Gavhane U, Pillai BGS, Gosavi U, Pal SK. Is it time to switch over to heparin plasma for biochemistry analysis over time tested serum samples? International Journal of Scientific Research. 12 (3): 62-65.

    19. Punatar S, Murugaiyan V, Kumnbhalwar K, Gokarn A, Chichra A, Mirgh S, Nayak L, Bonda A, Jindal N, Shirure V, Bagal B, Mathew L, Kannan S, Saikia T, Khattry N (2023). Comparison of outcomes of donor lymphocyte infusions with or without lenalidomide in patients with hematological malignancies post allogeneic HSCT. Indian Journal of Hematology and Blood Transfusion. 39(1):40-49. PMID: 36699432

    20. Ramaswamy A, Shah D, Bhargava P, Srinivas S, Kannan S, Shah M, Suman M, Das S, Trikha M, Ostwal V (2023). Modified FOLFIRINOX compared to Gemcitabine & nab-Paclitaxel in advanced pancreatic ductal adenocarcinoma - results of a match-pair analysis. Indian Journal of Medical Research. 157(1):57-65

    21. Ramalingam N, Chidambaranathan N, Thiagarajan S, Singh A, Chaukar D, Chaturvedi P (2023). Impact of changes in treatment paradigms on survival in oral squamous carcinoma— a Population-Level Study. Indian Journal of Surgical Oncology.

    22. Sabu TM, Noronha V, Rao A, Kumar A, Gattani S, Ramaswamy A, Pillai A, Dhekale R, Castelino R, Kumar S, Sehgal A, Rane P, Gota V, Badwe R, Prabhash K (2023). Uptake of vaccination in older Indian patients with cancer: A cross-sectional observational study. Cancer Research, Statistics, and Treatment 6(1): 52-61.

    23. Sahay A, Epari S, Chinnaswamy G, Chatterjee A, Goda JS, Patil V, Moyiadi A, Shetty P, Singh V, Sahu A, Choudhary A, Janu A, Gupta T (2023). Primary intracranial germ cell tumors: A study with an integrated clinicopathological approach. Neurology India. 71(3): 500-508.

    24. Srinivasan S, Dhamne C, Moulik NR, Chichra A, Tembhare P, Patkar N, Subramanian PG, Shetty D, Narula G, Banavali S (2023). Treatment of pediatric acute promyelocytic leukemia with retinoic acid and arsenic trioxide along with chemotherapy. Indian Journal of Pediatrics.

    25. Thorat J, Sengar M, Chanana R, Kapoor A, Singh A, Bonda A, Menon H, Bagal B, Laskar S, Khanna N, Goda JS, Epari S, Gujral S, Agarwal A, Sawant S, Daddi A, Shet T, Ghandade N, Jain H (2023). A Retrospective cohort study to evaluate the outcomes of HIV-associated high-grade B-Cell Non-Hodgkin Lymphoma (NHL) treated with dose adjusted EPOCH (+/−R) regimen. Indian Journal of Haematology and Blood Transfusion.
  • 2022
    1. Ambulkar, R, Rana P, Starr N, Moore J. Perioperative health care provider safety and resource availability during the COVID-19 pandemic in India and other low middle-income countries, Indian Journal of Anaesthesia. 66(3):220-223. PMID: 35497691
    2. Ambulkar R, Patil M, Sanika J, Divatia J (2022). Comparison of C-MAC videolaryngoscope with Macintosh laryngoscope for nasotracheal intubation by the novice anaesthesiologist. Indian Journal of Anaesthesia 66(12): 865-868. PMID: 36654894
    3. Anand KV, Mishra G, Pimple S, Biswas S, Kulkarni V, Salunkhe G (2022). Cross-sectional study of HPV self-sampling among Indian women—a way forward. Indian Journal of Medical and Paediatric Oncology. 43(1): 103-108.
    4. Antony S, Ahire S, Ingle A (2022). Maximising modern diagnostic approaches to assess genetic contamination in laboratory rodents. Indian Veterinary Journal. 99 (07): 24-34.
    5. Bahl A, Rajappa S, Rawal S, Bakshi G, Murthy V, Patil K (2022). A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone–releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix). Indian Journal of Cancer 59 (Suppl S1):160-74.PMID: 35343199
    6. Bandekar B, Awatagiri K, Kannan S, Rane P, Parikh P (2022). Audit of principal investigator's compliance for submission of continue review application and decisions taken on lapses in validity of approval by the Institutional Ethics Committee at tertiary oncology center in Navi Mumbai. Perspectives in Clinical Research 13(3): 145-150. PMID: 35928644
    7. Banerjee S, Basu S, Baheti A, Kulkarni S, Rangarajan V, Nayak P, Murthy V, Kumar A, Laskar S, Agarwal JP, Gupta S, Badwe RA (2022). Radiation and radioisotopes for human healthcare applications. Current Science. 123(3): 388-395.
    8. Behel V,Noronha V, Patil V, Menon N, Chandrani P, Kumar R, Rastogi S, Mahajan A, Chougule A, Dutt A, Prabhash K (2022). Molecular tumor board–guided treatment of non–small cell lung cancer with dual driver (ALK and EGFR) alterations. Cancer Research, Statistics and Treatment. 5(2): 337-341.
    9. Bhat V, Chavan P, Bhat P. Recommendations for COVID-19-related biomedical waste management in health care facilities. Indian Journal of Cancer. 59(1):149-150.PMID: 35645061
    10. Birur PN, Patrick S, Warnakulasuriya S, Gurushanth K, Raghavan SA, Rath GK, Chaturvedi P, Chandru V, Mathew B, Prabhash K, Gurudath S, Mukhia N, Sunny SP, Mehrotra R, Vivek V, Patil S, Kumar G S, Fasalkar S, Pratima R, Kuriakose MA (2022). Consensus guidelines on management of oral potentially malignant disorders. Indian Journal of Cancer 59:442-53. PMID: 36412324
    11. Biswas C, Jain K, Velayutham P, Singh V, Shetty P, Moiyadi A (2022). Awake mapping unmasks functional substrates guiding safe radical resection of “Nondominant” right insular glioma using a transopercular approach. Neurology India 70:1808-12. PMID: 36352570
    12. Budukh A, Shah S, Kulkarni S, Pimple S, Patil S, Chaukar D, Pramesh C S (2022). Tobacco and cancer awareness program among school children in rural areas of Ratnagiri district of Maharashtra state in India. Indian Journal of Cancer 59: 80-6.PMID: 33402603
    13. Budukh A, Maheshwari A, Bagal S, Singh A, Deodhar K, Panse N, Palyekar V, Dikshit R, Badwe R (2022). Factors influencing women to participate in cervical cancer screening by providing menstrual pads: A population-based study from rural areas of Maharashtra state, India. Indian Journal of Cancer 59(4): 462-468. PMID: 34380839
    14. Deshpande G, Menon S, Rekhi B. Mittal N, Maheshwari A, Shylashree TS, Chopra S, Gurram L, Ghosh J, Gulia S, Gupta S, Deodhar K(2022). Extramammary Paget’s disease of vulva: A vlinicopathological case series of a rare disease. Indian Journal of Gynecologic Oncology. 20:61.
    15. Dhumal S, Patil V, Noronha V, Prabahsh K (2022). Immune checkpoint inhibitors: Promising but still inaccessible treatment option for patients with head-and neck cancer in India. Cancer Research, Statistics, and Treatment. 5(3): 587-588
    16. Gattani S, Ramaswamy A, Noronha V, Castelino R, Kumar S, Rao A, Dhekle R, Krishnamurthy J, Kannan S, Gota V, Banavali S, Badwe R, Prabhash K (2022).ECOG performance status as a representative assessment of deficits in older Indian patients with cancer – A cross‑sectional analysis from a large cohort study. Cancer Research, Statistics and Treatment. 5(2): 280-286.
    17. Ghosh J, Joy Phillip DS, Ghosh J, Bajpai J, Gulia S, Parmar V, Nair N, Joshi S, Sarin R, Budrukkar AN, Wadasadawala T, Desai SB, Shet T, Patil A, Sawant SP, Dhir AA, Kembhavi S, Popat P, Hawaldar R, Kembhavi Y, Perumal P, Banavali SD, Badwe RA, Gupta S (2022). Survival outcomes with 12 weeks of adjuvant or neoadjuvant trastuzumab in breast cancer. Indian Journal of Cancer. 59:387-93. PMID: 33753616
    18. Gokarn A, Joshi A, Wadasadawala T, Gulia S, Wakle S, Singh A, Tiloda A, Singh A, Chakraborty D, Subramani V, Bajaj P, Chintala SK, Pathak B, Simha V, Sood S, Kalra B, Bhandari M, Avonu S, Elamarthy P, DAS S, Dash RS, Jansari J, Sehra N, Vispute T, Thakur J, Gawade L, Vemuri C, Nekkanti S, Bansod Y, Chauhan L, Chhatrala R, Gurukeerthi B, Shankar R, Narayanan R, Preeti V, Shetty P, Dikshit R, Khattry N, Gupta S, Goel N, Badwe RA (2022). Cancer care continuum at a tertiary care centre in India during the Covid-19 pandemic and nationwide lockdown: Healthcare delivery through telemedicine. National Medical Journal of India. 35(3):142-146.
    19. Joshi K, Joshi P, Nair S, Chaturvedi P (2022). Submandibular gland in squamous cell carcinoma of the tongue: Can preservation during neck dissection be a pragmatic option? Journal of Cancer Research and Therapeutics. 18(3): 612-616. PMID: 35900530
    20. Kapoor J, Mirgh SP, Agrawal N, Khushboo V, Tejwani N, Singh R, Mehta P, Bhurani D, Ahmed R (2022). High risk acute promyelocytic leukemia - An enigma for hematologists: Optimizing treatment with APML-4 Protocol. Indian Journal of Hematology and Blood Transfusion. 38: 394–402. PMID: 35496975
    21. Khanna N, Kumar A, Sehra N, Ghosh -Laskar S, Mummudi N, Gupta T, Tibdewal A, Pathak R, Wadasadawala T, Krishnatry R, Chopra S, Goda J, Chatterjee A, Budrukkar A, Gurram L, Engineer R, Murthy V, Swain M, Laskar S, Sarin R, Agarwal J (2022).Compliance of radiotherapy treatment at a tertiary cancer center in India—A clinical audit. Indian Journal of Medical and Paediatric Oncology. 43(1): 84-91.
    22. Kulkarni R, Gupta S (2022). Gynaecological oncology in India: Past, present and future. Indian Journal of Surgical Oncology. PMID: 36691500
    23. Kulkarni R, Gupta S, Maheshwari A (2022). Gynecologic Oncology: On the Shoulders of Giants. Indian Journal of Medical and Paediatric Oncology. 43(1): 34-39.
    24. Kulkarni VY, Mishra GA, Pimple SA, Patil AS, Bajpai J, Shylasree TS. Determinants of compliance for breast and cervical cancers screening among female police personnel of Mumbai, India—A Cross-sectional study. Indian Journal of Medical and Paediatric Oncology. 43(1): 60-7.
    25. Kulkarni VY, Mishra GA, Pimple SA, Shaikh HK, Awasthi AA. Compliance for community-based cervical cancer screening program among women of age 30–65 years residing in low socioeconomic settings of Mumbai, India. Indian Journal of Community Medicine. 47(3):414-9. PMID: 36438507
    26. Kumar S, Shriyan B, Patil A, Yadav S, Jadhav S, Asar M, Krishnamurthy MN, Patil V, Joshi A, Noronha V, Prabhash K, Gota V (2022). Effect of ADME gene polymorphisms on pemetrexed pharmacokinetics in patients with non-small-cell lung cancer: A prospective study. Cancer Research, Statistics, and Treatment. 5:437-44.
    27. Loyal A, Chopra S, Goel M, Mehta S, Patil P, Patkar S, Shrivastava S, Engineer R (2022). Predictors of toxicity after neoadjuvant chemoradiotherapy for locally advanced gall bladder cancer. Indian Journal of Cancer. 59:368-374. PMID: 33753615
    28. Mahajan A, Agarwal U, Patil V, Patil V, Vaish R, Noronha V,D'Cruz A, Chaturvedi P, Ghosh Laskar S, Sable N, Janu A, Shukla S, Patil A, Menon M, Rane S, Mittal N, Joshi A, Menon N, Prabhash K (2022). Proposed sub- compartmentalisation of high infratemporal fossa involvement in gingivobuccal cancers and its impact on clinical outcome and AJCC 8th edition. A narrative review. Cancer Research, Statistics Treatment. 5(2): 293-300.
    29. Mishra GA, Pimple SA, Kulkarni VY, Gupta SD, Mujmudar PV (2022). Tobacco cessation program among cab drivers in Mumbai, India: An Interventional Study. Indian Journal of Community Medicine. 47(3):347-51. PMID: 36438536
    30. Mishra GA, Goel NS, Gupta S, Laskar S, Tiloda A, Bhagwat A, Kulkarni V, Shaikh HK, Pramesh CS, Tandon SP, Sawakare SS, Sengar M, Biswas S, Epari S, Shetty O, Desai S, Badwe RA (2022). Efficacy of screening cancer patients at hospital entrance for COVID-19 with a questionnaire and thermal scanning: An audit. Indian Journal of Medical Sciences. 74:10-4.
    31. Moiyadi AV (2022). Neuropsychologists and Their role in developing an awake craniotomy program. Neurology India. 70:1291-1292.
    32. Nair NS, Gupta S, Ghosh J, Desai S, Parmar V, Shet T, Chitkara G, Siddique S, Badwe RA (2022). Access to HER2-targeted therapy at a tertiary care center in India: An evolution. Indian Journal of Cancer. 59:375-9.PMID: 33753630
    33. Naseem A, Ahire S, Ingle A (2022). Multiplexing: An efficient way of genetic monitoring of laboratory mice using microsatellite markers. Agricultural Science Digest. 42(3): 358-364.
    34. Pahwa V, Pimple S, Mishra G, Anand K (2022). Prevalence and Determinants of Human Papilloma Virus Infection and Cervical Intraepithelial Neoplasia (CIN) among Women Living with HIV/AIDS in Mumbai, India. Indian Jounral of Medical and Paediatric Oncology. 97-102.
    35. Panda PK, Gupta T, Jalali R (2022). A practice pilot survey on the current use of corticosteroid therapy in brain tumor patients. Neurology India 70:1896-900. PMID: 36352584
    36. Pathiyil RK, Moiyadi AV, Shetty P, Singh V, Velayutham P (2022). Transopercular approach to resection of dominant hemisphere diffuse insular glioma using multimodal intraoperative strategy with awake mapping. Neurology India. 70: 520-3. PMID: 35532613
    37. Patil V, Muthuluri H, Choudhary J, Parekh D, Abraham G, Noronha V, Menon N, Dhumal S, Prabhash K (2022). Nivolumab in platinum-refractory head-and-neck cancers: A retrospective observational audit from a tertiary cancer center. Cancer Research, Statistics, and Treatment. 5:468-73.
    38. Pimple SA, Pahwa V, Mishra GA, Anand KV, Pathuthara S, Biswas SK (2022). Screening for Early Detection of Cervical Cancer in Women Living with HIV in Mumbai, India-Retrospective Cohort Study from a Tertiary Cancer Center. Indian Journal of Medical and Paediatric Oncology. 43(01):073-83.
    39. Pimple S, Mishra G (2022). Cancer cervix: Epidemiology and disease burden. Cytojournal. 19: 21. PMID: 35510109
    40. Poddar P, Maheshwari A, Shylasree TS, Yadav S, Kannan S, Ghosh J, Gullia S, Rath S, Chopra S, Gurram L, Gupta S. Knowledge, Attitudes and Practices Towards COVID-19: A Cross-Sectional Survey. Indian J Gynecol Oncol. 20(2):23. PMID: 35441088
    41. Qureshi SS, Kazi M, Noronha J, Smriti V, Basu S, Shah S, Talole S (2022). Factors Influencing Cervical Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancers. Indian Journal of Surgical Oncology. 13: 92-98. PMID: 35462647
    42. Raj M, Shinde A, Ingle A (2022). Microbiological monitoring of Rodent pathogens using Multiplex method of PCR. Journal of Laboratory Animal Science.7 (1): 18-24.
    43. Rajput N, Gholap D, Mhatre S, Dikshit R (2022). Epidemiological Review: Esophagus squamous cell carcinoma in India. Indian Journal of Medical and Paediatric Oncology. 43(5): 393-403.
    44. Ranade M, Shah A, Yadav S, Menon S, Gupta S. (2022). Extra-nodal follicular dendritic cell sarcoma with unusual morphological features and PDL1 expression. Indian Journal of Medical and Paediatric Oncology.
    45. Rao AR, Kumar S, Dhekale R, Krishnamurthy J, Mahajan S, Daptardar A, Ramaswamy A, Noronha V, Gota V, Banavali S, Prabhash K (2022). Timed Up and Go as a predictor of mortality in older Indian patients with cancer: An observational study. Cancer Research Statistics and Treatment .5 :75-82.
    46. Rao S, Sahay A, Epari S (2022). Paediatric type diffuse high grade gliomas in the WHO CNS5 classification: What the pathologist needs to know? Indian Journal of Pathology & Microbiology 65(Suppl S1):50-8.PMID: 35562134
    47. Sengar M, Ranganathan P (2022). The Interplay between COVID-19 and Cancer: Challenges and Perspectives. Indian Journal of Medical and Paediatric Oncology. 43(1): 19-23.
    48. Shukla S, Agarwal U, Patil V, Rane S, Menon N, Noronha V, Patil V, Prabhash K, Mahajan A (2022). Diagnostic quandary over a cheek(y) neoplasm. Cancer Research Statistics and Treatment.5: 131-135.
    49. Singh A, Kumar R, Shetty O, Desai S, Rane S(2022). FISH patterns of ROS1, MET, and ALK with a correlation of ALK immunohistochemistry in lung cancer: a case for introducing ALK immunohistochemistry 'Equivocal' interpretation category in the Ventana anti-ALK (D5F3) CDx assay - A tertiary cancer center experience. Indian Journal of Cancer 59:18-25.PMID: 33402590
    50. Singh A, Nair N, Gupta S, Parmar V, Prabhu A, Hawaldar R, Badwe R (2022). Effect of menopausal status on chemotherapy-induced peripheral neuropathy: Single-institution retrospective audit. Indian Journal of Medical and Paediatric Oncology. 43(1): 68-72.
    51. Singh AG, Singhavi H, Sharin F, Lakdawala M, Mhatre S, Deodhar J, Chaturvedi P, Dikshit R (2022). Cross-Sectional and Longitudinal Mental Health Status Prevailing among COVID-19 Patients in Mumbai, India. Indian Journal of Community Medicine. 47 (1):55-60. PMID: 35368483
    52. Sudharsan MG, Venkatraman P (2022). A crystal form of PSMD10 Gankyrin with channels accessible to small molecules. Current Science. 122(6): 674-681.
    53. Thorat R (2022). LAS around the globe: Laboratory animal science in India: ‘Where we are’. Laboratoy Animals. 56(4): 317-318.
    54. Thorat R, Ahire S, Shinde A, Ingle A (2022). Cost-effective decontamination of conventional laboratory animal rooms using hydrogen peroxide aerosols. Journal of Laboratory Animal Science. 7(1): 22-36.
    55. Tiwari M, Rauthan A, Chavan P, Subramanian PG, Gujral S, Bhat V (2022). Quality evaluation of sample collection facilities of resource‑limited medical laboratories in various states of India: A comparison between accredited and nonaccredited laboratories. QAI Journal for Healthcare Quality and Patient Safety. 3:8-12
    56. Wadasadawala T, Kumar A, Laskar S, Mokal S, Kapoor R, Das A, Pradhan S, Pujari L, Mahantshetty U, Vadgaonkar R, Agarwal J (2022). A longitudinal study to Reexamine the mental health impact on radiation oncology health care workers with the launch of COVID-19 vaccination strategies in India. Indian Journal of Medical and Paediatric Oncology. 415-423.
    57. Wadasadawala T, Mangaj A, Mokal S, Pathak R, Sarin R, Gaikar M, Nair N, Bajpai J, Joshi J, Joshi S, Gulia S (2022). Measuring satisfaction in breast cancer patients receiving ambulatory care: A validation study. Indian Journal of Medical and Paediatric Oncology. 43(6): 473-479.
    58. Zodinpuii D, Pautu JL, Zothankima B, Khenglawt L, Lallawmzuali D, Lalmuanpuii R, Zuali L, Ralte L, Muthukumaran RB, Varma A, John Zothanzama J, Kumar NS (2022). Breast cancer is significantly associated with cancers in the first and second degree relatives in ethnic Mizo-Mongoloid population, Northeast India. National Journal of Community Medicine. 13(9): 606-611.
  • 2021
    1. Barange M, Epari S, Gurav M, Shetty O, Sahay A, Shetty P, Goda J, Moiyadi A, Gupta T, Jalali R (2021). TERT promoter mutation in adult glioblastomas: It's correlation with other relevant molecular markers. Neurology India. 69:126-34. PMID: 33642283

    2. Lewis S, Chopra S, Singh R, Engineer R (2021). A survey of the practice of stereotactic body radiotherapy for hepatocellular and pancreatic malignancies in India. Indian Journal of Cancer. 58(4): 532-538. PMID: 33753598

    3. Noronha V, Ramswamy A, Gattani SC, Krishnamurthy MN, Menon N, Patil V, Gota V, Banavali S, Prabhash K (2021). Polypharmacy and potentially inappropriate medication use in older Indian patients with cancer: A prospective observational study. Cancer Research Statistics and Treatment. 4(1): 67-73.

    4. Sharma P, Mahajan A, Rane S, Bhattarcharjee A (2021). Assessment of COVID-19 severity using computed tomography imaging: A systematic review and meta-analysis. Cancer Research Statistics and Treatment 4:78-87.

    5. Parmar V, Nair S, Thakkar P, Chitkara G( 2021) - Molecular biology in the Breast Clinics—Current status and future perspectives. Indian Journal of Surgical Oncology. 12: 7–20. PMID: 33994723

    6. Rajendra A, Gokarn A, Mirgh S, Ravind R, Singh A, Goli VB, Punatar S, Chichra A, Tembhare P, Patkar N, Bhat V, Chavan P, Trivedi B, Joshi A, Khattry N (2021). SARS-CoV2 Infection in Hematopoietic Stem Cell Transplant recipients: A Case Series from a Tertiary Cancer Centre in India. Indian Journal of Hematology and Blood Tansfusion. 37(4):1-3. PMID: 34007125

    7. Sangale A, Bhat V, Kelkar R, Biswas S (2021). Microbiology of Ventilator-associated Pneumonia in a Tertiary Care Cancer Hospital. Indian Journal of Critical Care Medicine. 25(4):421-428. PMID: 34045810

    8. Thiagarajan P, Thota RS, Divatia JV (2021). Efficacy of ultrasound-guided erector spinae plane block following breast surgery - A double-blinded randomised, controlled study. Indian Journal of Anaesthesia 65(5):377-382. PMID: 34211195

    9. Kazi, M., Qureshi, SS (2021). Primary Peritoneal Rhabdomyosarcomatosis in a 2-Year-Old Child Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy — Case Report and Review of Literature. Indian Journal of Surgical Oncology. 12: 322-326.

    10. Bapat P, Bhat S, Chakraborty C, Chirmule N, Kadam R, Kashyap S, Masurkar S, Paul R, Rao D, Reddy R, Togar T (2021). Mentoring during the COVID-19 pandemic:A perspective from graduate students in biomedical science studies in India. Proceedings of the Indian National Science Academy. 87(2): 320–323.

    11. Thorat RA, Ingle AD (2021). Tackling the Covid-19 Pandemic in Animal Facilities: ACTREC Perspectives. Agricultural Reviews. 42: 203-208.

    12. Shylasree TS, Ranade R, Kattepur AK, Kaur S, Dusane R, Maheshwari A, Mahantshetty U, Chopra S, Engineer R, Kerkar RA (2021). Quality of life in long term survivors of cervical cancer: A cross sectional study. Indian Journal of Cancer. 58:171-8. PMID: 34100410

    13. Madhugiri VS, Moiyadi A, Nagella AB, Singh V, Shetty P (2021). A Questionnaire-based survey of clinical Neuro-oncological practice in India. Neurology India. 69(3):659-664. PMID: 34169864

    14. Sarkar S, Deodhar K, Budukh A, Bal M, Ramadwar M (2021). Assessing the histopathology reports of colorectal carcinoma surgery: An audit of three years with emphasis on lymph node yield. Indian Journal of Cancer. PMID: 34380840

    15. Gaidhani RH, Balsubramaniam G (2021). An epidemiological review of pancreatic cancer with special reference to India. Indian Journal of Medical Sciences. 73(1):99-109.

    16. Noronha V, Abraham G, Bondili SK, Rajpurohit A, Menon RP, Gattani S, Trikha M, Tudu R, Kota KK, Singh AK, Elamarthi P, Panda GS, Rai RK, Krishna MR, Chinthala SK, Shah MJ, Shah D, Tiwari A, Vora DN, Tongaonkar AH, John G, Patil A, Menon NS, Patil VM, Joshi A, Banavali S, Badwe RA, Prabhash K. COVID-19 vaccine uptake and vaccine hesitancy in Indian patients with cancer: A questionnaire-based survey. Cancer Research, Statistics and Treatment. 4: 211-8, 2021.

    17. Shetty D, Jain H, Rohil Y, Khattry N, Sengar M, Bagal B, Jain H, Gokarn A, Punatar S, Avinash Bonda VN, Subramanian P G (2021). Role of cytogenetic abnormalities detected by fluorescence in situ hybridization as a prognostic marker: Pathogenesis & clinical course in patients with B-chronic lymphocytic leukaemia. Indian Journal of Medical Research.153:475-83 PMID: 34380794

    18. Bhat V, Chavan P, Khattry N, Gupta S (2021). Dynamics of viral RNA load, virus culture, seroconversion & infectivity in COVID-19 patients: Implications on isolation policy. Indian Journal of Medical Research. 153: 585-590. PMID: 34414920

    19. Swamidas J, Rose J, Chopra S, Paul SN, Joshi K, Panda S, Ph R, Agarwal JP (2021). Implementation of a visual feedback system for motion management during radiation therapy. Journal of Cancer Research and Therapeutics. 17(1):148-151. PMID: 33723146.

    20. Madhugiri VS, Subeikshanan V, Dutt A, Moiyadi A, Epari S, Shetty P, Gupta T, Jalali R, Dutt AK (2021). Biomarkers of Systemic Inflammation in Patients with Glioblastoma: An Analysis of Correlation with Tumour-Related Factors and Survival. Neurology India. 69(4):894-901. doi: 10.4103/0028-3886.323885. PMID: 34507408.

    21. Dixit H, Selvaa Kumar C, Dasgupta D, Gadewal N (2021). Molecular docking analysis of hyperphosphorylated tau protein with compounds derived from Bacopa monnieri and Withania somnifera. Bioinformation 17(9): 798-804.

    22. Kapoor A, Noronha V, Shetty OA, Kashyap L, Kumar A, Chandrani P, Patil VM, Joshi A, Menon N, Kumar R, Pragya R, Prabhash K(2021). Concurrent EGFR and PIK3CA mutations in non-small-cell lung cancer. Cancer Research Statistics Treatment. 4:541-6.

    23. Singh AG, Chaturvedi P (2021). Healing the healers. Cancer Research Statistics and Treatment. 4:533-5.

    24. Dhumal SB, Patil A, More A, Kamtalwar S, Gosavi A, Chandak M, Khattry N, Gupta S, Bhat P (2021). COVID-19 vaccine-related skin rash: A case report. Cancer Research Statistics and Treatment. 4:555-6.

    25. Pimple S, Mishra G (2021). Pitfalls of generalizing the causes of COVID-19 vaccine hesitancy among patients with cancer. Cancer Research Statistics and Treatment 4:566-7.

    26. Pimple S, Mishra G (2021). Need for a national consortium of clinical registries of cancer and COVID-19 for vaccine surveillance. Cancer Research Statistics and Treatment. 4:570-1.

    27. Dani MT, Singh AG, Chaturvedi P (2021). COVID-19 vaccine hesitancy in India. Cancer Research, Statistics and Treatment. 4:437-42

    28. Moiyadi AV, Shaikh ST. (2021) Intraoperative imaging in the management of brain tumors: A review of contemporary adjuncts used in routine practice. International Journal Neurooncology 4 (Suppl S1):132-44.

    29. Santosh V, Rao S, Dasgupta A, Gupta T (2021) Diagnosis and management of central nervous system embryonal tumors in the molecular era: A contemporary review. International Journal of Neurooncology. 4(Suppl S1):190-205.

    30. Shetty N, Chakrabarty N, Joshi A, Kulkarni S, Khattry N, Gupta S, Chavan P, Bhat P, Bhat V, Rane P (2021). Incidence of COVID-19 infection amongst the high risk versus low risk health care workers: an audit from a tertiary cancer care centre. International Journal of Community Medicine And Public Health. 8(7): 3474-3477.

    31. Sawakare S, Tandon S, Pramesh CS, Gupta S, Sengar M, Ghosh-Laskar S, Nair S, Mishra G, Goel N, Patkar S, Badwe R (2021). Risk assessment of acquiring SARS-CoV-2 infection among employees of a tertiary cancer care center. Indian Journal of Medical Sciences. 73: 343-347.

    32. Gupta S. (2021) What fascinates me in science... Indian Journal of Medical and Paediatric Oncology.

    33. Mishra GA, Pimple SA, Mittra I, Badwe RA. (2021) Screening for breast cancer: Cost-effective solutions for low- & middle-income countries. Indian Journal of Medical Research. 154(2):229-236. PMID: 34854430.

    34. Chaubal R, Gupta S. (2021) The true human cost of the Novel Coronavirus 2019 (COVID-19) pandemic. Indian Journal of Medical and Paediatric Oncology.

    35. Vinodhini M, Punatar S, Gokarn A, Nayak L, Bonda A, Mathew L, Khattry N. (2021) Lenalidomide as a Potent Inducer of Graft Versus Leukemia Effect in Patients with Hematologic Malignancies at High Risk of Relapse Post Allogeneic Stem Cell Transplant. Indian Journal of Hematology and Blood Transfusion. 37(3):500-502. . PMID: 34267474

    36. Yeole U, Singh V, Shetty P, Moiyadi A.(2021) Real-Time 2D Ultrasound Guided Frameless Biopsy of a Multifocal Glioma: Improving Accuracy and Diagnostic Yield. Neurology India. 69:1551-3.PMID: 34979640

    37. Chaturvedi P, Badwe RA. (2021) With the emergence of Omicron, SARS-CoV-2 is getting weaker and human species is getting stronger due to our inherent cellular intelligence. Cancer Research, Statistics and Treatment .4:608-10

    38. Dhumal S, Patil V, Noronha V, Joshi A, Menon N, Nawale K, Tambe R, Prabhash K. (2021) Post hoc analysis of the screening log of phase III investigator-initiated randomized clinical trial comparing palliative oral metronomic versus intravenous chemotherapy in head-and-neck cancer. Cancer Research Statisitcs, and Treatment.4:642-6

    39. Rao AR, Gattani S, Castelino R, Kumar S, Dhekale R, Krishnamurthy J, Ramaswamy A, Noronha V, Gota V, Banavali S, Badwe RA, Prabhash K. (2021)Utilization of technology among older Indian patients with cancer: A cross-sectional study. Cancer Research Statisitcs, and Treatment. 4:656-62

    40. Badwe RA, Parmar V, Nair NS. (2021) Predicting pathological complete response post neoadjuvant chemotherapy and personalizing therapy in breast cancer. Cancer Research Statisitcs, and Treatment . 4:726-7

    41. Mirgh SP ( 2021). (F)utility of day 14 bone marrow in acute myeloid leukemia on 3 + 7 induction – Is it time to bid adieu to day 14 bone marrow?. Cancer Research Statistics, and Treatment. 4:731-3

    42. Pimple S, Mishra GA. (2021) Need more evidence for establishing standard vaccination practices among patients with cancer. Cancer Research Statisitcs and Treatment. 4:804-5

    43. Halmare N, Gaonkar PP, Sonkusale PM, Somkuwar AP, Ingle AD, Kurkure NV (2021).Evaluation of anti-cancer activity of Tinospora cordifolia on experimentally induced spontaneous fibrosarcoma in Swiss albino mice. Indian Journal of Veterinary Pathology. 45(1): 15-23.

    44. Manjali JJ, Gupta T, Ghosh-Laskar S, Jalali R, Sarin R, Agarwal JP. (2021) Pilot testing and vernacular translation of a questionnaire for assessment of satisfaction in patients on radiotherapy in India. Indian Journal of Cancer. 58(4): 573-582. PMID: 33402589

    45. Devadas SK, Jain H, Bagal B, Sengar M, Dangi U, Khattry N, Ambre P, Patkar N, Subramaniam PG, Nair R, Menon H (2021). Sequential treatment of arsenic trioxide followed by all trans retinoic acid with anthracyclines has excellent long-term cure in acute promyelocytic leukemia. Indian Journal of Hematology and Blood Transfusion. 1. 37(1): 30-36. PMID: 33692610

    46. Sawant P, Engineer R, Chopra S. Gulia S,Ghosh J, Maheshwari A, Shylasree T, Mahantshetty U, Gupta S. Cross-sectional Analysis of Quality of Life in Long-Term Survivors of Carcinoma Cervix Treated with Chemoradiation/Neo-Adjuvant Chemotherapy Followed by Surgery. Indian Journal of Gynecologic Oncology 19: 90

    47. Kumar A, Chopra S, Gupta S (2021). Contribution of Tata Memorial Centre, India, to cervical cancer care: Journey of two decades. Indian Journal of Medical Research. 154: 319-328. PMID: 35229739.

    48. Gupta, S, Chopra S, Nair N. (2021) Improving outcomes of women's cancer in India: A multidisciplinary multisectoral approach. Indian Journal of Medical Research. 154:175-76. PMID: 35142651

    49. Parmar V, Koppiker B, Dixit S (2022). Breast conservation surgery & oncoplasty in India – Current scenario, Indian Journal of Medical Research. 154(2): 221-228. PMID: 35295011

    50. Mangaj, A, Chopra S, Nout R (2021). Defining the role of high-dose radiation in oligometastatic & oligorecurrent cervical cancer, Indian Journal of Medical Research. 154(2): 303-318. PMID: 35295014

    51. Shejul J, Chopra S, Ranjan, N, Mahantshetty U, Mehta, S,Patil, Prachi, Engineer R, Gurram L, Phurailatpam, R, Swamidas J, Gupta S, Shrivastava S, Temporal course of late rectal toxicity & impact of intervention in patients undergoing radiation for cervical cancer. Indian Journal of Medical Research. 154(2):375-382. PMID: 35142654

    52. Wadasadawala T, Mangaj A, Mokal S, Pathak R, Sarin R, Gaikar M, Nair N, Bajpai J, Joshi J, Joshi S, Gulia S (2021). Measuring satisfaction in breast cancer patients receiving ambulatory care: A validation study. Indian Journal of Medical and Paediatric Oncology.

    53. Chatterjee S, Chakraborty S, Wadasadawala T, Sarin R.... Parmar V...etal. ; Controversies to Consensus Author Group (2021). Consensus on contentious issues relevant for breast cancer management for the Indian scenario: Statements following a multicentre expert group meeting. Indian Journal of Medical Research. 2(2):180-188. PMID: 35142646.

    54. Srinivasan S, Kunder S, Maitre P, Murthy V (2021). Immediate or salvage radiotherapy after radical prostatectomy: Do we finally know? National Medical Journal of India 34:282–4.

    55. Ambulkar R, Manampadi U, Bhosale S, Rana M, Agarwal V, Solanki SL (2021). Pre-induction ultrasonographic evaluation of gastric residual volume in elective gastrointestinal cancer surgeries. Indian Journal of Surgical Oncology. 12(4):841-846. PMID: 35110912

    56. Rana PS, Ambulkar RP, Maji M, Solanki SL (2021). Four-quadrant transverse abdominis plane block: A relatively new frontier for postoperative analgesia after major abdominal surgery. Indian Journal of Pain. 35: 254-5.

    57. Sahu A, Kurki V, Vijan A, Janu A, Shetty P, Moiyadi A (2021). Case series of applications of resting state functional MRI in brain tumor surgery: A novel technique. Indian Journal of Radiology and Imaging. 31(4):990-997.


    58.  
  • 2020
    1. Deo A, Mukherjee S, Rekhi B, Ray P (2020) - Subtype specific biomarkers associated with chemoresistance in epithelial ovarian cancer. Indian Journal of Pathology and Microbiology. 63 (Supplement S1): 64-69. PMID: 32108633

    2. Sharin F, Singh AG, Qayyumi B, Chaturvedi P (2020). A critical review of outcomes of cancer during the COVID-19 pandemic. Indian Journal of Medical and Paediatric Oncology.41:461-467.

    3. Qayyumi B, Sharin F, Singh A, Tuljapurkar V, Chaturvedi P (2020). Management of COVID-19: A brief overview of the various treatment strategies. Cancer Research, Statistics and Treatment.3: 233-43

    4. Malik A, Fatehi KS, Menon NN, Chaturvedi P (2020). Review of medicinal use of Cannabis derivatives and the societal impact of legalization. Indian Journal of Palliative Care. 26: 369-80. PMID: 33311882

    5. Budukh A, Shah S, Kulkarni S, Pimple S, Patil S, Chaukar D, Pramesh CS (2020). Tobacco and cancer awareness program among school children in rural areas of Ratnagiri district of Maharashtra state in India. Indian Journal of Cancer. PMID: 33402603

    6. Chaturvedi P, Ramalingam N (2020). Into the past in the times of COVID pandemic. Cancer Research, Statisitcs and Treatment. 3(Suppl S1): 94-96.

    7. Balasubramaniam G, Gaidhani R, Khan A, Saoba S, Mahantshetty U, Maheshwari A (2020). Survival rate of cervical cancer from a study conducted in India. Indian Journal of Medical Sciences.

    8. Thota RS, Garg R, Ramkiran S, Divatia JV. Onco-anaesthesiology as an emerging sub-speciality domain: Need of the hour! Indian Journal of Anaesthesia. 64(1): 69-71, 2020. PMID: 32001913

    9. Singh A, Chaturvedi P (2020). Braving the SARS‑CoV‑2 pandemic – quandary of health‑care workers. Indian Journal of Medical and Paediatric Oncology. 41(4): 454-457.

    10. Shetty PM, Singh V, Moiyadi AV (2020). Perspectives on neurosurgical management of brain tumors during the COVID-19 outbreak. Cancer Research, Statistics and Treatment. 3:341-2.

    11. Sasidharan A, Mahantshetty U, Gurram L, Chopra S, Engineer R, Maheshwari A, Gupta S, Deodhar K, Rangarajan V, Thakur M, Shrivastava S. Patterns of first relapse and outcome in patients with locally advanced cervical cancer after radiochemotherapy: A single institutional experience. Indian Journal of Gynecologic Oncology. 18(4), 2020.

    12. Salunkhe R, Chopra S, Kulkarni S, Shetty N, Engineer R, Mahantshetty U, Ghosh J, Gupta S, Shrivastava S (2020). Outcomes of locally advanced cervical cancer presenting with obstructive uropathy: An institutional audit. Indian Journal of Cancer. 57:416-22. PMID: 33078748

    13. Salunkhe S, Biswas S, Bhat V (2020). Mask etiquette amidst COVID-19 crisis and personal protection equipment shortage. Indian Journal of Medical and Paediatric Oncology. 41(4): 458-460.

    14. Saini S, Kazi M, Qureshi SS (2020). Miserable 9 Years of Life: a Misdiagnosed and Mismanaged Case of Large Retroperitoneal Teratoma. Indian Journal of Surgical Oncology. 11(Suppl 2): 253-256. PMID: 33364712

    15. Rekhi B, Karmarkar S, Gupta C, Deodhar KK, Menon S, Pathuthara S, Maheshwari A, Shylasree TS, Gupta S (2020). Evaluation of cell blocks from effusion specimens in Gynecologic Oncopathology: An experience of 220 cases, diagnosed at a Tertiary Cancer Referral Center. Indian Journal of Pathology and Microbiology. 63(3):427-434. PMID: 32769333

    16. Ramkiran S, Thota RS (2020). Methadone in Cancer Pain. Indian Journal of Palliative Care. 26(2):215-220.PMID: 32874036

    17. Pramesh CS, Gupta S,Ghosh-Laskar S, Sengar M, Chinnaswamy G, Khattry N, Khobrekar S, Sawakare S, Patankar S, Samant V, Sathe A, Joshi S, Divatia J, Tandon S, Biswas S, Patkar S, Singh-Goel N, Lukose J, Tiwari A, Naik R, Jafri H, Jatia S, George B, Badwe R (The Tata Memorial Centre COVID-19 Working Group) (2020). The COVID-19 pandemic and the Tata Memorial Centre response. Indian Journal of Cancer. 57(2): 123-128. PMID: 32445314

    18. Patil VM, Noronha V, Joshi A, Talreja V, Dhumal S, Menon N, Abhyankar A, Dsouza H, Singh GK, Bhattacharjee A, Ghosh-Laskar S, Pai P, Chaturvedi P, Nair D, Chaukar D, DCruz A, Shetty P, Moiyadi A, Prabhash K (2020). Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy. Cancer Research, Statistics and Treatment. 3:201-6.

    19. Pathak R, Chitkara G, Kulkarni P, Bhattacharyya GS, Gupta S, Bajpai J (2020). Tale of constant adaptation, revision, and change of cancer therapy during the ongoing COVID crisis: Adapting to cope and win. Indian Journal of Medical and Paediatric Oncology.41:103-9.

    20. Patil V, Noronha V, Chaturvedi P, Talapatra K, Joshi A, Menon N, Pandey D, Prabhash K (2020). COVID-19 and head and neck cancer treatment. Cancer Research, Statisitcs and Treatment. 3(Suppl S1): 15-28.

    21. Patil V, Srikanth A, Noronha V, Joshi A, Dhumal S, Menon N, Prabhash K (2020). The pattern of care in head-and-neck cancer: Comparison between before and during the COVID-19 pandemic. Cancer Research, Statisitcs and Treatment. 3(Suppl S1): 7-12.

    22. Noronha V, Ramaswamy A, Dhekle R, Talreja V, Gota V, Gawit K, Krishnamurthy M, Patil VM, Joshi A, Menon N, Kapoor A, Sekar A, Shah D, Ostwal V, Banavali S, Prabhash K (2020). Initial experience of a geriatric oncology clinic in a tertiary cancer center in India. Cancer Research, Statistics and Treatment. 3: 208-17

    23. Manjali J, Gupta T (2020). Critical appraisal of a clinical research paper: What one needs to know. Cancer Research, Statistics, and Treatment. 3(3): 545-551

    24. Manjali JJ, Gupta T, Ghosh-Laskar S, Jalali R, Sarin R, Agarwal JP. Pilot testing and vernacular translation of a questionnaire for assessment of satisfaction in patients on radiotherapy in India. Indian Journal of Cancer. PMID: 33402589

    25. Mailankody S, Bajpai J, Gupta S (2020). “Petite” p value: A Researchers’ Dream! Readers, Beware of the Pit …. Indian Journal of Critical Care Medicine. 24(Suppl 3):S140–S141. PMID: 32704222

    26. Kothekar A, Narkhede AM (2020). Combined tracheal suctioning and expiratory pause: Novel theory but tricky implementation. Indian Journal of Critical Care Medicine. 24(1): 82. PMID: 32148358

    27. Munnolli SS (2020). Report of the LISACON 2020 - Third National Conference on Reinventing Excellence in Librarianship. Annals of Library and Information Studies. 67: 197-199.

    28. Khadilkar S, Bopana M, Parab P, Gulia S, Chhasatia S, Kothari S, Gogineni S, Taneja T, Perumal P, Jethwa D, Kembhavi Y, Gupta S (2020).A Multicentre observational study on risk factors for breast cancer. The Journal of Obstetrics and Gynecology of India. 70:371–375. PMID: 33041555

    29. Kapoor A, Noronha V, Toshniwal A, Menon S, Joshi A, Patil VM, Menon N, Prakash G, Murthy V, Krishnatry R, Bakshi G, Pal M, Popat P, Sable N, Prabhash K (2020). Exploring the role of systemic therapy in adult adrenocortical carcinoma: A single-center experience. Cancer Research, Statistics and Treatment.3: 192-200.

    30. Jalali R, Goda JS, Patil V (2020). Coronavirus disease 2019 pandemic and its implications on triaging patients with brain tumors for surgery, radiotherapy, and chemotherapy. Cancer Research, Statisitcs and Treatment. 3(Suppl S1): 49-53.

    31. Jain P, Thota RS (2020). The Indian society for study of pain, cancer pain special interest group guidelines on cancer pain management in adults. Indian Journal of Palliative Care 26:157-8. PMID: 32874027

    32. Gupta T, Singh V, Balsubramian A, Menon H, Kurkure P, Kumar S, Jalali R (2020). ISNO position statement on treatment guidance in neuro-oncology during pandemics. Neurology India. 68(4): 769-773. PMID: 32859812

    33. Gunatilake M,Ramchandra SG, Ingle A, Baumans V (2020). An overview on history of laboratory animal science in Asian countries. Journal of Laboratoty Animal Science. 6(2): 14-18.

    34. Bhat V, Chavan P, Biswas S, Gupta S, Khattry N, Thakkar P (2020). Laboratory biosafety issues related to coronavirus disease 2019. Indian Journal of Medical and Paediatric Oncology. 41(4): 450-453.

    35. Bhatia RK, Chopra S, Palkonda VAR, Giri GV, Senapati S, Bilimagga RS, Chadha M, Viswanathan AN, Grover S (2020). Assessing radiation oncology research needs in India: Results of a physician survey. Indian Journal of Cancer. 57:457-62. PMID: 32769296

    36. Gupta T, Chatterjee A (2020). Modern radiation therapy for pituitary adenoma: Review of techniques and outcomes. Neurology India 68, Suppl S1:113-22. PMID: 32611901

    37. Devdas SK, Jain H, Bagal B, Sengar M, Dangi U, Khattry N, Ambre P, Patkar N, Subramaniam PG, Nair R, Menon H (2020). Sequential treatment of arsenic trioxide followed by all trans retinoic acid with anthracyclines has excellent long-term cure in acute promyelocytic leukemia. Indian Journal of Hematology and Blood Transfusion.

    38. Dholam K, Sharma M, Gurav S, Singh GP, Manjrekar N (2020). Dental measures during the COVID-19 pandemic in cancer patients. Cancer Research, Statistics, and Treatment. 3 (3):429-33.

    39. Vaid A, Patil C, Sanghariyat A, Rane R, Visani A, Mukherjee S, Joseph A, Ranjan M, Augustine S, Sooraj K P, Rathore V, Nema S K, Agraj A, Garg G, Sharma A, Sharma M, Pansare K, CM Krishna, Banerjee J, Chandra S (2020) - Emerging advanced technologies developed by IPR for bio medical applications ‑.A review. Neurology India 68: 26-34. PMID: 32129239

    40. Bajpai J, Chandrashekharan A, Banavali SD, Gupta S. Osteosarcoma journey in India: Each step reveals a new horizon!. Indian Journal of Medical and Paediatric Oncology. 41:4-6

    41. Thorat RA, Ingle AD (2020). Tackling the Covid-19 Pandemic in Animal Facilities: ACTREC Perspectives. Agricultural Reviews.

    42. Thorat R, Ingle A. Breeding performance with special reference to pre-weaning mortality of C57BL/6 and B6D2F1 hybrid strain of mice maintained at ACTREC Animal Facility. Journal of Laboratoty Animal Science. 6(2): 19-23.

    43. Shah S, Verma T, Rashid M, Gadewal N, Gupta S (2020) - Histone H2A isoforms: Potential implications in epigenome plasticity and diseases in eukaryotes. Journal of Biosciences.

  • 2019
    1. Abraham G, Menon N, Patil VM, Joshi A, Prabhash K (2019). The efficacy of low-dose immunotherapy in head-and-neck cancer. Cancer Research, Statistics and Treatment. 2: 268-9.

    2. Ahmed A, Thota RS, Bhatnagar S, Jain P, Ramanjulu R, Salins N, Chatterjee A, Bhattacharya D (2019) - The Indian society for study of pain, cancer pain special interest group guidelines on complementary therapies for cancer pain. Indian Journal of Pain. 33: Suppl S1:37-41.

    3. Ahmed A, Thota RS, Chatterjee A, Jain P, Ramanjulu R, Bhatnagar S, Salins N, Bhattacharya D (2019) - The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on interventional management for cancer pain. Indian Journal of Pain. 33: Suppl S1: 42-8.Awatagiri K, Gadgil D, Kannan S, Rane P, Bandekar B, Sawant N, Parikh P, Murthy V (2019) - Effect of a Planned Training Session on Good Clinical Practice Knowledge in Research Professionals: A Pilot Study. Perspectives in Clinical Research. 10(1): 20-25. PMID: 30834203


    4. Bajpai J, Chiplunkar SV (2019) - Checkmate with checkpoint inhibitors: Hope and hype. Indian Journal of Medical and Paediatric Oncology. 40: 159-62.

    5. Bhat V, Vira HJ, Shetty P, Gupta S (2019) – Myroides odoratus central nervous infection in a postneurosurgery patient. Indian Journal of Medical and Paediatric Oncology. 40: 291-3,

    6. Desai BS, Dixit AS, Gota VS (2019) - Central Institutional Ethics Committee needed to facilitate timely review of multicenter clinical trials. Journal of Postgraduate Medicine. 65(2): 107-109. PMID: 30924443

    7. Bose A, Dalal SN (2019) - 14-3-3 proteins mediate the localization of Centrin2 to centrosome. Journal of Biosciences. 44: 42. PMID: 31180055

    8. Chatterjee A, Thota RS, Ramanjulu R, Ahmed A, Bhattacharya D, Salins N, Jain P, Bhatnagar S (2019) - The Indian Society for Study of Pain, Cancer Pain Special Interest Group (SIG) guidelines, for the diagnosis and assessment of cancer pain. Indian Journal of Pain. 33: Suppl S1: 1-10.

    9. Chavan PD, Bhat V, Poladia PP, Tiwari MR, Naresh C (2019). Reduction in sample rejections at the preanalytical phase - Impact of training in a tertiary care oncology center. Journal of Laboratory Physicians. 11(3): 229-233.

    10. Chaudhari S, Mittra I (2019) - Cell-free chromatin: A newly described mediator of systemic inflammation. Journal of Biosciences. 44: 32. PMID: 31180045

    11. D'mello C, Srivastava S, Tiwari R, Chaudhari P, Sawant S, Vaidya MM (2019) - Multifaceted role of keratins in epithelial cell differentiation and transformation. Journal of Biosciences. 44: 33, PMID: 31180046

    12. Dholam KP, Singh GP, Gurav SV, Shinde AA (2019) - An alternate method of fabrication of an obturator in a patient diagnosed with melanotic neuroectodermal tumor of infancy. Indian Journal of Medical and Paediatric Oncology. 40: Suppl S1: 148-51.

    13. Jain H, Thorat J, Sengar M, Dubey A (2019) - Ponatinib: A drug review. Cancer Research, Statistics and Treatment. 2(2): 190-6.

    14. Khanna D, Khargekar N, Budukh A. (2019) – Knowledge, attitude, and practice about cervical cancer and its screening among community healthcare workers of Varanasi district, Uttar Pradesh, India. Journal of Family Medicine and Primary Care. 8:1715-9. PMID: 31198742

    15. Mahajan A, Vaidya T, Gupta A, Rane S, Gupta S (2019) - Artificial intelligence in healthcare in developing nations: The beginning of a transformative journey. Cancer Research, Statistics and Treatment. 2(2): 182-9.

    16. Mathur R, Singhavi HR, Malik A, Nair S, Chaturvedi P (2019). Role of poor oral hygiene in causation of oral Cancer-a Review of Literature. Indian Journal of Surgical Oncology. 10(1): 184-195. PMID: 30948897.

    17. Parmar V, Nair S, Thakkar P, Chitkara G( 2019) - Molecular biology in the Breast Clinics—Current status and future perspectives. Indian Journal of Surgical Oncology.

    18. Patil VM, Noronha V, Joshi A, Abhyankar A, Menon N, Banavali S, Gupta S, Prabhash K( 2019) - Low doses in immunotherapy: Are they effective? Cancer Research, Statistics and Treatment. 2(1): 54-60.

    19. Phadke PR, Mhatre SS, Budukh AM, Dikshit RP (2019) - Trends in gallbladder cancer incidence in the high- and low-risk regions of India. Indian Journal of Medical and Paediatric Oncology. 40: 90-3.

    20. Pujar SM, Munnolli SS, Mundgod MB (2019) - Sharing economy and libraries: a challenge or an opportunity. Annals of Library and Information Studies. 66: 46-48.

    21. Ramanjulu R, Thota RS, Ahmed A, Jain P, Salins N, Bhatnagar S, Chatterjee A, Bhattacharya D (2019) - The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part I). Indian Journal of Pain. 33: Suppl S1:11-17.

    22. Ramanjulu R, Thota RS, Ahmed A, Jain P, Bhatnagar S, Salins N, Chatterjee A, Bhattacharya D (2019). The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part III). Indian Journal of Pain. 33: Suppl S1:30-36.

    23. Salins N, Thota RS, Bhatnagar S, Ramanjulu R, Ahmed A, Jain P, Chatterjee A, Bhattacharya D (2019) - The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on palliative care aspects in cancer pain management. Indian Journal of Pain 33: Suppl S1: 49-53.

    24. Sengar M, Fundytus A, Hopman WM, Malhotra H, Gupta S, Pramesh C S, Hammad N, Sullivan R, Vanderpuye V, Seruga B, Lopes G, Brundage MD, Booth CM (2019) - Medical oncology in India: Workload, infrastructure, and delivery of care. Indian Journal of Medical and Paediatric Oncology. 40: 121-7,

    25. Shaikh S, Moiyadi A (2019) - Intraventricular tumors - A mixed bag. Cancer Research Statistics and Treatment. 2(2): 245-6.

    26. Swamidas J, Rose J, Chopra S, Paul SN, Joshi K, Panda S, Ph R, Agarwal JP (2019) - . Implementation of a visual feedback system for motion management during radiation therapy. Journal of Cancer Research and Therapeutics.

    27. Talreja VT, Noronha V, Patil VM, Joshi A, Prabhash K (2019). Desperate times, desperate measures: Low-dose nivolumab-induced remission in relapsed NSCLC. Cancer Research, Statistics and Treatment. 2: 266-7.

    28. Thota RS, Ramanjulu R, Ahmed A, Jain P, Salins N, Bhatnagar S, Chatterjee A, Bhattacharya D (2019). The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part II). Indian Journal of Pain. 33: Suppl S1:18-29.

    29. Velayutham P, Cherian VT, Rajshekhar V, Babu KS (2019) - The effects of propofol and isoflurane on intraoperative motor evoked potentials during spinal cord tumour removal surgery - A prospective randomised trial. Indian Journal of Anaesthesia. 63(2): 92-9. PMID: 30814745

    30. Verma A, Epari S, Bakiratharajan D, Sahay A, Goel N, Chinnaswamy G, Shetty P, Moiyadi A, Goel A, Gupta T, Jalali R (2019) - Primary pineal tumors - Unraveling histological challenges and certain clinical myths. Neurology India. 67(2): 491-502. PMID: 31085866

    31. Verma A, Menon S, Rekhi B, Pai T, Maheshwari A, Ghosh J, Gupta S, Deodhar K (2019) - Utility of YWHAE fluorescent in-situ hybridisation in mesenchymal tumors of uterus- An initial experience from tertiary oncology centre in India. Indian Journal of Cancer. 56(4): 335-340, PMID: 31607703

    32. Vira HJ, D'Souza H, Bhat V, Bonda A (2019) - Strongyloides stercoralis hyperinfection complicated by secondary infections in a case of transformed diffuse large B-cell lymphoma. Indian Journal of Medical and Paediatric Oncology.40: 144-6.

  • 2018
    1. Arora I, Gurav M, Rumde R, Dhanavade S, Kadam V, Kurani H, Shetty O, Goda JS, Shetty P, Moiyadi A, Gupta T, Jalali R, Epari S (2018). MGMT gene promoter methylation and its correlation with clinicopathological parameters in glioblastomas. Neurology India. 66(4): 1106-1114. PMID: 30038102

    2. Bibi A, Java S, Chaudhary S, Joshi S, Mascerhenas R, Rabade N, Tembhare P, Subramanian PG, Gujral S, Menon H, Khattry N, Sengar M, Bagal B, Jain H, Patkar N (2018). BRAFV600E mutation in hairy cell leukemia: A single-center experience. Indian Journal of Pathology Microbiology. 61: 532-6, PMID: 30303143

    3. Chakrabarti S, Ghosh S, Qayyumi BN, Malik A, Nair D, Nair S, Chaturvedi P, Agrawal J P (2018). Besides and beyond histopathology; for adjuvant treatment in early tongue cancer. Indian Journal of Medical and Paediatric Oncology.39: 355-62.

    4. Chopra S, Gupta M, Mathew A, Mahantshetty U, Engineer R, Lavanya G, Gupta S, Ghosh J, Thakur M, Deodhar K, Menon S, Rekhi B, Bajpai J, Gulia S, Maheshwari A, Kerkar R, Shylasree TS, Shrivastava SK (2018). Locally advanced cervical cancer: A study of 5-year outcomes. Indian Journal of Cancer. 55(1): 45-49. PMID: 30177092

    5. Dalal SN (2018). The quality of students in PhD programmes. Current Science. 115(7):1231-1232.

    6. Doshi KH, Shriyan B, Nookala MK, Kannan S, Joshi A, Noronha V, Gota V, Prabhash K (2018). Prognostic significance of pretreatment sodium levels in patients of nonsmall cell lung cancer treated with pemetrexed-platinum doublet chemotherapy. Journal of Cancer Research and Therapeutics. 14(5): 1049-1053. PMID: 30197346

    7. Gupta A, Gokarn A, Rajamanickam D, Punatar S, Thippeswamy R, Mathew L, Bagal B, Kannan S, Khattry N (2018). Lomustine, cytarabine, cyclophosphamide, etoposide – An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors. Journal of Cancer Research and Therapeutics. 14(5): 926-933. PMID: 30197327

    8. Gupta S, Chatterjee S, Nigade J, Aggarwal S, Singhal M, Alurkar SS, Kukreja A, BK Smruti, Nag S, Agarwal A, Agarwal V, RT Chacko, Desai C, Goswami C, Keechilat P, Patil P, Prasad K, Rajendranath R, Rao RR, Sahoo TP, Ashish S, Singh R, Srinivasan S, Warrier A, Binay S, Bhattacharya P, Advani SH (2018). Current treatment options for human epidermal growth factor receptor 2-directed therapy in metastatic breast cancer: An Indian perspective. Indian Journal of Medical and Paediatric Oncology. 39: 368-79.

    9. Ingle AD (2018). Animal models for cancer research and treatment. J Lab Animal Sci. 5(1): 18-21.

    10. Khattry N, Laskar S, Sengar M, Rangarajan V, Shet T, Subramanian P G, Epari S, Bagal B, Goda JS, Agarwal A, Jain H, Tembhare P, Patkar N, Khanna N, Punatar S, Gokarn A, Shetty D, Jain H, Bonda A, Gota V, Hasan S, Kode J, Dutt S, Kulkarni S, Shetty N, Sable N, Deodhar J, Jadhav S, Pawaskar P, Mathew l, Menon H, Nair R, Kannan S, Chiplunkar SV, Gujral S (2018). Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit. Indian Journal of Cancer. 55:9-15. PMID: 30177087

    11. Malik A, Mishra A, Garg A, Shetty R, Mair M, Chakrabarti S, Nair D, Balasubramaniam G, Chaturvedi P (2018). Trends of oral cancer with regard to age, gender, and subsite over 16 years at a tertiary cancer center in India. Indian Journal of Medical and Paediatric Oncology. 39: 297-300.

    12. Mohanty SK, Chopra S, Mudaliar A, Kannan S, Mahantshetty U, Engineer R, Ghosh J, Bajpai J, Gupta S, Shrivastava S (2018). A comparative analysis of quality of life after postoperative intensity-modulated radiotherapy or three-dimensional conformal radiotherapy for cervical cancer. Indian Journal of Cancer. 55(4): 327-335. PMID: 30829265

    13. Moiyadi AV, Sridhar E, Shetty P, Madhugiri VS, Solanki S( 2018). What you see and what you don't - Utility and pitfalls during fluorescence guided resections of gliomas using 5-aminolevulinic acid. Neurol ogy India. 66(4): 1087-1093. PMID: 30038099

    14. Parab A, Kambli J, Hake S, Joshi N (2018). Evaluation of housekeeping genes for studies in breast cancer cell lines treated with progesterone. Biomed Research Journal. 5(1): 6–21.Parmar V (2018). Rising incidence of breast cancer in young fertile Indian population- A reality check. Indian Journal of Surgical Oncology. 9(3): 296-299.

    15. Rabade N, Subramanian PG, Kodgule R, Raval G, Joshi S, Chaudhary S, Mascarenhas R, Tembhare P, Gujral S, Patkar N (2018). Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India. Indian Journal of Pathology Microbiology. 61(2): 209-213. PMID: 29676359

    16. Thiagarajan S, Fathehi K, Nair D, Deshmukh A, Pantvaidya G, Chaukar DA, D'Cruz AK (2018). Surgical morbidities and outcomes of major salivary gland neoplasms treated at a tertiary cancer center. Indian Journal of Cancer. 55(1): 33-36. PMID: 30147090

    17. Vijaysekharan K, Punatar S, Bonda A, Mohite A, Shanmugam K, Nayak L, Gokarn A, Khattry N. (2018)Leflunomide: Is it the game changer in musculoskeletal chronic graft versus host disease? Indian Journal of Hematology Blood Transfusion. 34(3): 566-567.PMID: 30127579

  • 2017
    1. Agarwala V, Choudhary N, Gupta S (2017). A risk-benefit assessment approach to selection of adjuvant chemotherapy in elderly patients with early breast cancer: A mini review. Indian Journal of Medical and Paediatric Oncology. 38(4): 526-534. PMID: 29333024

    2. Ambulkar R, Patil V, Doctor JR, Desai M, Shetty N, Agarwal V. Accuracy of ultrasound imaging versus manual palpation for locating the intervertebral level. Journal of Anaesthesiology Clinical Pharmacology. 33(3): 348-352, 2017. PMID: 29109634

    3. Bakshi SG, Divatia JV, Kannan S, Myatra SN. Work-related stress: A survey of Indian anesthesiologists. Journal of Anaesthesiology Clinical Pharmacology. 33(1): 86-91, 2017. PMID: 28413278

    4. Chatterjee M, Murthy V, Nikam S, Kannan S, Gupta T, Ghosh-Laskar S, Agarwal JP (2017). Effect of progressive resistive exercise training (PRET) on shoulder joint abduction range of motion, pain and disability in post-operative oral cancer patients undergoing radiation therapy: A randomized controlled trial. Indian J Physiotherapy and Occupational Therapy-An International Journal. 11(1): 57-63.

    5. Chaudhari PR (2017). Preclinical PET, SPECT, CT, MRI and optical imaging in cancer research: An overview. Biomedical Research Journal. 4(2):162–188.

    6. Chavan P, Bhat V, Karmore A, Mohite R, Waykar S, Kadu H (2017). Establishing syva methotrexate assay on siemens dimension RxL analyzer: Experience in a tertiary cancer care laboratory. Journal of Laboratory Physicians. 9: 67-8. PMID: 28042223

    7. Chatterjee G, Gujaral S, Subramanian PG, Tembhare PR (2017). Clinical relevance of multicolour flow cytometry in plasma cell disorders. Indian Journal of Hematology and Blood Transfusion. 33(3): 303-15. PMID:28824230

    8. Ghodke KA, Patkar NV, Subramanian PG, Gujral S, Kadam PA, Tembhare PR (2017). Biclonal chronic lymphocytic leukemia: A study of two cases and review of literature. Indian Journal of Pathology and Microbiology. 60(1): 84-86. PMID: 28195098

    9. Ghodke K, Tembhare P, Patkar N, Subramanian PG, Arora B, Gujral S (2017). A rare extramedullary and extralymphoid presentation of mixed phenotypic blastic hematolymphoid neoplasm: A study of two cases. Indian Journal of Medical and Paediatric Oncology. 38(3): 394-397. PMID: 29200701

    10. Gupta A, Punatar S, Gawande J, Mathew L, Kannan S, Khattry N (2017). Analysis of factors affecting initial cyclosporine level and its impact on post-transplant outcomes in acute leukemia. Journal of Cancer Research and Therapeutics. 13(6): 981-988. PMID: 29237963

    11. Gupta T, Sarkar C, Rajshekhar V, Chatterjee S, Shirsat NV, Muzumdar D, Pungavkar S, Chinnaswamy G, Jalali R (2017). Indian Society of Neuro-Oncology consensus guidelines for the contemporary management of medulloblastoma. Neurology India. 65(2): 315-322. PMID: 28290395

    12. Jaiswal D, Ghalme A, Yadav P, Shankhdhar V, Deshpande A (2017). Free anteromedial thigh perforator flap: Complementing and completing the anterolateral thigh flap Indian Journal of Plastic Surgery. 50(1): 16-20. PMID: 28615805

    13. Kode J, Khattry N, Bakshi A, Amrutkar V, Bagal B, Karandikar R, Rane P, Fuji N, Chiplunkar SV. (2017). Study of stem cell homing & self-renewal marker gene profile of ex vivo expanded human CD34+ cells manipulated with a mixture of cytokines & stromal cell-derived factor 1. Indian Journal of Medical Research. 146(1): 56-70. PMID: 29168461

    14. Kothekar AT, Patil V, Konar N, Divatia J (2017). Fatal postoperative hemolysis due to severe falciparum malaria. Indian Journal of Critical Care Medicine. 21: 391-3. PMID: 28701845

    15. Kulkarni SS, Shetty NS, Polnaya AM, Janu A, Kumar S, Puri A, Gulia A, Rangarajan V (2017). CT-guided radiofrequency ablation in osteoid osteoma: Result from a tertiary cancer centre in India. Indian Journal of Radiology and Imaging. 27(3): 318-323. PMID: 29089682

    16. Maheshwari A, Gupta S (2017). Controversies in gynaecologic oncology. Indian Journal of Gynecologic Oncology. 15(Suppl 1): S1-S2.

    17. Moiyadi AV, Jalali R (2017). Outcome assessment in gliomas – The way forward. Neurology India. 65: 1302-3. PMID: 29133705

    18. Nair J, Muley P, Dutt S (2017). Therapy induced senescence and its implications in cancer. Biomedical Research Journal. 4(1): 28-48.

    19. Pai T, Epari S, Desai S, Wadile A, Gupta T, Goda JS, Moiyadi AV, Shetty P, Kane S, Jalali R (2017). Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion. Neurology India. 65(1): 113-120. PMID: 28084254

    20. Pai T, Harwani SR, Patil A, Sahay A, Shet T, Parmar V, Wadasadawala T, Desai SB (2017). Pilomatrix carcinoma masquerading as breast carcinoma. Indian Journal of Medical Paediatric Oncology. 38(3): 367-370, PMID: 29200693

    21. Patkar N, Rabade N, Kadam PA, Mishra F, Muranjan A, Tembhare P, Chaudhary S, Joshi S, Jain H, Dangi U, Bagal B, Khattry N, Menon H, Gujral S, Sengar M, Subramanian PG (2017). Immunogenetics of chronic lymphocytic leukemia. Indian Journal of Pathology and Microbiology. 60(1): 38-42. PMID: 28195089

    22. Ranade KJ, Nerurkar AV, Phulpagar MD, Shirsat NV, Shinde SS (2017). Evaluation of Satb1, Survivin, and Ki-67 as possible markers to differentiate phyllodes tumour from fibroadenoma. Indian J Mednodent and Allied Sciences. 5(1): 30-37.

    23. Sahu A, CM Krishna (2017). Optical diagnostics in oral cancer: An update on Raman spectroscopic applications. Journal of Cancer Research Therapeutics. 13: 908-15. PMID: 29237951

    24. Thorat R, Ingle A (2017). Cryopreservation of mouse embryo using vitrification method. Journal of Laboratory Animal Science. 4(2): 7-12.Wadasadawala T, Kannan S, Gudi S, Rishi A, Budrukkar A, Parmar V, Shet T, Desai S, Gupta S, Badwe R, Sarin R. Predicting loco-regional recurrence risk in T1, T2 breast cancer with 1-3 positive axillary nodes postmastectomy: Development of a predictive nomogram. Indian Journal of Cancer. 54(1): 352-357. PMID: 29199721

  • 2016
    1. Ambulkar RP, Agarwal V, Ranganathan P, Divatia JV. Awareness during general anesthesia: An Indian viewpoint. J Anaesthesiol Clin Pharmacol.32 (4): 453-457, 2016. PMID: 28096574

    2. Bagal B, Ramadwar M, Khattry N. Ascites as a manifestation of GVHD: A rare phenomenon. Ind J Hematol Blood Transfus. 32(suppl. 1): 189-191, 2016. PMID: 27408388

    3. Bansal A, Das P, Kannan S, Mahantshetty U, Mulherkar R. Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India. Indian J Med Res. 144(3): 359-365, 2016. PMID: 28139534

    4. Bhat V, Gupta S, Kelkar R, Biswas S, Khattry N, Moiyadi AV, Bhat P, Ambulkar R, Chavan P, Chiplunkar SV, Kotekar A, Gupta T. Bacteriological profile and antibiotic susceptibility patterns of clinical isolates in a tertiary care cancer center. Indian J Med Paediatr Oncol. 37: 20-24, 2016. PMID: 27051152

    5. Chavan P, Bhat V, Tiwari M, Gavhane U, Pal SK. Comparison of complete blood count parameters between venous and capillary blood in oncology patients. J Lab Physicians 8: 65-6, 2016. PMID: 27013818

    6. Chital NK, Bhat VG, Chavan PD, Bhat PC. The road to laboratory accreditation: Experience of a tertiary care oncology center. Indian J Cancer. 53(1): 204-5, 2016. PMID: 27146780

    7. Dandekar M, Trivedi R, Irawati N, Prabhash K, Gupta S, Agarwal JP, D’Cruz AK. Barriers in conducting clinical trials in oncology in the developing world: A cross-sectional survey of oncologists. Indian J Cancer 53: 174-7, 2016. PMID: 27146772

    8. Ghosh-Laskar S, Baijal G, Rangrajan V, Purandare N, Sengar M, Shah S, Gupta T, Budrukkar A, Murthy V, Pai PS, D’Cruz A, Agarwal JP. Fluorodeoxyglucose-positron emission tomography in carcinoma nasopharynx: Can we predict outcomes and tailor therapy based on postradiotherapy fluorodeoxyglucose-positron emission tomography?. Indian J Med Paediatr Oncol. 37: 47-52, 2016. PMID: 27051158

    9. Ghosh-Laskar S, Agarwal JP, Yathiraj PH, Tanawade P, Panday R, Gupta T, Budrukkar A, Murthy V. Brain metastasis from nonnasopharyngeal head and neck squamous cell carcinoma: A case series and review of literature. J Can Res Ther. 12: 1160-3, 2016. PMID: 28054528

    10. Goda JS, Pachpor T, Basu T, Chopra S, Gota V. Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers. Indian J Med Res. 143(2): 145-59, 2016. PMID: 27121513

    11. Gupta T, Epari S, Moiyadi AV. Prognostic factors in ependymal tumors: Molecular biology trumps histopathology. Neurol India. 64(2): 287-288, 2016. PMID: 26954808

    12. Joshi A, Zanwar S, Shetty N, Patil V, Noronha V, Bakshi G, Prakash G, Menon S, Prabhash K. Epidemiology of male seminomatous and nonseminomatous germ cell tumors and response to first‑line chemotherapy from a tertiary cancer center in India. Indian J Cancer. 53: 313-316, 2016. PMID: 28071636

    13. Kadam R, Teni T. Clusterin in Cancer: Dual role as a tumor suppressor gene and an oncogene. Biomed Res J. 3(2): 130-156, 2016.

    14. Mahalakshmi H, Venkatraman P. Quanternary structure of proteins by DLS and allied light scattering techniques. Spinco Biotech Cutting Edge. PP. 9-13, January 2016.

    15. Mhatre SS, Nagrani RT, Budukh A, Chiplunkar SV, Badwe R, Patil P, Laversanne M, Rajaraman P, Bray F, Dikshit R. Place of birth and risk of gallbladder cancer in India. Indian J Cancer. 53(2): 304-308, 2016. PMID: 28071634 "

    16. Murthy V, Kumar DP, Budrukkar A, Gupta T, Ghosh-Laskar S, Agarwal J. Twice-weekly palliative radiotherapy for locally very advanced head and neck cancers. Indian J Cancer. 53(1): 138-41, 2016. PMID: 27146764

    17. Murthy V, Swain M, Teni T, Pawar S, Kalkar P, Patil A,Chande A, Ghonge S,Laskar SG, Gupta T, Budrukkar A, Agrawal J. Human papillomavirus/p16 positive head and neck cancer in India: Prevalence, clinical impact, and influence of tobacco use. Indian J Cancer. 53: 387-93, 2016. PMID: 28244466

    18. Pai T, Shetty O, Patil A, Shet T, Desai S B. Coamplification with colocalization of the human epidermal growth factor receptor 2 and centromeric-17 signals on fluorescence in situ hybridization in invasive breast carcinoma: An exceedingly rare finding. J Postgrad Med. 62: 210-1, 2016. PMID: 27424555

    19. Punatar S, Gupta A, Gawande J, Bagal B, Mathew L, Kannan S, Khattry N. Chronic graft versus host disease in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplant: Analysis of risk factors, pattern and long term outcome. Indian J Hematol Blood Transfus. 32(1): 32-38, 2016. PMID: 26855504

    20. Shelly D, Epari S, Arora I, Pai T, Ahmed S, Moiyadi AV, Chinnaswamy G, Gupta T, Goda J, Shetty P, Kane SV, Desai SB, Jalali R. Epidermal growth factor receptor (EGFR) gene amplification in high-grade gliomas: Western Indian tertiary cancer center experience. Neurol India. 64(1): 115-20, 2016. PMID: 26755002

    21. Singh A, Parmar V. Micrometastases in axillary nodes: Out of the reckoning? South Asian J Cancer. 5(2): 66-69, 2016. PMID: 27275451

    22. Subramanian S, Pandey U, Chaudhari P, Tyagi M, Gupta S , Singh G, Dash A, Samuel G, Venkatesh M. Preliminary evaluation of indigenous 90Y-labelled microspheres for therapy of hepatocellular carcinoma. Ind J Med Res. 143(Suppl.) 74-81, 2016. PMID: 27748281

    23. Thondykandy BA, Swamidas JV, Agarwal JP, Gupta T, Laskar SG, Mahantshetty U, Iyer SS, Mukherjee IU, Shrivastava SK, Deshpande DD. Reply to the comments on “Setup error analysis in helical tomotherapy based image-guided radiation therapy treatments” by Slav Yartsev. J Med Phys. 41(1): 72, 2016. PMID: 27051175

    24. Thota RS, Doctor JR. Evaluation of paranasal sinuses on available computed tomography in head and neck cancer patients: An assessment tool for nasotracheal intubation. Indian J Anaesth 60: 960-1, 2016. PMID: 28003701


    25. Thota RS, Purohit R, Solanki SL. In response to unanticipated cannot intubate situation due to difficult mouth opening. J Anaesthesiol Clin Pharmacol. 32(1): 125, 2016. PMID: 27006564

    26. Thota RS. Conversion of a single lumen tube to double lumen tube in an anticipated difficult airway: Flexible fiberoptic bronchoscope assisted with intubating introducer-guided technique. Ann Card Anaesth. 19(1): 149-51, 2016. PMID: 26750689

    27. Thota RS. Myatra SN. Difficult bag mask ventilation: Catheter mount cap, a cause for concern. Indian J Anaesth. 60(6): 444-5, 2016. PMID: 27330216

    28. Venkatraman P. Assembly and Beyond–The Structure and Functions of Chaperones of the Proteasome. Biomed Res J, 2016.

    29. Vishal SS, Dalal SN. Transgenesis: Embryo modification to sperm mediated gene transfer. Ind J Biotech. 15(4): 459-466, 2016.

  • 2023
    1. Agrawal T, Epari S, Prakash G, Menon S (2023). Splenic surprise in a case of renal cell carcinoma: Unusual case or association? Journal of Postgraduate Medicine. PMID: 36891941

    2. Ambulkar R, Baskar V, Patkar S, Kunte A, Agarwal V, Solanki S, Divatia J (2023). Evaluation of perioperative routine coagulation testing versus thromboelastography for major liver resection – A single‑arm, prospective, interventional trial (PORTAL trial). Indian Journal of Anaesthesia.67:1077-83.

    3. Ambulkar R, Gholap S, Salunkhe B, Bakshi S (2023). Audit of pain management after colorectal surgeries in a tertiary care cancer hospital. Indian Journal of Surgical Oncology.

    4. Ambulkar R, Parab S, Vignesh B, Nagargoje V, Janu A, Parikh P, Moiyadi A.(2023) A prospective study to evaluate the use of surveillance venous ultrasonography to detect incidence of deep venous thrombosis following neurosurgical excision of brain tumors. Journal of Neurosciences in Rural Practice.14(2):252-257. PMID: 37181162

    5. Budukh A, Bagal S, Thakur JS, Khanna D, Sancheti S, Banavali S (2023). Pediatric cancer burden in different regions of India: Analysis of published data from 33 population-based Cancer Registries. Indian Pediatrics. 60(7):541-545. PMID: 37078481

    6. Budukh AM, Thakur JS, Dora TK, Kadam PR, Bagal SS, Patel KK, Goel AK, Sancheti SM, Gulia AR, Chaturvedi PP, Dikshit RP, Badwe RA (2023). Overall survival of prostate cancer from Sangrur and Mansa cancer registries of Punjab state, India. Indian Journal of Urology.39: 148-55. PMID: 37304993

    7. Chavan P, Bhat V, Joshi A, Gupta T, Murthy V, Noronha V, Rathish D, Prabhash K (2023). Salivary IgA as a surrogate biomarker for microbial infections in postoperative patients receiving chemo-radio-therapy for head and neck cancer. Journal of Laboratory Physicians. 15(2):264-268. PMID: 37323610

    8. Das S, Bagal B, Jain H, Kashyap L, Anbarsan S, Sharma A, Bondili S, Nayak L, Thorat J, Mirgh S, Gokarn A, Punatar S, Sahay A, Epari S, Tembhare P, Shetty P, Khanna N, Goda J, Moiyadi A, Gupta T, Sengar M, Khattry N, Menon H (2023).Demographic, pattern of care and outcomes of primary CNS lymphoma-experience from a tertiary care cancer center in India. Indian Journal of Hematology and Blood Transfusion. 39(1):57-70. PMID: 36699441

    9. Dash B, Shylasree TS, Rekhi B, Gulia S, Ghosh J, Maheshwari A, Patil A, Sable N, Gupta S (2023).Clinical observations and outcomes in advanced low-grade serous carcinoma of the ovary: Case series from a tertiary cancer center. Indian Journal of Surgical Oncology.

    10. Diyora B, Devani K, Epari S, Deshpande G, Puradare A, Wankhede R (2023). Mature teratoma with somatic type malignancy: An entity of unacquaintance— A Case Report. Asian Journal of Neurosurgery. 18(2):366-371. PMID: 37397059

    11. D'Silva SZ, Bodade A, Kadam S, Tambe M, Dhanda S, Bagal B, Sengar M, Jain H, Nayak L, Bonda A, Punatar S, Gokarn A, Khattry N, Singh M. Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian Cohort. Indian Journal of Hematology and Blood Transfusion. 39(1):50-56. PMID: 36699439

    12. Harankhedkar S, Patkat N(2023). Molecular MRD assessment in acute myeloid leukemias. Indian Journal of Medical and Paediatric Oncology.

    13. Jain H, Shetty D (2023). Role of cytogenetics and fluorescence In situ hybridization in the laboratory workup of acute myeloid leukemias. Indian Journal of Medical and Paediatric Oncology. 44(06): 543-553.

    14. Joshi S, Kothari B, Jaiswal D, Wadasadawala T, Badwe R (2023). Approach toward oncoplastic breast surgery: Local (Flap) solutions for Indian problems. Indian Journal of Surgical Oncology.

    15. Joshi S, Murali-Nanavati S, Shylasree TS, Hawaldar R, Tripathi S, Sahay A, Noronha J, Jain U, Thomas A, Kowtal P, Vanmali V, Nair N, Parmar V, Badwe RA, Sarin R (2023). Synchronous and Metachronous breast and ovarian vancers: Experience from a single tertiary care cancer centre in India. Indian Journal of Surgical Oncology. 14(4):809-821. PMID: 38187845

    16. Kamtalwar S, Mirgh S, More A, Gokarn A, Dhumal S, Sharma P, Lall S, Patkar N, Shetty N, Chatterjee G, Rajpal S, Bhat V, Khattry N, Gupta S (2023). Triple trouble: Disseminated Penicilliosis in a cancer patient with COVID-19. Indian Journal of Medical and Paediatric Oncology. 44(04): 445-448.

    17. Kothari B, Parab P, Gulia S, Rath S, Gupta S (2023). Ribociclib-induced delayed dermatological reaction: Case report of a rare adverse effect and review of literature. Indian Journal of Medical and Paediatric Oncology.

    18. Kothekar AT, Mohanty R, Joshi AV. Goal-directed Fluid Therapy in Neurosurgery: Three Feet from Gold? Indian Journal of Critical Care Medicine. 27(10):697-698. PMID: 37908432

    19. Krishnatry R, Mani S, Manjali JJ, Rane PP, Chatterjee A, Goda JS, Janu A, Sahu A, Gupta T, Jalali R (2023). Institutional patterns of care of diffuse intrinsic pontine glioma. Neurology India. 71(1):72-78. PMID: 36861577

    20. Kumar S, Gota V (2023). Logistic regression in cancer research: A narrative review of the concept, analysis, and interpretation. Cancer Research, Statistics, and Treatment 6(4): 573-578

    21. Majithia J, Mahajan A, Vaish R, Prakash G, Patwardhan S, Sarin R (2023). Imaging recommendations for diagnosis, staging, and management of hereditary malignancies. Indian Journal of Medical and Paediatric Oncology.

    22. Mohite A, Choudhury S, Purandare N, Agrawal T, Shet T, Agrawal A, Shah S, Puranik A, Rangarajan V (2023). Adenopathy in multiple myeloma: An enigma unravelled by FDG PET. Indian Journal of Hematology and Blood Transfusion. 39(3):515-517. PMID: 37304474

    23. Multani K, Jain K, Velayutham P, Shetty P, Singh V, Moiyadi A (2023). Awake mapping of supplementary motor area networks for maximal safe resection of left superior frontal gyrus low-grade glioma. Neurology India. 71(6): 1150-1154.

    24. Nayak P, Sinha S, Goda JS, Sahu A, Joshi K, Choudhry O Roy, Mhatre R, Mummudi N, Agarwal JP (2023). Computerized tomography-based first order tumor texture features in non-small cell lung carcinoma treated with concurrent chemoradiation: A simplistic and potential surrogate imaging marker for survival. Journal of Cancer Research and Therapeutics. 19(2): 366-375.PMID: 37313912

    25. Oak A, Sivaranjini K, Pathak R, Dikshit R (2023). Human papillomavirus self-sampling for cervical cancer screening: Review on the acceptance, accuracy, feasibility and incorporation in the National Screening Programme of India. Current Medicine Research and Practice. 13(2): 74-80.

    26. Ojha S, Patle V, Nagaraju P, Khattry N (2023). Blood components utilization in hematopoietic stem cell transplantation: Thirteen-year analysis from an apex oncology center of India. Asian Journal of Transfusion Science. 17(2):221-228. PMID: 38274961

    27. Pahwa V, Pimple S, Bhattacharjee A, Kuberkar D, Mishra G, Chaturvedi P (2023). Behavioural interventions for tobacco cessation in India: A systematic review and meta-analysis. Journal of Family Medicine and Primary Care. 12(11): 2542-2551.

    28. Patil S, Ambulkar R, Kulkarni A. (2023) Patient safety in intensive care unit: What can we do better? Indian Journal of Critical Care Medicine. 27(3): 163-165. PMID: 36960106

    29. Poladia P, Chavan P, Mohite R, Gavhane U, Pillai BGS, Gosavi U, Pal SK. Is it time to switch over to heparin plasma for biochemistry analysis over time tested serum samples? International Journal of Scientific Research. 12 (3): 62-65.

    30. Punatar S, Murugaiyan V, Kumnbhalwar K, Gokarn A, Chichra A, Mirgh S, Nayak L, Bonda A, Jindal N, Shirure V, Bagal B, Mathew L, Kannan S, Saikia T, Khattry N (2023). Comparison of outcomes of donor lymphocyte infusions with or without lenalidomide in patients with hematological malignancies post allogeneic HSCT. Indian Journal of Hematology and Blood Transfusion. 39(1):40-49. PMID: 36699432

    31. Rajput N. Mapping cancer in India: Implementing GIS for cancer research and registries. Indian Journal of Cancer. 60(3): 293-294. PMID: 37787187

    32. Ramalingam N, Chidambaranathan N., Thiagarajan S, Singh A, Chaukar D, Chaturvedi P (2023). Impact of Changes in Treatment Paradigms on Survival in Oral Squamous Carcinoma—a Population-Level Study. Indian Journal of Surgical Oncology.

    33. Ramaswamy A, Shah D, Bhargava P, Srinivas S, Kannan S, Shah M, Suman M, Das S, Trikha M, Ostwal V. Modified FOLFIRINOX compared to Gemcitabine & nab-Paclitaxel in advanced pancreatic ductal adenocarcinoma - results of a match-pair analysis. Indian Journal of Medical Research. 157(1):57-65. PMID: 37040228.

    34. Rao S, Epari S, Shet TM, Gujral S, Jain H, Bagal B, Senagar M, Shetty P, Moiyadi A, Goda JS, Gupta T (2023). Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes. Indian Journal of Pathology Microbiology. 66(3):549-555. PMID: 37530337

    35. Sabu TM, Noronha V, Rao A, Kumar A, Gattani S, Ramaswamy A, Pillai A, Dhekale R, Castelino R, Kumar S, Sehgal A, Rana P, Gota V, Badwe R, Prabhash K (2023). Uptake of vaccination in older Indian patients with cancer: A cross-sectional observational study. Cancer Research, Statistics, and Treatment 6(1): 52-61.

    36. Sahay A, Epari S, Chinnaswamy G, Chatterjee A, Goda JS, Patil V, Moyiadi A, Shetty P, Singh V, Sahu A, Choudhary A, Janu A, Gupta T (2023). Primary intracranial germ cell tumors: A study with an integrated clinicopathological approach. Neurology India. 71(3): 500-508. PMID: 37322747

    37. Sancheti S, Goel AK, Singla A, Chauhan KS, Arora K, Chaudhary D, Dora T, Tahlan S, Kadam P, Joshi P, Sali A, Brar RS, Budukh A, Gulia A, Divatia JV, Badwe R. Deciphering the Patterns of Dual Primary Cases Registered at the Hospital-Based Cancer Registry: First Experience from Rural Cancer Center in North India. Journal of Laboratory Physicians. 15(4):524-532. PMID: 37780887

    38. Sehgal A, Noronha V, Ramaswamy A, Kumar A, Pillai A, Rao A, Kumar S, Gattani S, Castelino R, Dhekale R, Mahajan S, Daptardar A, Ansari N, Vagal M, Sonkusare L, Mahajan P, Jagtap P, Tripathi V, Satamkar S, Nookala M, Gota V, Banavali S, Badwe R, Prabhash K (2023). Pattern of analgesic prescriptions and pain-related outcomes in older patients with cancer: A retrospective observational study. Cancer Research, Statistics, and Treatment 6(4): 541-548.

    39. Sengar M, Jain H, D'Souza S, Kannan S, Mokal S, Gurjar M, Ambotkar M, Sharma N, Boppanna , Gota V (2023). Exposure-responser relationship of posaconazole suspension in theprophylaxis of invasive Fungal Infections in patients with acute myeloid leukemia. Indian Journal of Hematology and Blood Transfusion.39 (2):200-207. PMID: 37006974

    40. Sivaranjini K, Oak A, Cheulkar S, Maheshwari A, Mahantshetty U, Dikshit R (2023). Role of education and income on disparities of time-to-treatment initiation and its impact on cervical cancer survival. Indian Journal of Public Health. 67(2):235-239. PMID: 37459018.

    41. Srinivasan S, Dhamne C, Moulik NR, Chichra A, Tembhare P, Patkar N, Subramanian PG, Shetty D, Narula G, Banavali S(2023). Treatment of pediatric acute promyelocytic leukemia with retinoic acid and arsenic trioxide along with chemotherapy. Indian J Pediatr. PMID: 37380920.

    42. Tembhare P (2023). Monitoring measurable/minimal residual disease in acute myeloid leukemia: Multiparametric flow cytometry-based approach. Indian Journal of Medical and Paediatric Oncology. 44(06): 554-565.

    43. Thota R, Seshadri R, Singh S, Damani A, Wajekar A, Koyyalagunta L (2023). A systematic review and quality analysis of cancer pain guidelines. Indian Journal of Anaesthesia 67(12): 1051-1060.

    44. Yadav N, Mirgh SP, Aggarwal M, Agrawal N, Mehta P, Khushoo V, Kapoor J, Bhatia N, Agrawal P, Ahmed R, Bhurani D (2023). Second stem cell transplantation for treatment of relapsed/refractory multiple myeloma after first autologous stem cell transplant: A 15-year retrospective institutional analysis. Indian Journal of Cancer. 60(3):316-324.PMID: 37787191.


    45.  
  • 2024
    1. Ambulkar R, Gholap S, Salunkhe B, Bakshi S (2024). Audit of pain management after colorectal surgeries in a tertiary care cancer hospital. Indian Journal of Surgical Oncology. 15(1):78-81. PMID: 38511048

    2. Bhattacharya PK, Chakrabarti A, Sinha S, Pande R, Gupta S, Kumar AA, Mishra VK, Kumar S, Bhosale S, Reddy PK (2024). ISCCM position statement on the management of invasive fungal infections in the intensive care unit. Indian Journal of Critical Care Medicine. 28(Suppl 2):S20-S41.

    3. Budukh A, Pradhan S, Singh VB, Khanna D, Bagal SS, Chakravarti PS, Sharma AN, Vishwakarma RK, Shinde SS, Khargekar NC, Chaturvedi P, Dikshit RP, Shukla VK, Badwe R (2024). Cancer pattern in Varanasi district from Uttar Pradesh state of India, a foundation for cancer control based on the first report of the population-based cancer registry. Indian Journal of Cancer. 61(2):383-389. PMID: 36861723

    4. Boppana M, Sengar M, Jain H, Gurjar M, Ambotkar M, Gota V, Bonda A, Bagal B, Thorat J, Gokarn A, Nayak L, Shetty N, Baheti A, Mokal S, Kannan S, Shetty A, Eipe T (2024). A prospective study to evaluate the effect of therapeutic drug monitoring-based posaconazole prophylaxis on invasive fungal infection rate during acute myeloid leukemia induction therapy. Indian Journal of Hematology and Blood Transfusion. 40(2): 204-212. PMID: 38708158

    5. Chugh S, Panda G, Mokal S, Jain H, Bagal B, Khanna N, Epari S, Punatar S, Nayak L, Gokarn A, Khattry N, Sengar M, Laskar S, Goda JS. (2024) Long-term clinical outcomes of combined modality therapy for advanced-stage Hodgkin lymphoma in the PET era: A retrospective study. Indian Journal of Medical Research. 159(2):193-205. PMID: 38577858

    6. Gayakwad S, Budrukkar A, Murthy V, Laskar SG, Upreti RR, Upreti U, Gupta T, Agarwal JP (2024). Volumetric and geometric changes in the parotid glands and target volume during image-guided radiotherapy for locally advanced oropharyngeal cancers. Journal of Cancer Research and Therapeutics. PMID: 38261432.

    7. George K, Chopra S, Rajamanickam K, Joshi K, Swamidas J, Shetty N, Engineer R (2024). Evaluation of liver segmental dose threshold for hepatocyte regeneration following liver stereotactic body radiation therapy. Indian Journal of Medical Research. PMID: 38442296.

    8. Joshi S, Chougle Q, Noronha J, Hawaldar R, Nair N, Vanmali V, Parmar V, Thakkar P, Chitkara G, Shet T, Badwe R(2024). Determinants of pathological complete response to neoadjuvant chemotherapy in breast cancer: A single institution experience. Indian Journal of Cancer.;61(2):324-331. PMID: 36861728

    9. Juneja D, Nasa P, Chanchalani G, Cherian A, Jagiasi BG, Javeri Y, Kola VR, Kothekar AT, Kumar P, Maharaj M, Munjal M, Nandakumar SM, Nikalje A, Nongthombam R, Ray S, Sinha MK, Sodhi K, Myatra SN (2024). The Indian Society of critical care medicine position statement on the management of sepsis in resource-limited settings. Indian Journal of Critical Care Medicine. 28(Suppl 2): S4-S19.

    10. Joshi S, Kothari B, Jaiswal D, Wadasadawala T, Badwe R (2024). Approach toward oncoplastic breast surgery: Local (Flap) solutions for Indian problems. Indian Journal of Surgical Oncology .15(1):95-102. PMID: 38511031

    11. Karbhari A, Vijan A, Janu AK, Gulia A, Kulkarni S, Shetty N, Gala K, Panjwani P (2024). Retrospective study of multimodality imaging features of chondroblastoma. Indian Journal of Orthopaedics. 58(9):1303-1309.

    12. Krishna R, Jadhav M, Sivasubramanian R, Sunkara G, Gota V, Niranjan V, Dhote V, Sapkal N, Rege NN, Sethi S, Medhi B, Kshirsagar N, Parmar D (2024). Advancing pediatric drug development in South Asia: Current landscape and vision for the future. Indian Journal of Pharmacology. 56(4): 285-289.

    13. Malik A, Sharin F, Balaji A, Mathur Y, Nair S, Chaturvedi P, Nair D (2024). Swallowing in advanced oral cancers: A prospective observational study. Journal of Cancer Research and Therapeutics. 20(1): 340-348. PMID: 38554344

    14. Manjali J, Keluskar Geyata, Patel Ruchi, Bano N, Shaikh F, Malhotra R, Mani S, Kumar A, Sinha S, Krishnamurthy R, Dasgupta A, Chatterjee A, Tibdewal A, Pathak R, Mummudi N, Wadasadwala T, Laskar S, Sarin R, Agarwal JP, Gupta T (2024). Validation testing of OUTPATSAT-35RT questionnaire to assess satisfaction in patients on outpatient radiotherapy in a large Indian cohort. Journal of Cancer Research and Therapeutics.

    15. Nair S, Sahu A, Prasad A, George A, Goel A, Gupta T. (2024) Unusual extra-axial and extracranial recurrence in an IDH mutant astrocytoma: A case report. Indian Journal of Radiology and Imaging. 34(2): 351-355. PMID: 38549893

    16. Puranik AD, Choudhury S, Ghosh S, Dev ID, Ramchandani V, Uppal A, Bhosale V, Palsapure A, Rungta R, Pandey R, Khatri S, George G, Satamwar Y, Maske R, Agrawal A, Shah S, Purandare NC, Rangarajan V. Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer. Indian Journal of Cancer. 61(Suppl 1): S1-S28. PMID: 38424680.

    17. Puranik AD, Dev ID, Rangarajan V, Kulkarni S, Shetty N, Gala K, Sahu A, Bhattacharya K, Dasgupta A, Chatterjee A, Gupta T, Sridhar E, Sahay A, Shetty P, Singh V, Moiyadi A, Menon N, Purandare NC, Agrawal A, Shah S, Choudhury S, Ghosh S, Jha AK (2024). PRRT with Lu-177 DOTATATE in treatment-refractory progressive meningioma: Initial experience from a tertiary-care Neuro-Oncology Center. Neurology India. 72(2):278-284.PMID: 38691470

    18. Rastogi S, Bhattacharya K, Mathur A, Sahu AA, Chaudhari A, Shridhar E. Atypical Meningioma with Perineural Spread Along Hypoglossal Nerve. Indian J Radiol Imaging. 28;34(3):566-568. PMID: 38912230

    19. Rekhi B, Dave V, Butle A, Dharavath B, Khetale S, Redhu A, Singh R, Dutt A (2024). Immunohistochemical expression of H3.3 G34W in 100 giant cell tumors of bone and its diagnostic mimics, including its value in resolving uncommon diagnostic scenarios: A single institutional study at a tertiary cancer referral center, India. Indian Journal of Pathology & Microbiology. PMID: 38391356

    20. Saklani A, Kazi M, Desouza A, Sharma A, Engineer R, Krishnatry R, Gudi S, Ostwal V, Ramaswamy A, Dhanwat A, Bhargava P, Mehta S, Sundaram S, Kale A, Goel M, Patkar S, Vartey G, Kulkarni S, Baheti A, Ankathi S, Haria P, Katdare A, Choudhari A, Ramadwar M, Menon M, Patil P. Tata Memorial Centre Evidence Based Management of Colorectal cancer. Indian Journal of Cancer. 61(Suppl 1): S29-S51. PMID: 38424681.

    21. Sarma R, Kashyap L, Srikanth A, Mondal T, Kashyap Y, Nandhana R, Bondili SK, Bonda A, Nayak L, Chatterjee G, Jain H, Patkar N, Tembhare P, Subramanian P, Gujral S, Sengar M, Menon H, Nair R, Bagal B (2024). Real world outcomes with treatment free remission in chronic myeloid leukemia-Experience from a tertiary care cancer centre. Indian Journal of Hematology and Blood Transfusion.

    22. Shakthi Devan R K, Ingle A, Ramachandra SG, Hegde N, Ramesh S, Nagarajan P, Muthukumar SP, Buragohain R, Singh V, Tamhankar C (2024). Advancements of 3Rs in biomedical research, laboratory animal science and welfare: International perspectives. Journal of Laboratory Animal Science. 7(2): 74-96.

    23. Siju J, Sahu A, Bhattacharya K, Prasad M, Sarin R, Gupta T. Demystifying the mystery of genes: A case report on constitutional mismatch repair deficiency. Indian J Radiol Imaging. 34(3):562-565. PMID: 38912246

    24. Singhavi HR, Chaturvedi P, Nair D. The human papillomavirus enigma: A narrative review of global variations in oropharyngeal cancer epidemiology and prognosis. Indian Journal of Public Health. 68(2):268-275. PMID: 38953816.

    25. Sree Ganesh B, Kazi M, Goel M, Saklani A, De Souza A, Devarmani S, Gala K, Shetty N, Kulkarni S, Ramaswamy A, Ostwal V, Bhargava P, Patkar S. Feasibility of Hepatic Artery Infusion Chemotherapy for Colorectal Liver Metastasis in an Indian Setting. Indian Journal of Surgical Oncology. 15(Suppl 2):275-280. PMID: 38817996

    26. Srinivasan S, Dhamne C, Moulik NR, Chichra A, Tembhare P, Patkar N, Subramanian PG, Shetty D, Narula G, Banavali S (2024). Treatment of pediatric acute promyelocytic leukemia with retinoic acid and arsenic trioxide along with chemotherapy. Indian Journal Pediatrics. 91(6):564-570. PMID: 37380920.

    27. Thomas A, Rane SU, Menon S. (2024) TFE3 rearranged epithelioid hemangioendothelioma of the lymph node: A rare primary presentation of vascular tumor. Indian Journal of Pathology and Microbiology. PMID: 38563707.

    28. Thorat J, Sengar M, Chanana R, Kapoor A, Singh A, Bonda A, Menon H, Bagal B, Laskar S, Khanna N, Goda JS, Epari S, Gujral S, Agarwal A, Sawant S, Daddi A, Shet T, Ghandade N, Jain H (2023). A Retrospective cohort study to evaluate the outcomes of HIV-associated high-grade B-Cell Non-Hodgkin Lymphoma (NHL) treated with dose adjusted EPOCH (+/−R) regimen. Indian Journal of Haematology and Blood Transfusion. 40(1):36-42.

    29. Vasundhara P, Nagaraju P (2024). Impact of balanced lifestyles on childhood development: A study at crèche.Journal of Addiction Therapy and Research. 8:1-8.

    30. Wadasadawala T, Joshi S, Rath S, Popat P, Sahay A, Gulia S, Bhargava P, Krishnamurthy R, Hoysal D, Shah J, Engineer M, Bajpai J, Kothari B, Pathak R, Jaiswal D, Desai S, Shet T, Patil A, Pai T, Haria P, Katdare A, Chauhan S, Siddique S, Vanmali V, Hawaldar R, Gupta S, Sarin R, Badwe R. Tata Memorial Centre Evidence Based Management of Breast cancer. Indian Journal of Cancer. 61(Suppl 1): S52-S79. PMID: 38424682.

  • 2015
    1. Barreto SG, Barreto M, Chaubal R, Dutt A. The fight against cancer: Is it worthwhile? Ind J Med Paediatr Oncol. 36(2): 85-86, 2015. PMID: 26157283

    2. Bhagat M, Kembhavi S, Qureshi SS. Fibrolamellar hepatocellular carcinoma with extensive vascular thrombosis. J Cancer Res Ther. 11(2): 493-4,2015. PMID: 26148628.

    3. Chaudhari P. Laboratory animal PET/SPECT-CT imaging for biomedical research. J Lab Animal Sci. 3(1): 21-24, 2015.

    4. Chavan P, Bhat V,Gosavi U, Pillai B. Cyclosporine drug levels: Comparison of the architect 1000i with the siemens dimension RXL system. J Lab Physicians. 7(2):137, 2015.PMID: 26417169

    5. Chopra S, Agarwal A, Engineer R, Dora T, Thomas B, Sonawone S, Paul SN, Kannan S, Patil P, Mehta S, Shrivastava SK. Intensity modulated radiation therapy (IMRT) is not superior to three-dimensional conformal radiation (3DCRT) for adjuvant gastric radiation: A matched pair analysis. J Cancer Res Ther.11(3): 623-629, 2015. PMID: 26458592

    6. Das P, Thomas A, Kannan S, Deodhar A, Shirvastava SK, Mahantshetty U, Mulherkar R. Human papillomavirus(HPV) genome status and cervical cancer outcome- A retrospective study. Ind J Med Res. 142: 525-532, 2015. PMID: 26658585

    7. Dash S, Sunkara RR, Waghmare SS. Developmental signalling in maintence and regulation of cancer stem cells. Biomed Res J. 2(1): 37-56, 2015.

    8. Dutta S, De A. Cancer gene therapy: Prospects of using human sodium iodide symporter gene in non-thyroidal cancer. Biomed Res J. 2(2): 198-219, 2015.

    9. Gota V, Divatia JV. Off‑label use of drugs: An evil or a necessity? Ind J Anaesth. 59: 767-68, 2015. PMID: 26903667

    10. Govekar R. Identification of Therapeutic Targets for Cancer: Proteomic Technologies and Strategies are the Key to Success. Biomed Res J. 2(2): 166-178, 2015.

    11. Gulia S, Gota V, Kumar SD, Gupta S. Acute renal failure secondary to ingestion of alternative medication in a patient with breast cancer. J Cancer Res Ther. 11(4): 1006-1008, 2015. PMID: 26881570

    12. Gupta A, Punatar S, Gawande J, Mathew L, Kannan S, Khattry N. Analysis of factors affecting initial cyclosporine level and its impact on post transplant outcomes in acute leukemia. J Cancer Res Ther. 2015.11(4): 1006-1008, 2015. PMID:26881570

    13. Ingle AD. CPCSEA inspections: Can it be done AAALAC way? J Lab Animal Sci. 3(1): 31-34, 2015.

    14. Jain H, Sengar M, Nair R, Menon H, Laskar S, Shet T, Gujral S, Sridhar E. Treatment results in advanced stage Hodgkin's lymphoma: A retrospective study. J Postgrad Med. 61(2): 88-91, 2015. PMID: 25766339

    15. Jamema SV, Kirisits C. Reply to the comment of S. VanDyk and K. Narayan on the editorial “IMRT, IGRT and other high technology become standard in external beam radiotherapy: But is image‑guided brachytherapy for cervical cancer too expensive?” J Med Phys .40: 1‑4, 2015.

    16. Kembhavi SA, Shah S, Rangarajan V, Qureshi S, Popat P, Kurkure P. Imaging in neuroblastoma: An update. Indian J Radiol Imaging. 25(2) : 129-36, 2015. PMID: 25969636

    17. Mittra I, Khare NK, Raghuram GV, Chaubal R, Khambatti F, Gupta D, Gaikwad A, Prasannan P, Singh A, Iyer A, Singh A, Upadhyay P, Nair NK, Mishra PK, Dutt A. Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes. J Biosci. 40(1): 91-111, 2015. PMID: 25740145

    18. Moiyadi A, Sridhar E. Intraoperative fluorescence reveals diffuse subpial spread in glioblastoma. Neurol India. 63(6): 960-963, 2015. PMID: 26588633

    19. Moiyadi AV, Kannan S, Shetty P. Navigated intraoperative ultrasound for resection of gliomas: Predictive value, influence on resection and survival. Neurol India. 63: 727-735, 2015. PMID: 26448233

    20. Rekhi B, Chinnaswamy G, Vora T, Shah S, Rangarajan V. Primary Ewing sarcoma of vulva, confirmed with molecular cytogenetic analysis: A rare case report with diagnostic and treatment implications. Indian J Pathol Microbiol. 2015. 58(3): 341-4, 2015. PMID: 26275259.

    21. S Rubina, CM krishna. Raman spectroscopy in cervical cancer: An update. J Cancer Res Ther. 11(1): 10-17, 2015. PMID: 25879329

    22. Sethi B, Pai T, Allam A, Epari S.Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumor with sarcomatous morphology and distant metastases: An unusual histomorphology and behavior. Indian J Pathol Microbiol. 58(4): 509-12, 2015. PMID: 26549078

    23. Shinde AD, Ingle AD. Detection of Pseudonomas aeruginosa infection from the water bottles immune-compromised mice by conventioanl and PCR based microbiology. J Lab Animal Sci. 3(1): 1-4, 2015.

    24. Solanki SL, Thota RS, Patil VP. Malpositioning of right internal jugular central venous catheter into right external jugular vein forming "figure of eight". Ann Card Anaesth. 18(3): 414-5, 2015. PMID: 26139750

    25. Thatte U, Chiplunkar S, Bhalerao S, Kulkarni A, Ghungralkar R, Panchal F, Vetale S, Teli P, Kumbhar D, Munshi R. Immunological & metabolic responses to a therapeutic course of Basti in obesity. Indian J Med Res. 142(1) :53-62 ,2015. PMID: 26261167

    26. Thondykandy BA, Swamidas JV, Agarwal J, Gupta T, Laskar SG, Mahantshetty U, Iyer SS, Mukherjee IU, Shrivastava SK, Deshpande DD. Setup error analysis in helical tomotherapy based image-guided radiation therapy treatments. J Med Phys. 40: 233-239, 2015. PMID: 26865780

    27. Thota RS, Divatia JV. WhatsApp: What an App! Indian J Crit Care Med. 19(6): 363-5, 2015. PMID: 26195867

    28. Vora T, Thacker N. Impacts of a biobank: Bridging the gap in translational cancer medicine. Indian J Med Paediatr Oncol. 36(1):17-23, 2015. PMID: 25810570

  • 2014
    1. Agrawal A, Kembhavi S, Purandare N, Shah S, Rangarajan V. Report of two cases of fluorodeoxyglucose positron emission tomography/computed tomography appearance of hibernoma: A rare benign tumor. Indian J Nucl Med. 29(1): 40-2, 2014. PMID: 24591783

    2. Bakshi SG, Jain PN, Kannan S. An assessment of basic pain knowledge and impact of pain education on Indian Anaesthesiologists - a pre and post questionnaire study. Indian J Anaesth 58:127-31, 2014. PMID: 24963174

    3. Sirohi B, Gupta S, Raghunadharao D, Shrikhande SV.Clinical trials in India: At uncertain crossroads? Indian J Med Paediatr Oncol. 35(2):133-5, 2014. PMID: 25197173

    4. Rath S, Nathani A, Patel D, Kulkarni P, Gota V. Status of technology transfer in India – The much needed magic remedy. Curr Sci. 106(8): 1058-1060, 2014.

    5. Raghuram GV, Mishra PK. Stress induced premature senescence : A new culprit in ovarian tumorigenesis? Indian J Med Res. 140(suppl): 120-129, 2014. PMID: 25673532

    6. Sarin R. Big Data V4 for integrating patient reported outcomes and quality-of-life indices in clinical practice. J Cancer Res Ther.10(3):453-455, 2014. PMID: 25313720

    7. Murthy V, Krishnatry R, Mallik S, Master Z, Mahantshetty U, Shrivastava S: Helical tomotherapy-based hypofractionated radiotherapy for prostate cancer: a report on the procedure, dosimetry and preliminary clinical outcome. J. Cancer Res. Ther 253-260, 2014. PMID: 23771369

    8. Mukherjee A, Sarma HD, Saxena S, Kumar Y, Chaudhari P, Goda JS, Adurkar P, Dash A, Samuel G.Bioevaluation of (125) I Ocu-Prosta seeds for application in prostate cancer brachytherapy. Indian J Med Res. 139(4): 555-60, 2014.

    9. Kinhikar RA, Pawar AB, Mahantshetty U, Murthy V, Dheshpande DD, Shrivastava SK.Rapid Arc, helical tomotherapy, sliding window intensity modulated radiotherapy and three dimensional conformal radiation for localized prostate cancer: A dosimetric comparison.J Cancer Res Ther. 10(3):575-582, 2014. PMID: 25313742

    10. Krishnatry R, Gupta T, Murthy V, Ghosh-Laskar S, Budrukkar A, Chaturvedi P, Nair S, Nair D, Kumar P, Joshi A, Agarwal JP.Factors predicting 'time to distant metastasis' in radically treated head and neck cancer. Indian J Cancer.51(3):231-235, 2014. PMID: 25494111

    11. Gota VS, Patial P.Toward better quality of anticancer generics in India. Indian J Cancer 51(3):366-368, 2014. PMID: 25494140

    12. Gupta A, Khattry N. Current status of hematopoietic stem cell transplant in chronic myeloid leukemia. Indian J Med Paediatr Oncol. 35(3): 207-10, 2014. PMID: 25336791

    13. Epari S, Bhatkar R, Moyaidi A, Shetty P, Gupta T, Kane S, Jalali R. Histomorphological spectrum and immunohistochemical characterization of hemangioblastomas: An entity of unclear histogenesis. Indian J Pathol Microbiol. 57(4):542-548, 2014. PMID: 25308004

    14. Chopra S, Mathew AS, Engineer R, Shrivastava SK.Positioning high-dose radiation in multidisciplinary management of unresectable cholangiocarcinomas: Review of current evidence.Indian J Gastroenterol. 33(5): 401-407, 2014. PMID: 25135161

    15. Bhargava A, Pathak N, Varshney S, Shrivastava M, Mishra PK. Molecular detection of window phase hepatitis C virus infection in voluntary blood donors and health care workers in A Cohort from central India. Indian J Community Med. 39(1): 51-52, 2014. PMID: 24696542

    16. Upadhyay P, Dwivedi R, Dutt A. Applications of next-generation sequencing in cancer. Curr Sci. 107(5): 795-802, 2014.

    17. Shome D, Kalita D, Jain V, Sarin R, Maru GB, Bellare JR. Carboplatin loaded polymethylmethacrylate nano-particles in an adjunctive role in retinoblastoma: An animal trial. Indian J Ophthalmol. 62:585-9, 2014. PMID: 24881606

    18. Raina S, Chande AG, Baba M, Mukhopadhyaya R. A reporter based single step assay for evaluation of inhibitors targeting HIV-1 Rev–RRE interaction. Indian J Virol 25: 101-106, 2014. PMID: 24426316

    19. Maru GB - An update on cancer prevention approaches. Biomed Res J. 1(2): 146-172, 2014.

    20. Kode J, Taur P, Gulia A, Jambhekar N, Agarwal M, Puri A. Pasteurization of bone for tumour eradication prior to reimplantation - An in vitro & pre-clinical efficacy study. Indian J Med Res. 139(4):585-597, 2014. PMID: 24927346

    21. Kotnis A, Mulherkar R.Novel inhibitor of DNA ligase IV with a promising cancer therapeutic potential. J Biosci. 39(3): 339-340, 2014. PMID: 24845497

    22. Joshi NN. Single nucleotide polymorphisms in human health and disease: Towards resolution of a conundrum. Biomed Res J. 1(1): 56-70, 2014.

    23. Ingle AD, Shinde A. Microbiological assessment of laboratory rodents: Perspectives from laboratory animal facility of ACTREC. J Lab Anim Sci. 2(1): 1-9, 2014.

    24. Chavan CA, Kaore MP, Ingle AD, Kurkure NV, Akhare SB, Bhandarkar AG. Immunohistochemical study of a rare case of bovine ameloblastoma. Ind J Vet Pathol. 38 (4): 275-277, 2014.

    25. Chaudhury S, Maheshwari A, Ray P. Ovarian cancer: An ever challenging malady. Biomed Res J. 1(1): 34-55, 2014.

  • 2013
    1. Basu T, Ghosh-Laskar S, Gupta T, Budrukkar A, Murthy V, Agarwal JP.Phytochemicals: The future of radiation induced mucositis prevention. J Cancer Res Ther. 9(4): 761-762, 2013.

    2. Choughule A, Noronha V, Joshi A, Desai S, Jambhekar N, Utture S, Thavamanni A, Prabhash K, Dutt A. Epidermal growth factor receptor mutation subtypes and geographical distribution among Indian non-small cell lung cancer patients. Indian J Cancer. 50(2):107-11,2013. PMID: 23979200

    3. Gaidhani SN, Singh A, Kumari S, Lavekar GS, Juvekar AS, Sen S, Padhi MM. Evaluation of some plant extracts for standardization and anticancer activity. Indian J tradit knowl. 12(4): 682-687, 2013

    4. Gogoi D, Chiplunkar SV. Targeting gamma delta T cells for cancer immunotherapy: Bench to bedside. Indian J Med Res. 138: 755-761, 2013. PMID: 24434328

    5. Joshi A, Patil VM, Noronha V, Juvekar S, Deshmukh A, Chatturvedi P, Chaukar DA, Agarwal JP, Ghosh S, Murthy V, D'cruz A, Prabhash K. Is there a role of induction chemotherapy followed by resection in T4b oral cavity cancers? Indian J Cancer. 50(4):349-55, 2013. PMID:24369216

    6. Kembhavi SA, Choudhary H, Deodhar K, Thakur MH. Reactive intramammary lymph node mimicking recurrence on MRI study in a patient with prior breast conservation therapy. J Cancer Res Ther.9(1): 111-113, 2013. PMID: 23575088

    7. Mahantshetty U, Shankar S, Engineer R, Chopra S, Gupta S, Maheshwari A, Kerkar R, Shrivastava SK.Image- guided intensity-modulated whole abdominal radiation therapy in relapsed epithelial ovarian cancers: A feasibility study. J Cancer Res Ther. 9(1): 17-21, 2013. 23575068

    8. Moiyadi AV,Shetty P, Biswas S. Fulminant post-craniotomy wound infection and meningitis with pneumocephalus caused by acinetobacter baumannii: An unusual presentation. J Neurosci Rural Pract. 4(Supp1): S136-S137, 2013. PMID: 24174785

    9. Munnolli SS, Pujar SM. Eugene to altmetrics: A chase for virtual footprints! Annals of Library and Information Studies. 60: 134-139, 2013.

    10. Murthy V, Krishnatry R, Mallick S, Master Z, Mahantshetty U, Shrivastava S. Helical tomotherapy-based hypofractionated radiotherapy for prostate cancer: A report on the procedure, dosimetry and preliminary clinical outcome. J Cancer Res Ther. 9(2): 253-260, 2013. PMID: 23771369

    11. Nirmala Shanoj,Banerjee G, Shinkar VP, Chiplunkar SV.Gamma delta T cell stimulatory activity of tea and Indian herb extracts.Int J of Tea Sci. 9 (2/3): 26-35, 2013.

    12. Pandey R, Mehrotra D, Mahdi AA, Sarin R, Kowtal P, Maurya SS, Parmar D.Association between mitochondrial C-tract alteration and tobacco exposure in oral precancer cases.Natl J Maxillofac Surg. 4(2):219-24, 2013. PMID: 24665180

    13. Pramesh CS, Shastri S, Mittra I, Badwe RA. Ethics of “standard care” in randomised trials of screening for cervical cancer should not ignore scientific evidence and ground realities.Indian J Med Ethics. X(4): 250, 2013. PMID: 24152348

    14. Ranjan A, Kalraiya RD. α2,6 Sialylation associated with increased β1,6-branched N-oligosaccharides influences cellular adhesion and invasion. J Biosci. 38(10): 1-10, 2013. PMID:24296889

    15. Roy PS, John S, Karankal S, Kannan S, Pawaskar P, Gawande J, Bagal B, Khattry N, Sengar M, Menon H, Gujral S, Nair R. Comparison of the efficacy and safety of Rituximab (Mabthera™) and its biosimilar (Reditux™) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis.Indian J Med Paediatric Oncol. 34(4): 292-298, 2013.

    16. Sarin R. Inheritance of maladies and the gene fairy. J Cancer Res Ther. 9(3): 341-342, 2013. PMID: 24125962

    17. Shivakumar T, Nair SV.Delayed Contralateral Intra-Parotid Nodal Metastasis from an Oral Squamous Cell Carcinoma. J Case Rep 3(2): 317-321, 2013.

    1. Acharekar A, Bachal K, Shirke P, Thorat R, Banerjee A, Gardi N, Majumder A, Dutt S (2023). Substrate stiffness regulates the recurrent glioblastoma cell morphology and aggressiveness. Matrix Biology. 115: 107-127. PMID: 36563706

    2. Anjikar A, Jadhav P, Hole A, Panneerselvam R, Ingle A, Yamamoto T, Noothalapati H, CM Krishna (2023). Removal of hemolysis interference in serum Raman spectroscopy by multivariate curve resolution analysis for accurate classification of oral cancers. Sensors and Diagnostics.

    3. Anand A, Khanna D, Singh P, Singh A, Pandey A, Budukh A, Pradhan S (2023). Evaluation of medical certification of cause of death in tertiary cancer hospitals in northern India. Health Information Management Journal.

    4. Asija S, Chatterjee A, Goda JS, Yadav S, Chekuri G (2023). Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option. Frontiers in Immunology.

    5. Badwe RA, Parmar V, Nair N, Joshi S, Hawaldar R, Pawar S, Kadayaprath G, Borthakur BB, Rao Thammineedi S, Pandya S, Balasubramanian S, Chitale PV, Neve R, Harris C, Srivastava A, Siddique S, Vanmali VJ, Dewade A, Gaikwad V, Gupta S (2023). Effect of peritumoral infiltration of local anesthetic before surgery on survival in early breast cancer. Journal of Clinical Oncology.

    6. Bagal B, Sarma R, Dey S, Nayak L, Bonda A, Goda J, Khanna N, Dasgupta A, Kakoti S, Chatarjee A, Jain H, Epari S, Laskar S, Sengar M, Gupta T (2023). Lenalidomide following whole-brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy. British Journal of Haematology.

    7. Barrios C, de Lima Lopes G, Yusof MM, Rubagumya F, Rutkowski P, Sengar M (2023). Barriers in access to oncology drugs - a global crisis. Nature Reviews Clinical Oncology. 20(1):7-15.

    8. Ballinger ML, Pattnaik S, Mundra PA.... Puri A, Sarin R et al.(2023) Heritable defects in telomere and mitotic function selectively predispose to sarcomas. Science. 379(6629):253-260.

    9. Banerjee A, Halder A, Jadhav P, Sarkar A, Hole A, Shastri J, Agrawal S, CM Krishna, Srivastava S (2022). SARS-CoV-2 severity classification from plasma sample using Confocal Raman spectroscopy. Journal of Raman Spectroscopy.

    10. Baviskar Y, Likonda B, Pant S, Mokal S, Pawar A, Dasgupta A, Chatterjee A, Gupta T (2023). Short-course palliative hypofractionated radiotherapy in patients with poor-prognosis high-grade glioma: Survival and quality of life outcomes from a prospective phase II study. Clinical Oncology.

    11. Budukh A, Kadam P, Singh D, Thakur JS (2023). Innovative field methods for residence confirmation and updating follow-up status of cancer cases: Experience from rural cancer registry, Punjab, India. Clinical Epidemiology and Global Helath.

    12. Barua SA, Choudhary RK, Gawde J, Mishra N, Varma AK (2023). Structural dynamics of clinically-reported VUS in the BARD1 ARD-BRCT region to predict the molecular basis of alterations. Journal of Biomolecular Structure and Dynamics.

    13. Butti R, Kapse P, Bhadauriya G, Ahmad S, Chaubal R, Parab P, Kadam R, Mahapatra SS, Shet T, Dutt A, Gupta S, Kundu GC(2023). Development and characterization of a patient derived orthotopic xenograft of therapy resistant breast cancer. Oncology Reports. 49(5): 99.

    14. Burikhanov R, Ganguly S, Ellingson S, Sviripa VM, Araujo N, Li S, Venkatraman P, Rao M, Choughule A, Brainson CF, Zhan CG, Spielmann HP, Watt DS, Govindan R, Rangnekar VM (2023). Crizotinib induces Par-4 secretion from normal cells and GRP78 expression on the cancer cell surface for selective tumor growth inhibition. American Journal of Cancer Research. 13(3):976-991.

    15. Chatterjee G, Patkar N. United we stand, divided we fall. Multicentre standardization of measurable residual disease assessment in acute leukaemia is the way forward. British Journal of Haematology. PMID: 36282207

    16. Chakraborty N, Jain BK, Shembekar S, Bhattacharyya D (2022). ER exit sites (ERES) and ER-mitochondria encounter structures (ERMES) often localize proximally. FEBS Letters. 77: 103800. PMID: 36103135

    17. Chakravorty G, Ahmad S, Godbole MS, Gupta S, Badwe RA, Dutt A (2023). Deciphering the mechanisms of action of progesterone in breast cancer. Oncotarget. 14: 660-667.

    18. Chavan P, Dey R, Castelino R, Kamble A, Poladia P, Bagal R, Jadhav M, Shirsat A, Chavan A, Dhumal S, Kumar S, Krishnamurty MN, Bhat V, Bhattacharjee A, Gota V (2023). Safety, immunogenecity and effectiveness of ChAdOx1 nCoV-19 vaccine during the second wave of pandemic in India: a real-world study. Drug Metabolism and Personalized Therapy.

    19. Chen Y, Li H, Janowczyk A, Toro P, Corredor G, Whitney J, Lu C, Koyuncu CF, Mokhtari M, Buzzy C, Ganesan S, Feldman MD, Fu P, Corbin H, Harbhajanka A, Gilmore H, Goldstein LJ, Davidson NE, Desai S, Parmar V, Madabhushi A (2023). Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer. NPJ Breast Cancer. 9(1):40

    20. Chikhale V, Goswami N, Khan MA, Borah P, Varma AK (2023). Evaluation of pathogenicity and structural alterations for the mutations identified in the conserved region of the C‑terminal kinase domain of Human-Ribosomal S6 Kinase 1. ACS Omega.

    21. Chopra S, Mulani J, Mittal P, Singh M, Shinde A, Gurram L, Scaria L, Dheera A, Kolhe S, Rane P, Ghadi Y, Rath S, Ghosh J, Gulia S, Gupta S, Kinhikar R, Laskar S, Agarwal J (2023). Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic. Brachytherapy. 22(2): 125–131.PMID: 36585283 – No. 30 Intenational Publications.

    22. Chopra S, Gupta A, Aoyama H, Wu HG, Mahmood H, Tharavichitkul E, Khine A, Gandhi A, Faruque GM, Cruz M, Kodrat H, Xue X, Abeysinghe P, Ho GF, Minjgee M, Tey J, Gao X (2023). Radiation Oncology Research in Asia: Current Status and a Peep Into the Future From the Federation of Asian Organizations for Radiation Oncology. JCO Global Oncology.

    23. Choudhary B, Chaudhary N, Shah M, Dwivedi N, Smitha PK, Das M, Dalal SN (2023). Lipocalin 2 inhibits actin glutathionylation to promote invasion and migration. FEBS Letters.

    24. Das S, Sakhare N, Kumar D, Mathur A, Mirapurkar S, Sheela M, Mohanty B, Chaudhari P, Chakraborty S (2023). Design, characterization and evaluation of a new 99mTc-labeled folate derivative with affinity towards folate receptor. Bioorganic & Medicinal Chemistry Letters. 15: 129240.

    25. Das S, Sakhare N, Kumar D, Mathur A, Mirapurkar S, Sheela M, Mohanty B, Chaudhari P, Chakraborty S (2023). Design, characterization and evaluation of a new 99mTc-labeled folate derivative with affinity towards folate receptor. Bioorganic & Medicinal Chemistry Letters. 86: 129240.

    26. Das L, Shekhar S, Chandrani P, Varma AK.(2021) In silico structural analysis of secretory clusterin to assess pathogenicity of mutations identified in the evolutionarily conserved regions.Journal of Biomolecular Structure & Dynamics.41(2):469-478. PMID: 34821197.

    27. Datta D, Dasgupta A, Chatterjee A, Sahu A, Bhattacharyya K, Meena L, Joshi K, Puranik A, Dev I, Moiyadi A, Shetty P, Singh V, Patil V, Menon N, Epari S, Sahay A, Gupta T (2023). Imaging-based patterns of failure following re-irradiation for recurrent/progressive high-grade glioma †. Journal of Personalized Medicine. 13(4): 685.

    28. Dutta RP, Kumar R, Tembhare PR, Bagal B, Swain RK, Hasan SK (2023). Targeting transcriptional kinase of CDK7 halts proliferation of multiple myeloma cells by modulating the function of canonical NF-kB pathway and cell cycle regulatory proteins. Translational Oncology. 35:101729.

    29. Dharavath B, Butle A, Pal A, Desai S, Upadhyay P, Rane A, Khandelwal R, Manavalan S, Thorat R, Sonawane K, Vaish R, Gera P, Bal M, D'Cruz AK, Nair S, Dutt A (2023). Role of miR-944/MMP10/AXL- axis in lymph node metastasis in tongue cancer. Communications Biology. 6(1):57.

    30. Dhumal S, Patil V, Parekh D, Noronha V, Menon N, Peelay Z, Nawale K, Prabhash K (2023). Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer. Lancet Regional Health – Southeast Asia

    31. Dilli Batcha JS, Raju AP, Matcha S, Raj SEA, Udupa KS, Gota, V, Mallayasamy S (2023). Factors influencing pharmacokinetics of tamoxifen in breast cancer patients: A systematic review of population pharmacokinetic models. Biology. 12:51.

    32. Diyora B, Devani K, Epari S, Deshpande G, Puradare A, Wankhede R (2023). Mature teratoma with somatic type malignancy: An entity of unacquaintance— A Case Report. Asian Journal of Neurosurgery.

    33. Dey P, Gadewal N, De A (2023). Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer. International Journal of Biological Macromolecules.

    34. D'Silva SZ, Tambe M, Pinto AS, Singh M (2022). Identification of the novel HLA-DQA1*01:01:01:11 and -DQA1*01:03:01:13 alleles in individuals from India. HLA. PMID: 36394229.

    35. D'Silva SZ, Tambe M, Pinto AS, Singh M (2023). Identification of the novel allele, HLA-C*06:02:38:02, in a Gujarati individual from India. HLA.101(1):69-70. PMID: 36087312.

    36. D'Silva SZ, Tambe M, Pinto AS, Singh M (2023). The novel HLA-B*52:01:01:23 allele in an individual from Uttar Pradesh, North India. HLA. 101(1):56-57. PMID: 36086925.

    37. Ecker S, Kirisits C, Schmid M, De Leeuw AAC, Seppenwoolde Y, Knoth J, Trnkova P, Heilemann G, Sturdza A, Kirchheiner K, Spampinato S, Serban M, Jürgenliemk-Schulz IM, Chopra S, Nout R, Tanderup K, P¨otter R, Eder-Nesvacil N (2023). Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer. Radiotherapy and Oncology.

    38. Fields E, Chopra S, Ludwig M, Taunk N, Chino J (2023). Pivotal science from the 2022 International Gynecologic Cancer Society Meeting. International Journal of Radiation Oncology, Biology, Physics. 116(3): 473-478.

    39. Gawali P, Saraswat A, Bhide S, Gupta S, Patel K (2023). Human solid tumors and clinical relevance of the enhanced permeation and retention effect: a 'golden gate' for nanomedicine in preclinical studies? Nanomedicine.

    40. Gupta SK, Gohil D, Dutta D, Panigrahi GC, Gupta P, Dalvi K, Khanka T, Yadav S, Kaushal RK, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Tembhare PR, Hasan SK, Sandur SK, Hingorani L, Khattry N, Gota V (2023). Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect. International Immunopharmacology. 121: 110437.

    41. Ghosh Laskar S, Chaukar D, Deshpande M, Chatterjee A, Sinha S, Chakraborty S, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Pai P, Chaturvedi P, Pantvaidya G, Deshmukh A, Nair D, Nair S, Prabhash K, Swain M, Kumar A, Noronha V, Patil V, Joshi A, D'Cruz A (2022). Oral Cavity Adjuvant Therapy (OCAT) -A phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) vs concurrent CT-RT vs accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity. European Journal of Cancer.

    42. Ghosh Laskar S, Sinha S, Gupta M, Karmakar S, Nivedha J M, Kannan S, Budrukkar A, Swain M, Kumar A, Gupta T, Murthy V, Chaukar D, Pai P, Chaturvedi P, Pantvaidya G, Nair D, Nair S, Thiagarajan S, Deshmukh A, Noronha V, Patil V, Joshi A, Prabhash K, Agarwal JP (2023). Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched-pair analysis. Head Neck.

    43. Gholap D, Dikshit R, Chaturvedi P, Chaturvedi A, Majrekar A, Mhatre S (2023). Exclusive use of different types of tobacco products, exposure to second hand tobacco smoke and risk of subtypes of head and neck cancer among Indian males. International Journal of Cancer. 152(3): 374-383.PMID: 36054453

    44. Ghantasala S, Bhat A, Agarwal U, Biswas D, Bhattarai P, Epari S, Moiyadi A, Srivastava S (2023). Deep Proteome investigation of high-grade gliomas reveals heterogeneity driving differential metabolism of 5-Aminolevulinic acid. Neuro-Oncology Advances.

    45. Gupta D, Singh A, Gupta N, Mehra N, Bahuguna P, Aggarwal V, Krishnamurthy MN, Roy PS, Malhotra P, Gupta S, Kumar L, Kataki A, Prinja S(2023). Cost-effectiveness of the first line treatment options For metastatic renal cell carcinoma in India. JCO Global Oncology.

    46. Gupta T, Maheshwari G, Joshi K, Sawant P, Mishra A, Khairnar S, Patel P, Sinha S, Swain M, Budrukkar A, Ghosh-Laskar S, Agarwal JP (2022). Image-guidance triggered adaptive radiation therapy in head and neck squamous cell carcinoma: single-institution experience and implications for clinical practice. Journal of Medical Imaging and Radiation Sciences.

    47. Gokarn A, Shenoy R, Punatar S, Mirgh S, Chichra A, Nayak L, Bonda A, Jindal N, Saroha M, Toshniwal A, Prayag P, Tripathi R, Kumar S, Bhat V, Biswas S, Khattry N (2023). Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants. Bone Marrow Transplantation. 58(2):209-211 PMID: 36310244.

    48. Gandhi VV, Gandhi KA, Goda JS, Kumbhare LB, Gota V, Kunwar A (2023). Post-radiation treatment of 3,3'-diselenodipropionic acid augments cell kill by modulating DNA repair and cell migration pathways in A549 cells. IUBMB Life.

    49. Harkenrider M, Fields E, Chopra S, Damast S, Kidd E, Chino J (2023). Recent key Studies in cancers of the uterine corpus and cervix: New updates in immunotherapy, the microbiome, bone density, quantifying lymphovascular invasion, and hypofractionated pelvic radiation therapy. International Journal of Radiation Oncology Biology Physics. 115(2): 269-275.

    50. Handley KF, Mehta S, Martin AL, Biswas S, Maharaj K, Nagy MZ, Mine JA, Cortina C, Yu X, Sprenger K, Mandal G, Innamarato P, Powers JJ, Harro CM, Chaurio RA, Anadon CM, Shahzad MM, Flores I, Conejo-Garcia JR (2023) . Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma. Gynecologic Oncology. 173: 114-121.

    51. Hande V, Chopra S, Polo A, Mittal P, Kohle S, Ghadi Y, Mulani J, Gupta A, Kinhikar R, Agarwal JP (2023). Transitioning India to advanced image based adaptive brachytherapy: a national impact analysis of upgrading National Cancer Grid cervix cancer guidelines. Lancet Regional Health - Southeast Asia.

    52. Jadhav P, Pansare K, Hole A, Ingle A, Govekar R, CM Krisha (2022). Serum Raman Spectroscopy in experimental carcinogenesis hamster buccal pouch model: exploring early diagnostic capability. Journal of Raman Spectroscopy.

    53. Jain B, Christopher Dee E, Jain U, Chaturvedi P, Murthy V. (2023)The implications of rising alcohol-associated cancer burden: Considerations for the Indian context. Asia Pacific Journal of Clinical Oncology. 19(1):275-276 PMID: 35098671.

    54. Joshi S, Anantharaman D, Muwonge R, Bhatla N, Panicker G, Butt J, Usha Rani Reddy Poli, Malvi S, Esmy P, Lucas E, Verma Y, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Divate U, Vashist S, Mishra G, Jadhav R, Siddiqi M, Sankaran S, Thiraviam Pillai Rameshwari Ammal Kannan, Kartha P, Shastri S, Sauvaget C, M. Radhakrishna Pillai, Waterboer T, Müller M, Sehr P, Unger E, Sankaranarayanan R, Basu P (2023). Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination. Vaccine. 41(1): 236-245.

    55. Joshi P, Waghmare S (2023). Molecular signaling in cancer stem cells of tongue squamous cell carcinoma: Therapeutic implications and challenges. World Journal of Stem Cells 15(5): 438-452.

    56. Jha AK, Mthun S, Sherkhane U, Jaiswar V, Osong B, Purandare N, Kannan S, Prabhash K, Gupta S, Vanneste B, Rangarajan V, Dekker A, Wee L (2023). Systematic review and meta-analysis of prediction models used in cervical cancer. Artificial Intelligence in Medicine.

    57. Kapoor A, Noronha V, Patil V, Menon N, Joshi A, Kumar A, Singh AK, Mahajan A, Janu A, Kumar R, Pai T, Chougule A, Shetty O, Prabhash K (2023). Clinical profile, practice pattern, and outcomes with first-line therapy in ALK-Positive lung cancer: Real-World data from resource-constrained settings. JTO Clinical and Research Reports. 4(1):100443.

    58. Khanna D, Budukh A, Sharma P, Shruti T, Vishwakarma R, Sharma AN, Bagal S, Vikraman SM, Vaza Y, Anand A, Chaturvedi P, Pradhan S (2023). Role of verbal autopsy in cancer registration: A mixed-methods study from the population-based cancer registry of Northern India. Tropical Medicine and International Health.

    59. Kumar A, Jha AK, Agarwal JP, Yadav M, Bandhe S, Sahay A, Epari S, Sahu A, Bhattarcharya K, Chatterjee A, Ganeshan B, Rangarjan V, Moiyadi A, Gupta T, Goda J (2023). Machine-learning-based radiomics for classifying glioma grade from magnetic resonance images of the brain. Journal of Personalized Medicine. 13(6): 920.

    60. Kuru D, Kumar AK, Chaturvedi P (2023). Barriers in quest for cancer care access in two states of northeast India. The International Journal of Health Planning and Management.

    61. Krishnatry R, Maitre P, Kumar A, Telkhade T, Bakshi G, Prakash G, Pal M, Joshi A, Menon S, Murthy V (2023). Utilising alternative cystoscopic schedules to minimise cost and patient burden after trimodality therapy for muscle-invasive bladder cancer. Cancer Medicine.

    62. Kode J, Maharana J, Dar A, Mukherjee S, Gadewal N, Sigalapalli D, Kumar S, Panda D, Ghosh S, Keshry S, Mamidi P, Chattopadhyay S, Pradhan T, Kailaje V, Inamdar S, Gujjarwar V (2023).6-Shogaol exhibits anti-viral and anti-inflammatory activity in COVID-19-associated inflammation by regulating NLRP3 inflammasomes. ACS Omega.

    63. Koppikar S, Oakin A, Babu KG, Lorusso D, Gupta S, We L-Y, Rajabto W, Harano K, Hong S-H, Malik RA, Strebel H, Aggarwal IM, Lai C-H, Dejthevaporn T, Tangjitgamol S, Cheng WF, Chay WY, Benavides D, Hashim NM, Moon YW, Yunokawa M, Anggraeni TD, Wei W, Curigalina G, Maheshwari A, Mahantshetty U, Sheshadri S, Peters S, Yoshino T, Pentheroudakis G (2023). Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer. ESMO Open. 8(1): 10074.

    64. Madhugiri V, Venkatesan S, Dutt A, Moiyadi AV, Shetty P, Gupta T, Epari S, Jalali R, Sasidharan GM, Kumar VR, Ganesh S, Ramesh A, Prabhu A, Dutt A (2022). An analysis of eosinophil and basophil based indices in patients with glioblastoma and their correlation with survival. World Neurosurgery. PMID: 36368458

    65. Mahadik P, Patwardhan S (2023). ECM stiffness-regulated exosomal thrombospondin-1 promotes tunneling nanotubes-based cellular networking in breast cancer cells. Archives of Biochemistry and Biophysics.

    66. Mani S, Chatterjee A, Dasgupta A, Shirsat N, Epari S, Chinnaswamy G, Gupta T (2023). WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? Oncotarget. 14: 105-110.

    67. Mohanty SK, Wadasadawala T, Sen S, Khan PK (2023). Socio-economic variations of breast cancer treatment and discontinuation: a study from a public tertiary cancer hospital in Mumbai, India. BMC Womens Health. 23(1):113.

    68. Mohite A, Rangarajan V, Goda J, Chugh S, Agrawal A, Sengar M. (2023). Metabolic tumor parameters complement clinicopathological factors in prognosticating advanced stage Hodgkin Lymphoma. Asia Oceania Journal of Nuclear Medicine & Biology.

    69. Mailankody S, Bajpai J, Budukh A, Swaminathan R, Dikshit R, Dhimal M, Perera S, Tshomo U, Bagal S, Bhise M, Chaturvedi P, Banavali S, Gupta S, Badwe R, Trama A. (2023) Epidemiology of rare cancers in India and South Asian countries-remembering the forgotten. Lancet Regional Health - Southeast Asia.

    70. Murthy V, Maitre P, Singh M, Pal M, Arora A, Pujari L, Kapoor A, Pandey H, Sharma R, Gudipudi D, Joshi A, Prabhash K, Noronha V, Menon S, Mehta P, Bakshi G, Prakash G (2023). Study protocol of the Bladder Adjuvant RadioTherapy (BART) trial: A randomised phase III trial of adjuvant radiotherapy following cystectomy in bladder Cancer. Clinical Oncology.

    71. Nair N, Das A, Shet T, Kirti K, Hawaldar R, Desai S, Parmar V, Joshi S, Badwe RA (2023). Accuracy of intraoperative frozen section analysis of lymph nodes in women undergoing axillary sampling for treatment of breast cancer: Single institution audit. Clinical Breast Cancer.

    72. Natu A, Pedgaonkar A, Gupta S (2023). Mitochondrial dysfunction and chromatin changes with autophagy-mediated survival in doxorubicin resistant cancer cell lines. Biochemical and Biophysical Research Communications.

    73. Nautiyal A, Jha AK, Konuparamban A, Mithun S, Srichandan T, Puranik A, Gala K, Shetty N, Kulkarni S, Rangarajan V (2023). A dosimetric comparison of systemic peptide receptor radionuclide therapy and intra-arterial peptide receptor radionuclide therapy in patients with liver dominant gastroenteropancreatic neuroendocrine tumours. Nuclear Medicine Communications.

    74. Nehra P, Singh Chauhan A, Malhotra P, Kumar L, Singh A, Gupta N, Mehra N, Mathew A, Kataki AC, Gupta S, Prinja S (2023). Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in India. The Lancet Regional Health - Southeast Asia. 13: 100201.

    75. Ostwal V, Ramaswamy A, Bhargava P, Srinivas S, Mandavkar S, Chaugule D, Peelay Z, Baheti A, Tandel H, Jadhav V, Shinde S, Jadhav S, Gota V, Mittra I (2023). A pro oxidant combination of resveratrol and copper reduces chemotherapy related non haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single arm study (RESCU III study). Medical Oncology. 40:17.

    76. Oak A, Sivaranjini K, Pathak R, Dikshit R (2023). Human papillomavirus self-sampling for cervical cancer screening: Review on the acceptance, accuracy, feasibility and incorporation in the National Screening Programme of India. Current Medicine Research and Practice. 13(2): 74-80.

    77. Pagdhune A, Kashyap R, SivaPerumal P, Balachandar R, Viramgami A, Sarkar K (2023). Occupational exposure of vehicular emissions and cardiorespiratory risk among urban metropolitan bus drivers: A cross-sectional comparative study. Work.

    78. Parui AL, Bose K (2023). Purification of hetero-oligomeric protein variants using a modified tandem affinity purification approach. STAR Protocols. 4(1): 102036.

    79. Patil A, Diwakar H, Sawant J, Kurian N, Yadav S, Rane S, Bameta T, Sethi A (2023). Efficient quality control of whole slide pathology images with human-in-the-loop training. Journal of Pathology Informatics.

    80. Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A, Nawale K, Jogdhankar S, Tambe R, Dhumal S, Sawant R, Alone M, Karla D, Peelay Z, Pathak S, Balaji A, Kumar S, Purandare N, Agarwal A, Puranik A, Mahajan A, Janu A, Kumar Singh G, Mittal N, Yadav S, Banavali S, Prabhash K. Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study. Journal of Clinical Oncology.PMID: 36265101

    81. Pattanaik S, Gota V, Tripathi SK, Kshirsagar NA (2023). Therapeutic Drug Monitoring in India: A SWOT Analysis. British Journal of Clinical Pharmacology.

    82. Pinto AS, Tambe M, D'Silva SZ, Singh M (2023). Identification of the novel HLA-C*12:02:47 allele in an individual from Maharashtra, India. HLA. 101(1):74-75. PMID: 36161710

    83. Panda TR, Manikandan M, Vaidya SP, Chhatar S, Sinha S, Mehrotra M, Chakraborty S, Gadre S, Duari P, Ray P, Patra M (2023). The Power of kinetic inertness in improving platinum anticancer therapy by circumventing resistance and ameliorating nephrotoxicity. Angewandte Chemie.

    84. Pinto AS, Tambe M, D'Silva SZ, Singh M. Identification of the novel HLA-DQB1*06:01:01:04 allele in an individual from Western India. HLA. 2023 Jan;101(1):90-91. doi: 10.1111/tan.14809. Epub 2022 Sep 21. PMID: 36086916.

    85. Pinto AS, Tambe M, D'Silva SZ, Singh M (2023). Identification of the novel HLA-DQA1*01:01:01:10 allele in an individual from Orissa, India. HLA. 101(2):190-191. PMID: 36181697

    86. Paul S, Gupta T, Purandare N, Joshi K, Ghosh-Laskar S, Budrukkar A, Swain M, Sinha S, Kumar A, Joshi A, Prabhash K, Nair S, Rangarajan V, Agarwal JP (2023). Diagnostic performance of response assessment FDG-PET/CECT in HNSCC treated with definitive Radio(chemo)therapy using NI-RADS. Otolaryngology- Head and Neck Surgery

    87. Phurailatpam R, Sah MK, Wadasadawala T, Khan A, Palottukandy J, Gayake U, Jain J, Sarin R, Pathak R, Krishnamurthy R, Joshi K, Swamidas J (2023). Can knowledge based treatment planning of VMAT for post-mastectomy locoregional radiotherapy involving internal mammary chain and supraclavicular fossa improve performance efficiency? Frontiers in Oncology. 13:991952.

    88. Prinja S, Dixit J, Gupta N, Dhankhar A, Kataki AC, Roy PS, Mehra N, Kumar L, Singh A, Malhotra P, Goyal A, Rajsekar K, Krishnamurthy MN, Gupta S (2023). Financial toxicity of cancer treatment in India: towards closing the cancer care gap. Frontiers in Public Health. 11:1065737.

    89. Rajak J, Tambe M, D'Silva SZ, Singh M (2023). Identification of the novel HLA-DPA1*02:82 allele in a Punjabi individual. HLA. 101(1):94-95. PMID: 36073256.

    90. Raj S, Kattepur A, Shylasree TS, Mishra G, Patil A, Pimple S, Noronha S, Pramesh CS (2023). Novel educational training of para medical professionals in cervical cancer screening. Gynecologic Oncology Reports.

    91. Ramalingam N, Chidambaranathan N, Thiagarajan S, Singh A, Chaukar D, Chaturvedi P (2023). Impact of changes in treatment paradigms on survival in oral squamous carcinoma— a Population-Level Study. Indian Journal of Surgical Oncology.

    92. Rauniyar S, Pansare K, Sharda A, Singh S, Saha P, CM Krishna, Gupta S (2023). Raman spectroscopy revealed cell passage-dependent distinct biochemical alterations in radiation-resistant breast cancer cells. ACS Omega.

    93. Reddy BRC,Musale D, Kadam D, Lanjekar K, Ogale G, Bhise M, Gore S, Chaturvedi P, Dikshit R, Budukh A (2023). Challenges faced by tobacco quitline services during the COVID-19 pandemic. Journal of Substance Use

    94. Rekhi B, Dave V, Butle A, Dutt A (2023). Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center. Annals of Diagnostic Pathology. 66: 152174.

    95. Saha P, Sawant S, Deshmukh A, Hole A, CM Krishna (2023). Serum Raman spectroscopy: Prognostic applications in oral cancers. Head Neck.

    96. Sahu A, Patnam N, Goda JS, Epari S, Sahay A, Mathew R, Choudhari A, Desai S, Dasgupta A, Chatterjee A, Pratishad P,Shetty P, Moiyadi A, Gupta T (2023). Multiparametric magnetic resonance imaging correlates of isocitrate dehydrogenase mutation in WHO high-Grade astrocytomas. Journal of Personalized Medicine. 13(1): 72.

    97. Sali AP, Prakash G, Murthy V, Joshi A, Shah A, Desai SB, Menon S (2023). Updates in staging of penile cancer: The evolution, nuances, and issues. Human Pathology. 133:76-86 PMID: 35714835. – No. 172 International Publications.
    98. Sandbhor P, Goda J, Mohanty B, Gera P, Yadav S, Chekuri G, Chaudhari P, Dutt S, Banerjee R (2023). Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model. Drug Delivery and Translational Research. 13(2):608-626. PMID: 36245060.

    99. Sawant P, Perera S, Jayanthi KGN, Ziyad AIA, Saoba S, Ervik M, Mery L, Bray F, Dikshit R, Budukh A (2023). Application of Rupantaran software to Sri Lankan hospitals: an innovative tool developed to merge population-based cancer registry data into CanReg5. Ecancermedicalscience. 17:1553.

    100. Spampinato S, Tanderup K, Lindegaard JC, Schmid MP, Sturdza A, Segedin B, Jürgenliemk-Schulz IM, De Leeuw A, Bruheim K, Mahantshetty U, Chargari C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Wiebe E, Villafranca E, Van Limbergen E, Pieters BR, Tee Tan L, C H W Lutgens L, Hoskin P, Smet S, Pötter R, Nout R, Chopra S, Kirchheiner K EMBRACE Collaborative Group (2023) Appendix. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors. Radiothery and Oncology. PMID: 36720348.

    101. Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT, Nout R, Nesvacil N, de Leeuw A, Pötter R, Kirisits C; EMBRACE Collaborative Group (2023). Risk factors for local failure following chemoradiation and magnetic resonance image-guided brachytherapy in locally advanced cervical cancer: Results from the EMBRACE-I Study. Journal of Clinical Oncology.

    102. Scheltes D, Mohanty S, Smits G, Steen-Banasik E, Murthy V, Hoskin P (2023). Function preservation with brachytherapy: Reviving the art. improving quality of life with brachytherapy for urological malignancies. Clinical Oncology.

    103. Sengar M, Jain H, Shet T, Sridhar E, Gota V, Rangarajan V, Laskar SS, Alahari A, Thorat J, Agarwal A, Sharma N, Gupta H, Kannan S, Kumar S, Nayak L, Menon H, Gujral S, Bagal B (2022). Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas. British Journal of Haematology. PMID: 36323643.

    104. Setia P, Bargir UA, Shanmukhaiah C, Jodhawat N, Gaikwad P, Vedpathak D, Dutta S, Kulkarni R, Kambli P, Dalvi A, Shinde S, Gupta M, Nambiar N, Sawant S, Shelar S, Dhawale A, Mohanty M, Yadav RM, Bose K, Madkaikar M (2023). Expanding the clinical phenotype of FADD deficiency with a novel mutation and its role in Fas-mediated apoptotic pathway. British Journal of Haematology.

    105. Shrivastav G, Datta D, Wadasadawala T, Rane P, Panda S, Pathak R, Scaria L, Krishnamurthy R, Sarin R. (2023). Clinical audit of breast cancer patients treated with helical tomotherapy for irradiation of the internal mammary chain. Journal of Radiotherapy in Practice.22:E23.

    106. Shenoy R, Rao AR, Rane P, Noronha V, Kumar A, Pillai A, Pathak S, Gattani S, Sehgal A, Kumar S, Castelino R, Dhekale R, Krishnamurthy J, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajam P, Timmanpyati S, Nokala M, Chitre A, Kapoor A, Gota V, Banavali S, Prabhash K, Ramaswamy A (2023). Validation of the Onco-MPI in predicting short-term mortality in older Indian patients with cancer. Journal of Geratric Oncology. 14(6): 101550.

    107. Srinivasan S, Prasad M, Parambil BC, Shrimal A, Gollamudi VRM, Subramani V, Ramadwar M, Khanna N, Baheti AD, Gala K, Patil V, Laskar S, Qureshi S, Chinnaswamy G (2023). Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach. Pediatric Blood Cancer.

    108. Singh B, Patnaik C, Bahadur R, Gandhi M, De A, Srivastava R (2023). Synthesis and degradation mechanism of renally excretable gold core-shell nanoparticles for combined photothermal and photodynamic therapy. Nanoscale. 15(3):1273-1288. PMID: 36541678..

    109. Sinha S, Kumar A, Maheshwari G, Mohanty S, Joshi K, Shinde P, Gupta D, Kale S, Phurailatpam R, Swain M, Budrukkar A, Kinhikar R, Ghosh-Laskar S (2023). Development and validation of single-optimization knowledge-based volumetric modulated arc therapy model plan in nasopharyngeal carcinomas. Advances in Radiation Oncology.

    110. Singh A, Shetty D, Patil J, More M, Chatterjee G, Rajpal S, Patkar NV, Subramanian PG, Gujral S, Tembhare PR (2023). Acute basophilic leukemia in a patient with down syndrome: A case report and review of literature. International Journal of Laboratory Hematology.

    111. Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia M, Miranda-Filho A, Ferlay J, Parkin D, Ranganathan R, Piñeros M, Znaor A, Mery L, Joko-Fru Y, Dikshit R, Sankaranarayanan R, Swaminathan R, Bray F (2023).Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncology. 24 (1): 22-32.

    112. Syamprasad NP, Rajdev B, Jain S, Panda S, Rao Puppala E, Chaudhari P, Rao Vaidya J, Kumar GJ, Naidu VGM (2023). Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis. International Immunopharmacology.119: 110145.

    113. Tambe M, D'silva SZ, Pinto AS, Parsaniya B, Singh M (2023). Identification of the novel allele, HLA-A*02:11:01:06, in two North Indian individuals in a Kshatriya family. HLA. 101(1): 43-44. PMID: 36087311

    114. Tambe M, D'Silva SZ, Pinto AS, Singh M (2022). Characterization of the novel HLA-B*58:01:01:19 allele by next-generation sequencing. HLA PMID: 36239076

    115. Tambe M, D'Silva SZ, Parsaniya B, Pinto AS, Singh M (2023) Identification of HLA-C*03:599 novel allele variant in two South Indian individuals in a Brahmin family. HLA. 101(1):66-67. PMID: 36088573.

    116. Verma T, Natu A, Khade B, Gera P, Gupta S (2023). An increase in polyadenylation of histone isoforms, Hist1h2ah and Hist2h3c2, is governed by 3'-UTR in de-differentiated and undifferentiated hepatocyte. Experimental Biology & Medicine.

    117. Venkatesulu B, Liauw SL, Joshi M, Brian Baumann B, Yoo R, Roupret M, Choudhury A, Efstathiou J, Murthy V, Sargos P, Solanki A (2023). Multidisciplinary management and radiotherapy recommendations for clinically and pathologically node-positive bladder cancer. Seminars in Radiation Oncology. 33 (1): 35-50.

    118. Wadasadawala T, Mohanty SK, Sen S, Khan PK, Pimple S, Mane JV, Sarin R, Gupta S, Parmar V (2023). Health-Related Quality of Life (HRQoL) Using EQ-5D-5L: Value set derived for Indian breast cancer ccohort. Asian Pacific Journal Cancer Prevention. 24(4):1199-1207.

    119. Wadasadawala T, Patil R, Carlton J, Verma S, Umesh N, Rane P, Sarin R, Pathak R, Bajpai J, Nair N, Shet T, Kaur R (2023). Long-term outcomes and prognostic factors in elderly patients with breast cancer: single-institutional experience. Ecancermedicalscience. 17: 1542.

    120. Wilson BE, Booth CM, Suvillian R, Aggarwal A, Sengar M, Jacob S, Bray F, Barton MB, Pearson S-A. Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement. Lancet Oncology. 24(6): 682-690.

    121. Yadav S, Mittal N, Rane SU, Bal M, Patil A, Ankathi SK, Nair D. Nonsalivary Primary Adenocarcinomas of the Base of Tongue. Arch Pathol Lab Med. 2023 PMID: 36602895.
  • 2022
    1. Abraham G, Noronha V, Rajappa S, Agarwal A, Batra U, Somani N, Raja T, Patil S, Kaushal AM, Joshi A, Radhakrishnan V, Singh N, Babu K G, Tewani R, Baghmar S, Dodagoudar C, Ananthakrishnan R, H P S, Sharma V, Menon N, Patil V, Joshi A, Gupta S, Prabhash K, Bajpai J (2022). The clinical utility and safety of Short-course Immune check point inhibitors (ICI) in multiple tumors - A real world multicentric study from India. International Journal of Cancer. 150(6):1045-1052. PMID: 34751432.
    2. Achrekar MS. (2022).Enhanced recovery after surgery (ERAS) nursing program. Asia-Pacific Journal of Oncology Nursing. 9(7):100041.PMID: 35620398
    3. Agarwal A, Khandelwal A, Pal K, Khare NK, Jadhav V, Gurjar M, Punatar S, Gokarn A, Bonda A, Nayak L, Kannan S, Gota V, Khattry N, Mittra I (2022). A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001). PLoS One. 17(2):e0262212. PMID: 35120140
    4. Alaggio R, Amador C, Anagnostopoulos I,... Laskar S, Tembhare P. et al. (2022). The 5th edition of the World Health Organization classification of haematolymphoid tumours: Lymphoid neoplasms. Leukemia. 36(7):1720-1748. PMID: 35732829
    5. Ashar S, Lipsa A, Khan N, Sarin R (2022). High cumulative risk of colorectal cancers and desmoid tumours and fibromatosis in South Asian APC mutation carriers. Journal of Medical Genetics. 59(5):492-495. PMID: 33766935
    6. Asija S, Chatterjee A, Yadav S, Chekuri G, Karulkar A, Jaiswal AK, Goda JS, Purwar R (2022). Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds. International Reviews of Immunology. PMID: 35938932
    7. Bajpai J, Kashyap L, Vallathol DH, Das A, Singh M, Pathak R, Rath S, Sekar A, Mohanta S, Reddy A, Joshi S, Nandhana R, Ravind R, Wadasadawala T, Nair N, Ghosh J, Parmar V, Gulia S, Desai S, Shet T, Thakur M, Patil A, Sarin R, Gupta S, Badwe R (2022). Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort. The Breast. 63:77-84. PMID: 35334242
    8. Bal M, Shah A, Rekhi B, Mittal N, Rane SU, Rabade K, Shetty O, Pantavaidya G, Nair D, Prabhash K, Aishwarya M, Govindarajan KK, Laskar S, Laskar SG, Patil A. (2022) Adamantinoma-Like Ewing Sarcoma of the head and neck: A case-series of a rare and challenging diagnosis. Head and Neck Pathology. 16(3):679-694.PMID: 35025056
    9. Bal M, Sharma A, Rane SU, Mittal N, Chaukar D, Prabhash K, Patil A (2022). Neuroendocrine Neoplasms of the Larynx: A Clinicopathologic Analysis of 27 Neuroendocrine Tumors and Neuroendocrine Carcinomas. Head and Neck Pathology. 16(2):375-387. PMID: 34401980.
    10. Banerjee A, Halder A, Jadhav P, Bankar R, Pattakine J, Hole A, Shah A, Goel A, CM Krishma, Srivastava S(2022). Metabolomics profiling of pituitary adenomas by Raman Spectroscopy, attenuated total reflection-fourier transform infrared spectroscopy, and mass spectrometry of serum samples. Analytical Chemistry. 94(34):11898-11907.
    11. Barua SA, Goswami N, Mishra N, Sawant UU, Varma A (2022). In silico and structure-based assessment of similar variants discovered in tandem repeats of BRCT domains of BRCA1 and BARD1 to characterize the folding pattern. ACS OMEGA.
    12. Behel V, Noronha V, Choughule A, Shetty O, Chandrani P, Kapoor A, Bondili SK, Bajpai J, Kumar R, Pai T, Bal M, Gurav M, Bapat P, Mittal N, Menon S, Patil V, Menon N, Dutt A, Prabhash K (2022). Impact of Molecular Tumor Board on the Clinical Management of Patients with Cancer. JCO Global Oncology. PMID: 35802838.
    13. Belavagi D, Bhandari R, Shafiq N, Gota V, Patil A, Pandey A, Mothsara C, Gupta R, Sahni N, Sharma N, Ray P, Kumar V, Sharma S, Malhotra S( 2022). A study to explore the appropriateness of dosing regimen of vancomycin in critically ill patients in a tertiary care unit of India. Germs. 2(2):238-252.PMID: 36504610
    14. Bhardwaj P, Gota V, Vishwakarma K, Pai V, Chaudhari P, Mohanty B, Thorat R, Yadav S, Gurjar M, Goda JS, Banerjee R. (2022) Loco-regional radiosensitizing nanoparticles-in-gel augments head and neck cancer chemoradiotherapy. Journal of Controlled Release. 343:288-302. PMID: 35101477.
    15. Bhatia N, Vatsa R, Dhingra VK, Dhawan DK, Chadha VD. Evaluation of tetrofosmin cold kit fractionation using alternative new method of quality control for testing radiochemical purity. World Journal of Nuclear Medicine. 21(4):314-319. PMID: 36398310
    16. Bhattacharjee A, Banerjee S, Vishwakarma G, Pashchenko A (2022). highMLR: An open-source package for R with machine learning for feature selection in high dimensional cancer clinical genome time to event data. Expert System with Applications. 210:118432.
    17. Capistrano I R, Paul S, Boere I, Pantziarka P, Chopra S, Nout RA, Bouche G. Drug repurposing as a potential source of innovative therapies in cervical cancer.International Journal of Gynecological Cancer. 32(11):1377-1386. PMID: 36137575.
    18. Castaño-Vinyals G, Sadetzki S, Vermeulen R, Momoli F, Kundi M, Merletti F, Maslanyj M, Calderon C, Wiart J, Lee AK, Taki M, Sim M, Armstrong B, Benke G, Schattner R, Hutter HP, Krewski D, Mohipp C, Ritvo P, Spinelli J, Lacour B, Remen T, Radon K, Weinmann T, Petridou ET, Moschovi M, Pourtsidis A, Oikonomou K, Kanavidis P, Bouka E, Dikshit R, Nagrani R, Chetrit A, Bruchim R, Maule M, Migliore E, Filippini G, Miligi L, Mattioli S, Kojimahara N, Yamaguchi N, Ha M, Choi K, Kromhout H, Goedhart G, 't Mannetje A, Eng A, Langer CE, Alguacil J, Aragonés N, Morales-Suárez-Varela M, Badia F, Albert A, Carretero G, Cardis E.(2022) Wireless phone use in childhood and adolescence and neuroepithelial brain tumours: Results from the international MOBI-Kids study. Environment International. 160:10769. PMID: 34974237.
    19. Chakraborty A, Bose R, Bose K. (2022) Unraveling the dichotomy of enigmatic serine protease HtrA2. Frontiers in Molecular Biosciences. 9: 824846. PMID: 35187085
    20. Chargari C, Arbyn M, Leary A, Abu-Rustum NR, Basu P, Bray F,Chopra S, Nout R, Tanderup K, Viswanathan A, Zacharipoulou C, Soria JC, Deutsch E, Gouy S, Morice P (2022). 1. Chargari C, Arbyn M, Leary A, Abu-Rustum NR, Basu P, Bray F, Chopra S, Nout R, Tanderup K, Viswanathan A, Zacharipoulou C, Soria JC, Deutsch E, Gouy S, Morice P (2022). Increasing global accessibility to high-level treatments for cervical cancers. Gynecologic Oncology. 164(1):231-241. PMID: 34716024
    21. Chatterjee A, Asija S, Yadav S, Purwar R, Goda JS (2022). Clinical utility of CAR T cell therapy in brain tumors: Lessons learned from the past, current evidence and the future stakes. International Reviews of Immunology. 41(6):606-624.PMID: 36191126
    22. Chatterjee A, Bhadane M, Manjali JJ, Dasgupta A, Epari S, Sahay A, Patil V, Moiyadi A, Shetty P, Gupta T. Optimizing post-operative adjuvant therapy in elderly patients with newly-diagnosed glioblastoma: Single-institution audit of clinical outcomes from a tertiary-care comprehensive cancer centre in India. World Neurosurgery. 161:e587-e595. PMID: 35192971.
    23. Chatterjee G, Sriram H, Ghogale S, Deshpande N, Khanka T, Girase K, Verma S, Arolkar G, Dasgupta N, Narula G, Shetty D, Dhamne C, Moulik NR, Rajpal S, Patkar NV, Banavali S, Gujral S, Subramanian PG, Tmbhare PR (2022). Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease. British Journal of Haematology. 196(2): 374-379. PMID: 34476808.
    24. Chaubal K, Shetty D (2022). B-cell acute lymphoblastic leukemia with t(3;9)(q25;p13) involving the PAX-5 and MBNL1. Atlas of Genetics Cytogenetics in Oncology and Haematology.
    25. Chaudhary N, Joshi N, Doloi R, Shivashankar A, Thorat R, Dalal S (2022). Plakophilin3 loss leads to an increase in autophagy and radio-resistance. Biochemical and Biophysical Research Communications. 620:1-7. PMID: 35772211
    26. Cho HL, Murthy V, Mouw KW, D'Amico AV, Nguyen PL, Leeman JE, Dee EC (2022). Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy. Prostate. 82(11):1098-1106. PMID: 35652585.
    27. Chopade P, Chopra S, Jain J, Panda S, Patil A, Patil G, Mahantshetty U, Engineer R, Gurram L, Mittal P, Ghosh J, Gupta S, Shrivastava K (2022). Serial bone density changes in women undergoing pelvic (chemo) radiation: Results from PARCER trial. International Journal of Radiation Oncology, Biology, Physics. 114(3):463-471. PMID: 35870710
    28. Chopade P, Maitre P, David S, Panigrahi G, Singh P, Phurailtpam R, Murthy V (2022).Common iliac node positive prostate cancer treated with curative radiotherapy: N1 or M1a? International Journal of Radiation Oncology, Biology Physics. 114(4):711-717. PMID: 35870708
    29. Chopra S, Goda J, Mittal P, Mulani J, Pant S, Pai V, Kannan S, Deodhar K, Krishnamurthy M, Menon S, Charnalia M, Shah S, Rangarajan V, Gota V, Naidu L, Sawant S, Thakkar P, Popat P, Ghosh J, Rath S, Gulia S, Engineer R, Mahantshetty U, Gupta S (2022). Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial. BMJ Open. 12(4):e055765.
    30. Chopra S, Kalra B, Mulani J, Jain J, Gurram L, Mittal P, Alone M, Ghosh J, Rath S, Gulia S, Gupta S (2022). Salvage (re) radiation in oligometastatic and oligorecurrent cervical cancer. International Journal of Radiation Oncology, Biology, Physics. 114(4):812-819. PMID: 35850364.
    31. Chopra S, Ranjan N, Charnalia M, Kannan S, Engineer R, Dora T, Gurram P, Maheshwari A, Shylasree TS, Shrivastava S, Gupta S (2022). Late toxicity within a Phase III clinical trial of IG-IMRT in cervix cancer (PARCER): Reanalysis with time weighted adverse event reporting (MOSES). Radiotherapy and Oncology. 177:16-20. PMID: 36270474
    32. Chopra S, Ranjan N, Mittal P (2022). Postoperative adjuvant radiation for cervix cancer: reflections on the evidence and a peep into the future. International Journal of Gynecoogical Cancer. 32(3):225-230. PMID: 35256407.
    33. Das S, Dholam K, Gurav S, Bendale K, Ingle A, Mohanty B, Chaudhari P, Bellare JR (2022). X-ray computed microtomography datasets for osteogenic nanofibrous coated titanium implants. Scientific Data. 9(1): 348. PMID: 35717538
    34. Dasgupta A, Gupta T, Maitre M, Kalra B, Chatterjee A, Krishnatry R, Goda JS, Shirsat N, Epari S, Sahay A, Janu A, Pungavkar S, Chinnaswamy G, Patil V, Moiyadi A, Shetty P, Jalali R. (2022) Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma. Strahlentherapie und Onkologie. 198(3):291-303. PMID: 35059761
    35. Deo A, Thorat R, Dhadve A, De A, Rekhi B, Ray P. (2022) IGF1R-α6 integrin-S100A4 network governs the organ-specific metastasis of chemoresistant epithelial ovarian cancer cells. Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease.1868 (1): 166282. PMID: 34600083
    36. Desai S, Dharavath B, Manavalan S, Rane A, Redhu A, Sunder R, Butle A, Mishra R, Joshi A, Togar T, Apte S, Bala P, Chandrani P, Chopra S, Bashyam M, Banerjee A, Prabhash K, Nair S, Dutt A(2022). Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer. NAR Cancer. 4(1): zcac006. PMID: 35252868
    37. Desai S, Mishra R, Ahmad S, Hait S, Joshi A, Dutt A (2022). TMC-SNPdb 2.0: an ethnic-specific database of Indian germline variants. Database: The Journal of Biological Databases and Curation.PMID: 35551364
    38. Dev ID, Puranik AD, Rangarajan V, Gupta T, Purandare NC, Agrawal A, Shah S. (2022) Radiation-Induced Meningioma in a Case of Medulloblastoma Treated 11 Years Ago-Detected on 68Ga-DOTANOC PET/CT. Clinical Nuclear Medicine. 47(1):e108-e110. PMID: 34183498.
    39. Dey P, Joshi M, Mujawar A, Malhotra R, De A (2022). Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer. Cellular Oncology (Dordr). 45(5):873-891. PMID: 35834098.
    40. Dhadve A, Ray P (2022). An active RUNX1-ID1/ID3 axis governs differentiation and chemoresistance of cancer stem cell population in epithelial ovarian cancer cells. Biocell. 46(1): 75-86.
    41. Dhawan A, Lokras A, Joshi G, Marwah M, Venkatraman M, Mohanty B, Darshan K, Chaudhaty P, Warawdekar U, Saraf M, Nagarsenkar M. Polysaccharide and monosaccharide guided liver delivery of Sorafenib Tosylate –a nano-strategic approach and comparative assessment of hepatospecificity. International Journal of Pharmaceutics. 625:122039. PMID: 35902059
    42. Dholam K, Singh G, Sathaye N, Gurav S, Shinde A (2022). Two-piece oral facial prothesis retained with magnets for a complex maxillary facial defect: A clinical report. The Journal of Prosthetic Dentistry. 128(6): 1365-1368.PMID: 34112522
    43. Dhumal S, Patil A, More A, Kamtalwar S, Joshi A, Gokarn A, Mirgh S, Thatikonda P, Bhat P, Murthy V, Chavan P, Oak A, Gore S, Bhattacharjee A, Patkar N, Kannan S, Shetty N, Rawat A, Achrekar M, Trivedi B, Laskar S, Chaturvedi P, Badwe R, Khattry N, Gupta S (2022). SARS-COV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study. International Journal of Infectious Diseases. 118: 95-103. PMID: 35192951
    44. Dongre HN, Mahadik S, Ahire C, Rane P, Sharma S, Lukmani F, Patil A, Chaukar D, Gupta S, Sawant SS (2022). Diagnostic and prognostic role of protein and ultrastructural alterations at cell-extracellular matrix junctions in neoplastic progression of human oral malignancy. Ultrastruct Pathol. PMID: 36049041.
    45. dos-Santos-Silva I, Gupta S, Orem J (2022). Shulman L. Global disparities in access to cancer care. Communications Medicine. 2:31.PMID: 35603309
    46. Dubey S, Mishra N, Goswami N, Siddiqui MQ, Varma A. Multimodal approach to characterize the tetrameric form of human PML-RBCC domain and ATO-mediated conformational changes. International Journal of Biogical Macromolecules. 223: 468-478. PMID: 36356867
    47. Duckworth E, Hole A, Deshmukh A, Chaturvedi P, CM Krishna Mora B, Roy D. Improving vibrational spectroscopy prospects in frontline clinical diagnosis: Fourier transform infrared on buccal mucosa cancer. Analytical Chemistry. 94(40):13642-13646. PMID: 36161799
    48. Dutta S, Khan N, Bose K, Poddar N (2022). A comparative in silico study to detect the effect of food-additives on metabolic protein and its perturbations compensated by osmolytes. International Journal of Biological Macromolecules.216:179-192. PMID: 35780921
    49. Gadre S, M M, Duari P, Chhatar S, Sharma A, Khatri S, Kode J, Barkume M, Kasinathan NK, Nagare M, Patkar M, Ingle A, Kumar M, Kolthur-Seetharam U, Patra M (2022). A rationally designed bimetallic platinum (II)-ferrocene antitumor agent induces non-apoptotic cell death and exerts in vivo efficacy. Chemistry. 28(46):e202201259. PMID: 35638709.
    50. Gandhi KA, Joshi A, Mehta P, Gurjar M, Rane P, Sharma J, Patil A, Nookala M, Noronha V, Prabhash K, Gota V. Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer. Cancer Chemotherapy Pharmacology. 89(6):751-759. PMID: 35441269.
    51. Ganguly R, Verma G, Ingle A, Kumar S, Sarma HD, Dutta D, Dutta B, Kunwar A, Ajish K, Bhainsa KC, Hassan PA, Aswal VK (2022). Structural, rheological and therapeutic properties of pluronic F127 hydrogel and beeswax based lavender oil ointment formulations. Journal of Molecular Liquids. 365: 120157.
    52. Gillessen S, Armstrong A, Attard G... Murthy V. et al. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology. 82(1):115-141. PMID: 35450732.
    53. Gohil D, Panigrahi GC, Gupta SK, Gandhi KA, Gera P, Chavan P, Sharma D, Sandur S, Gota V (2022). Acute and sub-acute oral toxicity assessment of 5-hydroxy-1, 4-naphthoquinone in mice. Drug and Chemical Toxicology. PMID: 35899689.
    54. Guha A, Goda JS, Dasgupta A, Mahajan A, Halder S, Gawde J, Talole S (2022). Classifying primary central nervous system lymphoma from glioblastoma using deep learning and radiomics based machine learning approach - a systematic review and meta-analysis. Frontiers in Oncology. PMID: 36263203
    55. Guha A, Vijan A, Agarwal U, Goda JS, Mahajan A, Shetty N, Khattry N. Imaging for plasma cell dyscrasias: What, when, and how? Frontiers in Oncology. 12: 825394. PMID: 35402253
    56. Gulia S, Kannan S, Ghosh J, Rath S, Maheshwari A, Gupta S (2022). Maintenance therapy with a poly(ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: individual patient data and trial-level meta-analysis. ESMO Open. 7(5): 100558.PMID: 36007449
    57. Gulia S, Kannan S, Gupta S (2022). Maintenance therapy with a poly (ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: Updated individual patient data and trial-level meta-analysis. ESMO Open. 7(6):100632. PMID: 36356417
    58. Gupta A, Ojha S, Nagaraju P, Poojary M, Ravatale A (2022). Plateletpheresis Donation through donor awareness, motivation, and recruitment drives: A unique concept and experience from a tertiary care oncology centre in India. Transfusion Clinuque Et Biologique. 29(1): 65-69. PMID: 34302952
    59. Gupta N, Khan MA, Capasso G, Zacchia M (2022). Computational and structural analysis to assess the pathogenicity of Bardet-Biedl syndrome related missense variants identified in Bardet-Biedl syndrome 10 gene (BBS10). ACS Omega. 7(42):37654-37662. PMID: 36312387
    60. Gupta SK, Jadhav S, Gohil D, Panigrahi G, Kaushal RK, Gandhi K, Patil A, Chavan P, Gota V (2022). Safety, toxicity and pharmacokinetic assessment of oral Withaferin-A in mice. Toxicology Reports. 9:1204-1212
    61. Gupta T, Kalra B, Goswami S, Deodhar J, Rane P, Epari S, Moidadi A, Dasgupta A, Chatterjee A, Chinnaswamy G (2022). Neuro-cognitive function and survival in children with average-risk medulloblastoma treated with hyperfractionated radiation therapy alone: long-term mature outcomes of a prospective study. Neuro-Oncology Practice .9(3):236-245.PMID: 35601967
    62. Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP (2022). Concurrent chemoradiotherapy with cisplatin given once-a-week versus every-three weekly in head and neck squamous cell carcinoma: Non-inferior, equivalent, or superior? Oral Oncology. 134: 106130. PMID: 36162191
    63. Gupta T, Maheshwari G, Kannan S, Nair S, Agarwal JP (2022). Should Sentinel Lymph Node Biopsy Be Considered the New Standard of Care for Early-Stage Clinically Node-Negative Oral Squamous Cell Carcinoma? Journal of Clinical Oncology. 40(15):1706-1709. PMID: 35298298.
    64. Gupta T, Maheshwari G, Kannan S, Nair S, Chaturvedi P, Agarwal J(2022). Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharyngeal squamous cell carcinoma: Evidence-base for practice and implications for research. Oral Oncology. 124: 105642. PMID: 34861565
    65. Gupta T, Nair S, Chaturvedi P, Agarwal J (2022). Can sentinel lymph-node biopsy become the new standard of care in clinically node-negative neck in early stage oral cancer? European Archives of Oto-Rhino-Laryngology. 279(10):5047-5048.PMID: 33439341
    66. Gupta T, Nayak P, Baviskar Y, Gupta M, Moiyadi A, Epari S, Janu A, Purandare N, Rangarajan V, Bagal B, Chatterjee A, Sastri GJ. Systemic inflammatory biomarkers in primary central nervous system lymphoma versus high-grade glioma: exploratory, comparative and correlative analysis. CNS Oncology. 11(2):CNS83.PMID: 35373582.
    67. Gupta T, Pervez S, Dasgupta A, Chatterjee A, Epari S, Chinnaswamy G, Jalali R (2022). Omission of upfront craniospinal irradiation in patients with low-risk WNT-pathway medulloblastoma is associated with unacceptably high risk of neuraxial failure. Clinical Cancer Research. 28(19):4180-4185. PMID: 35653134
    68. Gupta T, Thakkar P, Kalra B, Kannan S (2022). Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis. Reviews in Medical Virology. 32(2):e2276. PMID: 34245622.
    69. Gurav S, Dholam KP, Singh GP (2022). Treatment of Refractory Medicine Related Osteonecrosis of Jaw with Piezosurgical Debridement and Autologous Platelet Rich Fibrin: Feasibility Study. 33(3): e226-e230. Journal of Craniofacial Surgery. PMID: 34310422.
    70. Hande V, Chopra S, Kalra B, Abdel-Wahab M, Kannan S, Tanderup K, Grover S, Zubizarreta E, Rubio JAP (2022). Point-A vs Volume-based brachytherapy for the treatment of cervix cancer: A meta-analysis. Radiotheray Oncology. 170:70-78. PMID: 35259419.
    71. Hole A, Jadhav P, Pansare K, Noothalapati H, Deshmukh A, Gota V, Chaturvedi P, CM Krishna (2022). Saliva Raman Spectroscopy: Understanding alterations in saliva of tobacco habitués and oral cancer subjects. Vibrational Spectroscopy. 122:103414
    72. Horeweg N, Mittal P, Gradowska PL, Boere I, Nout RA, Chopra S. A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer. Critical Reviews in Oncology/ Hematology. 172: 103638 PMID: 35189325.
    73. Ivanisenko N, Seyrek K, Hiller-Richter L, König C, Espe J, Bose K, Lavrik I.(2022) Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks. Trends in Cancer. 8(3):190-209.PMID: 34973957
    74. Jha A, Ravichandran G, De A, Srivastava R (2022).NANOTORRID®: Graphene-like properties of a gold/polypropylene nanocomposite and its photothermal application. Journal of Materials Research. 37:1183–1200
    75. Jobanputra K, Nayak L, Jain H, Shet T, Epari S, Bonda VN, Thorat J, Bagal B, Laskar S, Rangarajan V, Agrawal A, Gujral S, Khanna N, Goda J, Sengar M (2022). Diffuse large B-Cell lymphoma in the elderly: Real-world outcomes from a developing country. Clinical Lymphoma Myeloma and Leukemia. 22 (10):e898-e906. PMID: 35810145
    76. Johnson S, Dhamne C, Sankaran H, Gandhi KA, Rane P, Moulik NR, Jadhav SM, Gurjar M, Narula G, Banavali S, Gota V (2022). A prospective, open-label, randomised, parallel design study of 4 generic formulations of intramuscular L-asparaginase in childhood precursor B-cell acute lymphoblastic leukaemia (ALL). Cancer Chemotherapy and Pharmacology. 90(6):445-453.PMID: 36251032
    77. Joshi A, Butle A, Hait S, Mishra R, Trivedi V, Thorat R, Choughule A, Noronha V, Prabhash K, Dutt A (2022). Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation. Translational Oncology. 22:101461.PMID: 35653897
    78. Joshi A, Kalra D, Simha V, Menon N, Noronha V, Bakshi G, Prakash G, Pal M, Murthy V, Menon S, Sable N, Agrawal A, Rane P, Prabhash K (2022) Second-line therapy in testicular germ cell tumours: results from a tertiary cancer care centre in India. Ecancermedicalscience 16:1408. PMID: 36072230
    79. Joshi R, Thomas M, Patkar S, Gupta AM, Panhale K, Rane PP, Ambulkar R, Goel M, Shrikhande SV, Agarwal V(2022). Impact of enhanced recovery pathway in 408 gallbladder cancer resections. HPB (Oxford). 24(1):47-56. PMID: 34187721.
    80. Joshi T, Mantri M, Hadgaonkar S, Rao N, Dhondge R, Jaiswal D, Mathews S, Qayyumi B, Chaturvedi P, Shankhdhar VK. Outcome Analysis of Advanced Oral Cancers Requiring Large Composite Fibular Osteocutaneous Flap Reconstruction: Experience from a Tertiary Care Cancer Hospital. Annals of Plastic Surgery. 88(6):635-640.PMID: 35502967.
    81. Khamkar V, Narasimhan M, Govekar R (2022). Improved identification of hydrophobic proteins by optimization of LC conditions within the LC-MS Run - A practical strategy for scanty clinical samples. Biomedical Journal of Scientific & Technical Research. 43(4): 34886-34892.
    82. Khan MA, Siddiqui MQ, Kuligina E, Varma AK (2022). Evaluation of conformational transitions of h-BRCA2 functional domain and unclassified variant Arg2502Cys using multimodal approach. International Journal of Biological Macromolecules. . 209: Part A: 716-724. PMID: 35413318
    83. Khan MA, Varma AK (2022). In silico and structure-based assessment to classify VUS identified in the α-helical domain of BRCA2.Journal of Biomolecular Structure and Dynamics. . PMID: 36404616.
    84. Khanna N, Ghosh Laskar S, Gupta T, Agarwal JP (2022). Compliance with Radiotherapy Treatment in an Apex Cancer Center of India. JCO Global Oncology. 8:e2100201. PMID: 34985910
    85. Khoury JD, Solary E, Abla O, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Khattry N, Subramanian PG. et al. (2022). The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myeloid and histiocytic/dendritic neoplasms. Leukemia. 36(7):1703-1719. PMID: 35732831.
    86. Khurud P, Gupta A, Krishnatry R, Panigrahi G, Phurailatpam RD, Menon S, Pal M, Bakshi G, Prakash G, Murthy V (2022). Optimizing target volume for adjuvant radiotherapy in penile cancer. Practical Radiation Oncology.
    87. Khurud P, Krishnatry R, Telkhade T, Patil A, Prakash G, Joshi A, Pal M, Noronha V, Menon S, Bakshi G, Prabhash K, Murthy V (2022). Impact of Adjuvant Treatment in pN3 Penile Cancer. Clinical Oncology (R Coll Radiol). 34 (2): 172-178. PMID: 34732295
    88. Krishnamurthy MN, Pradosh A, Varghese D, Halder S (2022). Clinical pharmacologist from the eyes of a clinical pharmacologist: A questionnaire‑based survey. European Journal of Clinical Pharmacology. 78(12):2003-2011. PMID: 36305906
    89. Krishnamurthy R, Mummudi N, Goda JS, Chopra S, Heijmen B, Swamidas J (2022). Using artificial intelligence for optimization of the processes and resource utilization in radiotherapy. JCO Global Oncology. PMID: 36395438.
    90. Krishnatry R, Gudi S, Siwach A, Patil A, Rajesh KR, Shekhar H, Sutar V, Chatterjee A, Goda J, Jalali R, Gupta T (2022). Impact of immobilisation and image guidance protocol on planning target volume margins for supine craniospinal irradiation. Reports of Practical Oncology and Radiotherapy. 27(2):250-259. PMID: 36299390
    91. Kumar M, Noronha S, Rangaraj N, Moiyadi A, Shetty P, Singh VK (2022). Choice of intraoperative ultrasound adjuncts for brain tumor surgery. BMC Medical Informatics and Decision Making. 22(1):307. PMID: 36437463.
    92. Kumar P, Ambulkar R, Ranganathan P, Patil S (2022). Use of the McGRATH™ MAC videolaryngoscope to evaluate the ability of anesthetists to give effective cricoid pressure an interventional study. Journal of Anaesthesiology Clinical Pharmacology. 48(3): 471-422.
    93. Kumar R, Abreu C, Toi M, Saini S, Casimiro S, Arora A, Paul AM, Velaga R, Rameshwar P, Lipton A, Gupta S, Costa L. Oncobiology and treatment of breast cancer in young women. Cancer Metastasis Reviews. 41(3):749-770. PMID: 35488982.
    94. Lall S, Bhat V, Biswas S, Joshi A, Janu A (2022). Delftia acidovorans: An unusual pathogen from an adenocarcinoma lung patient with pleural effusion. Journal of Global Infectious Diseases.
    95. Laskar S, Sinha S, Chatterjee A, Khanna N, Manjali JM, Puri A, Gulia A, Nayak P, Vora T, Chinnaswamy G, Prasad M, Bajpai J, Juvekar S, Desai S, Janu A, Rangarajan V, Purandare N, Shah S, Rekhi B, Jambhekar N, Muckaden M, Kurkure P (2022). Radiotherapy dose escalation in unresectable Ewing's sarcoma: Final results of a phase III randomized controlled trial. International Journal of Radiation Oncology, Biology, Physics. PMID: 35568246
    96. Laskar SG, Sinha S, Pai DP, Nair D, Budrukkar A, Swain M, Kimar A, Moiyadi A, Shetty P, Roy V, Johnny C, Murthy V, Gupta T, Menon N, Patil V, Noronha V, Joshi A, Prabhash K, Agarwal JP (2022). Definitive and adjuvant radiation therapy for external auditory canal and temporal bone squamous cell carcinomas: Long term outcomes. Radiotherapy Oncology. 170: 151–158. PMID: 35219800."
    97. Laskar SG, Sinha S, Singh M, Mummudi N, Mittal R, Gavarraju A, Budrukkar A, Swain M, Agarwal JP, Gupta T, Murthy V, Mokal S, Patil V, Noronha V, Joshi A, Menon N, Prabhash K (2022). Post-cricoid and Upper Oesophagus Cancers Treated with Organ Preservation Using Intensity-modulated Image-guided Radiotherapy: a Phase II Prospective Study of Outcomes, Toxicity and Quality of Life. Clinical Oncology(R Coll Radiol).34(4):220-229. PMID: 34872822
    98. Mahantshetty U, Naga P, Nachankar A, Ghadi Y, Dheera A, Scaria L, Epili D, Chopra S, Lavanya G, Shrivastava S (2022). Set-Up Errors, Organ Motion, Tumour Regression and its Implications on Internal Target Volume-Planning Target Volume during Cervical Cancer Radiotherapy: Results from a Prospective Study. Clinical Oncology (R Coll Radiol). 34(3): 189-197. PMID: 34736842
    99. Maheshwari A, Gupta S, Deodhar K, Chopra S, Rangarajan V, Purandare N, Mahantshetty U(2022). Preoperative imaging with positron emission tomography and computed tomography (18F-FDG PET/CT) or contrast-enhanced computed tomography (CECT) scan in operable cervical cancer: a prospective study. European Journal of Gynaecological Oncology. .43: 32-39
    100. Maitre M, Gupta T, Maitre P, Chatterjee A, Dasgupta A, Moiyadi A, Shetty P, Epari S, Sahay A, Patil V, Krishnatry R, Goda J, Jalali R (2022). High-dose salvage re-irradiation in recurrent/progressive adult diffuse gliomas: development of a novel prognostic scoring system. Cancer Radiotherapy. 26(8):994-1001.PMID: 35715356
    101. Maitre P, Sood S, Pathare P, Krishnatry R, Agarwal A, Rangarajan V, Murthy V (2022). Timing of Ga68-PSMA PETCT and patterns of recurrence after prostate radiotherapy: Implications for potential salvage. Radiotherapy Oncology. 169: 71-76.PMID: 35189154.
    102. Mal A, Prabhuraj RS, Malhotra R, Valvi S, Ingle A, Srivastava R, De A, Bandopadhyaya R (2022). pH-responsive sustained delivery of doxorubicin using aminated and PEGylated mesoporous silica nanoparticles leads to enhanced antitumor efficacy in pre-clinical orthotopic breast cancer model. Journal of Drug Delivery Science and Technology. 77: 103800.
    103. Mehta D, Roy S, Joshi P, Parab M, Waghmare S. (2022)Secretary phospholipase (sPLA2IIA) loss impairs tumorigenic and metastatic potential in breast cancer cells. Biochemical and Biophysical Research Communications. 597:102-108. PMID: 35134607
    104. Mehta P, Sinha S, Kashid S, Chakraborty D, Mhatre R, Murthy V (2022). Exploring texture analysis to optimize bladder preservation in muscle invasive bladder cancer. Clinical Genitourinary Cancer. PMID: 3662869
    105. Menon NS, Noronha V, Patil VM, Joshi A, Bhattacharjee A, Kalra D, Laskar SG, Mathrudev V, Nawale K, Bhelekar AS, Prabhash K (2022). Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatin. Cancer Medicine. (21):3939-3948. PMID: 35343648.
    106. MG Sudharsan M, Chikhale R, Nanaware N, Dalvi S, Venkatraman P. (2022) A druggable pocket on PSMD10Gankyrin that can accommodate an interface peptide and doxorubicin. European Journal of Pharmacology. 915: 174718. PMID: 34953804
    107. Mhatre S, Lacey B, Sherliker P, Chatterjee N, Rajaraman P, Goel M, Patkar S, Ostwal V, Patil P, Shrikhande SV, Chitkara G, Badwe R, Lewington S, Dikshit R (2022). Reproductive factors and gall-bladder cancer, and the effect of common genetic variants on these associations: a case-control study in India. International Journal of Epidemiology. 51(3):789-798. PMID: 34550362.
    108. Miriyala R, Mahantshetty U, Maheshwari A, Gupta S (2022). Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future. International Journal of Gynecological Cancer 32(3):260-265. PMID: 35256411.
    109. Mishra A, Janu A, Trivedi K, Shetty P, Singh V, Moiyadi A (2022). Subpial en bloc resection improves extent of resection in infiltrating gliomas – a propensity matched comparative cohort analysis. Clinical Neurology and Neurosurgery. 215:101977PMID: 35305392
    110. Mishra SK, Dhadve AC, Mal A, Reddy BPK, Hole A, CM Krishna, Ray P, Srivastava R, De A (2022). Photothermal therapy (PTT) is an effective treatment measure against solid tumors which fails to respond conventional chemo/radiation therapies in clinic. Biomaterials Advances. 143:213153. PMID: 36343390
    111. Mittal P, Chopra S, Charnalia M, Dora T, Engineer R, Mulani J, Scaria L, Prajapati K, Kannan S, Gurram L, Mahantshetty U, Gupta S, Shrivastava SK (2022). Patterns of Relapse after Adjuvant Chemoradiation for Cervical Cancer in a Phase 3 Clinical Trial (PARCER): An Evaluation of Updated NRG Oncology/RTOG Target Delineation Guidelines. International Journal of Radiation Oncology Biology Physics. 113(2):369-378. PMID: 35157993.
    112. Mohanty P, Shetty D, Liehr T, Mrasek K, Khattry N (2022). Intrachromosomal amplification of BCR expressed as homogenously staining region (hsr) in a case of acute myeloid leukemia with myelodysplasia-related changes. International Journal of Laboratory Hematology. 44(6):993-994. PMID: 35534180
    113. Moitra P, Chatterjee A, Kota PK, Epari S, Patil V, Dasgupta A, Kowtal P, Sarin R, Gupta T.(2022) Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic study. Journal of Neuro-oncology. 156(3):625-634. PMID: 35037156
    114. Morge S, Makani V, Pradhan S, Devre P, More S, Vaidya M, D'Mello C. Biomarker potential of vimentin in oral cancers.Life. 12(2): 150.PMID: 35207438
    115. More MH (2022), Varankar SS, Naik RR, Dhake RD, Ray P, Bankar RM, Mali AM, Subbalakshmi AR, Chakraborty P, Jolly MK, Bapat SA. A Multistep tumor growth model of high grade serous ovarian carcinomaidentifies hypoxia associated signatures. Cells Tissues Organs. PMID: 35970135.
    116. Mukherjee A, Pednekar CB, Kolke SS, Kattimani M, Duraisamy S, Burli AR, Gupta S, Srivastava S (2022). Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer. Proteomes. 10(2):13. PMID: 35645371
    117. Mukherjee S, Maddalena M, Lü Y, Martinez S, Nataraj NB, Noronha A, Sinha S, Teng K, Cohen-Kaplan V, Ziv T, Arandkar S, Hassin O, Chatterjee R, Pirona AC, Shreberk-Shaked M, Gershoni A, Aylon Y, Elazar Z, Yarden Y, Schramek D, Oren M. Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins. Proceedings of the National Academy of Sciences. 119(17):e2119644119. PMID: 35439056.
    118. Mukherjee S, Sakpal A, Mehrotra M, Phadte P, Rekhi B, Ray P (2022). Homo and heterotypic cellular cross-talk in epithelial ovarian cancer impart pro-tumorigenic properties through differential activation of the Notch3 pathway. Cancers. 14(14): 3365. PMID: 35884426
    119. Mukherjee S, Sharma S, Soni V, Joshi A, Gaikwad A, Bellare J, Kode J. Improved osteoblast function on titanium implant surfaces coated with nanocomposite Apatite-Wollastonite-Chitosan- an experimental in-vitro study. Journal of Materials Science: Materials in Medicine. 33(3):25. PMID: 35190908.
    120. Mukund Sudharsan MG, Dalvi S, Venkatraman P (2022). Snapshots of urea-induced early structural changes and unfolding of an ankyrin repeat protein at atomic resolution. Protein Science. 31(12):e4515. PMID: 36382986.
    121. Mulla SW, Venkatraman P (2022). Novel Nexus with NFκB, β-catenin, and RB1 empowers PSMD10/Gankyrin to counteract TNF-α induced apoptosis establishing its oncogenic role. International Journal of Biochemistry & Cell Biology. 146: 106209. PMID: 35378311.
    122. Mulye G, Gurram L, Chopra S, Gupta S, Ghosh J, Gulia S, Maheshwari A, Kerkar R, Shylasree TS, Scaria L, Dheera A, Ghadi Y, Kohle S, Kadam S, Mahantshetty U (2022). Clinical outcomes of patients treated with template based high-dose-rate interstitial brachytherapy boost for post-operative recurrent gynecological malignancies: A retrospective analysis. Journal of Contemporary Brachytherapy. 14(6): 560-567.
    123. Mummudi N , Tibdewal A, Gupta T, Patil V, Prabhash K, Agarwal JP (2022). Tackling brain metastases from lung cancer during the COVID-19 pandemic. Cancer Reports. 5:e1276. PMID: 32881412
    124. Murthy V, Adsul K, Maitre P, Singhla A, Singh P, Panigrahi G, Raveendran V, Phurailatpam R (2022). Acute and late toxicity of prostate-only or pelvic SBRT in prostate cancer: A Comparative study. International Journal of Radiation Oncology, Biology, Physics. 114(2):275-282. PMID: 35724773
    125. Narasimhan M, Khamkar V, Tilwani S, Dalal SN, Shetty D, Subramanian PG, Gupta S, Govekar R. Atypical activation of signaling downstream of inactivated Bcr-Abl mediates chemoresistance in chronic myeloid leukemia. Journal of Cell Communication and Signaling. 16(2):207-222. 2022. PMID: 34596797.
    126. Nimbalkar VK, Gangar J, Shai S, Rane P, Mohanta SK, Kannan S, Ingle A, Mittal N, Rane S, Mahimkar MB (2022). Prevention of carcinogen-induced oral cancers by polymeric black tea polyphenols via modulation of EGFR-Akt-mTOR pathway. Scientific Reports. 12(1):14516. PMID: 36008552
    127. Noronha V, Chougule A, Chandrani P, Kaushal RK, Patil VM, Menon N, Kapoor A, Chopade S, Singh A, Shetty O, Dutt A, Banavali S, Prabhash K. Lung cancer with dual EGFR and ALK driver alterations at baseline: A retrospective observational cohort study. Acta Oncologica. 61(9):1143-1147. PMID: 35972844.
    128. Noronha V, Patil VM, Menon NS, Joshi A, Goud S, More S, Kannan S, Pawar A, Nakti D, Yadav A, Shah S, Mahajan A, Janu A, Kumar R, Tibdewal A, Mummudi N, Agarwal JP, Banavali SD, Prabhash K (2022). Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: A randomized clinical trial. Esophagus. 19(4):670-682. PMID: 35614161
    129. Ojha S, Poojary M, Mokalikar U, Sumathi SH, Kumar A, Gupta A, Saha S (2022). The determinants of donor safety and product quality in optimization of apheresis granulocyte harvest: An experience from a tertiary care oncology centre in India. Transfusion and Apheresis Science. 61(5): 103445. PMID: 35450807
    130. Ostwal V, Ramaswamy A, Gota V, Bhargava PG, Srinivas S, Shriyan B, Jadhav S, Goel M, Patkar S, Mandavkar S, Naughane D, Daddi A, Nashikkar C, Shetty N, Ankathi SK, Banavali SD. Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH). Oncologist. 27(3):165-e222. PMID: 35274724
    131. Pal K, Raghuram GV, Dsouza J, Shinde S, Jadhav V, Shaikh A, Rane B, Tandel H, Kondhalkar D, Chaudhary S, Mittra I (2022). A pro-oxidant combination of resveratrol and copper down-regulates multiple biological hallmarks of ageing and neurodegeneration in mice. Scientific Reports. 12(1):17209. PMID: 36241685
    132. Panda G, Kalra B, Rishi A, Khanna N, Kakoti S, Sridhar E, Shet T, Sengar M, Nayak L, Bagal B, Jain H, Laskar S, Goda J.(2022) Long-term clinical outcomes and sequelae of therapy in early-stage orbital mucosa-associated lymphoid tissue lymphoma. Clinical Lymphoma Myeloma and Leukemia. 22(7):513-522. PMID: 35027338
    133. Pandya R, Uppangala S, Salian S, Gupta S, Kalthur G, Schlatt S, Adiga SK (2022). Short-term hypothermic holding of mouse immature testicular tissue does not alter the expression of DNA methyltransferases and global DNA methylation level, post-organotypic culture. Frontiers in Endocrinology.13:854297. PMID: 35399926
    134. Pansare K, Mohanty B, Dhotre R, Pettiwala AM, Parab S, Gupta N, Gera P, Gardi N, Dugge R, Sahu P, Alhans R, Kowtal P, Chaudhari P, Sarin R. (2022) Aspirin Inhibition of Group VI Phospholipase A2 Induces Synthetic Lethality in AAM Pathway Down-Regulated Gingivobuccal Squamous Carcinoma. Cells. 11(1):123. PMID: 35011685
    135. Pansare K, Vaid A, Singh S, Rane R, Visani A, Ranjan M, CM Krishna, Sarin R, Joseph A (2022). Effect of Cold Atmospheric Plasma Jet and Gamma Radiation Treatments on Gingivobuccal Squamous Cell Carcinoma and Breast Adenocarcinoma Cells. Plasma Chemistry and Plasma Processing. 42: 163–178.
    136. Pantvaidya G, Joshi S, Nayak P, Kannan S, Desouza A, Poddar P, Prakash G, Vijaykumaran P, Nair D, Vaish R, Patkar S, Niyogi D, Joshi P, Chaudhari V, Sigh V, Mathews S, Pramesh CS, Badwe R, Puri A (2022). Surgical Site Infections in patients undergoing major oncological surgery during the COVID-19 paNdemic (SCION): A propensity-matched analysis. Journal of Surgical Oncology. 125(3):327-335. PMID: 34729779
    137. Parekh D, Patil VM, Nawale K, Noronha V, Menon N, More S, Goud S, Jain S, Mathrudev V, Peelay Z, Dhumal S, Jogdhankar S, Prabhash K (2022) Audit of screen failure in 15 randomised studies from a low and middle-income country. Ecancermedicalscience. 16:1476
    138. Parsaniya BS, Pinto A, Tambe M, D'Silva SZ, Singh M (2022). Identification of the novel HLA allele, HLA-DRB1*14:245, in an individual from Northern India. HLA. PMID: 36006395
    139. Parsaniya BS, Tambe M, D'Silva SZ, Singh M (2022). Identification of the HLA-A allele, HLA-A*11:03:01:02, in two individuals in a Western Indian family. HLA. PMID: 36006407
    140. Parui A, Mishra V, Dutta S, Bhaumik P, Bose K (2022). Inter-subunit crosstalk via PDZ synergistically governs allosteric activation of proapoptotic HtrA2. Structure. 30(9): 1307-1320. e5.PMID: 35738282
    141. Patel U, Kannan S, Rane SU, Mittal N, Gera P, Patil A, Manna S, Shejwal V, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB. Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab. British Journal of Cancer. 126(10):1439-1449. PMID: 35140342
    142. Patil R, Gupta T, Maitre M, Dasgupta A, Sahay A, Epari S, Shirsat N, Chatterjee A, Krishnatry R, Goda JS, Moiyadi A, Patil V, Chinnaswamy G, Bano N, Jalali R (2022). Clinical audit of survival outcomes and prognostic factors in adolescents and adults with medulloblastoma. Journal of Adolescent and Young Adult Oncology. 11(1):68-77. PMID: 33891492
    143. Patil V, Menon N, Chatterjee A, Tonse R, Choudhari A, Mahajan A, Puranik A, Epari S, Jadhav M, Pathak S, Peelay Z, Walavalkar R, Muthuluri H, Krishna M, Chandrasekharan A, Pande N, Gupta T, Banvali S, Jalali R (2022). Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial. EClinicalMedicine. 49: 101449.PMID: 35747192
    144. Patil V, Noronha V, Joshi A, Menon N, Mathrudev V, Bhattacharjee A, Chandrasekharan A, Vallathol D, Dsouza H, Srinivas S, Mandal T, Chaturvedi P, Chaukar D, Pai P, Nair S, Thiagrajan S, Laskar S, Nawale K, Babanrao Dhumal S, Tambe R, Banavali S, Prabhash K. RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation. Oral Oncology.128: 105816. PMID: 35367787.
    145. Patwardhan S, Patil V, Baheti A, Shukla A, Qureshi S (2022). Relapse of acute lymphoblastic leukemia presenting with ovarian torsion: A rare case report. Pediatric Hematology Oncology Journal. 7(3): 81-83.
    146. Paul S, Arya S, Mokul S, Baheti A, Kumar S, Ramaswamy A, Ostwal V, Chopra S, Saklani A, deSouza A, Kazi M, Engineer R. Extramural vascular invasion as an independent prognostic marker in locally advanced rectal cancer: propensity score match pair analysis. Abdominal Radiology. 47(11):3671-3678. PMID: 36085377
    147. Pawar A, Chowdhury OR, Chauhan R, Talole S, Bhattacharjee A. (2022) Identification of key gene signatures for the overall survival of ovarian cancer. Journal of Ovarian Research. 15:12. PMID: 35057823
    148. Pilankar A, Singhavi H, Raghuram G, Siddiqui S, Khare N, Jadhav V, Tandel H, Pal K, Bhattacharjee A, Chaturvedi P, Mittra I (2022). A pro-oxidant combination of resveratrol and copper down regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer: Results of an exploratory study (RESCU 004).Frontiers in Oncology. PMID: 36185249
    149. Pinto AS, Tambe M, D'Silva SZ, Singh M (2022). Identification of the novel HLA-B*51:01:01:108 allele and confirmation of HLA-B*40:387 in two Indian individuals. HLA.
    150. Poojari R, Mohanty B, Kadwad V, Suryawanshi D, Chaudhari P, Khade B, Srivastava R, Gupta S, Panda D.(2022) Combinatorial Cetuximab targeted polymeric nanocomplexes reduce PRC1 level and abrogate growth of metastatic hepatocellular carcinoma in vivo with efficient radionuclide uptake. Nanomedicine: Nanotechnology, Biology and Medicine. 41: 102529.PMID: 35104671
    151. Pramesh CS, Badwe RA, Bhoo-Pathy N, Booth CM, Chinnaswamy G, Dare AJ, de Andrade VP, Hunter DJ, Gopal S, Gospodarowicz M, Gunasekera S, Ilbawi A, Kapambwe S, Kingham P, Kutluk T, Lamichhane N, Mutebi M, Orem J, Parham G, Ranganathan P, Sengar M, Sullivan R, Swaminathan S, Tannock IF, Tomar V, Vanderpuye V, Varghese C, Weiderpass E. Priorities for cancer research in low- and middle-income countries: a global perspective. Nature Medicine. 28(4):649-657. PMID: 35440716.
    152. Puja R, Chakraborty A, Dutta S, Bose K (2022). Purification, characterization and functional site prediction of the vaccinia-related kinase 2A small transmembrane domain. MethodsX. 9:101704. PMID: 35518920
    153. Punatar S, Kandekar S, Khattry N, Gokarn A, Prabhash K, Bakshi A, Rane P, Mathew L, Chiplunkar S, Kode J( 2022). CD26 expression on donor harvest as a risk predictive biomarker for developing Graft-versus-Host Disease post-Allogeneic Hematopoietic Stem Cell Transplantation: A tenyear followup study. Cancer Biomarkers. 33(1): 17-28. PMID: 34334382.
    154. Punatar S, Katti K, Rajamanickam D, Patil P, Dhakan C, Bagal B, Gokarn A, Bonda A, Nayak L, Gurjar M, Kannan S, Chiplunkar S, Gota V, Khattry N (2022). Cell Transplantation. PMID: 35435039
    155. Raghavan R, Koyande N, Beher R, Chetlangia N, Ramadwar M, Pawade S, Thorat R, Hengel J, Sklyarova T, Roy F, Dalal SN.(2022) Plakophilin3 loss leads to increased adenoma formation and rectal prolapse in APC min mice. Biochemical and Biophysical Research Communications. 58: 14-19. 34823217
    156. Rajak J, Tambe M, D'Silva SZ, Singh M (2022). Identification of the novel HLA-A*68:175:02 and -A*68:287 alleles in Indian individuals. HLA. 100(5):517-518. PMID: 35896953
    157. Rajak J, Tambe M, Phuntsok T, D'Silva SZ, Singh M (2022. The novel HLA-B*07:461 allele and confirmation of the HLA-C*15:193 allele in individuals from Eastern India. HLA. 100(3):262-263.
    158. Ramaswamy A, Bhargava P, Srinivas S, Kannan S, Bhandare M, Chaudhari V, Mantri A, Kapoor A, Das S, Booma N, Chaugule D, Shrikhande SV, Ostwal V (2022). Perioperative modified FLOT versus EOX in locally advanced resectable gastric and gastro-oesophageal junction adenocarcinoma: Results of a matched-pair analysis. Journal of Gastrointestinal Cancer.PMID: 36242748
    159. Ranjan N, Chopra S, Mangaj A, Rane P, Charnalia M, Kannan S, Dora T, Engineer R, Mahantshetty U, Gurram L, Mittal P, Ghosh J, Maheshwari A, Shylasree TS, Gupta S, Shrivastava SK (2022). Months and severity score (MOSES) in a phase III trial (PARCER): A new comprehensive method for reporting adverse events in oncology clinical trials. EClinicalMedicine. 47: 101390. PMID: 35480072
    160. Razis E, Escudero MJ, Palmieri C, Mueller V, Bartsch R, Rossi G, Gampenrieder SP, Kolberg HC, Zdenkowski N, Pavic M, Connolly RM, Rosset L, Arcuri J, Tesch H, Vallejos C, Retamales J, Musolino A, Del Mastro L, Christodoulou C, Aebi S, Paluch-Shimon S, Gupta S, Ohno S, Macpherson I, Ekholm M, Zaman K, Vidal M, Chakiba C, Fumagalli D, Thulin A, Witzel I, Kotecki N, Gil-Gil M, Linderholm B (2022). Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force. ESMO Open. 7(3): 100483. PMID: 35576695
    161. Reddy D, Bhattacharya S, Shah S, Rashid M, Gupta S (2022). DNA methylation mediated downregulation of histone H3 variant H3.3 affects cell proliferation contributing to the development of HCC.Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.1868: 166284.PMID: 34626773
    162. Rekhi B, Dodd L, Dharavath B, Dutt A (2022). Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result. Diagnostic Cytopathology. 50(12): E367-372. PMID: 35929754
    163. Rubagumya F, Sengar M, Ka S, Hammad N, Booth C, Karim S (2022). Choosing wisely—barriers and solutions to implementation in low and middle-income countries. Current Oncology. 29(7): 5091-5096. PMID: 35877263
    164. Saikia D, Jadhav P, Hole A, CM Krishna, Singh SP. Unraveling the secrets of colistin resistance with label-free Raman Spectroscopy. Biosensors. 12(9): 749.
    165. Saikia D, Jadhav P, Hole AR, CM Krishna, Singh SP (2022). Growth kinetics monitoring of gram-negative pathogenic microbes using Raman Spectroscopy. Applied Spectroscopy. 76(10):1263-1271. PMID: 35694822
    166. Sangle A, Bhat V, Biswas S, Tikhile A (2022). Microbiology, risk factors and clinical outcomes of Ventilator associated pneumonia at tertiary care Cancer hospital. MedPulse International Journal of Microbiology. 21(1): 15-20.
    167. Saju AC, Chatterjee A, Sahu A, Gupta T, Krishnatry R, Mokal S, Sahay A, Epari S, Prasad M, Chinnaswamy G, Agarwal JP, Goda JS (2022). Machine-learning approach to predict molecular subgroups of medulloblastoma using multiparametric MRI-based tumor radiomics. British Journal of Radiology. 23:20211359. PMID: 35262407.
    168. Sali A, Shah A, Prakash G, Murthy V, Bakshi G, Joshi A, Aggarwal A, Desai S, Menon S (2022). Predictors of pelvic lymph nodal metastasis in penile squamous cell carcinoma- Results from a matched-pair analysis. Clinical Genitourinary Cancer. PMID: 36535810
    169. Sanapalli B, Yele V, Sigalapalli D, Gadewal N, Shaik A, Bhandare R, Annadurai S, Karri VVSR. (2022) Forging of nicotine for the effective management of diabetic wounds: A hybrid of scaffold hopping and molecular dynamics simulation approaches. Arabian Journal of Chemistry. 15(2): 103585.
    170. Sandbhor P, Goda JS, Mohanty B, Chaudhari P, Dutt S, Banerjee R (2022). Bio-polymeric transferrin-targeted temozolomide nanoparticles in gel for synergistic post-surgical GBM therapy. Nanoscale. 14(35): 12773-12788. PMID: 36001382.
    171. Sawhney S, Thiagarajan S, Balaji A, Sathe P, Jain S, Rukmangathan TM, Kannan S, Shah S, Chaukar D.(2022) Results of sequential swallowing assessments in patients undergoing upfront surgery for oral tongue squamous cell carcinoma.Oral Oncology. 125:105684. PMID: 34963096
    172. Sen S, Khan PK, Wadasadawala T, Mohanty SK. Socio-economic and regional variation in breast and cervical cancer screening among Indian women of reproductive age: a study from National Family Health Survey, 2019-21. BMC Cancer. 22(1):1279. PMID: 36476339.
    173. Shah M, Noronha V, Ramaswamy A, Gattani S, Mokal S, Joshi A, Patil V, Menon S, Banavali S, Badwe R, Prabhash K (2022). G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer. Journal of Geriatric Oncology. 13(5):720-730PMID: 35283049
    174. Sharma A, Kumar A, Rashid M, Amnekar RV, Gupta S, Kaur J. (2022) A Phagosomally Expressed Gene, rv0428c, of Mycobacterium tuberculosis Demonstrates Acetyl Transferase Activity and Plays a Protective Role Under Stress Conditions. Protein Journal. 41(2):260-273. PMID: 35175508
    175. Sharma KS, Raju M S, Phapale S, Valvi SK, Dubey AK, Goswami D, Ray D, De A, Phadnis PP, Aswal VK, Vatsa R, Sarma HD (2022). Multimodal applications of zinc gallate-based persistent luminescent nanoparticles in cancer treatment: Tumor margining, diagnosis, and boron neutron capture therapy. ACS Applied Bio Materials. 5(7):3134-3145. PMID: 35758411.
    176. Shenoy P, Chakraborty S, Gaikwad S, Sakpal A, Ray P (2022). Developing clinically relevant acquired chemoresistance models in epithelial ovarian cancer cell lines. Bio-protocol. 12(3): e4310.
    177. Shetty A, Chatterjee G, Rajpal S, Srivastava T, Gardi N, Mirgh S, Gokarn A, Punatar S, Shetty N, Joshi A, Nair S, Murthy V, Khattry N, Tembhare P, Dikshit R, Chaturvedi P, More A, Kamtalwar S, Chavan P, Bhat V, Patil A, Dhumal S, Bhat P, Subramanian P, Gujral S, Badwe R, Patkar N, Gupta S.(2022) "Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai". International Journal of Clinical Practice. 2022: 24490682.PMID: 35685574
    178. Shetty D, Talker E, Dhamne C, Mohanty P, Chaubal K, Tembhare P, Patkar N, Subramanian PG, Moulik NR, Narula G, Banavali S (2022). Copy number gain of JAK2 on marker chromosome in a case of relapsed pediatric B-ALL. Pediatric Blood and Cancer. 69(10):e29658. PMID: 35373889.
    179. Shetty D, Talker E, Jain H, Talker J, Patkar N, Subramanian P, Jain H, Bonda A, Punatar S, Gokarn A, Bagal B, Sengar M, Khattry N (2022 ). Evaluation of cytogenetic response in CML patients with variant Philadelphia translocation. Asia Pacific Journal of Clinical Oncology. 18(1):99-108 PMID: 33629824
    180. Shetty K, Yasaswi S, Dutt S, Yadav K (2022). Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy. 3Biotech. 12(11):301. PMID: 36276454
    181. Shriyan B, Mehta P, Patil A, Jadhav S, Kumar S, Puri AS, Govalkar R, Krishnamurthy MN, Punatar S, Gokarn A, Khattry N, Gota V (2022). Role of ADME gene polymorphisms on imatinib disposition: results from a population pharmacokinetic study in chronic myeloid leukaemia. European Journal of Clinical Pharmacology. 78(8):1321-1330. PMID: 35652931.
    182. Shukla P, Dange P, Mohanty BS, Gadewal N, Chaudhari P, Sarin R (2022). ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and β-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications. Cancer Gene Therapy. 29(12):1908-1917. PMID: PMID: 35869277
    183. Singh AG, Sathe P, Roy S, Thiagrajan S, Chaukar D, Chaturvedi P (2022).Incidence and impact of skip metastasis in the neck in early oral cancer: Reality or a myth? Oral Oncology. 135: 106201.PMID: 36242909
    184. Singh B, Roy Chowdhury S, Mansuri MS, Pillai SJ, Mehrotra S (2022). The BRCA2 and CDKN1A-interacting protein (BCCIP) stabilizes stalled replication forks and prevents degradation of nascent DNA. FEBS Letters. 596(16):2041-2055. PMID: 35592921
    185. Singh GP, Dholam KP, V Gurav S (2022). Revisiting Stage II MRONJ. Proposal for modification of AAOMS staging system: An institutional experience. Oral Diseases. 28(4):1289-1291. PMID: 34228868
    186. Singh P, Ambulkar R, Gupta A, Maji M (2022). Timely diagnosis and intervention in a case of portal vein thrombosis, Journal of Anaesthesiology Clinical Pharmacology.
    187. Sitani K, Parghane R, Talole S, Basu S (2022). The efficacy, toxicity and survival of salvage retreatment PRRT with 177Lu-DOTATATE in patients with progressive NET following initial course of PRRT. British Journal of Radiology. 95(1137): 20210896. PMID: 35816545.
    188. Soh KT, Came N, Otteson GE, Jevremovic D, Shi M, Olteanu H, Natoni A, Lagoo A, Theakston E, Óskarsson JÞ, Gorniak M, Grigoriadis G, Arroz M, Fletcher M, Lin P, Ludwig P, Tembhare P, Matuzeviciene R, Radzevicius M, Kay S, Chen W, Cabrita C, Wallace PK. (2022) Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis. Cytometry Part B: Clinical Cytometry. 102(2):88-106. PMID: 35005838
    189. Spampinato AS Jensen N, Pötter R, Fokdal L, Chargari C, Lindegaard J, Schmid M, Sturdza A, Ina M. Schulz J, Mahantshetty U, Hoskin P, Segedin B, Rai B, Bruheim K, Wiebe E, Steen-Banasik E, Cooper R, Limbergen E, Sundset M, Pieters B, Lutgens L, Tan L, Villafranca E, Smet S, Jastaniyah N, Nout R, Kirisits C, Chopra S, Kirchheiner K, Tanderup K (2022). EMBRACE Collaborative Group. Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: lessons learned from EMBRACE-I and implications for the future. International Journal of Radiation Oncology Biology Physics. 112(3):681-693.PMID: 34678431
    190. Spohn S, Draulans C, Kishan A, Spratt D, Ross A, Maurer T, Tilki D, Berlin A, Blanchard P, Collins S, Bronsert P, Chen R, Pra A, Meerleer G, Eade T, Haustermans K, Hölscher T, Höcht S, Ghadjar P, Davicioni E, Heck M, Kerkmeijer L, Kirste S, Tselis N, Tran P, Pinkawa M, Pommier P, Deltas C, Schmidt-Hegemann N, Wiegel T, Zilli T, Tree A, Qiu X, Murthy V, Epstein J, Graztke C, Gao X, Grosu A, Kamran S, Zamboglou C (2022). Genomic classifiers in personalized prostate cancer radiotherapy approaches – A systematic review and future perspectives based on international consensus. International Journal of Radiation Oncology, Biology Physics. PMID: 36596346
    191. Sreevidya TS, Dalvi S, Venkatraman P, Vemparala S. (2022) Structural insights on the effects of mutation of a charged binding pocket residue on phosphopeptide binding to 14-3-3ζ protein. Proteins: Structure, Function, and Bioinformatics. 90(5): 1179-1189. PMID: 35006623.
    192. Srinivasan S, Dasgupta A, Chatterjee A, Baheti A, Engineer R, Gupta T, Murthy V (2022). The promise of magnetic resonance imaging in radiation oncology practice in the management of brain, prostate, and GI malignancies. JCO Global Oncology. 8:e2100366 PMID: 35609219
    193. Sriram H, Kunjachan F, Khanka T, Gawai S, Ghogale S, Deshpande N, Girase K, Patil J, Chatterjee G, Rajpal S, Patkar NV, Bagal B, Jain H, Sengar M, Hasan SK, Khattry N, Subramanian PG, Gujral S, Tembhare PR( 2022). Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent. Cytometry B Clinical Cytometry. 102(6):462-470. PMID: 36346307.
    194. Starr NE, Moore JN, Shreckengost CSH, Fernandez K, Ambulkar RP, Capo-Chichi N, Varallo JE, Ademuyiwa AO, Krouch S, Rana PS, Ingabire JA, Weiser TG, Mammo TN, Evans FM (2022). Perioperative provider safety in the pandemic: Development, implementation and evaluation of an adjunct COVID-19 Surgical Patient Checklist. Anaesthesia and Intensive Care. 50(6):457-467. PMID: 35765829.
    195. Sthanam L, Roy T, Patwardhan S, Shukla A, Sharma S, Shinde P, Kale H, Shekar P, Kondabagil K, Sen S. (2022).MMP modulated differentiation of mouse embryonic stem cells on engineered cell derived matrices. 280:121268 .Biomaterials.PMID: 34871878
    196. Sulkshane P, Teni T (2022). Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it. Exploration of Targeted Anti-tumor Therapy. 3: 278–96. Sulkshane P, Teni T (2022). Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it. Exploration of Targeted Anti-tumor Therapy. 3: 278–96. PMID: 36045907
    197. Sunkara RR, Koulgi S, Jani V, Gadewal N, Sonavane U, Joshi R, Waghmare SK (2022).Understanding the binding affinities between SFRP1CRD, SFRP1Netrin, Wnt5B and frizzled receptors 2, 3 and 7 using MD simulations. Journal of Biomolecular Structure and Dynamics. 40(15):6831-6844. PMID: 33666148
    198. Sunkara RR, Mehta D, Sarate RM, Waghmare SK (2022). BMP-AKT-GSK3β signalling restores hair follicle stem cells decrease associated with loss of Sfrp1. Stem Cells. 40(9):802-817. PMID: 35689817.
    199. Swain M, Kannan S, Srinivasan S, Agarwal JP, Gupta T (2022). Concurrent cetuximab-based bioradiotherapy versus cisplatin-based chemoradiotherapy in the definitive management of favourable biology human papillomavirus-associated oropharyngeal squamous cell carcinoma: systematic review and meta-analysis. Clinical Oncology (R Coll Radiol) 34:786-795.
    200. Swamidas J, Jain J, Nesvacil N, Tanderup K, Kirisits C, Schmid M, Agarwal P, Joshi K, Naga P, Ranjan Khadanga C, Gudi S, Gurram L, Chopra S, Mahantshetty U. Dosimetric impact of target definition in brachytherapy for cervical cancer - Computed tomography and trans rectal ultrasound versus magnetic resonance imaging. Physics and Imaging in Radiation Oncology. 21:126-133. PMID: 35257030
    201. Talukdar R, Epari S, Sahay A, Choudhari A, Dasgupta A, Chatterjee A, Gupta T (2022). Endolymphatic sac tumor: single-institution series of seven cases with updated review of literature. European Archives of Oto-Rhino-Laryngology. 279(5):2591-2598.PMID: 34410472
    202. Tambe M, Pinto A, D'Silva SZ, Singh M (2022). Identification of the novel HLA allele, HLA-DRB1*14:50:02, in an individual from southern India. HLA. 100(4):392-393. PMID: 35672230.
    203. Tembhare PR, Sriram HN, Chatterjee G, Khanka T, Gokarn A, Mirgh S, Rajendra A, Chaturvedi A, Ghogale SG, Deshpande N, Girase K, Dalvi K, Rajpal S, Patkar N, Trivedi B, Joshi A, Murthy V, Shetty N, Nair S, More A, Kamtalwar S, Chavan P, Bhat V, Bhat P, Subramanian PG, Gupta S, Khattry N (2022). Comprehensive immune cell profiling depicts an early immune response associated with severe COVID-19 disease in cancer patients. Immunology and Cell Biology. 100(1):61-73. PMID: 34582592.
    204. Tibdewal A, Pathak R, Kumar A, Anand S, Ghosh Laskar S, Sarin R, Chopra S, Engineer R, Laskar S, Murthy V, Gupta T, Agarwal JP (2022). Impact of the first Wave of COVID-19 pandemic on radiotherapy practice at Tata Memorial Centre, Mumbai: A longitudinal cohort study. JCO Global Oncology. PMID: 35802835.
    205. Turco F, Armstrong A, Attard G... Murthy V. et al. (2022). What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology. 82(1):6-11. PMID: 35393158
    206. Uthale A, Anatram A, Sulkshane P, Degani M, Teni T (2022). Identification of bicyclic compounds that act as dual inhibitors of Bcl-2 and Mcl-1. Molecular Diversity. PMID: 35909144
    207. Vahabi M, Lofters AK, Mishra G, Pimple S, Wong JP (2022). A family-centered sexual health intervention to promote cervical cancer screening uptake among low-income rural women in India: Protocol for a community-based mixed methods pilot study. JMIR Research Protocols. 11(9):e35093. PMID: 36074549
    208. Verghote F, Sargos P, Christodouleas JP, Murthy V, Baumann B, Dirix P, Berghen C, Paelinck L, Vercauteren T, Fonteyne V (2022). International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy: Update from an IBIS workgroup. Practical Radiation Oncology. 12(6):524-532. PMID: 35691550
    209. Vishwakarma GK, Kumari P, Bhattacharjee A.(2022) Thresholding of prominent biomarkers of breast cancer on overall survival using classification and regression tree. Cancer Biomarkers. 34(2):319-328. PMID: 35001879.
    210. Vu MT, Shalkow J, Naik- Mathuria B, Qureshi S, Ozgediz D, Lakhoo K, Abdelhafeez H, On behalf of the Pan African Paediatric Surgery Association (PAPSA) and Global Initiative for Children’s Surgery (GICS) initiative. Wilms’ tumor in low- and middle-income countries: survey of current practices, challenges, and priorities Annals of Pediatric Surgery (2022). 18:28.
    211. Waghmare M, Qureshi T, CM Krishna, Pansare K, Gadewal N, Hole A, Dongre P (2022). β-Lactoglobulin-gold nanoparticles interface and its interaction with some anticancer drugs – an approach for targeted drug delivery. Journal of Biomolecular and Structural Dynamics. 40(13):6193-6210. PMID: 33509048
    212. Yadav N, Sunder R, Desai S, Dharavath B, Chandrani P, Godbole M, Dutt A (2022). Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer. Breast Cancer Research. 24(1):97. PMID: 36578092.
  • 2021
    1. Anand D, Yashashwi K, Kumar N, Rane S, Gann PH, Sethi A (2021). Weakly supervised learning on unannotated hematoxylin and eosin stained slides predicts BRAF mutation in thyroid cancer with high accuracy. Journal of Pathology. 255(3):232-242 PMID: 34346511
    2. Anand S, Chatterjee A, Gupta T, Panda P, Moiyadi A, Epari S, Patil V, Krishnatry R, Goda JS, Jalali R (2021). Upfront therapy of aggressive/high-risk low-grade glioma: single institution outcome analysis of temozolomide-based radio-chemotherapy and adjuvant chemotherapy. World Neurosurgery.154: e176-e184 PMID: 34245877.
    3. Augustine S, Sooraj KP, Pachchigar V, CM Krishna, Ranjan M (2021). SERS based detection of Dichlorvos pesticide using silver nanoparticles arrays: Influence of array wavelength/amplitude. Applied Surface Science. 544: 148878
    4. Bajpai J, Simha V, Shylasree TS, Sarin R, Pathak R, Popat P, Mokal S, Dandekar S, Ghosh J, Nair N, Gulia S, Rath S, Joshi S, Wadasadawala T, Sheth T, Parmar V, Banavali SD, Badwe RA, Gupta S (2021). Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, India. Breast. 56: 88-95. PMID: 33640524
    5. Bajpai J, Pradeep V, Joshi S, Wadasadawala T, Rath S, Pathak R, Nandhara R, Mohanty S, Chougle Q, Engineer M, Abraham N, Ghosh J, Nair N, Gulia S, Popat P, Patil A, Sheth T, Desai S, Thakur M, Rangrajan V, Parmar V, Sarin R, Gupta S, Badwe R (2021). Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India. The Breast. 60: 177-184. PMID: 34655887
    6. Balla MMS, Patwardhan S, Melwani PK, Purwar P, Kumar A, Pramesh CS, Laskar S, Pandey BN (2021). Prognosis of metastasis based on age and serum analytes after follow-up of non-metastatic lung cancer patients. Translational Oncology. 14(1): 100933. PMID: 33188981
    7. Barreto SG, Gardi N, Dutt S. Birth of a solid organ cancer-the cell fusion hypothesis presented with pancreatic cancer as a model: a narrative review. Chinease Clinical Oncology.10(5):45. PMID: 34670374.
    8. Baumann BC, Zaghloul MS, Sargos P, Murthy V (2021). Adjuvant and neoadjuvant radiation therapy for locally advanced Bladder cancer. Clinical Oncology. 33(6): 391-399. PMID: 33972025
    9. Bhagatram J, Krishamurthy MN, Awase A, Joshi A,Patil V, Noronha V, Prabhash K, Gota V. Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy. Therapeutic Advances in Drug Safety. PMID: 33628419
    10. Bhardwaj P, Goda JS, Pai V, Chaudhari P, Mohanty B, Pai T, Vishwakarma K, Thorat R, Wadasadawala T, Banerjee R (2021). Ultrasound augments on-demand breast tumor radiosensitization and apoptosis through a tri-responsive combinatorial delivery theranostic platform. Nanoscale. 13(40):17077-17092.PMID: 34622906
    11. Bhat V, Chavan P, Bhat P, Khattry N (2021). COVID-19-positive health-care workers in an oncology setup: Considerations for return to work. International Journal of Health and Allied Sciences. 10(3): 249-251.
    12. Bhati M, Balakrishna G, Joshi K, Bhattacharya K, Bal M, Ghosh Laskar S, Sinha S, Joshi A, Joshi P, Nair S. Fibromatoses of head and neck: Case series and literature review. Rambam Maimonides Medical Journal. 12(3): e0022. PMID: 34270403
    13. Bhatia A, Victora CG, Beckfield J, Budukh A, Krieger N (2021). "Registries are not only a tool for data collection, they are for action": Cancer registration and gaps in data for health equity in six population-based registries in India. International Journal of Cancer. 148 (9): 2171-2183. PMID: 33186475.
    14. Bhattacharjee A, Hole A, Malik A, Sahu A, Singh SP, Deshmukh A, Nair S, Chaturvedi P, CM Krishna (2021). Risk prediction by Raman spectroscopy for disease-free survival in oral cancers. Lasers Medical Science. 36(8):1691-1700. PMID: 33661401
    15. Bier-Laning C, Cramer JD, Roy S, Palmieri PA, Amin A, Añon JM, Bonilla-Asalde CA, Bradley PJ, Chaturvedi P, Cognetti DM, Dias F, Di Stadio A, Fagan JJ, Feller-Kopman DJ, Hao SP, Kim KH, Koivunen P, Loh WS, Mansour J, Naunheim MR, Schultz MJ, Shang Y, Sirjani DB, St John MA, Tay JK, Vergez S, Weinreich HM, Wong EWY, Zenk J, Rassekh CH, Brenner MJ (2021). Tracheostomy during the COVID-19 Pandemic: Comparison of International Perioperative Care Protocols and Practices in 26 Countries. Otolaryngoly- Head Neck Surgery. 164(6):1136-1147. PMID: 33138722.
    16. Bishnu A, Phadte P, Dhadve A, Sakpal A, Rekhi B, Ray P (2021). Molecular imaging of the kinetics of hyperactivated ERK1/2-mediated autophagy during acquirement of chemoresistance. Cell death & disease, 12(2):161. PMID: 33558461
    17. Bishnu A, Mehrotra M, Dhadve A, Dimri S, De A, Ray P (2021). Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer. Translational Oncology. 14(11):101193. PMID: 34365218
    18. Borah P, Mirgh S, Sharma S, Bansal S, Dixit A, Dolai T, Lunkad S, Gupta N, Singh G, Jain A, Bansal D, Choudhary D, Khandelwal V, Doval D, Kumar M, Bhargava R, Chakrabarti A, Kalashetty M, Rauthan A, Kazi B, Mandal P, Jeyaraman P, Naithani R. AIIMS Hematology Alumni Group. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies. Blood Cells, Molecules, and Diseases. 87: 102525. PMID: 33338697
    19. Bose A, Modi K, Dey S, Dalvi S, Nadkarni P, Sudarshan M, Kundu TK, Venkatraman P, Dalal SN (2021). 14-3-3γ prevents centrosome duplication by inhibiting NPM1 function. Genes to Cells. 26(6):426-446. PMID: 33813791
    20. Bose K, Wagh A, Mishra V, Dutta S, Parui A, Puja R, Pandav-Mudrale S, Kulkarni S, Gai P, Sarin R (2021). Loss of GSK-3β mediated phosphorylation in HtrA2 contributes to uncontrolled cell death with Parkinsonian phenotype. International Journal of Biological Macromolecules. 180: 97-111. PMID: 33716130
    21. Budhraja A, Pandey S, Kannan S, Verma CS, Venkatraman P (2021). The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus – evolved or yet to evolve. Biochemistry and Biophysics Reports. 25: 10907. PMID: 33521335
    22. Budukh A, Dikshit R, Chaturvedi P (2021). Outcome of the randomized control screening trials on Oral, Cervix and Breast Cancer from India and way forward in COVID-19 pandemic situation. International Journal of Cancer. 149(8):1619-1620. PMID: 34152021
    23. Budukh A, Chaudhary D, Sancheti S, Dora T, Goel A, Singla A, Sali A, Shinde S, Chauhan K, Kadam P, Mohammad R, Kapoor R, Chaturvedi P, Dikshit R , Badwe R(2021) Determinants of completion of cancer directed treatment: an experience from a rural cancer centre, Sangrur, Punjab state, India. ecancer. 15:1313.PMID: 35047064
    24. Butle A, Joshi A, Noronha V, Prabhash K, Dutt A (2021). Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs. Translational Oncology. 14(8):101111. PMID: 33993094
    25. Chakraborty S, Varma AK (2021). Crystal structure of clinically reported mutations Gly656Arg, Gly656Glu and Asp751His identified in the kinase domain of EphA7. Biochemical and Biophysical Research Communications. 568: 62-67. PMID: 34186436
    26. Chatterjee G, Dudakia V, Ghogale S, Deshpande N, Girase K, Chaturvedi A, Shetty D, Senger M, Jain H, Bagal B, Bonda A, Punatar S, Gokarn A, Khattry N, Patkar NV, Gujral S, Subramanian PG, Tembhare PR (2021). Expression of CD304/neuropilin-1 in adult b-cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment. International Journal of Laboratory Hematology. 43(5):990-999. PMID: 33432783.
    27. Chatterjee M, Nakhate S, Trivedi B, Talole S. Efficacy of Pulmonary telerehabilitation of cancer patients infected with Covid -19 virus: Preliminary data of a pilot study. Journal of Cancer Rehabilitation. 4: 50-53.
    28. Chaudhary N, Choudhary BS, Shah SG, Khapare N, Dwivedi N, Gaikwad A, Joshi N, Raichanna J, Basu S, Gurjar M, Smitha PK, Saklani A, Gera P, Ramadwar M, Patil P, Thorat R, Gota V, Dhar SK, Gupta S, Das M, Dalal SN (2021). Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer. International Journal of Cancer. 149(7):1495-1511.PMID: 34146401
    29. Chilukuri S, Murthy V (2021) . Adjuvant radiation for prostate cancer: Too early to abandon? BJU International. 128(1):23-24. PMID: 33834591
    30. Chopra S, Mangaj A, Sharma A, Tan LT, Sturdza A, Schulz I, Han K, Huang F, Schmid M, Fokdal L, Chargari C, Diendorfer T, Tanderup K, Potter R, Nout R (2021). Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network 155: 151-159. Radiotherapy and Oncology. PMID: 33144247
    31. Chopra S, Gupta S, Kannan S, Dora T, Engineer R, Mangaj A, Maheshwari A, Shylasree TS, Ghosh J, Paul SN, Phurailatpam R, Charnalia M, Alone M, Swamidas J, Mahantshetty U, Deodhar K, Kerkar R, Shrivastava SK (2021). Late Toxicity after Adjuvant Conventional Radiation versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial. Journal of Clinical Oncology. 39(33):3682-3692. PMID: 34506246.
    32. Damast S, Fields E, Kidd E, Harkenrider M, Chopra S, Chino J (2021). Reports from Four International Clinical Trials for Cancers of the Cervix, Uterus and Vulva, and a New Guideline for Cervical Cancer. International Journal of Radiation Oncology Biology Physics. 111(2):299-306. PMID: 34473967
    33. Das D, Maitra A, Panda CK, Ghose S, Roy B, Sarin R, Majumder PP (2021). Genes and pathways monotonically dysregulated during progression from normal through leukoplakia to gingivo-buccal oral cancer. NPJ Genomic Medicine. 6(1):32. PMID: 33980865
    34. Das L, Shekhar S, Chandrani P, Varma AK.(2021) In silico structural analysis of secretory clusterin to assess pathogenicity of mutations identified in the evolutionarily conserved regions.Journal of Biomolecular Structure & Dynamics. PMID: 34821197.
    35. D'Cruz AK, Dhar H, Vaish R, Hawaldar R, Gupta S, Pantvaidya G, Chaukar D, Chaturvedi P, Pai P, Deshmukh A, Kane S, Nair D, Nair SV, Ghosh-Laskar S, Agarwal J (2021). Depth of invasion in early oral cancers- is it an independent prognostic factor? Eur J Surg Oncol. 47(8):1940-1946.PMID: 33814237.
    36. de Souza R, Mhatre S, Qayyumi B, Chitkara G, Madke T, Joshi M, Bharmal R, Asgaonkar DS, Lakhani P, Gupta S, Chaturvedi P, Dikshit R, Badwe R (2021). Clinical course and outcome of patients with COVID-19 in Mumbai City: an observational study. BMJ Open. 11(5): e042943. PMID: 33958335
    37. Deogharkar A, Singh SV, Bharambe HS, Paul R, Moiyadi A, Goel A, Shetty P, Sridhar E, Gupta T, Jalali R, Goel N, Gadewal N, Muthukumar S, Shirsat NV (2021). Downregulation of ARID1B, a tumor-suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways. Human Molecular Genetics. 30(18):1721-1733. PMID: 33949667
    38. Desai S, Rane A, Joshi A, Dutt A. IPD 2.0: To derive insights from an evolving SARS-CoV-2 genome. BMC Bioinformatics. 22(1): 247. PMID: 33985433
    39. Desai S, Rashmi S, Rane A, Dharavath B, Sawant A, Dutt A (2021). An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome. Briefings in Bioinformatics. 22(2):1065-1075. PMID: 33479725
    40. Deshpande G, Epari S, Gupta C, Shetty O, Gurav M, Chinnaswamy G, Gupta T (2021). Primary intracranial Ewing sarcoma/ peripheral primitive neuroectodermal tumor, an entity of unacquaintance: a series of 8 cases. Child's Nervous System. 37(3):839-849. PMID: 32761378
    41. Dev ID, Puranik AD, Purandare NC, Gupta T, Sridhar E, Shetty P, Moiyadi A, Agrawal A, Shah S, Rangarajan V (2021). Prognostic significance of 18F-FDG PET/CT parameters in IDH-1 wild-type GBM and correlation with molecular markers. Nuclear Medicine Communications. 11: 1233-1238. PMID: 34075008
    42. Dhawan V, Joshi G, Sutariya B, Shah J, Ashtikar M, Nagarsekar K, Steiniger F, Lokras A, Fahr A, Krishnapriya M, Warawdekar U, Saraf M, Nagarsenker M (2021). Polysaccharide conjugates surpass monosaccharide ligands in hepatospecific targeting - Synthesis and comparative in silico and in vitro assessment. Carbohydrate Research. 509: 108417. PMID: 34481155
    43. Dholam K, Sharma M, Gurav S, Singh GP, Prabhash K (2021). Oral and dental health status in patients undergoing neo-adjuvant chemotherapy for locally advanced head and neck cancer. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 132(5):539-548. PMID: 34489214
    44. D'Silva SZ, Phuntsok T, Tambe M, Rajak J, Singh M (2021). Identification of a novel HLA-A*24 allele, A*24:537, identified in three individuals in an Indian family. HLA. 98(3):225-226. PMID: 34213092.
    45. D'Silva SZ, Tambe M, Rajak J, Phuntsok T, Singh M (2021). Identification of the novel HLA-C*14:02:01:22 allele in an Indian individual. HLA. 98(3):232-233. PMID: 34212537
    46. Dutta S, Bose K (2021). Remodelling structure-based drug design using machine learning. Emerging Topics in Life Sciences. 5(1):13-27 PMID: 33825834 "
    47. Forester R, Zwahlen D, Buchali A, Tang H, Schroeder C, Windisch P, Vu E, Akbaba S, Bostel T, Sparve T, Zamboglou C, Zilli T, Stelmes J-J, Telkhade T, Murthy V (2021). Stereotactic body radiotherapy for high-risk prostate cancer: A systematic review. Cancers. 13(4):759. PMID: 33673077
    48. Fundytus A, Sengar M, Lombe D, Hopman W, Jalink M, Gyawali B, Trapani D, Roitberg F, De Vries EGE, Moja L, Ilbawi A, Sullivan R, Booth CM (2021). Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey. Lancet Oncology. 22(10):1367-1377. PMID: 34560006
    49. Gandhi V, Gandhi K, Kumbhare L, Goda J, Gota V, Priyadarsini K, Kunwar A (2021). 3,3′-diselenodipropionic acid (DSePA) induces reductive stress in A549 cells triggering p53-independent apoptosis: A novel mechanism for diselenides. Free Radical Biology and Medicine. 175: 1-17. PMID: 34425189
    50. Ganesan P, Jain H, Bagal B, Subramanian PG, George B, Korula A, Mehra N, Kalaiyarasi JP, Bhurani D, Agrawal N, Ahmed R, Kayal S, Bhattacharyya J, Yanamandra U, Kumar S, Philip CC, John MJ, Nadaraj A, Karunamurthy O, Lakshmanan J, Mathews V, Sengar M (2021). Outcomes in adolescent and young adult acute lymphoblastic leukaemia: A report from the Indian Acute Leukaemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC). British Journal of Haematology. 193: e1-e8. PMID: 33656752
    51. Gardi N, Ketkar M, McKinnon R, Pandol S, Dutt S, Barreto S (2021). Down-regulation of metabolic pathways could offset the poor prognosis conferred by co-existent diabetes mellitus in pancreatic (head) adenocarcinoma. ANZ Journal of Surgery. PMID: 34514690
    52. Gatellier L, Ong SK, Matsuda T, Ramlee N, Lau FN, Yusak S, Werdi Nintindo D HRS, Jayusman AM, Syarif AH, Pradhananga KK, Yusuf A, Huong GN, Sengar M, Pramesh CS, Mosavi Jarrahi A, Suzuki T, Hwang WY.(2021) Preparing for the Next Pandemic: An Asian National Cancer Centers Alliance (ANCCA) Initiative. Asian Pacific Journal of Cancer Prevention. 22(9):2945-2950. PMID: 34582666.
    53. Ghantasala S, Pai MGJ, Biswas D, Gahoi N, Mukherjee S, Kp M, Nissa MU, Srivastava A, Epari S, Shetty P, Moiyadi A, Srivastava S (2021). Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors. Frontiers in Oncology. 11: 548243. PMID: 34055594
    54. Glasbey J, Ademuyiwa A....Moiyadi A....etal;COVID Surge Colloborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncology. 22(11): 1507-1517. PMID: 34624250
    55. Godse R, Rathod M, De A, Shinde U (2021). Intravitreal Galactose Conjugated Polymeric Nanoparticles of Etoposide for Retinoblastoma. Journal of Drug Delivery Science and Technology. 61: 102259
    56. Gota V, Nookala M, Bonda A, Karanam A, Shriyan B, Kembhavi Y, Gurjar M, Patil A, Singh A, Goyal N, Gupta S (2021). Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer. Cancer Medicine. 10(9): 3068-3076. PMID: 33826243
    57. Gulia S, Gupta S (2021). Subgroup Analysis from SOLO1 Trial. Journal of Clinical Oncology. 39(3):255. PMID: 33326258
    58. Gupta A, Ojha S, P Nagaraju, Poojary M, Sumathi SH, Sathyan V, Ansari A (2021). Impact of the Novel Coronavirus Disease and Lockdown on the Packed Red Blood Cells Inventory Management: An Experience from a Tertiary Care Oncology Center in Western India. Hematology, Transfusion and Cell Therapy. 43(2): 126-32. PMID: 33521581
    59. Gupta S, Rajappa S, Advani S, Agarwal A, Aggarwal S, Goswami C, Palanki SD, Arya D, Patil S, Kodagali R (2021). Prevalence of BRCA1 and BRCA2 mutations among patients with ovarian, primary peritoneal, and fallopian tube cancer in India: A multicenter cross-sectional study. JCO Global Oncology.7: 849-861. PMID: 34101484
    60. Gupta S, Biswas G, Babu S, Maksud T, Lakshmaiah K, Patel J, Raja G, Boya R, Patil P, Choudhury K, Bondare S, Neve R, Bhat G, Mamillapalli G, Patel A, Patel P, Joshi N, Bajaj V, Khan M (2021). Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study. The Breast. 60: 147-154. PMID: 34624757
    61. Gupta SK, Gohil D, Panigrahi GC, Vaykar S, Rane P, Chavan P, Gota V. (2021) Comparison of different autoanalyzers for the determination of lymphocyte and neutrophil counts in mouse blood. Drug Metabolism and Personalized Therapy. 37(2):219-222. PMID: 34854273.
    62. Gupta T, Sinha, S, Chinnaswamy G, Vora T, Prasad M, Bhat V, Goda JS, Krishnatry R, Chatterjee A, Epari S, Sahay A, Moiyadi A, Shetty P, Patil V, Khatua S, Jalali R, Kurkure P. (2021). Safety and efficacy of concurrent carboplatin during full-dose craniospinal irradiation for high-risk/metastatic medulloblastoma in a resource-limited setting. Pediatric Blood & Cancer: e28925. PMID: 33533557
    63. Gupta T, Maitre M, Maitre P, Goda JS, Krishnatry R, Chatterjee A, Moiyadi A, Shetty P, Epari S, Sahay A, Patil V, Jalali R (2021). High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting? Clinical and Translational Oncology. 23(7):1358-1367. PMID: 33528810.
    64. Gupta T, Manjali J, Kannan S, Purandare N, Rangarajan V (2021). Diagnostic performance of pre-treatment 18F-fluoro-deoxy-glucose positron emission tomography with or without computed tomography in patients with primary central nervous system lymphoma: updated systematic review and diagnostic test accuracy meta-analyses. Clinical Lymphoma Myeloma and Leukemia. 21(8):497-507. PMID: 33947632
    65. Gupta T, Kannan S, Kalra B, Thakkar P (2021). Systematic review and meta-analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID-19): Evidence-base for practise and implications for research. Transfusion Medicine. 31(6):409-420. PMID: 34189780.
    66. Gupta T, Manjali JJ, Purandare N, Bagal B (2021). Bone marrow biopsy in PCNSL: Relevant or redundant? Neuro Oncology. 23(12):2117-2118. PMID: 34596688.
    67. Gupta T, Maheshwari G, Gudi S, Chatterjee A, Phurailatpam R, Prabhash K, Budrukkar A, Ghosh-Laskar S, Agarwal P.(2021) Radiation necrosis of the bone, cartilage or cervical soft-tissues following definitive high-precision radio(chemo)therapy for head-neck cancer: uncommon and under-reported phenomenon. Journal of Laryngology and Otology. PMID: 34823635
    68. Harish M, Venkatraman P (2021). Evolution of biophysical tools for quantitative protein interactions and drug discovery. Emerging Topics in Life Sciences. 5(1):1-12PMID: 33739398
    69. Ho KYL, Khadilkar RJ, Carr RL, Tanentzapf G (2021). A gap-junction-mediated, calcium-signaling network controls blood progenitor fate decisions in hematopoiesis. Current Biology.31 (21):4697-4712. PMID: 34480855
    70. Hole A, Tyagi G, Deshmukh A, Deshpande R, Gota V, Chaturvedi P, CM Krishna (2021). Salivary Raman Spectroscopy: Standardization of Sampling Protocols and Stratification of Healthy and Oral Cancer Subjects. Applied Spectroscopy. 75(5):581-588. PMID: 33107759
    71. Iwasaki K, Araki A, CM Krishna, Maruyama R, Yamamoto T, Noothalapati H.Identification of molecular basis for objective discrimination of breast cancer cells (MCF-7) from normal human mammary epithelial cells by Raman Microspectroscopy and multivariate curve resolution analysis. International Journal of Molecular Sciences. 22(2): 800. PMID: 33466869
    72. Jadhav SA, Biji P, Panthalingal MK, CM Krishna, Kulkarni A, Rajkumar S, Joshi DS, Nataranjan S (2021). Development of Integrated Microfluidic Platform Coupled with Surface-Enhanced Raman Spectroscopy for Diagnosis of COVID-19. Medical Hypothesis. 146: 110356. PMID: 33342643
    73. Jain H, Shetty D, Moulik N, Narula G, Subramanian PG, Banavali S (2021). A novel case of intrachromosomal amplification and insertion of RUNX1 on derivative chromosome 2 in pediatric AML. Cancer Genetics. 254-255: 65-69.PMID: 33647813
    74. Jain H, Shetty D, Narula G, Roy Moulik N, Tembhare P, Patkar N, Subramanian PG, Banavali S (2021). Cytogenetic profile and outcome of a pediatric acute promyelocytic leukemia patient presenting with isolated isochromosome 17q in absence of RARA rearrangement. Blood Cells, Molecules, and Disease. 88: 102443. PMID: 32414556
    75. Jain H, Sengar M, Goli VB, Thorat J, Tembhare P, Shetty D, Bonda A, Nayak L, Subramanian P, Bagal B, Patkar N, Sharma N, Gupta H, Gujral S (2021). Bortezomib and Rituximab in de-novo adolescent/adult CD20-positive, Ph-negative Pre B-cell acute lymphoblastic leukemia. Blood Advances. 5 (17): 3436–3444. PMID: 34461632.
    76. Jain S, Engineer R, Ostwal V, Ramaswamy A, Chopra S, Desouza A, Lewis S, Arya S, Patil P, Saklani A (2021). Addition of short course radiotherapy in newly diagnosed locally advanced rectal cancers with distant metastasis. Asia-Pacific Journal of Clinical Oncology. 17:e70-e76.PMID: 32030912
    77. Jose J, Al-Dorzi HM, Al-Omari A, Mandourah Y, Al-Hameed F, Sadat M, Al Qasim E, Alraddadi B, Al Harthy A, Al Mekhlafi GA, Almotairi A, Al Khatib K, Abdulmomen A, Qushmaq I, Sindi AA, Mady A, Solaiman O, Al-Raddadi R, Maghrabi K, Ragab A, Kharaba A, Shalhoub S, Al-Aithan AM, Vishwakarma GK, Bhattacharjee A, Arabi YM; Saudi Critical Care Trials Group (2021). Critically ill patients with diabetes and Middle East respiratory syndrome: a multi-center observational study. BMC Infectious Diseases. 21(1): 84. PMID: 33468070
    78. Jose J, Vishwakarma G, Bhattacharjee A (2021). Illustration of missing data handling technique generated from Hepatitis C induced hepatocellular carcinoma cohort study. Journal of King Saud University - Science. 33(4): 101403
    79. Joshi A, Mishra R, Desai S, Chandrani P, Kore H, Sunder R, Hait S, Iyer P, Trivedi V, Choughule A, Noronha V, Joshi A, Patil V, Menon N, Kumar R, Prabhash K, Dutt A (2021). Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations. Oncotarget. 12: 578-588. PMID: 33796225
    80. Joshi A, Patil V, Noronha V, Bhattacharjee A, Menon N, Kumar A, Jain P, Mukadam S, Shrinivas A, Punia A, Abhyankar A, Agarwal A, Khaddar S, Rajpurohit A,Kanteti A, Ravind R, Das K, Talreja V, Dhumal S, Prabhash K (2021) Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation – a phase 3 study. ecancer 15: 1318.PMID: 35047069
    81. Joshi K, Joshi P, Shetty T, Nair S, Chaturvedi P. Can BMI be a predictor of perioperative complications in Head and Neck cancer surgery? Pol Przegl Chir. 93:13-18. PMID: 35384860.
    82. Joshi S, Jaiswal D, Chougle Q, Wadasadawala T, Badwe R (2021). Transposition flap for the oncoplastic reconstruction of outer quadrant breast defects. Journal of Plastic, Reconstructive & Aesthetic Surgery. 74(9): 2176-2183. PMID: 33478895
    83. Kadam R, Harish M, Dalvi K, Teni T (2021). Novel nucleolar localization of clusterin and its associated functions in human oral cancers: An in vitro and in silico analysis. Cell Biochemistry and Function. 39: 380-391. PMID: 33155695
    84. Kalshetty A, Menon B, Rakshit S, Bhattacharjee A, Basu S( 2021). Correlation of lesional uptake parameters and ratios with miPSMA score and estimating normal physiological concentration: an exploratory analysis in mCRPC patients with 68Ga-PSMA-11 PET-CT. Journal of Nuclear Medicine Technology. 49(3):235-240. PMID: 34244223.
    85. Kamp MA, Malzkorn B, von Sass C, DiMeco F, Hadjipanayis CG, Senft C, Rapp M, Gepfner-Tuma I, Fountas K, Krieg SM, Neukirchen M, Florian IȘ, Schnell O, Mijderwijk HJ, Perin A, Baumgarten P, van Lieshout JH, Thon N, Renovanz M, Kahlert U, Spoor JKH, Hänggi D, McLean AL, Mäurer M, Sarrubbo S, Freyschlag CF, Schmidt NO, Vergani F, Jungk C, Stein M, Forster MT, Weinberg JS, Sinclair J, Belykh E, Bello L, Mandonnet E, Moiyadi A, Sabel M (2021). Proposed definition of competencies for surgical neuro-oncology training. Journal of Neuro-oncology. 153(1): 121–131. PMID: 33881726
    86. Kapoor J, Khushoo V, Garg A, Naim F, Bhatia N, Folbs B, Mehta P, Ahmed R, Agrawal N, Bhurani D, Mirgh SP (2021). An "impossible" harvest-GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma. Bone Marrow Transplantation. PMID: 33686246
    87. Kashte S, Dhumal R, Chaudhary P, Sharma RK, Dighe V, Kadam S (2021). Bone regeneration in critical-size calvarial defect using functional biocompatible osteoinductive herbal scaffolds and human umbilical cord Wharton’s Jelly-derived mesenchymal stem cells. Materials Today Communications. 102049.
    88. Kazi M, Kaushik P, Saini S, Premchandani D, Qureshi SS. Extensive cavo-atrial and hepatic venous tumor thrombus in a mismanaged retroperitoneal pediatric germ cell tumor: A unique surgical challenge.Annals of Hepato-Biliary-Pancreatic Surgery. 25(4):528-531. PMID: 34845126
    89. Krishnatry R, Manjali JJ, Chinnaswamy G, Chatterjee A, Goda JS, Janu A, Sahu A, Jalali R, Gupta T (2021). Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma. Japanese Journal of Clinical Oncology. 51(5): 762-768. PMID: 33521824.
    90. Kulkarni PD, Damle ND, Hingorani L, Bhaskar VH, Ghante MR, Patil A, Gurjar M, Gota V (2021). Pharmacokinetics of solid lipid Boswellia serrata particles in healthy subjects. Drug Metabolism and Personalized Therapy. 36(3):215-221. PMID: 33818023
    91. Kumar A, Wadasadawala T, Laskar SG, Gondhowiardjo S, Agarwal JP (2021). Mental health impact of COVID-19 in radiation oncology health care workers of Asian Countries. Clinical Oncology (R Coll Radiol).33(5):e243-e244. PMID: 33676823
    92. Kumar A, Wadasadawala T, Joshi K, Pathak R, Scaria L, Upreti RR, Bhajbhuje R, Shet T, Parmar V, Gupta S, Mokal S, Sarin R (2021). What is the dosimetric impact of isotropic vs anisotropic safety margins for delineation of the clinical target volume in breast brachytherapy? Brachytherapy. 20: 155-162. PMID: 32888852
    93. Kumar D, Sakhare N, Das S, Kale P, Mathur A, Mirapurkar S, Murlidharan S, Chaudhari P, Mohanty B, Ballal A, Patro P (2021). Development of technetium-99m labeled ultrafine gold nanobioconjugates for targeted imaging of folate receptor positive cancers. Nuclear Medicine and Biology. 93: 1-10 . PMID: 33212346
    94. Kumar R, Kuligina E, Sokolenko A, Siddiqui Q, Gardi N, Gupta S, Varma AK, Hasan SK (2021). Genetic ablation of pregnancy zone protein promotes breast cancer progression by activating TGF-β/SMAD signaling. Breast Cancer Research and Treatment. 185(2):317-330 PMID: 33057846
    95. Kumari N, Mathe VL, Krishna CM, Dongre PM (2021). BSA-drug-ZnO-PEI conjugates interaction with glycans of gp60 endothelial cell receptor protein for targeted drug delivery: a comprehensive spectroscopic study. Journal of Biomolecular and Structural Dynamics. PMID: 34018472
    96. Kummari R, Dutta S, Patil S, Pandav-Mudrale S, Bose K (2021). Elucidating the role of GRIM-19 as a substrate and allosteric activator of pro-apoptotic serine protease HtrA2. Biochemical Journal. 478(6):1241-1259. PMID: 33650635
    97. Kunder S, Chatterjee A, Manna S, Mahimkar M, Patil A, Rangarajan V, Budrukkar A, Agarwal J, Gupta T (2021). Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck. World Journal of Nuclear Medidicine. 20(3): 228-236.PMID: 34703390
    98. Lewis S, Pandey S, Salins N, Deodhar J, Patil V, Gupta T, Laskar SG, Budrukkar A, Murthy V, Joshi A, Prabhash K, Nair S, Chaturvedi P, Noronha V, Agarwal JP (2021). Distress Screening in Head and Neck Cancer Patients Planned for Cancer-Directed Radiotherapy. Laryngoscope. 131(9):2023-2029. PMID: 33720420.
    99. Maddalena M, Mallel G, Nataraj NB, Shreberk-Shaked M, Hassin O, Mukherjee S, Arandkar S, Rotkopf R, Kapsack A, Lambiase G, Pellegrino B, Ben-Isaac E, Golani O, Addadi Y, Hajaj E, Eilam R, Straussman R, Yarden Y, Lotem M, Oren M (2021). TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment. Proceedings of the National Academy of Sciences. 118(23):e2025631118. PMID: 34088837
    100. Madhok A, Bhatt S, Philip C, Sureshbabu SK, Chiplunkar SV, Galande S (2021). Transcriptome signature of Vγ9Vδ2 T Cells treated with phosphoantigens and notch inhibitor reveals interplay between TCR and notch signaling pathways. Frontiers in Immunology. 12: 660361. PMID: 34526984
    101. Madhugiri V, Moiyadi AV, Shetty P, Gupta T, Epari S, Jalali R, Subeikshanan V, Dutt A, Sasidharan G, Kumar V, Ganesh C V Ramesh A, Prabhu A (2021). An analysis of the factors associated with long term survival in patients with glioblastoma. World Neurosurgery. 149:e758-e765. PMID: 33540096
    102. Mahantshetty U, Gurram L, Bushra S, Ghadi Y, A D, Paul J, Hande V, Chopra S, Ghosh J, Ts S, Popat P, Sable N, Maheswari A, Gupta S (2021). Single application multi-fractionated image guided adaptive High Dose Rate Brachytherapy for Cervical Cancer- Dosimetric & Clinical Outcomes. International Journal of Radiation Oncology Biology and Physics. 111(3):826-834. PMID: 34146636
    103. Mahantshetty U, Lewis S, Engineer R, Swamidas J, Chopra S, Gurram L, Kinhikar R, Deshpande D, Kirisits C, Shrivastava S (2021). Low-Dose-Rate versus High-Dose-Rate intracavitary brachytherapy in cervical cancer - Final Results of a Phase III randomized trial. Brachytherapy. PMID: 34598883
    104. Maitre P, Gupta T, Maitre M, Goda J, Krishnatry R, Chatterjee A, Sridhar E, Sahay A, Mokal S, Moiyadi A, Shetty P, Patil V, Jalali R (2021). Prospective longitudinal assessment of quality of life. and activities of daily living as patient-reported outcome measures in recurrent/progressive glioma treated with high-dose salvage re-irradiation. Clinical Oncology (R Coll Radiol). 33(3):e155-e165. PMID: 32917486
    105. Mal A, Bukhari AB, Singh RK, Kapoor A, Barai A, Deshpande I, Wadasadawala T, Ray P, Sen S, De A. EpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer. Frontiers in Cell Developmental Biology. 8:597673 2021 PMID: 33490064
    106. Manubhai Kp, Kumar A, Biswas D, Moiyadi A, Shetty P, Gupta T, Epari S, Shirsat N, Srivastava S. The proteomic analysis shows enrichment of RNA surveillance pathways in adult SHH and extensive metabolic reprogramming in Group 3 medulloblastomas. Brain Tumor Pathology. 38(2):96-108. PMID: 33438046.
    107. Masurkar SA, Deogharkar A, Bharambe HS, Shirsat NV (2021). Downregulation of CRX, a Group 3-specific oncogenic transcription factor, inhibits TGF-β/activin signaling in medulloblastoma cells. Biochemical Biophysical Research Communications. 568:76-82. PMID: 34192607.
    108. McDonald JA, Rao R, Gibbons M, Janardhanan R, Jaswal S, Mehrotra R, Pandey M, Radhakrishnan V, Ramakant P, Verma N, Terry MB (2021). Symposium report: breast cancer in India-trends, environmental exposures and clinical implications. Cancer Causes and Control. 32(6):567-575. PMID: 33909208
    109. Menon N, Patil V, Noronha V, Joshi A, Bhattacharjee A, Satam B, Mathrudev V, Ghosh Laskar S, Prabhash K (2021). Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone – Additional data from a phase 3 trial, Oral Oncology. 122: 105517. PMID: 34560383
    110. Mhatre O, Reddy BP, Patnaik C, Chakrabarty S, Ingle A, De A, Srivastava R (2021). pH-Responsive Delivery of Anti-Metastatic Niclosamide Using Mussel Inspired Polydopamine Nanoparticles. International Journal of Pharmaceutics. 597: 120278
    111. Mhatre S, Richmond RC, Chatterjee N, Rajaraman P, Wang Z, Zhang H, Badwe R, Goel M, Patkar S, Shrikhande SV, Patil PS, Davey Smith G, Relton CL, Dikshit RP (2021). The Role of Gallstones in Gallbladder Cancer in India: A Mendelian Randomization Study. Cancer Epidemiology Biomarkers and Prevention. 30(2):396-40. PMID: 33187967
    112. Mirgh S, Gokarn A, Punatar S, Chichra A, Singh A, Rajendra A, Goli VB, Trivedi B, Joshi A, Patkar N, Tembhare P, Subramanian PG, Shetty N, Chavan P, Bhat V, Gupta S, Khattry N (2021). Clinical Course of Severe COVID19 treated with Tocilizumab and Antivirals Post-Allogeneic Stem Cell Transplant with Extensive Chronic GVHD. Transplant Infectious Disease. 23(4):e13576. PMID: 33523551.
    113. Mirgh S, Sharma A, Folbs B, Khushoo V, Kapoor J, Tejwani N, Ahmed R, Agrawal N, Choudhary PS, Mehta P, Bhurani D (2021). Daratumumab-based therapy after prior Azacytidine-Venetoclax in an octagenerian female with BPDCN (blastic plasmacytoid dendritic cell neoplasm) - a new perspective. Leukemia Lymphoma. 62(12):3039-3042. PMID: 34151693
    114. Mirgh S, Sharma A, Shaikh M, Kadian K, Agrawal N, Khushboo V, Mehta P, Ahmed R, Bhurani D (2021). Hypomethylating agents+venetoclax induction therapy in acute myeloid leukemia unfit for intensive chemotherapy - novel avenues for lesser venetoclax duration and patients with baseline infections from a developing country. American Journal of Blood Research. 11(3): 290-302. PMID: 34322294
    115. Mirgh SP, Gokarn A, Rajendra A, More A, Kamtalwar S, Katti KS, Singh A, Goli VB, Ravind R, Madala R, Kakoti S, Maitre P, Punatar S, Chichra A, Patil A, Trivedi B, Joshi A, Patkar N, Tembhare P, Khanka T, Rajpal S, Chatterjee G, Kannan S, Subramanian PG, Murthy V, Shetty N, Chavan P, Bhat V, Nair S, Khattry N, Gupta S (2021). Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India. Cancer Medicine. 10(24):8777-8788. PMID: 34786866.
    116. Mishra SK, Hole A, Reddy BPK, Srivastava R, CM Krishna, De A. ( 2021) Raman Micro-spectroscopic Map estimating in vivo precision of tumor ablative effect achieved by photothermal therapy procedure. Nanomedicine: Nanotechnology, Biology and Medicine. 37:102437. PMID: 34273597
    117. Mittal R, Murthy V, Krishnatry R, Maitre P (2021). Recommendations and clinical validation of inguinal Clinical Target Volume (CTV) delineation in Penile cancer. International Journal Radiation Oncology Biology and Physics. 111(3):741-753. PMID: 34174355
    118. Mittra I, Mishra GA, Dikshit RP, Gupta S, Kulkarni VY, Shaikh HKA, Shastri SS, Hawaldar R, Gupta S, Pramesh CS, Badwe RA (2021). Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. British Medical Journal. 372: n256. PMID: 33627312
    119. Mojindra R, Hole A, Iwasaki K, Noothalapati H, Yamamoto T, Krishna CM, Govekar R (2021). DNA fingerprint analysis of Raman Spectra captures global genomic alterations in Imatinib-resistant chronic myeloid leukemia: A potential single assay for screening Imatinib resistance. Cells. 10(10): 2506.
    120. Mukherjee S, Biswas D, Epari S, Shetty P, Moiyadi A, Ball GR, Srivastava S (2021). Comprehensive proteomic analysis reveals distinct functional modules associated with skull base and supratentorial meningiomas and perturbations in collagen pathway components. Journal of Proteomics.246: 104303. PMID: 34174477
    121. Munshi R, Joshi S, Panchal F, Kumbhar D, Chaudhari P.Does Panchatikta ghrita have anti-osteoporotic effect? Assessment in an experimental model in ovariectomized rats. Journal of Ayurveda and Integrative Medicine. 12(1): 35-42. PMID: 31708331
    122. Murthy V, Maitre P, Kannan S, Panigrahi G, Krishnatry R, Bakshi G, Prakash G, Pal M, Menon S, Phurailatpam R, Mokal S, Chaurasiya D, Popat P, Sable N, Agarwal A, Rangarajan V, Joshi A, Noronha V, Prabhash K, Mahantshetty U (2021). Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial. Journal of Clinical Oncology. 39(11):1234-1242. PMID: 33497252
    123. Murthy V, Bakshi G, Manjali JJ, Prakash G, Pal M, Joshi A, Dholkia K, Bhattacharjee A, Talole S, Puppalwar A, Srinivasan S, Panigrahi G, Salunkhe R, Menon S, Noronha V, Prabhash K, Krishantry R (2021). Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapy. Urologic Oncology: Seminars and Original Investigations. 39(8):496.e9-496.e15. PMID: 33573998
    124. Murthy V, Maitre P (2021). A nodal risk cutoff for whole pelvic radiotherapy for prostate cancer? Lancet Oncology. 22(11):e467. PMID: 34735809
    125. Nadkarni AR, Vijayakumaran SC, Gupta S, Divatia JV. Mortality in cancer patients with COVID-19 who are admitted to an ICU or who have severe COVID-19: A systematic review and meta-analysis. JCO Global Oncology. 7:1286-1305. PMID: 34406802
    126. Nair J, Syed SB, Mahaddalkar T, Ketkar M, Thorat R, Sastri Goda J, Dutt S (2021). DUSP6 regulates radio-sensitivity in glioblastoma by modulating the recruitment of p-DNAPKcs at DNA double-strand breaks. Journal of Cell Science 134 (24): jcs259520. PMID: 34792128.
    127. Nair N, Chitkara G, Hawaldar R, Parmar V, Joshi S, Thakkar P, Shet T, Wadasadawala T, Badwe R (2021). En-bloc excision of phyllodes tumour of the breast: Radical approach heralds’ better outcome. Clinical Breast Cancer. 21(3):e228-e234. PMID: 33046357
    128. Nair NS, Penumadu P, Yadav P, Sethi N, Kohli PS, Shankhdhar V, Jaiswal D, Parmar V, Hawaldar RW, Badwe RA. (2021). Awareness and Acceptability of Breast Reconstruction among Women With Breast Cancer: A Prospective Survey. JCO global oncology, 7, 253–260. PMID: 33571006
    129. Narkhede AM, Kothekar AT (2021). Anticipated difficult airway: Planning, safety and ethics while applying a novel technique. Saudi Journal of Anaesthesia. 15:74-5. PMID: 33824651
    130. Natu A, Singh A, Gupta S. (2021) Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities. World Journal of Hepatology. 13(11):1568-1583. PMID: 34904030
    131. Nautiyal A, Jha AK, Mithun S, Shetye B, Kameswaran M, Shah S, Rangarajan V, Gupta S (2021). Analysis of absorbed dose in radioimmunotherapy with 177Lu-trastuzumab using two different imaging scenarios: A pilot study. Nuclear Medicine Communications. 42(12):1382-1395. PMID: 34406146
    132. Navalkar A, Pandey S, Singh N, Patel K, Datta D, Mohanty B, Jadhav S, Chaudhari P, Maji S (2021). Direct evidence of cellular transformation by prion-like p53 amyloid infection. Journal of Cell Science. 134 (11): jcs258316 PMID: 34085695
    133. Nikam SS, Gurjar M, Singhavi H, Patil A, Singh A, Villalta P, Chaturvedi P, Khariwala SS, Gota V , Stepanov I (2021). Simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, N'-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry. Scientific Reports. 11(1):20007. PMID: 34625573.
    134. Ojha S, Tirlotkar A, Gupta AM, Sumathi SH, Chavan P, Poojary M (2021). Comparative analysis of platelet concentrates prepared after two hours and overnight storage of buffy coat at room temperature. Transfusion and Apheresis Science. 60:103014. PMID: 33262053
    135. Ostwal V, Ramaswamy A, Bhargava P, Hatkhambkar T, Swami R, Rastogi S, Mandavkar S, Ghosh J, Bajpai J, Gulia S, Srinivas S, Rath S, Gupta S. Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study. BMJ Open. 2021 11(6):e047376. PMID: 34187825.
    136. Otitoju AP, Longdet IY, Alemika TE, Gota VP (2021). Chloroform extract and acetyl-11-keto-beta-boswellic acid from Boswellia dalzielii stem bark induce apoptosis and cell cycle blockage in AW8507 cells. Journal of the Egyptian National Cancer Institute. 33(1): 20. PMID: 34368899.
    137. Pai T, Shet T, Patil A, Parmar V, Wadasadawala T, Sangeeta Desai S (2021). Epithelioid hemangioendothelioma of breast with nodal metastasis masquerading as breast carcinoma: An unusual case with review of literature. Human Pathology: Case Reports. 23: 200465.
    138. Panda D, Chatterjee G, Khanka T, Ghogale S, Badrinath Y, Deshpande N, Sardana R, Chaturvedi A, Rajpal S, Shetty D, Patkar NV, Gujral S, Subramanian PG, Tembhare PR (2021). Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre-myelomastocytic leukemia condition. Cytometry B Clinical Cytometry. 100(3):331-344. PMID: 32738100
    139. Paradkar P, Juvekar A, Barkume M, Amonkar A, Joshi J, Soman G, Vaidya A (2021). In vitro and in vivo evaluation of a standardized haridra (Curcuma longa Linn) formulation in cervical cancer. Journal of Ayurveda and Integrative Medicine. 12(4):616-622. PMID: 34531090
    140. Parghane RV, Bhandare M, Chaudhari V, Shrikhande SV, Ostwal V, Ramaswamy A, Talole S, Basu S (2021). Surgical feasibility, Determinants and overall efficacy assessment of neoadjuvant PRRT with 177Lu-DOTATATE for locally advanced unresectable gstroenteropancreatic neuroendocrine tumors. Journal of Nuclear Medicine. PMID: 33637590
    141. Parghane RV, Talole S, Basu S (2021). 131I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with 177Lu-DOTATATE peptide receptor radionuclide therapy. Annals of Nuclear Medicine. 35(1):92-101. PMID: 33135123
    142. Patel U, Mittal N, Rane S, Patil A, Gera P, Kannan S, Joshi A, Noronha V, Patil V, Prabhash K, Mahimkar M (2021).Correlation of transcriptionally active human papillomavirus status with the clinical and molecular profiles of head and neck squamous cell carcinomas. Head and Neck. 43(7):2032-2044. PMID: 33751711
    143. Patil A, Shriyan B, Mehta P, Patil M, Gurjar M, Nookala M, Patil V, Joshi A, Noronha V, Prabhash K, Gota V(2021). ADME gene polymorphisms do not influence the pharmacokinetics of docetaxel: Results from a population pharmacokinetic study in Indian cancer patients. Cancer Medicine. 10:4948–4956. PMID: 34156160
    144. Patil VM, Singhai P, Noronha V, Bhattacharjee A, Deodhar J, Salins N, Joshi A, Menon NS, Abhyankar A, Khake A, Dhumal SB, Tambe R, Muckaden MA, Prabhash K (2021). Effect of early palliative care on quality of life of advanced head and neck cancer patients: A phase III Trial. Journal of National Cancer Institute. 113(9):1228-1237.PMID: 33606023
    145. Patkar N, Kakirde C, Shaikh AF, Salve R, Bhanshe P, Chatterjee G, Rajpal S, Joshi S, Chaudhary S, Kodgule R, Ghoghale S, Deshpande N, Shetty D, Khizer SH, Jain H, Bagal B, Menon H, Khattry N, Sengar M, Tembhare P, Subramanian P, Gujral S (2021). Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML). Leukemia. 35(5):1392-1404. PMID: 33558666.
    146. Patkar N, Rajpal S, Shetty N, Gokarn A, Mirgh S, Munipally S, Nair S, Joshi A, Murthy V, Khattry N, Gupta S (2021). Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is influenced by the type of transport medium: Implications for diagnosis and monitoring. International Journal of Clinical Practice. 75(8):e14311. PMID: 33932309
    147. Patwardhan S, Mahadik P, Shetty O, Sen S (2021). ECM stiffness-tuned exosomes drive breast cancer motility through thrombospondin-1. 279: 121185.Biomaterials.PMID: 34808560
    148. Paul R, Bapat P, Deogharkar A, Kazi S, Singh SKV, Gupta T, Jalali R, Sridhar E, Moiyadi A, Shetty P, Shirsat NV (2021). MiR-592 activates the mTOR kinase, ERK1/ERK2 kinase signaling and imparts neuronal differentiation signature characteristic of group 4 medulloblastoma. Human Molecular Genetics. 30(24):2524-2525. PMID: 34274968.
    149. Pawar D, Chatterjee A, Epari S, Sahay A, Janu A, Krishantry R, Goda JS, Shetty P, Moiydai A, Gupta T (2021). Clinico-radiological characteristics, histo-pathological features and long-term survival outcomes in central neurocytoma: A single-institutional audit. Journal of Clinical Neurosciecne. 84:91-96. PMID: 33358093
    150. Phuntsok T, D'Silva S, Tambe M, Singh M (2021). Identification of the novel HLA-B*35:03:01:22 allele in an individual of Nepalese origin. HLA. 98(4):389-390 PMID: 34212523.
    151. Poojari R, Bhujbal M, Hole A, CM Krishna (2021). Distinct stratification of normal liver, Hepatocellular carcinoma (HCC), and anticancer nanomedicine treatment in tumour tissues by Raman fingerprinting for HCC therapeutic monitoring. Nanomedicine: Nanotechnology, Biology and Medicine. 33: 102352. PMID: 33418135
    152. Portner R, Bajaj A, Elumalai T, Huddart R, Murthy V, Nightinghale H, Patel K,Sargos P, Song Y, Hoskin P, Choudhury A (2021). A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer. Clinical and Translational Radiation Oncology. 31:1-7. PMID: 34466667
    153. Pramesh CS, Babu GR, Basu J, Bhushan I, Booth CM, Chinnaswamy G, Guleria R, Kalantri SP, Kang G, Mohan P, Mor N, Pai M, Prakash M, Rupali P, Sampathkumar P, Sengar M, Sullivan R, Ranganathan P (2021). Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians. Nature Medicine. 27(8):1324-1327. PMID: 34226738.
    154. Pramesh CS, Chinnaswamy G, Sengar M, Ranganathan P, Badwe R. (2021) COVID-19 and cancer care in India. Nature Cancer. 2: 1257-1259.
    155. Punatar S, Kalantri SA, Chichra A, Agrawal AK, Nayak L, Bonda A, Gokarn A, Bagal B, Mathew L, Kannan S, Khattry N (2021). Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomes. Bone Marrow Transplantation. 1558- 1562. PMID: 33514924
    156. Punatar S, Gokarn A, Nayak L, Bonda A, Mirgh S, Chichra A, Singh M, D'silva S, Khattry N. Human leukocyte antigen (HLA) alleles as predictive factors for benefit from lenalidomide in acute myeloid leukemia (AML). American Journal of Blood Research. 11(5):564-570. PMID: 34824888
    157. Punatar S, Gokarn A, Nayak L, Bonda A, Chichra A, Mirgh S, Bagal B, Tembhare P, Subramanian P, Khattry N.(2021) Long term outcome of a patient with relapsed refractory early thymic precursor acute lymphoblastic leukemia treated with daratumumab. Americal Journal of Blood Research. 11(5):528-533. PMID: 34824885
    158. Puranik AD, Rangarajan V, Dev ID, Jain Y, Purandare NC, Sahu A, Choudhary A, Gupta T, Chatterjee A, Moiyadi A, Shetty P, Sridhar E, Sahay A, Patil VM, Shah S, Agrawal A (2021). Brain FET PET tumor-to-white mater ratio to differentiate recurrence from post-treatment changes in high-grade gliomas. Journal of Neuroimaging. 31(6):1211-1218. PMID: 34388273.
    159. Qureshi SS, Bhagat M, Smriti V, Murli D, Baheti A, Yadav S, Prasad M, Khanna N, Laskar S, Kembhavi S, Vora T, Chinnaswamy G, Amin N, Ramadwar M, Talole S (2021). Intravascular extension of Wilms tumor: Characteristics of tumor thrombus and their impact on outcomes. Journal of Pediatric Urology. 17(1): 69.e1-69.e8. PMID: 33087302
    160. Qureshi SS, Kembhavi SA, Kazi M, Smriti V, Baheti A, Vora T, Chinnaswamy G, Prasad M, Amin N, Ramadwar M, Khanna N, Laskar S (2021). Feasibility of nonanatomical liver resection in diligently selected patients with hepatoblastoma and comparison of outcomes with anatomic resection. European Journal of Pediatric Surgery. 31(3):236-244. PMID: 32422675
    161. Qureshi SS, Ramraj D, Chinnaswamy G, Parambil BC, Prasad M, Amin N, Ramanathan S, Khanna N, Laskar S (2021). Assessment of outcomes of elective cancer surgeries in children during coronavirus disease 2019 pandemic: Retrospective cohort study from a tertiary cancer center in India. Medicine (Baltimore). 100(35): 26752. PMID: 34477115.
    162. Rajendra A, Jain H, Bonda VNA, Nayak L, Tembhare P, Shetty D, Thorat J, Jain H, Subramanian PG, Patkar N, Chatterjee G, Khattry N, Gokarn A, Punatar S, Mokal S, Bagal B, Sengar M (2021). Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol. Blood Advances. 5(5):1178-1193. PMID: 33635331
    163. Rajendra J, Ghorai A, Dutt S. 14-3-3ζ negatively regulates mitochondrial biogenesis in GBM residual cells. Heliyon. 7(11):08371. PMID: 34825085
    164. Ramanujam P, Mehrotra S, Kumar R, Verma S, Deshpande G, Mishra R, Galande S (2021). Global chromatin organizer SATB1 acts as a context-dependent regulator of the Wnt/Wg target genes. Scientific Reports. 11:3385. PMID: 33564000
    165. Ramaswamy A, Ostwal V, Sharma A, Bhargava P, Srinivas S, Goel M, Patkar S, Mandavkar S, Jadhav P, Parulekar M, Choudhari A, Gupta S. Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT). JAMA Oncology. 7(3):436-439. PMID: 33270098.
    166. Ranganathan P, Sengar M, Chinnaswamy G, Agrawal G, Arumugham R, Bhatt R, Bilimagga R, Chakrabarti J, Chandrasekharan A, Chaturvedi HK, Choudhrie R, Dandekar M, Das A, Goel V, Harris C, Hegde SK, Hulikal N, Joseph D, Kantharia R, Khan A, Kharde R, Khattry N, Lone MM, Mahantshetty U, Malhotra H, Menon H, Mishra D, Nair RA, Pandya SJ, Patni N, Pautu J, Pavamani S, Pradhan S, Thammineedi SR, Selvaluxmy G, Sharan K, Sharma BK, Sharma J, Singh S, Srungavarapu GC, Subramaniam R, Toprani R, Raman RV, Badwe RA, Pramesh CS (2021); National Cancer Grid of India. Impact of COVID-19 on cancer care in India: a cohort study. Lancet Oncology. 22(7):970-976. PMID: 34051879.
    167. Rao M, Venkatraman P , Mukhopadhyay D, Roychoudhury S, Vanderford NL, Rangnekar VM (2021). Value added by an inter-continental cancer consortium. Genes and Cancer. 12: 65-68. PMID: 34046148
    168. Rashid M, Shah SG, Verma T, Chaudhary N, Sukanya, Patel VB, Gera PB, Smoot D, Ashaktorab H, Dalal SN, Gupta S (2021). Tumor-specific overexpression of histone gene, H3C14 in gastric cancer is mediated through EGFR-FOXC1 axis.Biochimica Et Biophysica Acta (BBA) - Gene Regulatory Mechanisms.13:194703. PMID: 33727172.
    169. Rashid M, Shah SG, Natu A, Verma T, Rauniyar S, Gera PB, Gupta S (2021). RPS13, a potential universal reference gene for normalisation of gene expression in multiple human normal and cancer tissue samples. Molecular Biology Reports. 48(12):7967-7974. PMID: 34657252.
    170. Rath S, Elamarthi P, Parab P, Gulia S, Nandhana R, Mokal S, Kembhavi Y, Perumal P, Bajpai J, Ghosh J, Gupta S (2021). Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice. PLoS One. 16(7):e0253722. . PMID: 34292933.
    171. Roy S, Sunkara RR, Parmar MY, Shaikh S, Waghmare SK (2021). EMT imparts cancer stemness and plasticity: New perspectives and therapeutic potential. Frontiers in Bioscience (Landmark Ed).26: 238-265. PMID: 33049669
    172. Sajnani AK, Shah SG, Rashid M, Natu A, Gera PB, Gupta S (2021). In-Silico Analysis of Chromatin Modifiers and Profiling of Histone Deacetylases (HDAC's) in Human Oral Cancer. Chonnam Medical Journal. 57(3):176-184.: PMID: 34621637
    173. Sali AP, Epari S, Nagaraj TS, Sahay A, Chinnaswamy G, Shetty P, Moiyadi A, Gupta T (2021). Atypical Teratoid/Rhabdoid Tumor: Revisiting Histomorphology and Immunohistochemistry with Analysis of Cyclin D1 Overexpression and MYC Amplification. International Journal of Surgical Pathology. 29(2):155-164. PMID: 32703045.
    174. Salunkhe S, Mishra SV, Nair J, Shah S, Gardi N, Thorat R, Sarkar D, Rajendra J, Kaur E, Dutt S (2021). Nuclear localization of p65 reverses therapy induced senescence. Journal of Cell Science. 134(6):jcs253203 PMID: 33526713
    175. Sandbhor P, Goda J, Mohanty B, Chaudhari P, Dutt S, Banerjee R (2021). Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models. Nanoscale. 14(1): 108-126. PMID: 34897360.
    176. Sarkar K, Dhatrak S, Sarkar B, Ojha U, Raghav P, Pagdhune A.(2021) Secondary prevention of silicosis and silico-tuberculosis by periodic screening of silica dust exposed workers using serum club cell protein 16 as a proxy marker. Health Science Reports. 4(3): e73. PMID: 34589615
    177. Sengupta A, Gupta S, Sharda A, Hemant S, Ingle A (2021). Effect of low frequency electrical current on the biophysical and molecular properties of cancer cells. Cancer and Clinical Research. 8:145.
    178. Shabrish S, Mittra I (2021). Cytokine storm as a cellular response to dsDNA breaks: A new proposal. Frontiers in Immunology. 12:622738.
    179. Sharma S, Sharma U, Chaudhary A, Naithani M, Naithani P, Prashar S, Sharma B, Nagar PK, Bhukya P, Bhalerao U, Singh M, Srivastava M, Barman M, Attri S, Gairolla J (2021). SARS-CoV-2: Insights from the Immunopathogenesis and Current Clinical Diagnosis and Therapeutic Strategies. Journal of Immunological Sciences. 5(2): 1-15.
    180. Sharma SK, Swathi Raju M, Goswami D, De A, Phadnis P, Vatsa RK (2021). pH-(Low)-Insertion Peptide-Assisted Detection and Diagnosis of Cancer Using Zinc Gallate-Based Persistent Luminescence Nanoparticles. ACS Applied Bio Materials. 4(1): 742-751.
    181. Shetty D, Talker E, Jain H, Patil S, Tembhare P, Patkar N, Nayak L, Jain H, Sengar M (2021). Additional Cytogenetic Aberrations Indicative of Poor Prognosis in AML with RUNX1/RUNX1T1 Rearrangement: Karyotype a Chromosomal Blueprint. Annals of Hematology and Oncology. 8(1): 1325.
    182. Shetty D, Mohanty P, Talker E, Jain H, Chaubal K, Tembhare P, Patkar N, Subramanian P, Moulik NR, Dhamne C, Narula G, Banavali S (2021). Importance of conventional cytogenetics in the identification of ins(19;X)(q13.1;p11.2q28) and t(1;11)(q10;p10), both, novel cytogenetic abnormalities in a pediatric AML case. Cancer Genetics. 256-257:17-20. PMID: 33823403
    183. Shetty O, Gurav M, Bapat P, Karnik N, Wagh G, Pai T, Epari S, Desai S (2021). Moving Next-Generation Sequencing into the Clinic. Indian Journal of Medical and Paediatric Oncology. 42(3): 221-228.
    184. Shetty P, Singh VK, Choudhari A, Moiyadi AV (2021). Development of a standardized semantic feature-based reporting proforma for intraoperative ultrasound findings in brain tumors and application in high-grade gliomas - A preliminary study. Ultrasound International Open. 7(2):E55-E63. PMID: 34804772
    185. Shinghal A, Paul S, Chopra S, Gurram L, Scaria L, Kohle S, Rane P, Dheera A, Puravath J, Jain J, Swamidas J, Ghosh J, Gupta S, Rath S, Ghosh Laskar S, Agarwal JP (2021). Impact of COVID -19 pandemic on Gynaecological cancer radiation during complete nationwide lockdown: Observations and Reflections from Tertiary care institute in India. Advances in Radiation Oncology. 6(6):100725. PMID: 34075350
    186. Shirsat A, Pashilkar S, Chavan A, Kalra D, Gota V, Joshi A, Krishnamurthy M.(2021) Effect of the pandemic on quality-of-life data collection in prostate cancer patients.ClinicoEconomics and Outcomes Research. 13:937-941. PMID: 34819738
    187. Shrivastava A, Aggarwal LM, CM Krishna, Pradhan S, Mishra SP, Choudhary S, Patel C, Singla S, Ashish, Singh RK (2021). Diagnostic and Prognostic Application of Raman Spectroscopy in Carcinoma Cervix: A Biomolecular Approach. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 250:119356. PMID: 33401183
    188. Singh AG, Chaukar D, Gupta S, Pramesh CS, Sullivan R, Chaturvedi P, Badwe R. A prospective study to determine the cost of illness for oral cancer in India. Ecancermedicalscience. 15:1252. PMID: 34267808
    189. Singhavi H, Khare N, Singh A, Khandelwal A, Kannan S, Patil A, Mittra I, Chaturvedi P (2021). Impact of pre-operative serum C-reactive protein and cell-free chromatin levels on tumor aggressiveness and survival outcome in oral cavity squamous cell carcinoma. Oral Oncology. 114: 105078. PMID: 33183996
    190. Sinha S, Agarwal JP, Mahajan A, Chaturvedi P, Balaji A, Juvekar S, Gupta T, Budrukkar A, Murthy V, Mummudi N, Swain M, Jadhav R, Laskar SG (2021 Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective study. Head Neck. 43(4):1289-1299. PMID: 33368793.
    191. Sitani K, Parghane R, Talole S, Basu S (2021). Long-term outcome of indigenous 177Lu-DOTATATE PRRT in patients with Metastatic Advanced Neuroendocrine Tumours: a single institutional observation in a large tertiary care setting. British Journal of Radiology. 94(1117):20201041. PMID: 33095671
    192. Solanki SL, Thota RS, Rajan J, Gangakhedkar GR, Jain P, Gottumukkala V, Garg R, Cata JP, Goswami J, Ranganath N, Ramkiran S, Ghai B, Popat KU, Buggy DJ, Pingle AA, Baxi V, Rayani BK, Thomas M, Bhatnagar S, Divatia JV (2021). Multimodal opioid sparing onco-anesthesia: A consensus practice guideline from Society of Onco-Anesthesia and Perioperative Care (SOAPC). Journal of Opioid Management. 17(5):417-437. PMID: 34714542.
    193. Solanki SL, Pandrowala S, Nayak A, Bhandare M, Ambulkar RP, Shrikhande SV (2021). Artificial intelligence in perioperative management of major gastrointestinal surgeries. World Journal of Gastroenterology. 27(21):2758-2770. PMID: 34135552
    194. Solanki SL, Kaur J, Gupta AM, Patkar S, Joshi R, Ambulkar RP, Patil A, Goel M (2021). Cancer related nutritional and inflammatory markers as predictive parameters of immediate postoperative complications and long-term survival after hepatectomies. Surgical Oncology. 37:101526. PMID: 33582497
    195. Sood S, Gurram L, Aravindakshan D, Paul J, Chopra S, Swamidas J, Patil A, Mahantshetty U (2021). Reporting of dose-volume specifications for "Martinez Universal Perineal Interstitial Template-based interstitial high-dose-rate brachytherapy for gynecological cancers" according to International Commission on Radiation Units and Measurements 58 with early clinical outcomes. Brachytherapy. 20: 550-556. PMID: 33648892
    196. Srinivasan S, Gurram L, Johny C, Chopra S, Dheera A, Baheti A, Popat P, Sable N, Rangarajan V, Mahantshetty U (2021). Validation and applicability of para-aortic lymph nodal contouring atlas in cervical cancer. Radiotherapy and Oncology. 165:32-36. PMID: 34710510
    197. Sriram H, Khanka T, Kedia S, Tyagi P, Ghogale S, Deshpande N, Chatterjee G, Rajpal S, Patkar NV, Subramanian PG, Gujral S, Hasan S, Tembhare PR. Improved protocol for plasma microRNA extraction and comparison of commercial kits. Biochemia Medica. 131(3):030705. PMID: 34658646
    198. Starr N, Capo-Chichi N, Moore J, Shreckengost CH, Fernandez K, Ambulkar R, Varallo JE, Ademuyiwa AO, Krouch S, Rana PS, Ingabire JA, Weiser TG, Mammo TN, Evans FM (2021). Perioperative provider safety in low and middle-income countries during the COVID-19 pandemic: a call for renewed investments in resources and training. Annals of Surgery. 274(6):e525-e627. PMID: 34225300.
    199. Subedi R, Dhimal M, Budukh A, Chapagain S, Gyawali P, Gyawali B, Dahal U, Dikshit R, Jha AK (2021)443-452. Epidemiologic Pattern of Cancer in Kathmandu Valley, Nepal: Findings of Population-Based Cancer Registry, 2018. JCO Global Oncology. 443-452. PMID: 33788597
    200. Subedi R, Budukh A, Chapagain S, Gyanwali P, Gyawali B, Khadka K, Thakur C, Dahal U, Dikshit R, Kumar Jha A, Dhimal M (2021) Differences in cancer incidence and pattern between urban and rural Nepal: one-year experience from two population-based cancer registries. Ecancermedicalscience. 15: 1229. PMID: 34158833
    201. Sulkshane P, Pawar SN, Waghole R, Pawar SS, Rajput P, Uthale A, Oak S, Kalkar P, Wani H, Patil R, Nair S, Rane P, Teni T (2021). Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers. British Journal of Cancer. 125(4):547-560. PMID: 34079080
    202. Suman S, Parghane RV, Joshi A, Prabhash K, Talole S, Basu S (2021). Prostate. 81(15):1225-1234 PMID: 34469602.
    203. Sureshbabu SK, Godbole JH, Vaibhaw A, Chiplunkar SV (2021). Immunosuppressive microenvironment in oral cancer: Implications for cancer immunotherapy. Exploration of Immunology. 1:166-198.
    204. Swain M, Ghosh-Laskar S, Budrukkar A, Patil R, Murthy V, Gupta T, Mummudi N, Prabhash K, Joshi A, Patil VM, Naronha V, Agarwal JP (2021). Concurrent chemoradiotherapy for locally advanced unresectable adenoid cystic carcinoma of head and neck: experience from a single institute. European archives of oto-rhino-laryngologyl. 278(11):4423-4431 PMID: 33564909.
    205. Swamidas J, Pradhan S, Chopra S, Panda S, Gupta Y, Sood S, Mohanty S, Jain J, Joshi K, Phurailatpam R, Gurram L, Mahantshetty U, Agarwal J (2021). Development and clinical validation of Knowledge-based planning for Volumetric Modulated Arc Therapy of cervical cancer including pelvic and para aortic fields. Physics and Imaging in Radiation Oncology. 18: 61-67. PMID: 34258410
    206. Tambe M, Phuntsok T, D'Silva SZ, Rajak J, Singh M. Characterization of a novel HLA-C*04:01:01:102 allele in an individual from West Bengal. HLA. 98(4):393-394. PMID: 34237196
    207. Telkhade T, Murthy V, Kanala TS, Mathew JM, Phurailatpam R, Mokal S, Chourasiya D, Panigrahi G, Krishnatry R (2021). Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate Cancer. Clinical Oncology. 33(3):172-180. PMID: 33214044
    208. Tembhare P, Chatterjee G, Khanka T, Ghogale S, Badrinath Y, Deshpande N, Panda D, Patkar N, Narula G, Girase K, Verma S, Sanyal M, Sriram H, Banavali S, Gujral S, Subramanian PG (2021). Eleven‐marker 10‐color flow cytometric assessment of measurable residual disease for T‐cell acute lymphoblastic leukemia using an approach of exclusion Cytometry Part B: Clinical cytometry. 100(4): 421-433. PMID: 32812702
    209. Thekkeveettil M, Tandon S, Moiyadi A, Gujral S. Narula G (2021). Extramedullary Sarcoma of Brain with Extracranial Extension Mimicking a Primary Brain Tumor. Journal of Pediatric Hematology/Oncology. 43(1):e149-e151.PMID: 32852393
    210. Thomas A, Vishwakarma G, Bhattacharjee A (2021). Joint modeling of longitudinal and time-to-event data on multivariate protein biomarkers. Journal of Computational and Applied Mathematics. 381: 113016.
    211. Thomas A, Mittal N, Rane SU, Bal M, Patil A, Ankathi SK, Vaish R. Papillary and medullary thyroid carcinomas presenting as collision tumors: A case series of 21 cases at a tertiary care cancer center. Head and Neck Pathology. 15(4):1137-1146. PMID: 33840044
    212. Tilwani S, Gandhi K, Narayan S, Ainavarapu SRK, Dalal SN (2021). Disruption of desmosome function leads to increased centrosome clustering in 14-3-3γ-knockout cells with supernumerary centrosomes. FEBS Letters. 595(21):2675-2690. PMID: 34626438.
    213. Tiwari R, Ganguli N, Alam H, Sahu I, Vadivel CK, Sinha S, Patel S, Jamghare SN, Bane S, Thorat R, Manjumdar SS, Vaidya MM (2021). Generation of a tissue-specific transgenic model for K8 phosphomutants: A tool to investigate the role of K8 phosphorylation during skin carcinogenesis in vivo. Cell Biology International. 45(8):1720-1732. PMID: 33847415.
    214. Tripathy B, Pal K, Shabrish S, Mittra I (2021). A New perspective on the origin of DNA double-strand breaks and its implications for ageing. Genes. PMID: 33530310
    215. Wadasadawala T, Sen S, Watekar R, Rane P, Sarin R, Gupta S, Parmar V, Kannan S, Mohanty SK (2021). Economic Distress of Breast Cancer Patients Seeking Treatment at a Tertiary Cancer Center in Mumbai during COVID-19 Pandemic: A Cohort Study. Asian Pacific Journal Cancer Prevention. 22(3):793-800. PMID: 33773543
    216. Wagal OS, Joshi AJ, Joshi UJ, Bhojwani HR, Begwani KV, Dawne HA, Gude RP, Sathaye SS, Kanchan DM (2021). Studies in molecular modeling, in-vitro CDK2 inhibition and antimetastatic activity of some synthetic flavones. Frontiers in Bioscience ( Landmark Ed). 26: 664-681. PMID: 33049687
    217. Warawdekar U, Jain V, Patel H, Nanda A, Kamble V (2021). Modifying gap junction communication in cancer therapy. Current Research in Translational Medicine. 69(1):103268. PMID: 33069641
    218. Yadav S, Pant D, Samaiya A, Kalra N, Gupta S, Shukla S (2021). ERK1/2-EGR1-SRSF10 axis mediated alternative splicing plays a critical role in head and neck cancer. Frontiers in Cell and Developmental Biology. 9:713661. PMID: 34616729
  • 2020
    1. Acharya S, Dutta S, Bose K (2020). A distinct concerted mechanism of structural dynamism defines activity of human serine protease HtrA3. Biochemical Journal. 477(2):407-429. PMID: 31899476
    2. Acharya S, Dutta S, Pandav-Mudrale S, Bose K (2020). Dual specificity phosphatase 9: A novel binding partner cum substrate of proapoptotic serine protease HtrA2. Biochemical and Biophysical Research Communications. 533: 607-612. PMID: 32988583
    3. Achrekar MS, Murthy V, Kannan S (2020). Are Patient’s Satisfied With Nurses’ Communication? A Cross Sectional Survey. HSOA Journal of Practical and Professional Nursing. 4: 021.
    4. Agarwal JP, Sinha S, Goda JS, Joshi K, Mhatre R, Kannan S, Laskar SG, Gupta T, Murthy V, Budrukkar A, Mummudi N, Ganeshan B (2020) - Tumor radiomic features complement clinico-radiological factors in predicting long-term local control and laryngectomy free survival in locally advanced laryngo-pharyngeal cancers. British Journal of Radiology. 93(1109): 20190857. PMID: 32101463
    5. Amnekar RV, Khan SA, Rashid M, Khade B, Thorat R, Gera P, Shrikhande SV, Smoot DT, Ashktorab H, Gupta S (2020). Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer. World Journal of Gastroenterology. 26(6): 598-613. PMID: 32103870
    6. Anand D, Kurian NC, Dhage S, Kumar N, Rane S, Gann PH, Sethi A (2020). Deep learning to estimate human epidermal growth factor receptor 2 status from hematoxylin and Eosin-Stained breast tissue images. Journal of Pathology Informatics. 11:19 PMID: 33033656
    7. Anand KV, Mishra G, Pimple S, Pathuthara S, Kulkarni V (2020). Detection of rare parasite on Pap smear. CytoJournal 17:18. PMID: 33093854
    8. Arora R, Choi JE, Harms PW, Chandrani P (2020). Merkel cell polyomavirus in merkel cell carcinoma: Integration sites and involvement of the KMT2D tumor suppressor gene. Viruses. 12(9). PMID: 32878339
    9. Bagal B, Gokarn A, Punatar S, Das S, Bonda A, Nayak L, Chichra A, Kannan S, Mathew LJ, Tembhare P, Patkar N, Poojary M, Ojha S, Subramanian PG, Gujral S, Khattry N (2020). Bortezomib and cyclophosphamide based chemo-mobilization in multiple myeloma. International Journal of Hematology.112(6):835-840. PMID: 32876851
    10. Bagal B, Kumar R, Gaur T, Talreja V, Bonda A, Patkar N, Shetty D, Kowtal P, Subramanian PG, Gupta S, Sarin R, Hasan SK (2020). Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapy. Medical Oncology. 37(5): 48. PMID: 32277283
    11. Baid U, Talbar S, Rane S, Gupta S, Thakur MH, Moiyadi A, Sable N, Akolkar M, Mahajan A (2020). A Novel approach for fully automatic intra-Tumor segmentation with 3D U-Net architecture for gliomas. Frontiers in Computational Neuroscience. 14:10. PMID: 32132913
    12. Bajpai J, Mailankody S, Nair R, T Surappa S, Gupta S, Prabhash K, Banavali SS, Malhotra H, Bhattacharyya GS, Smruti BK, Babu G (2020). Gender climate in Indian oncology: national survey report. ESMO Open. 5(2):e000671. PMID: 32354723
    13. Bandekar M, Maurya DK, Sharma D, Checker R, Gota V, Mishra N, Sandur SK (2020). Xenogeneic transplantation of Human WJ-MSCs rescues mice from acute radiation syndrome via Nrf2 dependent regeneration of damaged tissues. American Journal of Trasplantation. 20(8):2044-2057.PMID: 32040239
    14. Behera G, Chhabra G, Sable MN, Panigrahi A, Shetty D. (2020). Multinucleated lymphocytes in chronic lymphocytic leukemia-A rare morphological finding with review. International Journal of Laboratory Haematology. PMID: 32347621
    15. Benor G, Fuks G, Chin SF, Rueda OM, Mukherjee S, Arandkar S, Aylon Y, Caldas C, Domany E, Oren M (2020). Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features. Molecular Oncology. 14(8):1640-1652. PMID: 32484602
    16. Bhagwat GS, Athawale RB, Gude RP, Md S, Alhakamy NA, Fahmy UA, Kesharwani P (2020). Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy. Frontiers in Pharmacology.11: 614290. PMID: 33329007
    17. Bharambe HS, Joshi A, Yogi K, Kazi S, Shirsat NV (2020). Restoration of miR-193a expression is tumor-suppressive in MYC amplified Group 3 medulloblastoma. Acta Neuropathologica Communications. 8(1):70. PMID: 32410663
    18. Bhattacharjee A (2020) - Bayesian competing risks analysis without data stratification. Clinical Epidemiology and Global Health. 8: 265-270.
    19. Bhattacharjee A (2020). Estimation of treatment effect with missing observations for three arms and three periods crossover clinical trials. 7: 447–460 Annals of Data Science.
    20. Bhattacharjee A, Patil VM, Dikshit R, Prabhash K, Singh A, Chaturvedi P (2020). Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic. Head & Neck.42(6):1173-78. PMID: 32329953
    21. Bhattacharjee A, Rajendra J, Dikshit R, Dutt S (2020). HER2 borderline is a negative prognostic factor for primary malignant breast cancer. Breast Cancer Research and Treatment. 181(1):225-231 PMID: 32236825
    22. Chandane P, Jori C, Chaudhari H, Bhapkar S, Deshmukh S, Jadhav U (2020). Bioleaching of copper from large printed circuit boards for synthesis of organic-inorganic hybrid. Environmental Science and Pollution Research. 27(6):5797-5808. PMID: 31858414
    23. Chargari C, Chopra S, Viswanathan AN, Deutsch E. Brachytherapy Issues and Priorities in the Context of the Coronavirus Disease 2019 (COVID-19) Outbreak (2020). Advances in Radiation Oncology. 5(4):640-643. PMID: 32775774
    24. Chatterjee A, Goda JS, Gupta T, Kamble R, Mokal S, Krishnatry R, Sarin R, Jalali R (2020). A randomized trial of Stereotactic vs. Conventional radiotherapy in young patients with low grade brain tumors: Occupational therapy based neurocognitive data. Neuro-Oncology Advances. 2(1): vdaa130.
    25. Chopra S, Engineer R, Shah S, Shukla R, Dora T, Gupta P, Paul SN, Popat P, Swamidas J, Mahantshetty U, Varghese L, Gupta S, Rangrajan V, Shrivastava S. MRI and PET Guided Interstitial Brachytherapy for post-surgical vaginal recurrences of cervical cancer: Results of phase II study. International Journal of Radiation Oncology Biology Physics. 106(2): 310-319, 2020. PMID: 31682968
    26. Chowdhury SR, Bhattacharjee C, Casier JC, Jain BK, Glick BS, Bhattacharyya D (2020) - ER arrival sites associate with ER exit sites to create bidirectional transport portals. Journal of Cell Biology. 219 (4): e201902114. PMID: 32328626
    27. CM Krishna( 2020). Raman theranostic applications in major cancers in India. Asian Journal of Physics. 29(1-2): 87-99.
    28. Dar AA, Patil RS, Pradhan TN, Chaukar DA, D'Cruz AK, Chiplunkar SV (2020) - Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma. Cancer Immunology, Immunotherapy. 69(6):1071-1086. PMID: 32103293
    29. Das L, Murthy V, Varma AK (2020). Comprehensive analysis of low molecular weight serum proteome enrichment for mass spectrometric studies. ACS OMEGA. 5(44): 28877-2888. PMID: 33195941
    30. de Las Heras B, Saini KS, Boyle F, Ades F, de Azambuja E, Bozovic-Spasojevic I, Romano M, Capelan M, Prasad R, Pattu P, Massard C, Portera C, Saini ML, Singh BP, Venkitaraman R, McNally R, Leone M, Grande E, Gupta S (2020). Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months. Oncology and Therapy. 8(2):171-182. PMID: 32749634
    31. Desai S, Mishra S, Joshi A, Sarkar D, Hole A, Mishra R, Dutt S, CM Krishna, Gupta S, Dutt A (2020). Raman Spectroscopy Based Detection of RNA viruses in Saliva: a preliminary report. Journal of Biophotonics. 13(10): e202000189. PMID: 32609429
    32. Dhadve AC, Hari K, Rekhi B, Jolly MK, De A, Ray P (2020). Decoding molecular interplay between RUNX1 and FOXO3a underlying the pulsatile IGF1R expression during acquirement of chemoresistance. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(6): 165754 PMID: 32142859
    33. Dharavath B, Yadav N, Desai S, Sunder R, Mishra R, Ketkar M, Bhanshe P, Gupta A, Redhu AK, Patkar N Dutt S, Gupta S, Dutt A (2020). A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2. Heliyon. 6(7):e04405. PMID: 32665985
    34. Dhawan V, Sutariya B, Lokras A, Thamm J, Saraf M, Warawdekar U, Fahr A, Nagarsenker M (2020). Lipid nanoconstructs for superior hepatoprotection: In vitro assessments as predictive tool for in vivo translation. International Journal of Pharmaceutics. 579: 119176. PMID: 32119898
    35. Dimri S, Malhotra R, Shet T, Mokal S, Gupta S, De A (2020). Noncanonical pS727 post translational modification dictates major STAT3 activation and downstream functions in breast cancer. Experimental Cell Research. 396(2): 112313. PMID: 33002501
    36. Dixit H, Kumar CS, Chaudhary R, Thacker D, Gadewal N, Dasgupta D (2020). Role of Phosphorylation and Hyperphosphorylation of Tau in its interaction with βα Dimeric Tubulin Studied from a Bioinformatics Perspective. Avicenna Journal of Medical Biotechnology.
    37. Doval DC, Radhakrishna S, Tripathi R, Kashinath RI, Talwar V,Batra U, Mullapudi NA, Kumar K, Dewan AK, Chaturvedi H, Tayal J, Mehta A, Gupta S, Nimmagadda RBV (2020). A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery. Scientific Reports. 10(1): 5886. PMID: 32246015
    38. Dumal S, Hole A, Choudhary S, Naidu I, Bhubna S, CM Krishna (2020). Serum Raman spectroscopy: exploring delineation of oral premalignant disorders. Proceedings of SPIE 11247, Optical Diagnostics and Sensing XX: Toward Point-of-Care Diagnostics, (14 February 2020), 1124707.
    39. Elledge CR, Beriwal S, Chargari C, Chopra S, Erickson BA, Gaffney DK, Jhingran A, Klopp AH, Small W Jr, Yashar CM, Viswanathan AN (2020).Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations. Gynecologic Oncology. 158(2):244-253. PMID: 32563593
    40. Gadewal N, Kumar R, Aher S, Gardane A, Gaur T, Varma AK, Khattry N, Hasan SK (2020). miRNA-mRNA profiling reveals prognostic impact of SMC1A 4 expression in acute myeloid leukemia. Oncology Research. 28(3): 321-330. PMID: 32059753
    41. Gahoi N, Syed P, Choudhary S, Epari S, Moiyadi A, Varma SG, Gandhi MN, Srivastava S (2020). A Protein Microarray-Based Investigation of Cerebrospinal Fluid Reveals Distinct Autoantibody Signature in Low and High-Grade Gliomas. Frontiers in Oncology. 10: 543947. PMID: 33415070
    42. George G, Lewis S, Chopra S, Phurailatpam R, Engineer R. A retrospective study of the dosimetric parameters and duodenal toxicity in patients with upper gastrointestinal and gynaecological cancers treated with radiation therapy. Clinical Oncology (R Coll Radiol). 32(2): e53-e59, 2020. PMID: 31495648
    43. Ghantasala S, Gollapalli K, Epari S, Moiyadi A, Srivastava S (2020) - Glioma tumor proteomics: clinically useful protein biomarkers and future perspectives. Expert Review of Proteomics. 17(3): 221-232. PMID: 32067544
    44. Ghorai A, Mahddalkar T, Thorat R, Dutt S (2020). Sustained inhibition of PARP-1 activity delays glioblastoma recurrence by enhancing radiation-induced senescence. Cancer Letters. 490:44-53. PMID: 32645394
    45. Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A (2020). Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. European Urology. 77(4): 508-547. PMID: 32001144
    46. Goda JS, Dutta D, Krishna U, Goswami S, Gupta T, Kothavade V, Kannan S, Maitre M, Bano N, Jalali R (2020). Hippocampal radiotherapy dose-constraints for predicting long-term neurocognitive outcomes: Mature data from a prospective trial in young patients with brain tumors. Neuro-Oncology. 22(11):1677. PMID: 32227185
    47. Goda JS, Gaikwad U, Narayan A, Kurkure D, Yadav S, Khanna N, Jain H, Bagal B, Epari S, Singh P, Sengar M, Laskar S (2020). Primary diffuse large B cell lymphoma of Uterine Cervix: Treatment outcomes of a rare entity with literature review. Cancer Reports. 3(5):e1264. PMID: 32761885
    48. Gulia S, Ghosh J, Bajpai J, Rath S, Maheshwari A, Shylasree TS, Deodhar K, Thakur M, Gupta S (2020). Pazopanib and Oral Cyclophosphamide in Women With Platinum-Resistant or -Refractory Epithelial Ovarian Cancer. JCO Global Oncology. 6: 542-547. PMID: 32228315
    49. Gulia S, Kannan S, Badwe R, Gupta S (2020). Evaluation of 1-Year vs Shorter Durations of Adjuvant Trastuzumab Among Patients With Early Breast Cancer: An Individual Participant Data and Trial-Level Meta-analysis. JAMA Network Open. 3(8):e2011777. PMID: 32833018
    50. Gupta N, Verma RK, Gupta S, Prinja S (2020). Cost effectiveness of Trastuzumab for management of breast cancer in India. JCO Global Oncology. 6: 205-216. PMID: 32045547
    51. Gupta S, Aitken J, Bartels U, Bhakta N, Bucurenci M, Brierley JD, De Camargo B, Chokunonga E, Clymer J, Coza D, Fraser C, Fuentes-Alabi S, Gatta G, Gross T, Jakab Z, Kohler B, Kutluk T, Moreno F, Nakata K, Nur S, Parkin DM, Penberthy L, Pole J, Poynter JN, Pritchard-Jones K, Ramirez O, Renner L, Steliarova-Foucher E, Sullivan M, Swaminathan R, Van Eycken L, Vora T, Frazier AL. Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines. Lancet Oncology. 21(9): e444-e451. PMID: 32888473
    52. Gupta S, Shaikh AM, Mohanty B, Chaudhari P, Parab PB, Apte KG (2020). Evaluation of Antiosteoporotic potential of Sesbania grandiflora Linn. aqueous fraction in ovariectomised rats. Research Journal of Pharmacy and Technology. 13(4): 1806-1814.
    53. Gupta T, Chatterjee A, Patil V (2020). Extended adjuvant temozolomide in newly-diagnosed glioblastoma: is more less? Neuro-Oncology. 22(12): 1887-1888. PMID: 32777076
    54. Gupta T, Ghosh-Laskar S, Agarwal JP (2020). Resource-sparing curative-intent hypofractionated-accelerated radiotherapy in head and neck cancer: More relevant than ever before in the COVID era. Oral Oncology. 111: 105045. PMID: 33091846
    55. Gupta T, Maitre M, Gupta P, Krishanty R, Chatterjee A, Moiyadi AV, Shetty P, Singh V, Chinnaswamy G, Epari S, Sahay A, Patil V, Goda JS (2020). Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma. Journal of Neuro-Oncology. 147(2):405-4 PMID: 32072441
    56. Gupta T, Manjali J, Kannan S, Purandare N, Rangarjan V (2020). Diagnostic yield of extensive systemic staging including whole-body 18F-fluoro-deoxy-glucose positron emission tomography with or without computed tomography in patients with primary central nervous system lymphoma: systematic review and meta-analysis. Clinical Lymphoma Myeloma and Leukemia. 20(11): e836-e845. PMID: 32712087
    57. Gupta T, Sinha S, Ghosh-Laskar S, Budrukkar A, Mummudi N, Swain M, Phurailatpam R, Prabhash K, Agarwal JP (2020). Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial. Radiation Oncology. 15: 218. PMID: 32938468
    58. Gurjar M, Mehta P, Sharma J, Patil S, Kulkarni P, Patil A, Nookala M, Joshi A, Gota V (2020). An HPLC method for simultaneous quantification of sunitinib and its active metabolite, SU12662, using hydrophilic interaction chromatography principle. Bioanalysis. 12(2): 75-85. PMID: 31928228
    59. Hasan SK, Patkar NV, Rajamanickam D, Gokarn A, Lucena-Araujo AR, Tembhare P, Bagal B, Amare PK, Jain H, Gujral S, Sengar M, Subramanian PG, Khattry N. Over-expression of BAALC and ERG is associated with poor outcome in acute myeloid leukemia. Hematological Oncology. 38(5):808-816. PMID: 32893896
    60. Hole A, Kumar P, Ingle A, CM Krishna (2020). Raman microspectroscopy of oral mucosa: exploring Raman mapping in experimental carcinogenesis. Proceedings of SPIE 11213, Imaging, Therapeutics, and Advanced Technology in Head and Neck Surgery and Otolaryngology, (19 February 2020) 1121307.
    61. Jadhav PA, Singh SR, Sawant PN, Vaswani H, Pansare K, Hole A, Ingle A, CM Krishna (2020). Serum Raman spectroscopy: Evaluation in hamster buccal pouch models. Proceedings of SPIE 11213, Imaging, Therapeutics, and Advanced Technology in Head and Neck Surgery and Otolaryngology, (19 February 2020) 1121305.
    62. Jain H, Shetty D, Narula G, Roy Moulik N, Tembhare P, Patkar N, Subramanian PG, Banavali S (2020). Cytogenetic profile and outcome of a pediatric acute promyelocytic leukemia patient presenting with isolated isochromosome 17q in absence of RARA rearrangement. Blood Cells, Molecules, and Disease.PMID: 32414556
    63. Jain NK, Dimri S, Prasad R, Ravichandran G, De A, Srivastava R (2020). Characteristics of molecularly engineered anticancer drug conjugated organic nanomicelles for site-selective cancer cell rupture and growth inhibition of tumor spheroids. ACS Applied Bio Materials.3 (10): 7067–7079
    64. Jain S, Engineer R, Ostwal V, Ramaswamy A, Chopra S, Desouza A, Lewis S, Arya S, Patil P, Saklani A (2020). Addition of short course radiotherapy in newly diagnosed locally advanced rectal cancers with distant metastasis. Asia-Pacific Journal of Clinical Oncology. PMID: 32030912
    65. Joshi H, Patil V, Tilekar K, Upadhyay N, Gota V, Ramaa CS(2020). Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with Imatinib. Bioorganic & Medicinal Chemistry. 30(1): 127561. PMID: 32961322
    66. Kadam R, Harish M, Dalvi K, Teni T (2020). Novel nucleolar localization of clusterin and its associated functions in human oral cancers: An in vitro and in silico analysis. Cell Biochemistry and Function. PMID: 33155695
    67. Kalra B, Kannan S, Gupta T (2020). Optimal adjuvant therapy in elderly glioblastoma: results from a systematic review and network meta-analysis. Journal of Neurooncology. 146(2): 311-320. PMID: 31894517
    68. Karmakar S, Murthy V (2020). Dose-escalation of radiation may improve out-comes of squamous cell carcinoma of bladder. Clinical and Translational Radiation Oncology. 20: 51. PMID: 31886420
    69. Kaur E, Nair J, Ghorai A, Mishra SV, Achareker A, Ketkar M, Sarkar D, Salunkhe S, Rajendra J, Gardi N, Desai S, Iyer P, Thorat R, Dutt A, Moiyadi A, Dutt S(2020). Inhibition of SETMAR-H3K36me2-NHEJ repair axis in residual disease cells prevent glioblastoma recurrence. Neuro-Oncology.22(12):1785-1796. PMID: 32458986.
    70. Kaushik A, Dwarakanath TA, Bhutani G, Moiyadi A, Chaudhari P (2020). Validation of high precision robot-assisted methods for intracranial applications: Preliminary study. World Neurosurgery. 137: 71-77. PMID: 32032794
    71. Khadilkar R, Ho K, Venkatesh B, Tanetzapf G (2020). Integrins modulate extracellular matrix organization to control cell signaling during hematopoiesis. Current Biology. 30(17): 3316-3329. PMID: 32649911
    72. Kholiya F, Chatterjee S, Bhojani G, Sen S, Barkume M, Kasinathan NK, Kode J, Ramavatar M (2020). Seaweed polysaccharide derived bioaldehyde nanocomposite: Potential application in anticancer therapeutics. Carbohydrate Polymers. 240: 116282. PMID: 32475566
    73. Kode J, Kovvuri J, Nagaraju B, Jadhav S, Barkume M, Sen S, Kasinathan NK, Chaudhari P, Mohanty BS, Gour J, Sigalapalli DK, Kumar CG, Pradhan T, Banerjee M, Kamal A (2020).Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors. 105:104447. Bioorganic Chemistry. PMID: 33207276
    74. Kothekar A, Divatia JV, Myatra SN, Patil A, Nookala Krishnamurthy, M, Maheshwarappa HM, Siddiqui SS, Gurjar M, Biswas S, Gota V (2020)- Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria. Annals of Intensive Care. 10(1): 4. PMID: 31925610
    75. Kothekar AT, Patil VP (2020). Transoesophageal echocardiographic thoracic inferior vena caval index: Is it validated and accurate for identifying fluid responders? Saudi Journal of Anesthesia. 14(2):279-280. PMID: 32317903
    76. Krishnamurthy R, Wadasadawala T, Rane P, Phurailatpam R, Sarin R (2020). Defining dose constraints for catheter insertion sites to minimize toxicity after interstitial breast brachytherapy. Brachytherapy. 19(5): 694-699. PMID: 32684407
    77. Krishnmurthy M, Narula G, Gandhi K, Awase A, Pandit R, Raut S, Singh R, Gota V, Banavali S (2020). Randomized, parallel group, open-label bioequivalence trial of intramuscular pegaspargase in patients With Relapsed Acute Lymphoblastic Leukemia. JCO Global Oncology. 6:1009-1016. PMID:32628582
    78. Kuligina ES, Sokolenko AP, Bizin IV, Romanko AA, Zagorodnev KA, Anisimova MO, Krylova DD, Anisimova EI, Mantseva MA, Varma AK, Hasan SK, Ni VI, Koloskov AV, Suspitsin EN, Venina AR, Aleksakhina SN, Sokolova TN, Milanović AM, Schürmann P, Prokofyeva DS, Bermisheva MA, Khusnutdinova EK, Bogdanova N, Dörk T, Imyanitov EN (2020). Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39. Breast Cancer Research and Treatment. 179(3): 731-742. PMID: 31754952
    79. Kulkarni P, Damle N, Singh S, Yadav K, Ghante M, Bhaskar V, Hingorani L, Gota V (2020). Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee. Drug Metabolism and Personalized Therapy. 35(2). PMID: 32549135
    80. Kumar M, Bhattacharjee A, Sonker PK, Saroj A, Jain A (2020)- Parametric survival analysis using R: Illustration with lung cancer data. Cancer Reports. 3(4):e1210
    81. Kumar R, George B, Campbell MR, Verma N, Paul AM, Melo-Alvim C, Ribeiro L, Pillai MR, da Costa LM, Moasser MM. HER family in cancer progression: From discovery to 2020 and beyond. Advances in Cancer Research. 147:109-160. PMID: 32593399.
    82. Kumar S, Vahanwala S, CM Krishna, Waghmare M, Pagare S, Santosh V, Shetty N, Reema M, Bhutani H, Gavand K (2020).Salivary spectrum evaluation with Raman's Spectrometer. International Journal of Dentistry Research. 5(3): 126-130.
    83. Laxman K, Reddy BPK, Mishra SK, Gopal MB, Robinson A, De A, Srivastava R, Ravikanth M (2020). BF2-Oxasmaragdyrin Nanoparticles: A Non-toxic, Photostable, Enhanced Non-radiative Decay-Assisted Efficient Photothermal Cancer Theragnostic Agent. ACS Applied Materials and Interfaces. 12(47):52329-52342. PMID: 33170618
    84. Laxman K, Reddy PK, Mishra SK, Robinson A, De A, Srivastava R, Ravikanth M (2020). Bioinspired carrier-free peptide conjugated BF2-oxasmaragdyrin dye-based nano self-assemblies: a photostable NIR cancer theragnostic agent. NPG Asia Materials. 12:75.
    85. Maithania HV, Mohanty BS, Chaudhari PR, Samad A, Devarajan PV. Shape mediated splenotropic delivery of buparvaquone loaded solid lipid nanoparticles. Drug Delivery Transational Research 10(1): 159-167, 2020. PMID: 31468307
    86. Mal A, Dey P, Hayes RM, McCarthy JV, Ray A, De A (2020). In Silico Identification of Potential Phosphorylation in the Cytoplasmic Domain of Epithelial Cell Adhesion Molecule. ACS Omega. 5(48): 30808-30816. PMID: 33324790
    87. Malhotra H, Kowtal P, Mehra N, Pramak R, Sarin R, Thangarajan R, Gupta S, Bapna A, Bhattarcharyya G, Gupta S, Maheshwari A, Mannan AU, Kundur R, Sekhon R, Singhal M, Smruti BK, Somashekhar SP, Suryavanshi M, Verma A (2020). Genetic counseling, testing, and management of HBOC in India: An expert consensus document From Indian Society of Medical and Pediatric Oncology. JCO Global Oncology. 6: 991-1008. PMID: 32628584
    88. Malik A, Nair S, Singh A, Lamba K, Rane S, Bal M, Bhattacharjee A, Mehanna H, Chaturvedi P (2020). Soft tissue deposit in neck dissection specimen carries a poor prognosis in oral cancer: A matched pair analysis. Head and Neck. 42(8):1783-1790. PMID: 32043658
    89. Malik A, Nair S, Sonawane K, Lamba K, Ghosh-Laskar S, Prabhash K, Pai P, Chaukar D, Nair D, Chaturvedi P (2020). Outcomes of a telephone-Based questionnaire for follow-up of patients who have completed curative-intent treatment for oral cancers. JAMA Otolaryngology Head and Neck Surgery. 146(12):1102-1108. PMID: 32880626
    90. Marathe P, Mahadeva Swamy HS, Nair D, Bhattacharyya D (2020). mEosBrite are bright variants of mEos3.2 developed by semirational protein engineering. Journal of Fluorescence. 30(3):703-715. PMID: 32385659
    91. Mehrotra S, Bansal P, Oli N, Pillai S, Galande S (2020). Defective proventriculus regulates cell specification in the gastric region of Drosophila intestine. Frontiers in Physiology. 11:711. PMID: 32760283
    92. Mehrotra S, Mittra I (2020). Origin of genome instability and determinants of mutational landscape in cancer cells. Genes. 11(9): 1101. PMID: 32967144
    93. Mehta M, Gohil D, Khattry N, Kumar R, Sandur S, Sharma D, Checker R, Agarwal B, Jha D, Majumdar A, Gota V (2020). Prevention of acute graft-versus-host-disease by Withaferin a via suppression of AKT/mTOR pathway. International Immunopharmacology. 84: 106575. PMID: 32416453
    94. Menon BK, Kalshetty A, Bhattacharjee A, Basu S (2020). Standardized uptake values and ratios on 68Ga-DOTATATE PET-computed tomography for normal organs and malignant lesions and their correlation with Krenning score in patients with metastatic neuroendocrine. Nuclear Medicine Communications. 41(10):1095-1099. PMID: 32732598
    95. Mhatre S, Rajaraman P, Chatterjee N, Bray F, Goel M, Patkar S, Ostwal V, Patil P, Manjrekar A, Shrikhande S, Badwe R, Dikshit R (2020). Mustard oil consumption, cooking method, diet and gallbladder cancer risk in high- and low-risk regions of India. International Journal of Cancer. 147(6): 1621-1628. PMID: 32142159
    96. Mirji G, Banavali S, Sengar M, Chiplunkar SV (2020). Immunophenotype and function define TCRγδ + T-ALL as a distinct subgroup from TCRαβ + T-ALL patients. Leukemia and Lymphoma. 61(1): 108-117. PMID: 31393182
    97. Mishra A, Shetty P, Singh V, Moiyadi A (2020). Microsurgical subpial resections for diffuse gliomas—old wine in a new bottle. Acta Neurochirugica. PMID: 32772163
    98. Mishra V, Kowtal P, Rane P, Sarin R. Modulatory role of single nucleotide polymorphisms of distinct genetic pathways on clinical behavior of medullary thyroid carcinoma. Asian Pacific Journal of Cancer Prevention. 21(5):1289-1293. PMID: 32458635
    99. Mittra I, Pal K, Pancholi N, Tidke P, Siddiqui S, Rane B, D'souza J, Shaikh A, Parab S, Shinde S, Jadhav V, Shende S, Raghuram GV (2020). Cell-free chromatin particles released from dying host cells are global instigators of endotoxin sepsis in mice. PLoS One. 15(3): e0229017. PMID: 32130239
    100. Modi K, Dalvi S, Venkatraman P (2020). Two negatively charged invariant residues influence ligand binding and conformational dynamics of 14-3-3ζ. FEBS Letters. 594(5):878-886. PMID: 31693753
    101. Mukherjee S, Agarwal M, Bakshi A, Sawant S, Thomas L, Fujii N, Nair P, Kode J (2020).Chemokine SDF1 Mediated Bone Regeneration Using Biodegradable Poly(D,L-lactide-co-glycolide) 3D Scaffolds and Bone Marrow-Derived Mesenchymal Stem Cells: Implication for the Development of an “Off-the-Shelf” Pharmacologically Active Construct. Biomacromolecules. 21(12):4888-4903. PMID: 33136384
    102. Mukherjee S, Biswas D, Gadre R,Jain P, Syed N, Stylianou J, Zeng Q, Mahadevan A, Epari S, Shetty P, Moiyadi A, Roy Ball G, Srivastava S (2020). Comprehending meningioma signaling cascades using multipronged proteomics approaches & targeted validation of potential markers. Frontiers in Oncology. 10:1600. PMID: 32974197
    103. Mundhe D, Waghole R, Pawar S, MIshra R, Shetty A, Gera P, Kannan S, Teni T. Concomitant overexpression of Activin A and p63 is associated with poor outcome in oral cancer patients. Journal of Oral Pathology and Medicine. 49(9):876-885. PMID: 32512627
    104. Murthy V, Maitre P, Bhatia J, Kannan S, Krishnatry R, Prakash G, Bakshi G, Pal M, Menon S, Mahantshetty U (2020). Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial. Radiotherapy and Oncology. 145: 71-80. PMID: 31923712
    105. Murthy V, Mallick I, Gavarraju A, Sinha S, Krishnatry R, Telkhade T, Moses A, Kannan S, Prakash G, Pal M, Menon S, Popat P, Rangarajan V, Agarwal A, Kulkarni S, Bakshi G (2020). Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL). BMJ Open. 10(2): e034623. PMID: 32114475
    106. Muwonge R, Basu P, Gheit T, Anantharaman D, Verma Y, Bhatla N, Joshi S, Esmy PO, Poli URR, Shah A, Zomawia E, Shastri SS, Pimple S, Prabhu PR, Hingmire S, Chiwate A, Sauvaget C, Lucas E, Malvi SG, Siddiqi M, Sankaran S, Kannan TPRA, Varghese R, Divate U, Vashist S, Mishra G, Jadhav R, Tommasino M, Pillai MR, Sankaranarayanan R, Jayant K; Indian HPV vaccine study group. Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study. PLoS One. 15(12):e0244242. PMID: 33373380.
    107. Myint H, Tondon S, Narula G, Prasad M , Subramaniam P, Patkar N, Tembhare P, Gujral S, Banavali S (2020). Clinicoepidemiological profile and outcome predicted by minimal residual disease in children with mixed-phenotype acute leukemia treated on a modified MCP-841 protocol at a tertiary cancer institute in India. Journal of Pediatric Hematology/ Oncology. 42(7):415-419. PMID: 3260433.
    108. Nekkanti SS, Vasudevan Nair S, Parmar V, Saklani A, Shrikhande S, Sudhakar Shetty N, Joshi A, Murthy V, Patkar N, Khattry N, Gupta S (2020). Mandatory preoperative COVID-19 testing for cancer patients-Is it justified? Journal of Surgical Oncology. 122(7):1288-1292. PMID: 32841386
    109. Nimbalkar VK, Manna S, Maru GB, Mahimkar MB (2020). Head and neck cancer prevention by phytochemicals: Current status and challenges. 6: 85–102. Current Pharmacology Reports.
    110. Noronha V, Bhattacharjee A, Patil VM, Joshi A, Menon N, Shah S, Kannan S, Mukadam SA, Maske K, Ishi S, Prabhash K (2020). Aprepitant for cough suppression in advanced lung cancer: A randomized trial. Chest. 157(6): 1647-1655 PMID: 31958446
    111. Noronha V, Patil V, Joshi A, Mahimkar M, Patel U, Pandey MK, Chandreasekharan A, D'souza H, Bhattacharjee A, Mahajan A, Sable N, Agarwal JP, Ghosh-Laskar S, Budrukkar A, D'Cruz A, Chaturvedi P, Pai PS, Chaukar D, Nair S, Thiagarajan S, Banavali S, Prabhash K ( 2020). Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer. Oncotarget. 11: 399-408. PMID: 32064043
    112. Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Bhattacharjee A, Shah S, Yadav A, Trivedi V, Behel V, Dutt A, Banavali SD, Prabhash K. Gefitinib Versus gefitinib plus pemetrexed and carboplatin chemotherapy in EGFR-Mutated lung cancer. Journal of Clinical Oncology. 38(2): 124-136. PMID: 31411950
    113. Noronha V, Talreja V, Patil V, Joshi A, Menon N, Mahajan A, Janu A, Prabhash K (2020). Real-World Experience of Patients with Inoperable, Stage III Non-small-Cell Lung Cancer Treated with Durvalumab after Chemoradiotherapy: Indian Experience. South Asian Journal of Cancer.
    114. Ojha S, Gupta A, Nagaraju P, Poojary M, Sumathi SH (2020). Challenges in platelet inventory management at a tertiary care oncology center during the novel coronavirus disease (COVID-19) pandemic lockdown in India. Transfusion and Apheresis Science. 59(5):102868. PMID: 32646793
    115. Ostwal V, Kapoor A , Mandavkar S, Chavan N, Gupta T, Mirani J, Saklani A, Desouza A, Shrinivasan K, Nashikkar C, Gupta S, Ramaswamy A (2020). Effect of a Structured Teaching Module Including Intensive Prophylactic Measures on Reducing the Incidence of Capecitabine-Induced Hand-Foot Syndrome: Results of a Prospective Randomized Phase III Study. Oncologist. 25(12): e1886-e1892. PMID: 32717127
    116. Otitoju AP, Longdet IY, Alemika TE, Gota V (2020). Antiproliferative Activity of Ethanol Extract of Boswellia dalzielii (Hutch) Stem Bark in Breast Cancer Cell Line. Journal of Complimentary and Alternative Medical Research. 11(2): 11-16. PMID: PMID: 33093854
    117. Panda S, Swamidas J, Chopra S, Mangaj A, Fogliata A, Kupelian P, Agarwal JP, Cozzi L (2020). Treatment planning comparison of volumetric modulated arc therapy employing a dual-layer stacked multi-leaf collimator and helical tomotherapy for cervix uteri. Radiation Oncology. 15(1): 22. PMID: 32000832
    118. Pansare K, CM Krishna (2020). Raman Theranostics: An overview of Raman applications in therapeutic monitoring. Asian Journal of Physics. 29(3-4): 261-272.
    119. Pansare K, Singh SR, Chakravarthy V, Gupta N, Hole A, Gera P, Sarin R, CM Krishna (2020). EXPRESS: Raman Spectroscopy: An exploratory study to identify post-radiation cell survival. Applied Spectroscopy. 74(5): 553-562. PMID: 32031014
    120. Parghane RV, Naik C, Talole S, Desmukh A, Chaukar D, Banerjee S, Basu S (2019) - Clinical utility of (177) Lu-DOTATATE PRRT in somatostatin receptor-positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity. Head Neck. 42(3): 401-416. PMID: 31755622
    121. Parikh P, Kumar S, Banerjee T, Kode J, Zunjar V, Singh R, Nagar P, Patel J (2020). Prophylactic potential of Indian medicinal plants in the management of influenza like illness especially COVID-19. Medicinal Plants- International Journal of Phytomedicines and Related Industries. 12(3): 323-337.
    122. Park YH, Senkus-Konefka E, Im SA, Pentheroudakis G, Saji S, Gupta S, Iwata H, Mastura MY, Dent R, Lu YS, Yin Y, Smruti BK, Toyama T, Malwinder S, Lee SC, Tseng LM, Kim JH, Kim TY, Suh KJ, Cardoso F, Yoshino T, Douillard JY (2020). Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS. Annals of Oncology. 31(4):451-469. PMID: 32081575
    123. Parmar V, Nair N, Vanamali V, Hawaldar R, Siddique S, Shet T, Desai S, Rangarajan V, Patil A, Gupta S, Badwe R (2020). Sentinel node biopsy versus low axillary sampling in predicting nodal status of postchemotherapy axilla in women with breast cancer. JCO Global Oncology. 6: 1546-4553. PMID: 33074737
    124. Pasqual E, Castaño-Vinyals G, Thierry-Chef I, Kojimahara N, Sim MR, Kundi M, Krewski D, Momoli F, Lacour B, Remen T, Radon K, Weinmann T, Petridou E, Moschovi M, Dikshit R, Sadetski S, Maule M, Farinotti M, Ha M, 't Mannetje A, Alguacil J, Aragonés N, Vermeulen R, Kromhout H, Cardis E (2020). Exposure to medical radiation during fetal life, childhood and adolescence and risk of brain tumor in young age: Results from the MOBI-Kids case-control Study. Neuroepidemiology.54:343–355. PMID: 32200380
    125. Patel U, Pandey M, Kannan S, Samant TA, Gera P, Mittal N, Rane S, Patil A, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB (2020). Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab. British Journal of Cancer. 123(12):1757-1766. PMID: 32939054
    126. Patil V, Noronha V, Dhumal S, Joshi A, Menon N, Bhattacharjee A, Kulkarni S, Ankathi S, Mahanaj A, Sable N, Nawale K, Bhelekar A, Mukadam S, Chandrasekharan A, Das S, Vallathol D, D'Souza H, Kumar A, Agrawal A, Khaddar S, Rathnasamy N, Shenoy R, Kashyap L, Kumar R, Abraham G, Saha S, Majumdar S, Karvandan N, Simha V, Babu V, Elamarthi P, Rajpurohit A, Kumar KA, Srikanth A, Ravindra R, Banavali S, Prabhash K (2020). Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial. Lancet Global Health. 8(9): e1213-e1222. PMID: 32827483
    127. Patil VM, Bhelekar A, Menon N, Bhattacharjee A, Simha V, Abhinav R, Abhyankar A, Sridhar E, Mahajan A, Puranik AD, Purandare N, Janu A, Ahuja A, Krishnatry R, Gupta T, Jalali R. Reverse swing-M, phase 1 study of repurposing mebendazole in recurrent high-grade glioma. Cancer Medicine. 9(13):4676-4685. PMID: 32400117
    128. Patil VM, Noronha V, Thiagarajan S, Joshi A, Chandrasekharan A, Talreja V, Agarwal J, Ghosh-Laskar S, Budrukkar A, Juvekar S, Mahajan A, Agarwal A, Purandare N, Bhattacharjee A, D'Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Prabhash K (2020). Salvage surgery in head and neck cancer: Does it improve outcomes? European Journal of Surgical Oncology. 46(6):1052-1058. PMID: 32014275
    129. Patkar N, Bhanshe P, Rajpal S, Joshi S, Chaudhary S, Chatterjee G, Tembhare P, Dhamne C, Prasad M, Moulik NR, Shetty D, Gokarn A, Bonda A, Nayak L, Punatkar S, Bagal B, Sengar M, Narula G, Khattry N, Banavali S, Subramanian PG, Gujral S (2020). NARASIMHA: Novel assay based on targeted RNA sequencing to identify ChiMeric gene fusions in hematological malignancies. Blood Cancer Journal. 10(5): 50. PMID: 32372024
    130. Paul R, Bharambe H, Shirsat NV (2020). Autophagy inhibition impairs the invasion potential of medulloblastoma cells. Molecular Biology Reports. 47(7): 5673-5680. PMID: 32621115
    131. Phurailatpam R, Wadasadawala T, Chauhan K, Panda S, Sarin R (2020). Dosimetric comparison of volumetric-modulated arc therapy and helical tomotherapy for adjuvant treatment of bilateral breast cancer. Journal of Radiotherapy in Practice.
    132. Pires N, Gota V, Gulia A, Hingorani L, Agarwal M, Puri A (2020) - Safety and pharmacokinetics of withaferin-A in advanced stage high grade osteosarcoma: A phase I trial. Journal of Ayurveda and Integrative Medicine. 11 (1): 68-72. PMID: 30904387
    133. Pradhan P, Srivastava A, Singh J, Biswas B, Saini A, Siddique I, Kumari P, Khan MA, Mishra A, Yadav PK, Kumar S, Bhavesh NS, Venkatraman P, Vivekanandan P, Kundu B(2020)- Prion protein transcription is auto-regulated through dynamic interactions with G-quadruplex motifs in its own promoter. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1863(3):194479. PMID: 31931179
    134. Prusty RK, Begum S, Patil A, Naik DD, Pimple S, Mishra G (2020). Knowledge of symptoms and risk factors of breast cancer among women: A community based study in a low socio-economic area of Mumbai, India. BMC Womens Health. 20(1): 106.PMID: 32423488
    135. Punatar S, Mohite A, Gokarn A, Nayak L, Bonda A, Shanmugam K, Vijaysekharan K, Khattry N. Leflunomide for chronic musculoskeletal graft versus host disease following allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant. 55(2):467-469, 2020. PMID: 31089281
    136. Purandare NC, Puranik A, Shah S, Agrawal A, Gupta T, Moiyadi A, Shetty P, Shridhar E, Patil V, Rangarajan V. Differentiating dural metastases from meningioma: Role of 68Ga DOTA-NOC PET/CT. Nuclear Medicine Communication. 41(4):356-362. 2020. PMID: 31939900
    137. Qureshi SS, Bhagat M, Kazi M, Kembhavi SA, Yadav S, Parambil BC, Smriti V, Baheti A, Prasad M, Khanna N, Laskar S, Vora T, Chinnaswamy G, Amin N, Ramadwar M, Talole S (2020). Standardizing lymph nodal sampling for Wilms tumor: A feasibility study with outcomes. Journal of Pediatric Surgery.55(12):2668-2675. PMID: 32854922
    138. Qureshi SS, Bhagat M, Verma K, Yadav S, Prasad M, Vora T, Chinnaswamy G, Amin N, Laskar S, Khanna N, Smriti V, Baheti A, Ramadwar M, Shah S (2020). Incidence, treatment, and outcomes of primary and recurrent non-wilms renal tumors in children: Report of 109 patients treated at a single institution. Journal of Pediatric Urology. 16(4):475. PMID: 32620510
    139. Qureshi SS, Suresh M, Dhareshwar J, Smriti V (2020). Limb sparing surgery with vascular reconstruction for nonrhabdomyosarcoma soft tissue sarcoma in infants: A novel solution using allogenic vein graft from the parent. Journal of Pediatric Surgery. 55(8): 1673-76. PMID: 32409175
    140. Ramaswamy A, Ostwal V, Sharma A, Bhargava P, Srinivas S, Goel M, Patkar S, Mandavkar S, Jadhav P, Parulekar M, Choudhari A, Gupta S (2020). Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT). JAMA Oncology. PMID: 33270098
    141. Rao S, Shet T, Shetty D, Jain H, Ankolkar M, Joshi S (2020). Florid lymphoid hyperplasia in breast: Waxing and Waning process. Breast Journal. 26(11): 2252-2254. PMID: 33012115
    142. Rathod M, Kelkar M, Valvi S, Salve G, De A (2020). FOXA1 regulation turns benzamide HDACi treatment effect specific in breast cancer promoting NIS gene mediated targeted radioiodine therapy. Molecular Therapy: Oncolytics. 19: 93-104. PMID: 33102692
    143. Raut A, Chopra S, Mittal P, Patil G, Mahantshetty U, Gurram L, Swamidas J, Ghosh J, Gulia S, Popat P, Deodhar K, Maheshwari A, Gupta S (2020). FIGO classification 2018: Validation study in patients with locally advanced cervix cancer treated with chemo-radiation. International Journal of Radiation Oncology, Biology Physics. 108(5):1248-1256. PMID: 32681859
    144. Reddy BP, Mishra SK, Ravichandran G, Chauhan DS, Srivastava S, De A (2020). Preclinical evaluation of multi stimuli responsive core-plasmonic nanoshell for photo-triggered tumor ablation: A disintegrable nanohybrid. Applied Materials Today. 20:100684.
    145. Sahay A, Epari S, Gupta P, Goda J, Shetty P, Patil V, Bajpai J, Moiyadi A, Gupta T (2020). Melanotic schwannoma, a deceptive misnomer for a tumor with relative aggressive behavior: A series of 7 cranial and spinal Cases. International Journal of Surgical Pathology. 28(8):850-858 PMID: 32456496
    146. Sali AP, Chaubey V, Kodare D, Sahay A, Epari S (2020) - The rare phenomenon of loss of INI1 expression at recurrence/progression of primary central nervous system tumors: Report of 3 Cases. International Journal of Surgical Pathology. 28(3): 341-347. PMID: 31680589
    147. Salunkhe S, Chandran N, Chandrani P, Dutt A, Dutt S (2020). CytoPred: 7-gene pair metric for AML cytogenetic risk prediction. Briefings in Bioinformatics. 21(1): 348-354. PMID: 30380003
    148. Salunkhe S, Mishra SV, Ghorai A, Hole A, Chandrani P, Dutt A, CM Krishna, Dutt S (2020). Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1861(12):148300. PMID: 32858000.
    149. Sankaran H, Sengupta S, Purohit V, Kotagere A, Roy Moulik N, Prasad M, Dhamne C, Narula G, Banavali S, Gota V (2020). A comparison of asparaginase activity in generic formulations of E-coli derived L- asparaginase: In-vitro study and retrospective analysis of asparaginase monitoring in pediatric patients with leukemia. British Journal of Clinical Pharmacology. 86(6):1081-1088. PMID: 31925802
    150. Shah SG, Mandloi T, Kunte P, Natu A, Rashid M, Reddy D, Gadewal N, Gupta S (2020). HISTome2: a database of histone proteins, modifiers for multiple organisms and epidrugs. Epigenetics Chromatin. 13(1):31. PMID: 32746900
    151. Shaikh AF, Kakirde C, Dhamne C, Bhanshe P, Joshi S, Chaudhary S, Chatterjee G, Tembhare P, Prasad M, Roy Moulik N, Gokarn A, Bonda A, Nayak L, Punatkar S, Jain H, Bagal B, Shetty D, Sengar M, Narula G, Khattry N, Banavali S, Gujral S, Subramanian PG, Patkar N (2020). Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1. Leukemia and Lymphoma. 61(13):3154-3160. PMID: 32757686
    152. Sharda A, Rashid M, Shah SG, Sharma AK, Singh SR, Gera P, CM Krishna, Gupta S (2020). Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells. Clinical Epigenetics. 12(1): 4. PMID: 31900196
    153. Sharma DK, Siddiqui MQ, Gadewal N, Kumar Choudhary R, Varma AK, Misra HS, Rajpurohit YS (2020) - Phosphorylation of deinococcal RecA affects its structure and function dynamics implicated for its roles in radioresistance of Deinococcus radiodurans. Journal of Biomolecular Structure and Dynamics. 38(1): 114-123. PMID: 30688163
    154. Shetty D, Amare PK, Mohanty P, Talker E, Chaubal K, Jain H, Tembhare P, Patkar N, Chaturvedi A, Subramanian PG, Moulik N, Dhamne C, Jain H, Bagal B, Narula G, Sengar M, Khattry N, Banavali S. Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALL. Blood Cells, Molecules, and Diseases. 85: 102465. PMID: 32693366
    155. Shetty D, Talker E, Mohanty P, Jain H, Yadav AK, Jain H, Nayak L, Tembare P, Patkar N, Subramanian PG, Kumar A (2020). Clinical, hematological and cytogenetic profile in fibroblast growth factor receptor 1 rearranged hematoloymphoid malignancies. International Journal of Research in Medical Sciences. 8 (4): 1556-1563.
    156. Shriyan B, Patil D, Gurjar M, Nookala M, Patil A, Kannan S, Patil V, Joshi A, Noronha V, Prabhash K, Gota V (2020). Safety and CSF distribution of high-dose erlotinib and gefitinib in patients with non-small cell lung cancer (NSCLC) with brain metastases. European Journal of Clinical Pharmacology. 76(10):1427-1436. PMID: 32529316
    157. Singh A, Dikshit R, Chaturvedi P (2020). Betel nut use: The south asian story. Substance Use and Misuse. 55(9):1545-1551. PMID: 32569532
    158. Singh A, Mishra A, Sharin F, Bal M, Ghosh-Laskar S, Prabhash K, Chaturvedi P (2020). Optimum surgical margins in squamous cell carcinoma of the oral tongue: Is the current definition adequate? Oral Oncology. 111: 104938. PMID: 32739791
    159. Singh A, Sharin F, Singhavi H, Patil A, Nair S, Chaturvedi P (2020). Sarcomatoid variant of squamous carcinoma in recurrent and second primary tumors of the oral cavity. Journal Oral Pathology Medicine. 49(9):914-919. PMID: 32506553
    160. Singh G, Bendale K, Talwelkar S, Pawade S, Gera P, Patil A, Chavan P, Subramanian S, Chaudhari P. Establishment of an orthotopic syngeneic rat model of hepatocellular carcinoma and its validation with microPET-CT imaging. Integrative Cancer Science and Therapeutics. 7: 1-5.
    161. Singh G, Bendale K, Talwelkar S, Pawade S, Gera P, Patil A, Chavan P, Subramanian S, Chaudhari P. Establishment of an orthotopic syngeneic rat model of hepatocellular carcinoma and its validation with microPET-CT imaging. Integrative Cancer Science and Therapeutics. 7: 1-5.
    162. Singhavi HR, Chakrabarti S, Singh A, Mair M, Bhattacharjee A, Shetty R, Qayyumi B, Pai A, Joshi P, Nair D, Nair S, Chaturvedi P (2020) - Comparison of the 7th and 8th edition AJCC classification system in oral cavity squamous cell cancers. International Journal of Cancer. 16(12): 3379-3384. PMID: 31583706.
    163. Sinha S, Agarwal JP, Mahajan A, Chaturvedi P, Balaji A, Juvekar S, Gupta T, Budrukkar A, Murthy V, Mummudi N, Swain M, Jadhav R, Laskar SG (2020). Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective study. Head Neck. PMID: 33368793.
    164. Solanki SL, Thota RS (2020). Comment on the published article: Accidental injection of succinylcholine into epidural space as a test dose. Saudi Journal of Anaesthesia. 14(3):410-411. PMID: 32934643
    165. Subedi R, Dhimal M, Budukh A, Gyawali P, Jha AK (2020). Challenges and way forward for establishing population based cancer registry in Nepal. Journal of Nepal Health Research Council.18(3): 544-546. PMID: 33210656
    166. Sunkara RR, Sarate RM, Setia P, Shah S, Gupta S, Chaturvedi P, Gera P, Waghmare SK (2020) - SFRP1 in skin tumor initiation and cancer stem cell regulation with potential implications in epithelial cancers. Stem Cell Reports. 14(2):271-284. PMID: 31928951
    167. Sureshbabu SK, Chaukar D, Chiplunkar SV (2020). Hypoxia regulates the differentiation and anti-tumor effector functions of γδT cells in oral cancer. Clinical and Experimental Immunology. 201(1):40-57. PMID: 32255193
    168. Swamidas J, Kirisits C, De Brabandere M, Hellebust TP, Siebert FA, Tanderup K (2020). Image registration, contour propagation and dose accumulation of external beam and brachytherapy in gynecological radiotherapy. Radiotherapy Oncology. 143: 1-11. PMID: 31564555
    169. Talker E, Shetty D, Jain H (2020).Preclinical in-house validation of commercially available fluorescence in-situ hybridization probes used in diagnosis of haematological malignancies. European Journal of Molecular Cancer. 3(1): 1-6.
    170. Tembhare P, Narula G, Khanka T, Ghogale S, Chatterjee G, Patkar N, Prasad M, Badrinath Y, Deshpande N, Gudapati P, Verma S, Sanyal M, Kunjachan F, Mangang G, Gujral S, Banavali S, Subramanian P (2020). Post-induction measurable residual disease using multicolor flow cytometry is strongly predictive of inferior clinical outcome in the real-life management of childhood T-cell acute lymphoblastic leukemia: A study of 256 patients. Frontiers in Oncology. 10: 577. PMID: 32391267
    171. Tembhare P, Sriram H, Khanka T, Chatterjee G, Panda D, Ghogale S, Badrinath Y, Deshpande N, Patkar N, Narula G, Bagal B, Jain H, Sengar M, Khattry N, Banavali S, Gujral S, Subramanian PG (2020). Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: An implication for anti-CD38 immunotherapy. Journal for ImmunoTherapy of Cancer. 8:e000630. PMID: 32439800
    172. Tembhare PR, Subramanian PG, Ghogale S, Chatterjee G, Patkar NV, Gupta A, Shukla R, Badrinath Y, Deshpande N, Narula G, Rodrigues P, Girase K, Dhaliwal D, Prasad M, Shetty D, Banavali S, Gujral S (2020). A High-sensitivity 10-color flow cytometric minimal residual disease assay in B-Lymphoblastic leukemia/lymphoma can easily achieve the sensitivity of 2-in- 106 and is superior to standard minimal residual disease assay: A study of 622 Patients. Cytometry B Clinical Cytometry. 98(1): 57-67. PMID: 31197916
    173. Thakkar K, Jadhav S, Kasaliwal R, Memon SS, Patil VA, Thadani P, Lomte NK, Sankhe SS, Goel A, Epari S, Goel N, Lila AR, Shah N, Bandgar TR (2020)- Sellar surprises: a single centre experience of unusual sellar masses. Endocrine Connections. 9(2): 111-121. PMID: 31910151
    174. Thiagarajan S, Dhar H, Bhattacharjee A, Fatehi KS, Shah SB, Chaukar D, Nair D, Deshmukh A, Prabhash K, Joshi A, Patil V, Noronha V, Laskar SG, D'Cruz AK (2020). Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to Neo-Adjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncology. 100: 104455. PMID: 31739192
    175. Togar T, Desai S, Mishra R, Terwadkar P, Ramteke M, Ranjan M, Kawle D, Sahoo B, Pal A, Upadhyay P, Dutt A (2020). Identifying cancer driver genes from functional genomics screens. Swiss Medical Weekly. 150: w20195. PMID: 32083704
    176. Tokala R, Sana S, Lakshmi UJ, Sankarana P, Sigalapalli DK, Gadewal N, Kode J, Shankaraiah N (2020). Design and synthesis of thiadiazolo-carboxamide bridged β-carboline-indole hybrids: DNA intercalative topo-IIα inhibition with promising antiproliferative activity. Bioorganic Chemistry. 105: 104357. PMID: 33091673
    177. Tripathi N, Keshari S, Shahi P, Maurya P, Bhattacharjee A, Gupta K, Talole S, Kumar M (2020). Human papillomavirus elevated genetic biomarker signature by statistical algorithm. Journal of Cellular Physiology. 235(12):9922-9932. PMID: 32537823
    178. Upreti RR, Budrukkar A, Upreti U, Wadasadawala T, Pathak R, Misra S, Gurrum L, Kinhikar RA, Deshpande DD (2020). Coverage with dosimetric concordance index (CDCI): a tool for evaluating dosimetric impact of inter-observer target variability in brachytherapy. Journal of Contemporary Brachytherapy. 12(2): 160-165. PMID: 32395140
    179. Vaid AK, Gupta S, Doval DC, Agarwal S, Nag S, Patil P, Goswami C, Ostwal V, Bhagat S, Patil S, Barkate H (2020). Expert consensus on effective management of chemotherapy-induced nausea and vomiting: An Indian perspective. Frontiers in Oncology.10:400. PMID: 32292721
    180. Vijayasekharan K, Chatterjee G, Ramanathan S, Narula G, Tembhare P, Subramanian PG, Patkar N, Gujral S, Shetty D, Banavali S. Sudden blast phase in pediatric chronic myeloid leukemia-chronic phase with abnormal lymphoid blasts detected by flow cytometry at diagnosis: Can it be considered a warning sign? Cytometry Part B: Clinical Cytometry. PMID: 33030302
    181. Wadasadawala T, Bushra S, Gurram L, Scaria L, Phurailatpam R, Rane P, Sarin R. (2020). Is it important to define skin sub-volumes in breast brachytherapy? Journal of Radiotherapy in Practice.
    182. Wadasadawala T, Lewis S, Gaikwad U, Gayale U, Phurailatpam R, Tambe S, Sarin R (2020). Mono versus dual isocentric technique for breast cancer radiotherapy: evaluation of planning, dosimetry and treatment delivery. Journal of Radiotherapy in Practice.
    183. Wadasadawala T, Sinha S, Parmar V, Verma S, Gaikar M, Kannan S, Mondal M, Pathak R, Jain U, Sarin R (2020). Comparison of subjective, objective and patient-reported cosmetic outcomes between accelerated partial breast irradiation and whole breast radiotherapy: A prospective propensity score-matched pair analysis. Breast Cancer. 27(2):206-212. PMID: 31512161
    184. Waghmare MN, Qureshi TS, Shaikh AN, Khade BS, CM Krishna, Dongre PM (2020). Functionalized Alpha‐lactalbumin conjugated with gold nanoparticle for targeted drug delivery. Chemistry Select. 5(6): 2035-2049.
    185. Walawalkar S, Joshi M, Khattry N, Sapra BK, Khan A, Pujari PK, Mohan L, Srivastava SP, Naresh C, Badwe R, Gupta S (2020). Particle removal from air by face masks made from Sterilization Wraps: Effectiveness and Reusability. PLoS One. 15(10):e0240398. PMID: 33052962
    186. Yadav N, Rajendra J, Acharekar A, Dutt S, Vavia P (2020). Effect of glucosamine conjugate-functionalized liposomes on glioma cell and healthy brain: An Insight for future application in brain infusion. AAPS PharmSciTech. 21(1): 24. PMID: 31845106
    187. Yeole U Singh V, Mishra A, Shaikh S, Shetty P, Moiyadi A (2020). Navigated intraoperative ultrasonography for brain tumors: technique, utility and benefits in neuro-oncology. Ultrasonography. 39(4):394-406. PMID: 32660206
  • 2019
    1. Acharya S, Dutta S, Chopra S, Bose K (2019) - Identification of a distal allosteric ligand binding pocket in HtrA3. Biochemical and Biophysical Research Communications. 516(4): 1130-1136. PMID: 31280864
    2. Adamane SA, Mittal N, Teni T, Pawar S, Waghole R, Bal M (2019) - Human papillomavirus-related multiphenotypic sinonasal carcinoma with unique HPV type 52 association: A case report with review of literature. Head and Neck Pathology. 13(3): 331-338. PMID: 30259271
    3. Alfonso V, Iaccarino L, Ottone T, Cicconi L, Lavorgna S, Divona M, Cairoli R, Cristiano A, Ciardi C, Travaglini S, Falconi G, Hasan SK, Venditti A, Arcese W, Voso MT, Lo-Coco F (2019) - Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia. Leukemia. 33(6): 1527-1530. PMID: 30651632
    4. Arora R, Rekhi B, Chandrani P, Krishna S, Dutt A (2019) - Merkel cell polyomavirus is implicated in a subset of Merkel cell carcinomas, in the Indian subcontinent. Microbial Pathogenesis. 137: 103778. PMID: 31600537
    5. Bajpai J, Chandrasekharan A, Simha V, Mandal T, Shah K, Hingmare S, Rangarajan B, Shetty N, Vora T, Ghosh J, Rekhi B, Banavali S, Gupta S (2019) - Osteosarcoma journey over two decades in India: Small steps, big changes. Pediatric Blood and Cancer. 66(9): e27877. PMID: 31207015
    6. Basu P, Muwonge R, Bhatla N, Nene BM, Joshi S, Esmy PO, Poli URR, Joshi G, Verma Y, Zomawia E, Shastri SS, Pimple S, Anantharaman D, Prabhu PR, Hingmire S, Sauvaget C, Lucas E, Pawlita M, Gheit T, Jayant K, Malvi SG, Siddiqi M, Michel A, Butt J, Sankaran S, Rameshwari Ammal Kannan TP, Varghese R, Divate U, Willhauck-Fleckenstein M, Waterboer T, Müller M, Sehr P, Vashist S, Mishra G, Jadhav R, Thorat R, Tommasino M, Pillai MR, Sankaranarayanan R Indian HPV vaccine study group (2019) - Two dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow up cohort study. Papillomavirus Research. 7:75-81. PMID: 30711698.
    7. Berger T, Seppenwoolde Y, Pötter R, Assenholt MS, Lindegaard SJ, Nout R, Leeuw A, Jürgenliemk-Schulz I, Tee Tan L, Georg D, Kirisits C, Dumas I, Nesvacil N, Swamidas J, Hudej R, Lowe G, Hellebust TP, Menon G, Fokdal L, Tanderup K (2019) - Importance of technique, target selection, contouring, dose prescription and dose-planning in external beam radiotherapy for cervix cancer: evolution of practice from EMBRACE-I to II. International Journal of Radiation Oncology, Biology, Physics. 104(4): 885-894. PMID: 30904706
    8. Bharambe HS, Paul R, Panwalkar P, Jalali R, Sridhar E, Gupta T, Moiyadi A, Shetty P, Kazi S, Deogharkar A, Masurkar S, Yogi K, Kunder R, Gadewal N, Goel A, Goel N, Chinnaswamy G, Ramaswamy V, Shirsat NV (2019) - Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas. Acta Neuropathologica Communications. 7(1): 52. PMID: 30944042.
    9. Bhattacharjee A, Budukh A, Dikshit R (2019)- Prostate cancer survival estimates: An application with piecewise hazard function derivation. South Asian Journal of Cancer. 8(3): 150-159. PMID: 31489286
    10. Bhattacharjee A, Vishwakarma GK (2019)- Time-course data prediction for repeatedly measured gene expression. International Journal of Biomathematics.
    11. Bishnu A, Sakpal A, Ghosh N, Choudhury P, Chaudhury K, Ray P (2019) - Long term treatment of metformin impedes development of chemoresistance by regulating cancer stem cell differentiation through Taurine generation in ovarian cancer cells. International Journal of Biochemistry and Cell Biology. 107: 116- 127. PMID: 30593952
    12. Biswas NK, Das C, Das S, Maitra A, Nair S, Gupta T, D'Cruz AK, Sarin R, Majumder PP (2019) - Lymph node metastasis in oral cancer is strongly associated with chromosomal instability and DNA repair defects. International Journal of Cancer. 145(9): 2568-2579. PMID: 30924133
    13. Chaganti LK, Dutta S, Kuppili RR, Mandal M, Bose K (2019) - Structural modeling and role of HAX-1 as a positive allosteric modulator of human serine protease HtrA2. Biochemical Journal. 476(20): 2965-2980. PMID: 31548268
    14. Chakrabarti S, Singhavi HR, Bal M, Mair M, Malik A, Mahuvakar A, Singh A, Mathur R, Joshi P, Nair S, Nair D, Chaturvedi P (2019) - Intraoperative frozen section for detection of occult metastasis in clinically N0 neck does not improve outcome in oral cavity carcinomas. European Archives of Oto-Rhino-Laryngology. 276(8): 2325-2330. PMID: 31147769
    15. Chapagain S, Budukh A, Dangal G, Jha AK (2019) – Initiation of Population-based Cancer Registry in Nepal. Journal of Nepal Health Research Council. 17(3): I-II. PMID: 31735915
    16. Chaugule SR, Sureshbabu SK, Dakave S, CM Krishna, Chaudhari PR, Indap MM, Chiplunkar SV (2019) - Hexane fraction of Turbo brunneus inhibits intermediates of RANK-RANKL signaling pathway and prevent ovariectomy induced bone loss. Frontiers in Endocrinology. 10: 608. PMID: 31555218
    17. Chauhan DS, Reddy BPK, Mishra SK, Prasad R, Dhanka M, Vats M, Ravichandran G, Poojari D, Mhatre O, De A, Srivastava R (2019) - A Comprehensive evaluation of degradable and cost effective plasmonic nanoshells for localized photothermolysis of cancer cells. Langmuir. 35(24): 7805-7815. PMID: 31090425
    18. Chiplunkar SV, Gogoi D (2019) - The multifaceted role of notch signal in regulating T cell fate. Immunology Letters. 206: 59- 64. PMID: 30629981
    19. Chopra S, Deodhar K, Pai V, Pant S, Rathod N, Goda JS, Sudhalkar N, Pandey P, Waghmare S, Engineer R, Mahantshetty U, Ghosh J, Gupta S, Shrivastava S. Cancer Stem Cells, CD44, and Outcomes Following Chemoradiation in Locally Advanced Cervical Cancer: Results From a Prospective Study. International Journal of Radiation Oncology, Biology , Physics. 103(1): 161-168. PMID: 30213750.
    20. Chopra S, George K, Engineer R, Rajamanickam K, Nojin S, Joshi K, Swamidas J, Patkar S, Patil P, Ostwal V, Mehta S, Goel M (2019) - Stereotactic body radio therapy for inoperable hepatocellular cancers: Results from a clinical audit. British Journal of Radiology. 92(1101): 20181053. PMID: 31219706
    21. Chopra S, Mittal P, Viswanathan A, Tharavichitkul E, Zubizarreta E, Nout RA, Yap ML, Grover S, Rodin D, Rai B, Gondhowiardjo S, Shrivastava SK (2019) - Global collaborations for cervical cancer: Can the East–West alliance facilitate treatment for all? Clinical oncology (Royal College of Radiologists (Great Britain)). 31(8): 529-538. PMID: 31229379
    22. Chopra S, Shukla R, Budukh A, Shrivastava SK (2019) - External radiation and brachytherapy resource deficit for cervical cancer in India: Call to action for treatment of all. Journal of Global Oncology. PMID: 31166825
    23. Chovatiya GL, Sunkara RR, Roy S, Godbole SR, Waghmare SK (2019) - Context-dependent effect of sPLA2-IIA induced proliferation on murine hair follicle stem cells and human epithelial cancer. EBioMedicine. 48: 364-376. PMID: 31521610
    24. Das D, Ghosh S, Maitra A, Biswas NK, Panda CK, Roy B, Sarin R, Majumder PP (2019) – Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer. Clinical Epigenetics. 11: 178. PMID: 31796082
    25. Dasgupta A, Gupta T (2019) - MRI-based prediction of molecular subgrouping in medulloblastoma: Images speak louder than words. Oncotarget. 10(47): 4805-4807. PMID: 31523387
    26. Dasgupta A, Gupta T (2019) - Radiogenomics in medulloblastoma: Can the human brain compete with artificial intelligence and machine learning? AJNR. American Journal of Neuroradiology. 40(5): E24-E25. PMID: 30975654
    27. Dasgupta A, Gupta T, Pungavkar S, Shirsat N, Epari S, Chinnaswamy G, Mahajan A, Janu A, Moiyadi A, Kannan S, Krishnatry R, Goda JS, Jalali R (2019) - Nomograms based on pre-operative multi-parametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: Results from a radiogenomics study of 111 Patients. Neuro- Oncology. 21(1): 115-124. PMID: 29846693
    28. Dasgupta A, Gupta T, Sridhar E, Shirsat N, Krishnatry R, Goda JS, Chinnaswamy G, Jalali R (2019) - Pediatric patients with SHH medulloblastoma fail differently as compared With adults: Possible implications for treatment modifications. Journal of Pediatric Hematology/Oncology. 41(8): e499-e505, PMID: 30973484.
    29. Deo A, Chaudhury S, Kannan S, Rekhi B, Maheshwari A, Gupta S, Ray P (2019) - IGF1R predicts better survival in high-grade serous epithelial ovarian cancer patients and correlates with hCtr1 levels. Biomarkers in Medicine. 13(7): 511-521. PMID: 31140856
    30. Dey P, Rathod M, De A (2019) Targeting stem cells in the realm of drug-resistant breast cancer. Breast Cancer (Dove Med Press). 11: 115-135. PMID: 30881110
    31. Dimri S, Arora R, Jasani A, De A (2019)- Dynamic monitoring of STAT3 activation in live cells using a novel STAT3 Phospho-BRET sensor. American Journal of Nuclear Medicine and Molecualr Imaging. 9(6): 321-334.
    32. Elmore S, Grover S, Bourque J-M, Chopra S, Nyakabau A, Ntizimira C, Krakauer E, Balboni T, Gospodarowicz M, Rodin D (2019) - Global palliative radiotherapy: A framework to improve access in resource-constrained settings. Annals of Palliative Medicine. 8(3): 274-284. PMID: 30823841
    33. Gandhi KA, Goda JS, Gandhi VV, Sadanpurwala A, Jain VK, Joshi K, Epari S, Rane S, Mohanty B, Chaudhari P, Kembhavi S, Kunwar A, Gota V, Priyadarsini KI (2019) - Oral administration of 3,3'-diselenodipropionic acid prevents thoracic radiation induced pneumonitis in mice by suppressing NF-kB/IL-17/G-CSF/neutrophil axis. Free Radical Biology and Medicine.145: 8-19, PMID: 31521664
    34. Gawas NP, Navarange SS, Chovatiya GL, Chaturvedi P, Waghmare SK (2019) - Establishment and characterization of novel human oral squamous cell carcinoma cell lines from advanced stage tumors of buccal mucosa. Oncology Reports. 41(4): 2289-2298. PMID: 30816493
    35. Goda JS, Lewis SC, Laskar S, Kannan S, Khanna N, Jain H, Bagal B, Epari S (2019) - A phase III randomized controlled trial of radiation dose optimization in non‐Hodgkin lymphoma‐diffuse large B‐cell lymphoma (DOBL study): Study protocol and design. Cancer Reports.
    36. Gokarn A, Toshniwal A, Pathak A, Arora S, Bonda A, Punatar S, Nayak L, Dwivedi P, Bhat V, Biswas S, Kelkar R, Kannan S, Khattry N (2019) - Use of leflunomide for treatment of cytomegalovirus infection in recipients of allogeneic stem cell transplant. Biology of Blood and Marrow Transplantation. 25(9): 1832-1836. PMID: 31054984
    37. Goud BK, Shinde DD, Udupa DV, CM Krishna, Rao KD, Sahoo NK (2019) - Low cost digital holographic microscope for 3-D cell imaging by integrating smartphone and DVD optical head. Optics and Lasers in Engineering. 114: 1-6.
    38. Gupta M, Chopra S, Kunder S, Dheera A, Sampathirao D, Engineer R, Ghosh J, Gurram L, Mahantshetty U, Gupta S, Shrivastava S (2019). Early toxicity and treatment outcomes of extended field-intensity modulated radiotherapy for cervical cancer patients with para-aortic nodal metastasis. Ecancermedicalscience. 13:957. PMID: 31645885;
    39. Gupta M, Gupta T, Purandare M, Rangarajan V, Puranik A, Moiyadi A, Shetty P, Epari S, Sahay A, Mahajan A, Janu A, Bagal B, Menon H, Kannan S, Krishnatry R, Sastri G, Jalali R (2019) - Utility of flouro-deoxy-glucose positron emission tomography/computed tomography in the diagnostic and staging evaluation of patients with primary CNS lymphoma. CNS Oncology. 8(4): CNS46. . PMID: 31779471
    40. Gupta S (2019) - Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbroken. Journal of Gynecologic Oncology. 30(4):e97, PMID: 31140218
    41. Gupta S, Gulia S, Kannan R, Rodrigues C, Dhareshwar J, Vora A(2019) - Nocardial endocarditis in native aortic valve with nocardial sepsis in a case of breast cancer. BMJ Case Reports. 12: e229370. PMID: 31300597
    42. Gupta S, Nag S, Aggarwal S, Rauthan A, Warrier N. Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives - A review. Journal of Ovarian Research. 12(1): 103. PMID: 31685032
    43. Gupta T, Achari R, Chatterjee A, Chen ZP, Mehta M, Bouffet E, Jalali R(2019) - Comparison of epidemiology and outcomes in neuro-oncology between the east and the west: Challenges and opportunities. Clinical oncology (Royal College of Radiologists (Great Britain)). 31(8):539-548, PMID: 31182288
    44. Gupta T, Chatterjee A, Rangarajan V, Purandare N, Arya S, Murthy V, Budrukkar A, Ghosh-Laskar S, Agarwal JP(2019) - Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma. Quarterly Journal of Nuclear Medicine and Molecular Imaging. PMID: 31496204
    45. Harish M, Kannan S, Puttagunta S, Pradhan M, Verma C, Venkatraman P (2019) - A novel determinant of PSMD9 PDZ binding guides the evolution of first generation of super binding peptides. Biochemistry. 58(32): 3422-3433, PMID: 31287951
    46. Hole A, Bhujbal M, Bendale K, Kumar P, Gera P, CM Krishna, Chaudhari P (2019) - Preliminary study of canine oral cancer by Raman spectroscopy. Proceedings of SPIE. 10869, Optics and Biophotonics in Low-Resource Settings V, 1086917 (26 February 2019).
    47. Hudlikar RR, Pai V, Kumar R, Thorat RA, Kannan S, Ingle AD, Maru GB, Mahimkar MB(2019) - Dose-related modulatory effects of polymeric black tea polyphenols (PBPs) on initiation and promotion events in B(a)P and NNK-induced lung carcinogenesis. Nutrition and Cancer. 71(3): 508-523. PMID: 30857437
    48. Iyer P, Shrikhande SV, Ranjan M, Joshi A, Gardi N, Prasad R, Dharavath B, Thorat R, Salunkhe S, Sahoo B, Chandrani P, Kore H, Mohanty B, Chaudhari V, Choughule A, Kawle D, Chaudhari P, Ingle A, Banavali S, Gera P, Ramadwar MR, Prabhash K, Barreto SG, Dutt S, Dutt A (2019) - ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer. International Journal of Cancer. 144(8): 2008-2019, PMID: 30304546
    49. Iyer P, Sutradhar S, Paul R, Bhattacharyya D (2019). A novel combinatorial approach of quantitative microscopy and in silico modeling deciphers Arf1-dependent Golgi size regulation. The European Physical journal E : Soft Matter and Biological Physics. 42(12): 154.
    50. Jain BK, Dahara R, Bhattacharyya D( 2019) - Golgin PpImh1 mediates reversible cisternal stacking in Golgi apparatus of budding yeast Pichia pastoris. Journal of Cell Science. 2019. PMID: 31391238
    51. Jalali R, Goda JS (2019) - Proton beam therapy in pediatric brain tumor patients: Improved radiation delivery techniques improve neurocognitive outcomes. Neuro- Oncology. 21(7): 830-831. PMID: 31081892
    52. Jalali R, Maitre M, Gupta T, Goda JS, Shah N, Krishna U, Swamidas J, Kannan S, Dutta D, Sarin R. (2019) - Dose constraint model to predict neuroendocrine dysfunction in young patients with brain tumours: Data from a prospective study. Practical Radiation Oncology. 9(4):e362-e371. PMID: 30826479
    53. Jha P, Kumar D, Dikshit R, Budukh A, Begum R, Sati P, Kolpak P, Wen R, Raithatha SJ, Shah U, Li ZR, Aleksandrowicz L, Shah P, Piyasena K, McCormick TH, Gelband H, Clark SJ (2019) - Automated versus physician assignment of cause of death for verbal autopsies: Randomized trial of 9374 deaths in 117 villages in India. BMC Medicine. 17(1): 116. PMID: 31242925
    54. Kale T, Bendale K, Singh KK, Chaudhari P (2019) - Albumin based iohexol nanoparticles for computed tomography: An in vivo study. Journal of Biomedical Nanotechnology. 15(2): 236-247. PMID: 30596547
    55. Kaur E, Goda JS, Ghorai A, Salunkhe S, Shetty P, Moiyadi A, Sridhar E, Mahajan A, Jalali R, Dutt S (2019) - Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome - A short report. Cellular oncology (Dordrecht). 42(1): 107-116. PMID: 30361826
    56. Kumar A, Drusbosky LM, Meacham A, Turcotte M, Bhargav P, Vasista S, Usmani S, Pampana A, Basu K, Tyagi A, Lala D, Rajagopalan S, Birajdar SC, Alam A, Ghosh Roy K, Abbasi T, Vali S, Sengar M, Chinnaswamy G, Shah BD, Cogle CR(2019) - Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomics. Leukemia Research. 78: 3-11. PMID: 30641417
    57. Kumar A, Mhatre S, Godbole S, Jha P, Dikshit R (2019) - Optimization of extraction of genomic DNA from archived dried blood spot (DBS): potential application in epidemiological research & bio banking. Version 3. Gates Open Research. 2: 57. PMID: 31815249
    58. Kumar CS, Gadewal N, Choudhary R, Dasgupta D (2019) - Insights into the flexibility of the T3 loop and GTPase activating protein (GAP) domain of dimeric α and β tubulins from a molecular dynamics perspective. Computational Biology and Chemistry. 82: 37-43. PMID: 31255973
    59. Kumar M, Bhattacharjee A, Sonker PK, Saroj A, Jain A (2019)- Parametric survival analysis using R: Illustration with lung cancer data. Cancer Reports.
    60. Kumar P, Ingle A, CM Krishna (2019) - In vivo Raman spectroscopy: Monitoring cancer progression post carcinogen withdrawal. Proceedings of SPIE. 10853, Optical Imaging, Therapeutics, and Advanced Technology in Head and Neck Surgery and Otolaryngology 2019, 108530K (26 February 2019).
    61. Kumar S, Jena L, Sahoo M, Mohod K, Varma AK (2019) - Effect of single amino acid mutations on C-terminal domain of breast cancer susceptible protein 1. International Journal of Bioinformatics and Research Applications. 15(4): 305-323.
    62. Kummari R, Dutta S, Chaganti LK, Bose K (2019) - Discerning the mechanism of action of HtrA4: a serine protease implicated in the cell death pathway. Biochemical Journal. 476(10): 1445-1463. PMID: 31036715
    63. Lipsa A, Kowtal P, Sarin R (2019) - Novel germline STK11 variants and breast cancer phenotype identified in an Indian cohort of Peutz-Jeghers syndrome. Human Molecular Genetics. 28(11): 1885-1893. PMID: 30689838
    64. Mahantshetty U, Sturdza A, Pusha Naga CH, Berger D, Fortin I, Motisi L, Schmid MP, Aravindakshan D, Ghdi Y, Swamidas JV, Chopra S, Gurram L, Nescacil N, Kirisits C, Richard Pötter (2019) - Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome. Radiotherapy and Oncology. 141: 123-129, 2019. PMID: 31495516
    65. Maheshwari A, Gupta S, Prat J (2019) - A proposal for updating the staging of endometrial cancer. International Journal of Gynaecology and Obstetrics. 145(2): 245-252. PMID: 30776091
    66. Malik A, Mishra A, Chopda P, Singhvi H, Nair S, Nair D, Laskar SG, Prabhash K, Agarwal JP, Chaturvedi P(2019) - Impact of age on elderly patients with oral cancer. European Archives of Oto-Rhino-Laryngology. 276(1): 223-231. PMID: 30402794
    67. Malik A, Qayyumi BN, Mair M, Singhavi H, Mathur Y, Nair D, Ghosh-Laskar S, Agrawal JP, Prabash K, Chaturvedi P (2019- Outcome of patients following neo-adjuvant chemotherapy for unresectable cervical nodes in head and neck squamous cell carcinomas. European Archives of Oto-Rhino-Laryngology. 276(2):567-574. PMID: 30556102
    68. Menon B, Bhattacharjee A, Basu S (2019) - Findings for differentiated thyroid carcinoma by γ-Camera-Based and Uptake-Probe-Based methods in comparison with diagnostic radioiodine scanning. Journal of Nuclear Medicine Technology. 47(3): 238-242. PMID: 30413599
    69. Mishra V, Kowtal P, Rane P, Sarin R (2019) - Genetic risk association of CDKN1A and RET gene SNPs with medullary thyroid carcinoma: Results from the largest MTC cohort and meta-analysis. Cancer Medicine. 8(13): 6151-6161. PMID: 31408923
    70. Monpara J, Velga D, Verma T, Gupta S, Vavia P. Cationic cholesterol derivative efficiently delivers the genes: in silico and in vitro studies. Drug Delivery and Translational Research. 9(1): 106-122, 2019. PMID: 30132199
    71. Murthy V (2019) - International consensus for advanced bladder cancer: An opportunity between the lines. Annals of Oncology. 30(11): 1688-1690. PMID: 31750878
    72. Murthy V, Gupta P, Baruah K, Krishantry R, Joshi A, Prbhasha K , Noronha V, Menon S, Pal M, Prakash G, Bakshi G(2019) - Adaptive radiotherapy for carcinoma of the urinary bladder: Long-term outcomes with dose escalation. Clinical oncology (Royal College of Radiologists (Great Britain)). 31(9): 646-652. PMID: 31301959
    73. Murthy V, Johnny C, Huddart R (2019) - Positron Emission Tomography-positive post-chemotherapy seminoma masses: Time to reevaluate the role of radiotherapy? Journal of Clinical Oncology. 37(11): 937-938. PMID: 30811289
    74. Murthy V, Sinha S, Kannan S, Datta D, Das R, Bakshi G, Prakash G, Krishnatry R (2019) - Safety of SBRT in post TURP prostate cancer patients: A propensity score matched pair analysis. Practical Radiation Oncology. 9(5): 347-353. PMID: 30978467
    75. Nair NS, Parmar V, Badwe RA (2019) - Intent of surgery of the primary tumor in metastatic breast cancer remains palliative. Breast Journal. 25(2): 353 PMID: 30761690
    76. Narasimhan M, Kannan S, Chawade A, Bhattacharjee A, Govekar R (2019) - Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method. Journal of Translational Medicine. 17(1): 184. PMID: 31151397
    77. Nemani T, Udwadia-Hegde A, Keni Karnavat P, Kashikar R, Epari S (2019) - CLIPPERS spectrum disorder: A rare pediatric neuroinflammatory condition. Child Neurology Open. 6: 2329048X19831096, 2019. PMID: 30873425
    78. Page EC, Bancroft EK, Brook MN, Assel M, Hassan Al Battat M, Thomas S, Taylor N, Chamberlain A, Pope J, Raghallaigh HN, Evans DG, Rothwell J, Mahle L, Grindedal EMM, James P, Mascarenhas L, McKinley J, Side L, Thomas T, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Jensen TD, Osther PJS, Helfand BT, Genova E, Oldenburg RA, Cybulski C, Wokolorczyk D, Ong KR, Huber C, Lam J, Taylor L, Salinas M, Feliubadaló L, Oosterwijk JC, van Zelst-Stams W, Cook J, Rosario DJ, Domchek S, Powers J, Buys S, O'Toole K, Ausems MGEM, Schmutzler RK), Rhiem K, Izatt L, Tripathi V, Teixeira MR, Cardoso M, Foulkes WD, Aprikian A, van Randeraad H, Davidson R, Longmuir M, Ruijs MWG, Helderman van den Enden ATJM, Adank M, Williams R, Andrews L, Murphy DG, Halliday D, Walker L, Liljegren A, Carlsson S, Azzabi A, Jobson I, Morton C, Shackleton K, Snape K, Hanson H, Harris M, Tischkowitz M, Taylor A, Kirk J, Susman R, Chen-Shtoyerman R, Spigelman A, Pachter N, Ahmed M, Ramon Y Cajal T, Zgajnar J, Brewer C, Gadea N, Brady AF, van Os T, Gallagher D, Johannsson O, Donaldson A, Barwell J, Nicolai N, Friedman E, Obeid E, Greenhalgh L, Murthy V, Copakova L, Saya S, McGrath J, Cooke P, Rønlund K, Richardson K, Henderson A, Teo SH, Arun B, Kast K, Dias A, Aaronson NK, Ardern-Jones A, Bangma CH, Castro E, Dearnaley D, Eccles DM, Tricker K, Eyfjord J, Falconer A, Foster C, Gronberg H, Hamdy FC, Stefansdottir V, Khoo V, Lindeman GJ, Lubinski J, Axcrona K, Mikropoulos C, Mitra A, Moynihan C, Rennert G, Suri M, Wilson P, Dudderidge T, IMPACT Study Collaborators, Offman J, Kote-Jarai Z, Vickers A, Lilja H, Eeles RA (2019) - Interim results from the IMPACT study: Evidence for prostate-specific antigen screening in BRCA2 mutation carriers. European Urology. 76(6): 831-842. PMID: 31537406
    79. Pansare K, Gardi N, Kamat S, Dange P, Previn R, Gera P, Kowtal P, Amin K, Sarin R (2019) - Establishment and genomic characterization of gingivobuccal carcinoma cell lines with smokeless tobacco associated genetic alterations and oncogenic PIK3CA mutation. Scientific Reports. 9(1): 8272. PMID: 31164688
    80. Pansare K, Pillai D, Parab S, Singh SR, Kannan S, Ludbe M, Hole A, Krishna CM, Gera P (2019) - Quality assessment of cryopreserved biospecimens reveals presence of intact biomolecules. Journal of Biophotonics. 12(12): e201960048. PMID: 31569303
    81. Parab A, Mhatre S, Hake S, Kannan S, Pai P, Kane S, Joshi N (2019) - Identification of stably expressed genes for normalization of gene expression data in oral tumors: A preliminary analysis. Oral Cancer. 3: 49–58.
    82. Patel D, Kharkar PS, Gandhi NS, Kaur E, Dutt S, Nandave M. Novel analogs of sulfasalazine as system xc - antiporter inhibitors: Insights from the molecular modeling studies. Drug Development Research. 80(6):758-777. 2019. PMID: 31199023
    83. Patel S, Rajora N, Kumar S, Sahu A, Kochar S, CM Krishna, Srivastava S (2019) - Rapid discrimination of malaria and dengue infected patients sera using Raman Spectroscopy. Analytical Chemistry. 91(11): 7054-7062. PMID: 31033270
    84. Patil A, Singh V, Sukumar V, Shetty P, Moiyadi A (2019) - Comparison of outcomes of free hand 2D-ultrasound guided versus navigated 3D-ultrasound guided biopsy for supratentorial tumors: a single institution experience with 125 cases. Ultrasonography. 38(3): 255-263, PMID: 30779873
    85. Patil VM, Chandrasekharan A, Vallathol DH, Malhotra M, Abhinav R, Agarwal P, Rajpurohit A, Tonse R, Bhattacharjee A, Jalali R.- Antiemetic prophylaxis with temozolomide: an audit from a tertiary care center. Neuro-Oncology Practice.2019. 6(6):479-483. PMID: 31832218
    86. Patil VM, Joshi A, Noronha V, Agarwala V, Chougule A, Kanan S, Bhattacharjee A, Chandrasekharan A, Pande N, Simha V, Goud S, More S, Kumar R, Mahajan A, Janu A, Purandare N, Prabhash K (2019)- Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer. Oncotarget. 10(59): 6297-6307. PMID: 31695838
    87. Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N, Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D'Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A, Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R, Vallathol DH, Dsouza H, Shrirangwar S, Turkar S, Abraham G, Thanky AH, Patel U, Pandey MK, Prabhash K (2019) - A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer. Cancer. 125 (18): 3184-3197. PMID: 31150120.
    88. Patil VM, Noronha V, Joshi A, Dhumal S, Mahimkar M, Bhattacharjee A, Gota V, Pandey M, Menon N, Mahajan A, Sable N, Kumar S, Nawale K, Mukadam S, Solanki B, Das S, Simha V, Abraham G, Chandrasekharan A, Talreja V, D’souza H, Srinivas S, Kashyap L, Banavali S, Prabhash K (2019) - Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early-failure oral cancer. Journal of Clinical Oncology. 37(32): 3032-3041. PMID: 31539316
    89. Patkar N, Kakirde C, Bhanshe P, Joshi S, Chaudhary S, Yajamanam B, Ghogale S, Deshpande N, Tembhare P, Kadechkar S, Kannan S, Shetty D, Gokarn A, Punatar S, Bonda A, Nayak L, Jain H, Bagal B, Menon H, Sengar M, Hasan KS, Khattry N, Gujral S, Subramanian P (2019) - Utility of immunophenotypic measurable residual disease in adult acute myeloid leukemia –Real world context. Frontiers in Oncology. 9:450. PMID: 31263671
    90. Patkar N, Shaikh AF, Kakirde C, Nathany S, Ramesh H, Bhanshe P, Joshi S, Chaudhary S, Kannan S, Khizer SH, Chatterjee G, Tembhare P, Shetty D, Gokarn A, Punatkar S, Bonda A, Nayak L, Jain H, Khattry N, Bagal B, Sengar M, Gujral S, Subramanian P (2019) - A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1. Blood Cancer Journal. 9(10): 79, PMID: 31575857
    91. Pawar N, Panchal S, Kawle D, Gadgoli C, Maru G (2019) - Evaluation of genotoxic and modulatory effects of Nyctanthes arbor-tristis calyx extract and the isolated crocin in Ames' assay. Natural Product Research. 33(6): 884-888. PMID: 29224365
    92. Pimple SA, Mishra GA (2019)- Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges. Minerva Ginecologica. 71: 365-71. PMID: 31698891.
    93. Pimple SA, Mishra GA (2019)- Global strategies for cervical cancer prevention and screening. Minerva Ginecologica 71: 313-319. PMID: 30808155
    94. Prajapati MK, Bishnu A, Ray P, Vavia PR (2019) - Selectivity enhancement of paclitaxel liposome towards folate receptor-positive tumor cells by ligand number optimization approach. AAPS PharmSciTech. 20(8): 317. PMID: 31605252
    95. Qureshi SS, Kembhavi SA, Bhagat M, Kapadia T, Prasad M, Vora T, Chinnaswamy G, Ramadwar M, Laskar S, Khanna N, Baheti A, Shah S, Kurkure P, Talole S (2019) - Customized approach for upfront or delayed resection using radiological criteria in unilateral, nonmetastatic pediatric renal tumors: A prospective study. Pediatric Blood and Cancer. 66: Suppl 3: e27815. PMID: 31099132
    96. Raghuram GV, Chaudhary S, Johari S, Mittra I (2019) - Illegitimate and repeated genomic integration of cell-free chromatin in the aetiology of somatic mosaicism, ageing, chronic diseases and cancer. Genes (Basel). 10(6): 407. PMID: 31142004
    97. Raphael MJ, Fundytus A, Hopman WM, Vanderpuye V, Seruga B, Lopes G, Hammad N, Sengar M, Brundage MD, Sullivan R, Booth CM (2019) - Medical oncology job satisfaction: Results of a global survey. Seminars in Oncology. 46(1): 73-82, PMID: 30685074
    98. Rathod M, Chatterjee S, Dutta S, Kalraiya R, Bhattacharyya D, De A (2019) - Mannose glycosylation is an integral step for human NIS localization and function in breast cancer cells. Journal of Cell Science. PMID: 31455607
    99. Rohil Y, Shetty D, Jain H, Nayak LR (2019) - Isochromosome i(9)(q10): A Rare Chromosomal Aberration in B-cell Acute Lymphoblastic Leukemia. Clinical Oncology: Case Reports. 2: 2.
    100. Rohil Y, Shetty D, Narula G, Banavali SD (2019) - A novel case of ABL2 chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia. Journal of the Association of Genetic Technologist. 45(2): 73-76, PMID: 31189154
    101. Sahu A, Gera P, Malik A, Nair S, Chaturvedi P, CM Krishna (2019) - Raman exfoliative cytology for prognosis prediction in oral cancers: A proof of concept study. Journal of Biophotonics. 12(8): e20180033. PMID: 30719849
    102. Sahu I, Nanaware P, Mane M, Mulla SW, Roy S, Venkatraman P (2019) – Role of a 19S Proteasome Subunit- PSMD10Gankyrin in Neurogenesis of Human Neuronal Progenitor Cells. International Journal of Stem Cells. 12(3): 463-473, PMID: 31474027
    103. Sawant S, Dongre H, Kanojia D, Jamghare S, Borges A, Vaidya M (2019) - Role of electron microscopy in early detection of altered epithelium during experimental oral carcinogenesis. Microscopy and Microanalysis. 25(6): 1367-1375. PMID: 30867083
    104. Shah SG, Rashid M, Verma T, Ludbe M, Khade B, Gera PB, Gupta S (2019) - Establishing a correlation between RIN and A260/280 along with the multivariate evaluation of factors affecting the quality of RNA in cryopreserved cancer bio-specimen. Cell and Tissue Banking. 20(4): 489-499, PMID: 31444592
    105. Shetty D, Talker E, Chaubal K, Bhat V, Narula G (2019) - dic(7;9)(p11.1;p11.1) and del(7)(q36) as a Primary Abnormality in Childhood B-cell Precursor ALL: A Case Report. Journal of Association of the Genetic Technologists. 45(3): 121-123, PMID: 31554744
    106. Shetty D, Talker E, Sengar M, Subramanian PG (2019) - Isoderivative Chromosome 17 With Multiple Copies of RARA–PML fusions and Tp53 deletion in a rare case of APML. Hematology/Oncology and Stem Cell Therapy. PMID: 30981688
    107. Shetty D, Talker E, Yadav AK, Jain H, Mistri V, Chaubal K, Khattry N (2019) - Monosomy 20 as a sole cytogenetic abnormality in adult B-ALL. Acta Scientific Cancer Biology. 3(1): 14-16.
    108. Shetty D, Usarthi R, Talker E, Jain H (2019) - Duplication of isoderivative Ph Chromosome with Tp53 deletion in a case of Imatinib resistant CML. International Journal of Human Genetics. 19 (2): 64-67.
    109. Sikder S, Kumari S, Kumar M, Sen S, Bora Singhal N, Chellappan S, Godbole M, Chandrani P, Dutt A, Gopinath KS, Kundu TK (2019) - Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a. Oncotarget. 10: 6855-6869. PMID: 31839879
    110. Singh A, Budukh A, Chaturvedi P, Dikshit R. (2019) – Systematic review on telephonic Quit line and its effects on smokeless tobacco. International Journal of Non‑Communicable Diseases.4: 65-72.
    111. Singh S, Kumar M, Kumar S, Sen S, Upadhyay P, Bhattacharjee S, Naveen M, Tomar VS, Roy S, Dutt A, Kundu TK (2019) - The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis. Journal of Biological Chemistry. 294(38): 14081–14095.
    112. Singh V, Borkar A, Moiyadi A, Shetty P(2019) - Tetraventricular atypical central neurocytoma. World Neurosurgery. 122: 454-457. PMID: 30439524
    113. Srinivasan M, Chaturvedula A, Fossler MJ, Patil A, Gota V, Prabhash K (2019) - Population pharmacokinetics of pemetrexed in adult non-small cell lung cancer in Indian patients. Journal of Clinical Pharmacology. 59(9): 1216-1224, PMID: 30973978
    114. Sugoor P, Verma K, Chaturvedi A, Kannan S, Desouza A, Ostwal V, Engineer R, Saklani A (2019) - Robotic versus laparoscopic sphincter-preserving total mesorectal excision: A propensity case-matched analysis. International Journal of Medical Robotics and Computer. 15(1): e1965. PMID: 30318725
    115. Suman S, Parghane RV, Joshi A, Prabhash K, Bakshi G, Talole S, Banerjee S, Basu S (2019) - Therapeutic efficacy, Prognostic variables and Clinical Outcome of ¹⁷⁷Lu-PSMA-617 PRLT in Progressive mCRPC following multiple lines of treatment: prognostic implications of high FDG uptake on dual tracer PET-CT vis-à-vis Gleason Score in such cohort. British Journal of Radiology. 92(1104): 20190380. PMID: 31600089
    116. Swain M, Gupta T, Kannan S, Agarwal J (2019) - Cisplatin-based chemoradiotherapy trumps cetuximab-based bioradiotherapy in p16/HPV-positive oropharyngeal cancers. European Archives of Otorhinolaryngol. 276(7): 2111-2112. PMID: 31025112
    117. Tan LT, Tanderup K, Kirisits C, de Leeuw A, Nout R, Duke S, Seppenwoolde Y, Nesvacil N, Georg D, Kirchheiner K, Fokdal L, Sturdza A, Schmid M, Swamidas J, Limbergen V E, Haie-Meder C, Mahantshetty U, Jürgenliemk-Schulz I, Lindegaard JC, Pötter R (2019) - Image-guided adaptive radiotherapy in cervical cancer. Seminars in Radiation Oncology. 29(3): 284-298, PMID: 31027645
    118. Taneja N, Gota V, Gurjar M, Singh KK. Development and validation of high-performance liquid chromatographic method for quantification of irinotecan and its active metabolite SN-38 in colon tumor bearing NOD/SCID mice plasma samples: Application to pharmacokinetic study. Acta Chromatographica. 31(3): 166-172, 2019.
    119. Varshney K, Epari S, Sahay A, Gupta T, Shetty P, Moiyadi A (2019) - Pigmented primary epithelial tumor of the sella: A report of an intriguing case. Neuropathology. 39(5): 378-381, PMID: 31373070
    120. Varshney N, Som S, Chatterjee S, Sridhar S, Bhattacharyya D, Paul R, Sanyal K (2019) - Spatio-temporal regulation of nuclear division by Aurora B kinase Ipl1 in Cryptococcus neoformans. PLoS Genetics. 15(2): e1007959, PMID: 30763303
    121. Vora C, Gupta S (2019) - Targeted therapy in cervical cancer. ESMO Open. 3: e000462, PMID: 30997156
    122. Wadasadawala T, Sinha S, Verma S, Parmar V, Kannan S, Pathak R, Sarin R, Gaikar M (2019) - A prospective comparison of subjective and objective assessments of cosmetic outcomes following breast brachytherapy. Journal of Contemporary Brachytherapy. 11(3): 207-214, PMID: 31435427
    123. Warawdekar UM (2019) - An assay to assess gap junction communication in cell lines. Journal of Biomolecular Techniques. 30(1): 1-6. PMID: 30723387
    124. Zanwar S, Jain P, Gokarn A, Devadas SK, Punatar S, Khurana S, Bonda A, Pruthy R, Bhat V, Qureshi S, Khattry N (2019) - Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infection. Transplant Infectious Disease. 2191: e13017. PMID: 30369006
  • 2018
    1. Agarwal V, Thomas MJ, Joshi R, Chaudhari V, Bhandare M, Mitra A, deSouza A, Ambulkar R, Shrikhande SV (2018). Improved outcomes in 394 pancreatic cancer resections: The impact of enhanced recovery pathway. Journal of Gastrointestinal Surgery. 22(10): 1732-1742. PMID: 29777454
    2. Agarwala V, Ramaswamy A, Joshi A, Patil VM, Noronha V, Menon S, Popat B P, Sable N, Prabhash K (2018). Treatment outcomes of metastatic nonclear cell renal cell carcinoma: A single institution retrospective analysis. South Asian Journal of Cancer. 7:226-30. PMID: 30430089
    3. Agrawal S, kelkar M, De A, Kulkarni AR, Gandhi MN (2018). Newly emerging mesoporous strontium hydroxyapatite nanorods: microwave synthesis and relevance as doxorubicin nanocarrier. Journal of Nanoparticle Research
    4. Amnekar RV, Gupta S (2018). HDAC inhibitors in solid tumors: An incomplete story. Journal of Clinical Epigenetics. 4(2):8.
    5. Bagal B, Chandrasekharan A, Chougule A, Khattry N (2018). Low, fixed dose defibrotide in management of hepatic veno-occlusive disease post stem cell transplantation. Hematology/Oncology and Stem Cell Therapy. 11(4): 47-51. PMID: 28460209
    6. Bajpai J, Panda PK, Kagwade S, Govilkar M, Velaskar S, Kembhavi Y, Gupta S, Ghosh J, Deodhar J (2018). Translation and validation of European Organization for research and treatment for cancer quality of life questionnaire-OV-28 module into Indian languages (Hindi and Marathi) to study quality of life of ovarian cancer patients from a tertiary care cancer center. South Asian J Cancer 7: 37-41. PMID: 29600233
    7. Balaji SA, Shanmugam A, Chougule A, Sridharan S, Prabhash K, Arya A, Chaubey A, Hariharan A, Kolekar P, Sen M, Ravichandran A, Katragadda S, Sankaran S, Bhargava S, Kulkarni P, Rao S, Sunkavalli C, Banavali S, Joshi A, Noronha V, Dutt A, Bahadur U, Hariharan R, Veeramachaneni V, Gupta V (2018). Analysis of solid tumor mutation profiles in liquid biopsy. Cancer Medicine. 7(11): 5439-5447. PMID: 30264478
    8. Barreto SG, Dutt A, Sirohi B, Shrikhande SV (2018). Gallbladder cancer: A journey of a thousand steps. Future Oncology. 14(13): 1299-1306. PMID: 29722272
    9. Basu S, Chaudhary N, Shah S, Braggs C, Sawant A, Vaz S, Thorat R, Gupta S, Dalal SN (2018). Plakophilin3 loss leads to an increase in lipocalin2 expression, which is required for tumour formation. Experimental Cell Research. 369(2): 251-265. PMID: 29803740
    10. Bhat SA, Vedpathak D, Chiplunkar SV (2018). Checkpoint blockade rescues the repressive effect of HDAC inhibitors on γδ T cell function. Front Immunol. 9:1615. PMID: 30072989Bhat V, Vira H (2018). Quality control issues in antibiotic susceptibility testing by disc diffusion technique. Clinical Infectious Diseases. 2(1): 104.Bhori M, Singh K, Marar T, CM Krishna (2018). Exploring the effect of Vitamin E in cancer chemotherapy‐ A biochemical and biophysical insight. Journal of Biophotonics. 11(9):e201800104, 2018. PMID: 29770585
    11. Bonda A, Punatar S, Gokarn A, Mohite A, Shanmugam K, Nayak L, Bopanna M, Cheriyalinkal Parambil B, Khattry N (2018). Daratumumab at the frontiers of post-transplant refractory T-acute lymphoblastic leukemia-a worthwhile strategy? Bone Marrow Transplantation. 53: 1487-89. PMID: 29884853
    12. Chaganti LK, Venkatakrishnan N, Bose K (2018). An efficient method for FITC-labelling of proteins using tandem affinity purification. Bioscience Reports. 38(6): BSR20181764 PMID: 30413608
    13. Chatterjee A, Gupta T, Rangarajan V, Purandare N, Kunder S, Murthy V, Budrukkar A, Ghosh-Laskar S, Agarwal J. Optimal timing of fluorine-18-fluoromisonidazole positron emission tomography/computed tomography for assessment of tumor hypoxia in patients with head and neck squamous cell carcinoma. Nuclear Medicine Communications. 39(9): 859-864. PMID: 29939883Chatterjee S, Chaubal R, Maitra A, Gardi N, Dutt A, Gupta S, Badwe RA, Majumder PP, Pandey P. (2018). Pre-operative progesterone benefits operable breast cancer patients by modulating surgical stress. Breast Cancer Research and Treatment. 170(2): 431-438, 2018. PMID: 29564740
    14. Chaturvedi P, Singhavi H, Malik A, Nair D (2018). Outcome of head and neck squamous cell cancers in low-resource settings: Challenges and opportunities. Otolaryngologic Clinics of North America. 51(3): 619-629. PMID: 29501327
    15. Chaudhary S, Raghuram GV, Mittra I (2018). Is inflammation a direct response to dsDNA breaks? Mutation Research. 808: 48-52, 2018. PMID: 29518635
    16. Chauhan DS, Arunkumar P, Prasad R, Mishra S, Pradeep B, Reddy K, De A, Srivastava R (2018). Facile synthesis of plasmonic zein nanoshells for imaging-guided photothermal cancer therapy. Materials Science and Engineering: C. 90: 539-548. PMID: 29853123
    17. Chauhan DS, Bukhari AB, Ravichandran G, Gupta R, George L, Poojari R, Ingle A, Rengan AK, Shanavas A, Srivastava R, De A (2018). Enhanced EPR directed and imaging guided photothermal therapy using vitamin E modified toco-photoxil. Scientific Reports. 8(1): 16673, 2018. PMID: 30420735Chauhan DS, Kumawat MK, Prasad R, Reddy PK, Dhanka M, Mishra SK, Bahadur R, Neekhra S, De A, Srivastava R. Plasmonic carbon nanohybrids for repetitive and highly localized photothermal cancer therapy. Colloids and Surfaces B: Biointerfaces. 172: 430-439. PMID: 30196228
    18. Chikhale R, Thorat S, Choudhary RK, Gadewal N, Khedekar P (2018). Design, synthesis and anticancer studies of novel aminobenzazolyl pyrimidines as tyrosine kinase inhibitors. Bioorganic Chemistry. 77: 84-100. PMID: 29342447
    19. Chopra S, Mathew A, Maheshwari A, Bhatla N, Singh S, Rai B, Surappa ST, Ghosh J, Sharma D, Bhaumik J, Biswas M, Deodhar K, Popat P, Giri S, Mahantshetty U, Tongaonkar H, Billimaga R, Engineer R, Grover S, Pedicayli A, Bajpai J, Rekhi B, Alihari A, Babu G, Thangrajan R, Menon S, Shah S, Palled S, Kulkarni Y, Gulia S, Naidu L, Thakur M, Rangrajan V, Kerkar R, Gupta S, Shrivastava SK (2018). National Cancer Grid of India consensus guidelines on the management of cervical cancer. Journal of Global Oncology. 4: 1-15. PMID: 30085891
    20. Chopra S, Viswanathan A, Mittal P, Laskar SG, Reddy VA, Nair R, Bajpai J, Chaukar D, Gupta S, Cruz AD, Badwe R (2018). Reducing gender disparity in oncologists in India: An opportunity to address workforce challenges. Clinical Oncology (R Coll Radiol).30(12): 805-809. PMID: 30243557
    21. Chowdhary RK, Siddiqui MQ, Gadewal N, Kumar NK, Kuligina ES, Verma AK. Biophysical evaluation to categorize pathogenicity of cancer-predisposing mutations identified in the BARD1 BRCT domain. RSC Advances . 8: 34056-34068, 2018.
    22. Das S, Gurav S, Soni V, Ingle A, Mohanty BS, Chaudhari P, Bendale K, Dholam K, Bellare JR (2018). Osteogenic nanofibrous coated titanium implant results in enhanced osseointegration: In vivo preliminary study in a rabbit model. Tissue Engineering and Regenerative Medicine. 15(2): 231-247.
    23. Dawn S, Pal R, Bakshi AK, Kinhikar RA, Joshi K, Jamema SV, Haneefa A, Selvam TP, Deshpande DD, Datta D (2018). Evaluation of in-field neutron production for medical LINACs with and without flattening filter for various beam parameters - Experiment and Monte Carlo simulation. Radiation Measurements. 118: 98-107.
    24. Desai S, Barai A, Bukhari AB, De A, Sen S. α-Actinin-4 confers radioresistance coupled invasiveness in breast cancer cells through AKT pathway. Biochimica et Biophysica Acta. 1865(1): 196-208, 2018. PMID: 29055790
    25. Devadas SK, Toshniwal M, Bagal B, Khattry N. Successful treatment of transplant associated thrombotic microangiopathy (TA-TMA) with low dose defibrotide. Indian Journal of Hematology and Blood Transfusion. 34(3): 469-473, 2018. PMID: 30127555
    26. Devanand T, Venkatraman P, Vemparala S (2018). Phosphorylation promotes binding affinity of Rap-Raf complex by allosteric modulation of switch loop dynamics. Scientific Reports. 8(1): 12976. PMID: 30154518
    27. Dmello C, Sawant S, Chaudhari PR, Dongre H, Ahire C, D'Souza ZC, Charles SE, Rane P, Costea DE, Chaukar D, Kane S, Vaidya M (2018). Aberrant expression of vimentin predisposes oral premalignant lesion derived cells towards transformation. Experimental and Molecular Pathology. 105(3): 243-51. PMID: 30189187
    28. Doshi J, Kuppili RR, Gurdasani S, Venkatakrishnan N, Saxena A, Bose K (2018). PDZscape: A comprehensive PDZ-protein database. BMC Bioinformatics. 19:160.
    29. Dube B, Pandey A, Joshi G, Mulherkar R, Sawant K. Cholic acid-modified polyethylenimine: In vitro and in vivo studies. International Journal of Nanomedicine. 13: 83-85, 2018. PMID: 29593402
    30. Fundytus A, Hopman WM, Hammad N, Biagi JJ, Sullivan R, Vanderpuye V, Seruga B, Lopes G, Sengar M, Brundage MD, Booth CM (2018). Medical oncology workload in Canada: infrastructure, supports, and delivery of clinical care. Current Oncology. 25(3): 206-212. PMID: 29962838
    31. Gillessen S, Attard G, Beer TM, Beltran H, Bossi A, Bristow R, Carver B, Castellano D, Chung BH, Clarke N, Daugaard G, Davis ID, Bono J, dos Reis RB, Drake CG, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Higano CS, James J, Kantoff P, Kellokumpu-Lehtinen P-L, Khauli RB, Kramer G, Logothetis C, Maluf F, Morgans AK, Morris MJ, Mottet N, Murthy V, Oh W, Ost P, Padhani AR, Parker C, Pritchard CC, Roach M, Rubin MA, Ryan C, Saad F, Sartor O, Scher H, Sella A, Shore N, Smith M, Soule H, Sternberg CN, Suzuki H, Sweeney C, Sydes MR, Tannock I, Tombal B, Valdagni R, Wiegel T, Omlin A (2018). Management of Patients with Advanced Prostate Cancer: The report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. European Eurology. 73(2): 178-211. PMID: 28655541
    32. Godbole M, Togar T, Patel K, Dharavath B, Yadav N, Janjuha S, Gardi N, Tiwary K, Terwadkar P, Desai S, Prasad R, Dhamne H, Karve K, Salunkhe S, Kawle D, Chandrani P, Dutt S, Gupta S, Badwe RA, Dutt A (2018). Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells. Journal of Biological Chemistry. 293(50): 19263-19276. PMID: 30337371
    33. Gupta M, Gamre P, Kannan S, Rokde G, Krishnatry R, Murthy V (2020). Effect of imaging frequency on PTV margins and geographical miss during image guided radiotherapy for prostate cancer. Practical Radiation Oncology. 8(2): e41-47, 2018. PMID: 29122556
    34. Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri Chopra S, Kerkar R, Engineer R, Tongaonkar H, Ghosh J, Gulia S,Kumar N, Shylasree TS, Gawade R, Kembhavi Y, Gaikar M, Menon S, Thakur M, Shrivastava S, Badwe R. Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: A randomized controlled trial. Journal of Clinical Oncology. 36(16): 1548-1555, 2018. PMID: 29432076
    35. Gupta S, Maheshwari A, Parab P (2018). Reply to V.G. Gupta et al and W. Zou et al. Journal of Clinical Oncology. 36(27): 2813-2814. PMID: 29897828
    36. Gupta S, Singh M, Vora A, Babu G, Walia M, Nautial V, Saha R, Smruti BK, Sharma JB, Koul R, Parikh PM, Aggarwal S (2018). Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer. South Asian Journal of Cancer. 7(2): 142-145. PMID: 29721482
    37. Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP (2018). Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma. PLoS One. 13(7): e0200137. PMID: 29979726
    38. Gupta T, Tibdewal A, Mohanty S, Pietsch T, Kannan S, Juvekar S, Merchant N, Epari S, Moiyadi A, Shetty P, Goda JS, Jalali R(2018). Correlation of conventional magnetic resonance imaging features with O6-methylguanine-DNA-methyltransferase gene promoter methylation status and survival outcomes in patients with newly diagnosed glioblastoma: Single-center correlative imaging substudy from a prospective clinical trial. Glioma. 1(2): 50-58.
    39. Gurjar M, Raychaudhuri K, Mahadik S, Reddy D, Atak A, Shetty T, Rao K, Karkhanis MS, Gosavi P, Sehgal L, Gupta S, Dalal S (2018). Plakophilin3 increases desmosome assembly, size and stability by increasing expression of desmocollin2. Biochemical and Biophysical Research Communication. 495(1): 768-774. PMID: 29146182
    40. Haque MM, Kowtal P, Sarin R (2018). TP53 gene allele dropout in Li-Fraumeni syndrome and oral cancer cohorts. Scientific Reports. 8: 11705. PMID: 30076369
    41. Hole A, Cardoso-Avila PE, Sridharan S, Sahu A, Nair J, Dongre H, Goda JS, Sawant S, Dutt S, Pichardo-Molina JL, CM Krishna. Study of interaction of GNR with glioblastoma cells. Proceedings of SPIE 10456, Nanophotonics Australasia 2017, 1045623 (2 January 2018)
    42. Hole A, Sahu A, Shaikh R, Tyagi G, CM Krishna. Raman spectroscopic studies on exfoliated cells of oral and cervix. Proceedings of SPIE 10456, Nanophotonics Australasia 2017, 104562S (2 January 2018)
    43. Hole A, Tyagi G, Sahu A, Shaikh R, Krishna CM (2018). Exploration of Raman exfoliated cytology for oral and cervical cancers. Vibrational Spectroscopy. 98: 35-40.
    44. Iaccarino L, Ottone T, Hasan SK, Divona M, Cicconi L, Lavorgna S, Alfonso V, Basso G, Barragán E, Bocchia M, Rego EM, Grimwade D, Voso MT, Lo-Coco F (2018). Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia and Lymphoma. 59(5): 1268-1270. PMID: 28838264
    45. Iyer P, Bhave M, Jain BK, RoyChowdhury S, Bhattacharyya D (2018). Vps74p controls Golgi size in an Arf1-dependent manner. FEBS Letters. 592(22):3720-3735. PMID: 30291722
    46. Jacith R, Datta KK, Farooqee SB, Thorat R, Kumar K, Gardi N, Kaur E, Nair J, Salunkhe S, Patkar K, Desai S, Goda JS, Moiyadi AV, Dutt A, Venkartaraman P, Gowda H, Dutt S. Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells. Oncotarget. 9(45): 27667-27681, 2018. PMID: 29963228
    47. Jain BK, Thapa PS, Varma A, Bhattacharyya D. Identification and characterization of GRIP domain Golgin PpImh1 from Pichia pastoris. Yeast. 35(8): 495-506, 2018. PMID: 29707810
    48. Jain H, Shetty D, Jain H, Sengar M, Khattry N, Subramanian PG. A rare case of Hepatosplenic γδ T-cell lymphoma expressing CD19 with ring chromosome 7 and trisomy 8. Cancer Genetics. 228-229: 17-20, 2018.
    49. Jamema SV, Phurailatpam R, Paul SN, Joshi K, Deshpande DD (2018). Commissioning and validation of commercial deformable image registration software for adaptive contouring. Physica Medica. 47: 1-8. PMID: 29609810
    50. Joshi AA, Nerurkar AV, Shirsat NV (2018). hsa-miR-543 acts as a tumor suppressor by targeting NMYC. J Cancer Treat Res. 6(2): 31-36.
    51. Kalal BS, Fathima F, Pai VR, Sanjeev G, CM Krishna, Upadhya D (2018). Inhibition of ERK1/2 or AKT activity equally enhances radiation sensitization in B16F10 cells. World Journal of Oncology. 9(1): 21-28. PMID: 29581812
    52. Kapoor A, Barai A, Thakur B, Das A, Patwardhan SR, Monterio M, Gaikwad S, Bukhari AB, Mogha P, Majumder A, De A, Ray P, Sen S. Soft drug-resistant ovarian cancer cells migrate via two distinct mechanisms utilizing myosin II-based contractility. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(2): 392-405, 2017. PMID: 29175377
    53.  
    54. Kirolikar S, Prasannan P, Raghuram GV, Pancholi N, Saha T, Tidke P, Chaudhari P, Shaikh A, Rane B, Pandey R, Wani H, Khare NK, Siddiqui S, D'souza J, Prasad R, Shinde S, Parab S, Nair NK, Pal K, Mittra I (2018). Prevention of radiation-induced bystander effects by agents that inactivate cell-free chromatin released from irradiated dying cells. Cell Death and Disease. 9(12): 1142. PMID: 30442925
    55. Kumar CS, Dasgupta D, Gadewal N (2018). Bioinformatics based understanding of effect of mutations in the human β tubulin outside drug binding sites and its significance in drug resistance. Open Bioinformatics Journal. 11: 29-37.
    56. Kunwar A, Patil A, Kumar S, Deshpande R, Gota V, Goda JS, Jain VK, Indira Priyadarsini K (2018). Toxicological safety evaluation of 3,3'-diselenodipropionic acid (DSePA), a pharmacologically important derivative of selenocystine. Regulatory Toxicology and Pharmacology. 99: 159-167. PMID: 30240831
    57. Lewis S, Chopra S, Naga P, Pant S, Dandpani E, Bharadwaj N, Mahantshetty U, Engineer R, Swamidas J, Ghosh J, Gupta S, Shrivastava S (2018). Acute hematological toxicity during post-operative bowel sparing image-guided intensity modulated radiation with concurrent cisplatin. British Journal of Radiology. 91(1092):20180005. PMID: 30179056
    58. Mahantshetty U, Naga P, Khadanga CR, Gudi S, Chopra S, Gurram L, Jamema S, Ghadi Y, Shrivastava S (2018). A prospective comparison of computerized-tomography (CT) based with trans-rectal-ultrasonography (TRUS) assistance and magnetic-resonance imaging (MRI) based target-volume definition during image guided adaptive brachytherapy for cervical cancers. International Journal of Radiation Oncology Biology and Physics. 102(5): 1448-1456. PMID: 30146092
    59. Mahantshetty U, Teni T, Naga P, Hotwani C, Umesh S, Kannan S, Hande V, Pawar S, Engineer R, Chopra S, Deodhar K, Maheshwari A, Gurram L, Gupta S, Shrivastava S (2018). Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study. Gynecologic Oncology. 148(2): 299-304, PMID: 29203175
    60. Mair M, Nair D, Nair S, Malik A, Mishra A, Kannan S, Bobdey S, Singhvi H, Chaturvedi P (2018). Comparison of tumor volume, thickness, and T classification as predictors of outcomes in surgically treated squamous cell carcinoma of the oral tongue. Head Neck . 40(8): 1667-1675, PMID: 29734474
    61. Mandlik SK, Ranpise NS, Mohanty BS, Chaudhari PR. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers. Drug Delivery and Translational Research. 8(3): 797-805, 2018. PMID: 29380155
    62. Mehta K, Atak A, Sahu A, Srivastava S, CM Krishna (2018). An early investigative serum Raman spectroscopy study of meningioma. Analyst. 143(8): 1916-1923. PMID: 29620771
    63. Mikropoulos C, Selkirk CGH, Saya S, Bancroft E, Vertosick E, Dadaev T, Brendler C, Page E, Dias A, Evans DG, Rothwell J, Maehle L, Axcrona K, Richardson K, Eccles D, Jensen T, Osther PJ, van Asperen CJ, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Hart R, Glover W, Lam J, Taylor L, Salinas M, Feliubadaló L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Cook J, Rosario DJ, Buys SS, Conner T, Domchek S, Powers J, Ausems MG, Teixeira MR, Maia S, Izatt L, Schmutzler R, Rhiem K, Foulkes WD, Boshari T, Davidson R, Ruijs M, Helderman-van den Enden AT, Andrews L, Walker L, Snape K, Henderson A, Jobson I, Lindeman GJ, Liljegren A, Harris M, Adank MA, Kirk J, Taylor A, Susman R, Chen-Shtoyerman R, Pachter N, Spigelman A, Side L, Zgajnar J, Mora J, Brewer C, Gadea N, Brady AF, Gallagher D, van Os T, Donaldson A, Stefansdottir V, Barwell J, James PA, Murphy D, Friedman E, Nicolai N, Greenhalgh L, Obeid E, Murthy V, Copakova L, McGrath J, Teo SH, Strom S, Kast K, Leongamornlert DA, Chamberlain A, Pope J, Newlin AC, Aaronson N, Ardern-Jones A, Bangma C, Castro E, Dearnaley D, Eyfjord J, Falconer A, Foster CS, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Lubinski J, Grindedal EM, McKinley J, Shackleton K, Mitra AV, Moynihan C, Rennert G, Suri M, Tricker K; IMPACT study collaborators, Moss S, Kote-Jarai Z, Vickers A, Lilja H, Helfand BT, Eeles RA (2018). Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition. British Journal of Cancer. 118(2):266-276. PMID: 29301143
    64. Mittal P, Chopra S, Pant S, Mahantshetty U, Engineer R, Ghosh J, Gupta S, Ghadi Y, Menachery S, Swamidas J, Gurram L, Shirvastava SK (2018). Standard chemoradiation and conventional brachytherapy for locally advanced cervical cancer: Is it still applicable in the era of magnetic resonance–based brachytherapy? Journal of Global Oncology. 4: 1-9. PMID: 30085892
    65. Moiyadi A, Velayutham P, Shetty P, Seidel K, Janu A, Madhugiri V, Singh V, Patil A, John R(2018). Combined motor evoked potential monitoring and subcortical dynamic mapping in motor eloquent tumors allows safer and extended resections. World Neurosurgery. 120:e259-e268, 2018. PMID: 30138733
    66. Moiyadi AV, Velayutham P, Doctor J, Borkar A, Singh V ( 2018). Continuous dynamic subcortical mapping using a suction monopolar device in a child: Case report and technical note. Journal of Pediatric Neurosciences. 13(2): 279-282, 2018. PMID: 30090158
    67. Murthy V, Gupta M, Mulye G, Maulik S, Munshi M, Krishnatry R, Phurailatpam R, Mhatre R, Prakash G, Bakshi G (2018). Early results of extreme hypofractionation using stereotactic body radiation therapy for high-risk, very high-risk and node-positive prostate cancer. Clinical Oncology. 30(7): 442-447. PMID: 29571936
    68. Murthy V, Lewis S, Kannan S, Khadanga CR, Rangarajan V, Joshi K, Gandhi M, Dey S, Rokde G, Budrukkar A (2018). Submandibular function recovery after IMRT in head and neck cancer: A prospective dose modelling study. Radiotherapy Oncology. 129(1):38-43. PMID: 29724411Naga Ch P, Gurram L, Chopra S, Mahantshetty U (2018). The management of locally advanced cervical cancer. Current Opinion Oncology. 30(5): 323-329. PMID: 29994902
    69. Nair SV, Nair M, Sawarkar N, Chakrabarti S, Qayyumi B, Nair D, Chaturvedi P, Gupta T, Agrawal JP (2018). Organ preservation vs primary surgery in the management of T3 laryngeal and hypopharyngeal cancers. European Archives of Oto-Rhino-Laryngology. 275(9): 2311-2316. PMID: 29959566
    70. Naresh C, Bhat V, Chavan P, Bhat P, Vira H (2018). Staff perceptions, awareness and compliance to safety: A survey of occupational hazards in a cancer centre. Journal of Oncology Translational Research. 4: 128.
    71. Ng AK, Yahalom J, Goda JS, Constine LS, Pinnix CC, Kelsey CR, Hoppe B, Oguchi M, Suh CO, Wirth A, Qi S, Davies A, Moskowitz CH, Laskar S, Li Y, Mauch PM, Specht L, Illidge T (2018). Role of radiation therapy in patients With relapsed/refractory diffuse large B-cell lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology Biology and Physics. 100(3): 652-669. PMID: 29413279
    72. Noronha V, Joshi A, Patil VM, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, D'Cruz AK, Banavali S, Pai PS, Chaturvedi P, Chaukar D, Pande N, Chandrasekharan A, Talreja V, Vallathol DH, Mathrudev V, Manjrekar A, Maske K, Bhelekar AS, Nawale K, Kannan S, Gota V, Bhattacharjee A, Kane S, Juvekar SL, Prabhash K (2018). Once-a-Week versus Once-every-3-Weeks cisplatin chemoradiation for locally advanced head and neck Cancer: A phase III randomized noninferiority trial. Journal of Clinical Oncology. 10; 36(11): 1064-1072. PMID: 29220295
    73. Ottone T, Alfonso V, Iaccarino L, Hasan SK, Mancini M, Divona M, Lavorgna S, Cicconi L, Panetta P, Maurillo L, Del Principe MI, Irno Consalvo M, Franceschini L, Francesca Angelini D, Battistini L, Guerrera G, De Bardi M, Fabiani E, Falconi G, Arcese W, Amadori S, Buccisano F, Venditti A, Voso MT, Lo-Coco F (2018). Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia. American Journal of Hematology. 93(5): E120-123. PMID: 29417611
    74. Pahuja KB, Nguyen TT, Jaiswal BS, Prabhash K, Thaker TM, Senger K, Chaudhari S, Kljavin NM, Antony A, Phalke S, Kumar P, Mravic M, Stawiski EW, Vargas D, Durinck S, Gupta R, Khanna-Gupta A, Trabucco SE, Sokol ES, Hartmaier RJ, Singh A, ChouguleA, Trivedi V, Dutt A, Patil V, Joshi A, Noronha V, Ziai J, Banavali SD, Ramprasad V, DeGrado WF, Buneo R, Jura N, Seshgiri S (2018). Actionable activating oncogenic ERBB2/HER2 transmembrane and juxtamembrane domain mutations. Cancer Cell. 34(5): 792-806. PMID: 30449325
    75. Pai T, Gupta S, Gurav M, Nag S, Shet T, Patil A, Desai S (2018). Evidence for the association of epstein-barr virus in breast cancer in Indian patients using in-situ hybridization technique. Breast Journal. 24(1): 16-22. PMID: 28557251
    76. Pai T, Shet T, Patil A, Shetty O, Singh A, Desai SB (2018). Utility of alternate, noncentromeric chromosome 17 reference probe for human epidermal growth factor receptor fluorescence in situ hybridization testing in breast cancer cases. Archives of Pathology & Laboratory Medicine. 142(5): 626-633. PMID: 29384691
    77. Pal T, Sharda A, Khade B, Ramaa CS, Gupta S (2018). Repositioning of difluorinated propanediones as inhibitors of histone methyltransferases and their biological evaluation in human leukemic cell lines. Anti-Cancer Agents in Medicinal Chemistry. 18(13):1892-1899. PMID: 29623853
    78. Pant S, Tonse R, Kannan S, Moiyadi A, Shetty P, Epari S, Sahay A, Goda JS, Jalali R, Gupta T (2018). Impact of timing of radiotherapy on outcomes in atypical meningioma: A clinical audit. Practical Radiation Oncology. 8(5): e275-284. PMID: 29861352
    79. Patil V, Noronha V, Joshi A, Deodhar J, Goswami S, Chkraborty S, Ramaswamy A, Dhumal S, Chandrakanth MV, Karpe A, Pande N, Talreja V, Chandrasekharan A, Trukar S, Prbhash K. (2018). Distress management in patients with head and neck cancer before start of palliative chemotherapy: A practical approach. Journal of Global Oncology. 4: 1-10.
    80. Patil VM, Noronha V, Joshi A, Bhattarcharjee A, Goel A, Talreja V, Chandrasekhran A, Pande N, Mandal T, Ramaswamy A, Prabhash K (2018). Influence of hypothyroidism after chemoradiation on outcomes in head and neck Cancer. Clinical Oncology. 30(10): 675. PMID: 30033049
    81. Patkar N, Kodgule R, Kakirde C, Raval G, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Kadechkar S, Khizer SH, Kannan S, Shetty D, Gokarn A, Punatkar S, Jain H, Bagal B, Menon H, Sengar M, Khattry N, Tembhare P, Subramanian P, Gujral S (2018). Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia. Oncotarget. 9(93): 36613-36624. PMID: 30564301
    82. Qureshi SS, Bhagat M, Harris C, Chinnaswamy G, Vora T, Kembhavi S, Prasad M, Ramadwar M, Shetty O, Laskar S, Khanna N, Amin N, Talole S (2018). Outcomes and complications of surgery in patients with intermediate-risk neuroblastoma: Experience from an Indian tertiary Cancer Centre. Pediatric Surgery International. 34(4):435-442. PMID: 29487992
    83. Rabade N, Raval G, Chaudhary S, Subramanian PG, Koduge R, Joshi S, Tembhare P, Hasan Sk, Jain H, Sengar M, Narula G, Banavali S, Amare Kadam P, Shetty D, Gujral S, Patkar N (2018). Molecular heterogeneity in actute promyelocytic leukemia - A single centre experience form India. Mediterranean Journal of Hematology and Infectious Diseases. 10: e2018002.
    84. Reddy D, Bhattacharya S, Jani V, Sonavane U, Joshi R, Gupta S. Biochemical and Biophysical Characterisation of Higher Oligomeric Structure of Rat Nucleosome Assembly Protein 1. Protein Journal. 37(1): 58-69, 2018. PMID: 29209909
    85. Salunkhe S, Chandran N, Chandrani P, Dutt A, Dutt S. CytoPred: 7-gene pair metric for AML cytogenetic risk prediction. Briefings in Bioinformatics. 2018. PMID: 30380003
    86. Salunkhe S, Mishra SV, Nair J, Ghosh S, Choudhary N, Kaur E, Shah S, Patkar K, Anand D, Khattry N, Hasan SK, Dutt S (2018). Inhibition of novel GCN5-ATM axis restricts the onset of acquired drug resistance in leukemia. International Journal of Cancer. 142(10): 2175-85. PMID: 29297932
    87. Sargos P, Baumann BC, Eapen L, Christodouleas J, Bahl A, Murthy V, Efstathiou J, Fonteyne V, Ballas L, Zaghloul M, Roubaud G, Orré M, Larré S (2018). Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy. Cancer Treatment Reviews. 70: 88-97. PMID: 30125800
    88. Sawant S, Ahire C, Dongre H, Joshi S, Jamghare S, Rane P, Kane S, Chaukar D (2018). Prognostic significance of elevated serum CD44 levels in patients with oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 47(7):665-673, 2018. PMID: 29752852
    89. Sawant S, Dongre H, Ahire C, Sharma S, Jamghare S, Kansara Y, Rane P, Kanojia D, Patil A, Chaukar D, Gupta S, D'Cruz A, Vaidya M, Dongre P (2018). Alterations in desmosomal adhesion at protein and ultrastructure levels during the sequential progressive grades of human oral tumorigenesis. European Journal of Oral Sciences. 126(4): 251-262. PMID: 29905981
    90. Shah D, Sulkshane P, Lalwani R, Pawar S, Teni T, Kakade A (2018). Comparative evaluation of the clonogenic capacity of periodontal ligament fibroblasts in Hank's Balanced Salt Solution and Egg Albumen: An in vitro study. Dental Traumatology. 34: 278-283. PMID: 29729064
    91. Shanavas A, Rengan AK, Chuhan D, George L, Vats M, Samra Kaur N, Yadav P, Mathur P, Chakraborty S, Tejaswini A, De A, Srivastava R. Glycol chitosan assisted in situ reduction of gold on polymeric template for anti-cancer theranostics. International Journal of Biological Macromolecules. 110: 392-398, 2018. PMID: 29174361
    92. Shrimali P, Peter M, Singh A, Dalal N, Dakave S, Chiplunkar SV, Tayalia P. Efficient in situ gene delivery via PEG diacrylate matrices. Biomater. Sci. 6(12): 3241-3250, 2018. PMID: 30334035Shrivastava SK, Lewis S, Sastri Chopra S, Lavanya G, Mahantshetty U, Engineer R (2018). Cancer cervix: Establishing an evidence-based strategy, an experience of a tertiary care centre in India. Current Problems in Cancer. 42(2):137-147. PMID: 29433826
    93. Singhal M, Sahoo TP, Aggarwal S, Singhvi A, Kaushal V, Rajpurohit S, Parthsarthi KM, Vora A, Ganvir M, Gupta S, Parikh PM (2018). Practical consensus recommendations on ovarian suppression in early breast cancer (adjuvant). South Asian Journal of Cancer. 7(2): 151-155. PMID: 29721484
    94. Singhavi H, Ahluwalia JS, Stepanov I, Gupta PC, Gota V, Chaturvedi P, Khariwala SS (2018). Tobacco carcinogen research to aid understanding of cancer risk and influence policy. Laryngoscope Investigative Otolaryngology. 3(5): 372-376. PMID: 30450409
    95. Sivasanker M, Madhugiri VS, Moiyadi AV, Shetty P, Subi TS. Surgery for brain metastases: An analysis of outcomes and factors affecting survival. Clin Neurol Neurosurg. 168:153-162, 2018. PMID: 29554624
    96. Srivastava SS, Alam H, Patil SJ, Shrinivasan R, Raikundalia S, Chaudhari PR, Vaidya MM (2018). Keratin 5/14‑mediated cell differentiation and transformation are regulated by TAp63 and Notch‑1 in oral squamous cell carcinoma‑derived cells. Oncology Reports.39(5): 2393-2401. PMID: 29512781
    97. Tembhare PR, Ghogale S, Ghatwai N, Badrinath Y, Kunder N, Patkar NV, Bibi AR, Chatterjee G, Arora B, Narula G, Banawali S, Deshpande N, Amare P, Gujral S, Subramanian PG(2018). Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD assay. Cytometry Part B: Clinical Cytometry. 94(1): 100-111. PMID: 27718302
    98. Tembhare PR, Ghogale S, Tauro W, Badrinath Y, Deshpande N, Kedia S, Cherian K, Patkar NV, Chatterjee G, Gujral S, Subramanian PG. Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies. Cytometry Part B: Clinical Cytometry. 94(3):509-519, 2018. PMID: 29316178
    99. Tiwari R, Sahu I, Soni BL, Sathe GJ, Thapa P, Patel P, Sinha S, Vadivel CK, Patel S, Jamghare SN, Oak S, Thorat R, Gowda H, Vaidya MM (2018). Depletion of Keratin 8/18 modulate oncogenic potential by governing multiple signaling pathways. FEBS Journal. 285(7):1251-1276, PMID: 29427328
    100. Tonse R, Gupta T, Epari S, Shastri JG, Gurav M, Bano N, Jalali R. Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma. Journal of Neuro-oncology. 136(2): 343-350, 2018. PMID: 29147864
    101. Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, Ng AK, Ricardi U, Suh C-Ok, Mauch PM, Specht L, Yahalom J (2018). Radiation therapy for solitary plasmacytoma and multiple myeloma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). International Journal of Radiation Oncology Biology and Physics. 101(4): 794-808. PMID: 29976492
    102. Upreti R, Budrukkar A, Upreti U, Wadasadawala T, Misra S, Gurram L, Pathak R, Deshpande D. Impact of inter-observer variations in target volume delineation on dose volume indices for accelerated partial breast irradiation with multi-catheter interstitial brachytherapy. Radiotherapy and Oncology. 129(1):173-179, 2018. PMID: 30318170Vadgaonkar R, Epari S, Chinnaswamy G, Krishanty R, Tonse R, Gupta T, Jalali R. Distinct demographic profile and molecular markers of primary CNS tumor in 1873 adolescent and young adult patient population. Child's Nervous System .34(8): 1489–1495, 2018. PMID: 29730791
    103. Veldore VH, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, Dutt A, Gupta R, Vedam R, Prabhash K (2018). Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer. Lung Cancer (Auckl). 9: 1-11. PMID: 29379323
    104. Vira HJ (2018). Importance of assessing total vitamin B12 and active B12 levels in cancer patients. Journal of Molecular Cancer. 1(1): 10.
    105. Vishal SS, Tilwani S, Dalal SN (2018). Plakoglobin localization to the cell border restores desmosome function in cells lacking 14-3-3γ. Biochemical and Biophysical Research Communication. 495(2): 1998-2003. PMID: 29253567
    106. Wadasadawala T, Lewis S, Parmar V,Budrukkar A, Gupta S, Nair N, Shet T, Badwe R, Sarin R (2018). Bilateral breast cancer following multimodality treatment- A report of clinical outcome in Asian population. Clinical Breast Cancer.30: 442-447. PMID: 29254601Wadasadawala T, Mondal M, Paul SN, Parmar V, Nair N, Shet T, Desai S, Gupta S, Sarin R (2018). Should molecular subtype be recommended as one of the selection criteria for accelerated partial breast irradiation? Preliminary results from an Asian cohort. Journal of Contemporary Brachytherapy. 10(1): 47-57. PMID: 29619056
    107. Wagh AR, Bose K (2018). Structural basis of inactivation of human vounterpart of mouse motor neuron degeneration 2 mutant in serine protease HtrA2. Bioscience Reports. 38(5). 2018. PMID: 30068699
    108. Waghmare M, Khade B, Chaudhari P, Dongre P (2018). Multiple layer formation of bovine serum albumin on silver nanoparticles revealed by dynamic light scattering and spectroscopic techniques. Journal of Nanoparticle Research. 20: 185.
  • 2017
    1. Anupama S, Laha P, Sharma M, Pathak K, Bane S, Ingle AD, Gota V, Kalraiya RD, YU L-G, Rhodes JM, Swamy BM, Inamdar SR (2017). Pharmacokinetics, biodistribution and antitumour effects of Sclerotium rolfsii lectin in mice. Oncology Reports. 37(5): 2803-2810. PMID: 28394001
    2. Ashraf R, Hamidullah, Hasanain M, Pandey P, Maheshwari M, Singh LR, Siddiqui MQ, Konwar R, Sashidhara KV, Sarkar J (2017). Coumarin-chalcone hybrid instigates DNA damage by minor groove binding and stabilizes p53 through post translational modifications. Scientific Reports 7: 45287. PMID: 28349922
    3. Bhat S, Gardi N, Hake S, Kotian N, Sawant S, Kannan S, Parmar V, Desai S, Dutt A, Joshi NN (2017). Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients. Journal of Cancer Research and Clinical Oncology. 143(9): 1745-1756. PMID: 28470472
    4. Bhat V, Vira H, Khattry N, Toshniwal M (2017). Cryptococcus laurentii diarrhea post hematopoietic stem cell transplant. Transplant Infectious Disease. 19(2): e12663. PMID: 28083955
    5. Bhat VG, Vira HJ, Kelkar RS, Biswas SK, Chavan PD (2017). Gram negative bacterial sepsis in a cancer centre: Bacteriological spectrum and antibiotic susceptibility profiles. Journal of Basic and Clinical Pharmacy. 8 :144-148.
    6. Bhargava A, Khare NK, Bunkar N, Chaudhury K, Pandey KC, Jain SK, Mishra PK (2017). Cell-free circulating epigenomic signatures: Non-invasive biomarker for cardiovascular and other age-related chronic diseases. Current Pharmaceutical Design. 23(8): 1175-1187. PMID: 27817745
    7. Bhattacharya S, Reddy D, Jani V, Gadewal N, Shah S, Reddy R, Bose K, Sonavane U, Joshi R, Gupta S. Histone isoform H2A1H promotes attainment of distinct physiological states by altering chromatin dynamics. Epigenetics and Chromatin. 10(1): 48. PMID: 29047414
    8. Bhattacharyya T, Bhattacharjee A (2017). A new index to measure intra-observer variation in delineating GTV primary in head and neck cancer. MOJ Cell Science and Report. 4(4): 00093
    9. Bhattacharyya T, Bhattacharjee A, Santhosh S, Kiran P, Sadanandan VP, Geetha M (2017). Impact of waiting time for treatment on survival in patients undergoing radiotherapy for head and neck cancer. Journal of Cancer Policy. 13: 1-4.
    10. Baumann BC, Sargos P, Eapen LJ, Efstathiou JA, Choudhury A, Bahl A, Murthy V, Ballas LK, Fonteyne V, Richaud PM, Zaghloul MS, Christodouleas JP (2017). The Rationale for post-operative radiation in localized bladder cancer. Bladder Cancer. 3(1): 19-30. PMID: 28149931
    11. Bhosale PG, Cristea S, Ambatipudi S, Desai RS, Kumar R, Patil A, Kane S, Borges AM, Schäffer AA, Beerenwinker N, Mahimkar MB (2017). Chromosomal alterations and gene expression changes associated with the progression of leukoplakia to advanced gingivobuccal cancer. Translational Oncology. 10(3): 396-409. PMID: 28433800
    12. Bhosale PG, Pandey M, Cristea S, Shah M, Patil A, Beerenwinkel N, Schäffer AA, Mahimkar MB (2017). Recurring amplification at 11q22.1-q22.2 locus plays an important role in lymph node metastasis and radioresistance in OSCC. Scientific Reports. 7(1): 16051. PMID: 29167558
    13. Budukh A, Palayekar V, Maheshwari A, Deodhar K, Purwar P, Bagal S, Vadigoppula A, Lokhande M, Panse N, Dikshit R, Badwe R (2017). Menstrual pad, a cervical cancer screening tool, a population-based study in rural India. European Journal of Cancer Prevention. PMID: 28704213
    14. Cardoso Avila PE, Rangel Mendoza A, Pichardo Molina JL, Flores Villavicencio LL, Castruita Dominguez JP, CM Krishna, Sabanero Lopez M (2017). Biological response of HeLa cells to gold nanoparticles coated with organic molecules. Toxicology In Vitro. 42:114-122. PMID: 28414162
    15. Catoe H, Jarvis J, Gupta S, Ginsburg O, de Lima Lopes G Jr (2017). The road to addressing noncommunicable diseases and cancer in global health policy. American Society of Clinical Oncology Educational Book. 37: 29-33, 2017. PMID: 28561645
    16. Krishna CM, Sahu A (2017). Water concentration analysis of the surgical margin. Cancer Research. 77(11): 3121-3122, 2017. PMID: 28526772
    17. Chandrani P, Prabhash K, Choughule A, Prasad R, Sethunath V, Ranjan M, Iyer P, Aich J, Dhamne H, Iyer DN, Upadhyay P, Mohanty B, Chandna P, Kumar R, Joshi A, Noronha V, Patil V, Ramaswamy A, Karpe A, Thorat R, Chaudhari P, Ingle A, Dutt A (2017). Drug-sensitive FGFR3 mutations in lung adenocarcinoma. Annals of Oncology.28(3): 597-603. PMID: 27998968
    18. Chaudhari PR, Charles SE, Vaidya MM (2017). Role of BPAG1e in neoplastic progression of oral squamous cell carcinoma derived cells. International Journal of Pharma Biosciences. 8(1): (B) 519-527.
    19. Chaudhari PR, Charles SE, D'Souza ZC, Vaidya MM (2017). Hemidesmosomal linker proteins regulate cell motility, invasion and tumorigenicity in oral squamous cell carcinoma derived cells. Experimetal Cell Research.360(2):125-137. PMID: 28867478
    20. Chavan C, Bala P, Pal K, Kale SN (2017). Cross-linked Chitosan-dextran sulphate vehicle system for controlled release of Ciprofloxaxin drug: An ophthalmic application. OpenNano. 2: 28-36, 7.
    21. Chavare A, Chowdari P, Ghosh S, Pawan P, Patkar M, Dakave S, Gota V, Chaudhari P, Chiplunkar SV, Kane S, Suresh AK, Bellare J (2017). Safety and bioactivity studies of Jasad Bhasma and its In-process intermediate in swiss mice. Journal of Ethnopharmacology. 197(2): 73-86. PMID: 27377339
    22. Chaturvedi P, Malik A, Nair D, Nair S, Mishra A, Garg A, Vaishampayan S (2017). Oral squamous cell carcinoma associated with oral submucous fibrosis have better oncologic outcome than those without. Oral Surgery Oral Medicine Oral Pathology Oral Radiology. 124(3): 225-230. PMID: 28606826
    23. Chopra S, Engineer R, Mathew A, Mehta S, Ostwal V, Goel M, Rajamanickam K, Patil P, Gupta S, Shetty N, Kannan S, Polnaya A, Patkar S, Rangrajan V, Agarwal A, Ramadwar M, Shrikhande S, Joshi K, Dandpani E, Shrivastava S (2017). Protocol for a phase III randomized trial of chemoradiation and systemic chemotherapy vs. systemic chemotherapy alone in patients with unresectable nonmetastatic cholangiocarcinoma. International Journal of Clinical Trials. 4(1): 14-9.
    24. Chopra S, Shetty N, Goel M, Engineer R, Rajamanickam K, Kulkarni S, Polnaya A, Patkar S, Ostwal V, Ramadwar M, Swamidas J, Phurailatpam R, Paul S, Dandapani E, Joshi K, Kannan S, Rangrajan V, Mehta S, Patil P, Shrivastava S (2017). Protocol for an integrated phase II/III randomised controlled trial of transarterial chemotherapy and sorafenib with or without stereotactic body radiation therapy in patients with nonmetastatic unresectable hepatocellular carcinoma. International Journal of Clinical Trials. 4(1): 31-38.
    25. Chauhan DS, Indulekha S, Gottipalli R, Reddy BPK, Chikate TR, Gupta R, Jahagirdar DN, Prasad R, De A, Srivastava R (2017). NIR light-triggered shrinkable thermoresponsive PNVCL nanoshells for cancer theranostics. RSC Advances. 7: 44026-44034.
    26. Chaugule SR, Indap MM, Chiplunkar SV (2017). Marine natural products: New avenue in treatment of osteoporosis. Frontiers in Marine Science.
    27. Choudhary RK, Siddiqui MQ, Thapa PS, Gadewal N, Nachimuthu SK, Varma AK (2017). Structural basis to stabilize the domain motion of BARD1-ARD BRCT by CstF50. Scientific Reports. PMID: 28634376
    28. Chovatiya GL, Sarate RM, Sunkara RR, Gawas NP, Kala V, Waghmare SK (2017). Secretory phospholipase A2-IIA overexpressing mice exhibit cyclic alopecia mediated through aberrant hair shaft differentiation and impaired wound healing response. Scientific Reports. 7(1): 11619. PMID: 28912581
    29. Dar AA, Bhat SA, Gogoi D, Gokhale A, Chiplunkar SV (2017). Inhibition of notch signalling has ability to alter the proximal and distal TCR signalling events in human CD3 (+) αβ T-cells. Molecular Immunology. 92: 116-124. PMID: 29078088
    30. Dange MC, Bhonsale HS, Godbole RK. More SK, Bane SM, Kulkarni MJ, Kalraiya RD (2017). Mass spectrometry based identification of galectin-3 interacting proteins potentially involved in lung melanoma metastasis. Molecular Biosystems. 13(11): 2303-2309. PMID: 28875213
    31. Devadas SK, Khairnar M, Hiregoudar SS, Ojha S, Punatar S, Gupta A, Gokarn A, Bhole P, Kannan S, Khattry N (2017). Is long term storage of cryopreserved stem cells for hematopoietic stem cell transplantation a worthwhile exercise in developing countries? Blood Research. 52(4): 307-310. PMID: 29333408
    32. Dhadve A, Deo A, Bishnu A, Mukherjee S, Ray P (2017). Molecular imaging in cancer: How the hallmarks aid in hunting. International Journal of Drug Research a Technology. 7(1): 1-19.
    33. Dimri S, Sukanya, De A (2017). Approching non-canonical STAT3 signalling to redefine cancer therapeutic strategy. Integrative Molecular Medicine. 4(1)- 1-10.
    34. D’Mello C, Sawant S, Alam H, Gangadaran P, Mogre S, Tiwari R, D'Souza Z, Narkar M, Thorat R, Patil K, Chaukar D, Kane S, Vaidya MM (2017). Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients. PLoS One. 12(2): e0172559. PMID: 28225793
    35. Dube B, Pandey A, Joshi G, Sawant K (2017). Hydrophobically modified polyethylenimine-based ternary complexes for targeting brain tumor: Stability, in vitro and in vivo studies. Artificial Cells Nanomedicine, and Biotechnology. 45(8):1685-1698. PMID: 28278583
    36. Engineer R, Ostwal V, Arya S, Gupta P, Chopra S, Patil P, Jatal S, Saklani A (2017). Additional chemotherapy and salvage surgery for poor response to chemoradiotherapy in rectal cancers. Asia Pacific Journal of Clinical Oncology. 13(4): 322-328. PMID: 28304150
    37. Fundytus A, Sullivan R, Vanderpuye V, Seruga B, Lopes G, Hammad N, Sengar M, Hopman WM, Brundage MD, Booth CM (2017). Delivery of global cancer care: An international study of medical oncology workload. Journal of Global Oncology. PMID: 29244632.
    38. Ghodke K, Bibi A, Rabade N, Patkar N, Subramanian PG, Aamre Kadam P, Badrinath Y, Ghogale S, Gujral S, Tembhare P. CD19 Negative precursor B acute lymphoblastic leukemia (B-ALL) - immunophenotypic challenges in diagnosis and monitoring: A study of three cases. Cytometry Part B Clinical Cytometry. 92B (4):315-318, 2017. PMID: 27018867
    39. Ghosh S, Salot S, Sengupta S, Navalkar A, Ghosh D, Jacob R, Das S, Kumar R, Jha NN, Sahay S, Mehra S, Mohite GM, Ghosh SK, Kombrabail M, Krishnamoorthy G, Chaudhari P, Maji SK (2017). p53 amyloid formation leading to its loss of function: Implications in cancer pathogenesis. Cell Death and Differentiation. 24: 1784- 1798. PMID: 28644435
    40. Godbole M, Tiwary K, Badwe R, Gupta S, Dutt A (2017). Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status - A short report. Cellular Oncology (Dordr). 40(4): 411-17. PMID: 28653288
    41. Godbole M, Chandrani P, Gardi N, Dhamne H, Patel K, Yadav N, Gupta S, Badwe R, Dutt A (2017). miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells. Cancer Biology and Therapy. 18(10): 801-805. PMID: 28876975
    42. Gollapalli K, Ghantasala S, Kumar S, Srivastava R, Rapole S, Moiyadi AV, Epari S, Srivastava S (2017). Subventricular zone involvement in glioblastoma - A proteomic evaluation and clinicoradiological correlation. Scientific Reports. 7(1): 1449. PMID: 28469129
    43. Gollapalli K, Ghantasala S, Atak A, Rapole S, Moiyadi A, Epari S, Srivastava S (2017). Tissue proteome analysis of different grades of human gliomas provides major cues for glioma pathogenesis. OMICS. 21(5): 275-284. PMID: 28481733
    44. Gomes M, Begum R, Sati P, Dikshit R, Gupta PC, Kumar R, Sheth J, Habib A, Jha P (2017). Nationwide mortality studies to quantify causes of death: Relevant lessons from India's million death study. Health Affirmations (Millwood). 36(11): 1887-1895. PMID: 29137507
    45. Gulia S, Sengar M, Badwe R, Gupta S (2017). National cancer control programme in India: Proposal for organization of chemotherapy and systemic therapy services. Journal of Global Oncology. 3(3): 271-274. PMID: 28717770
    46. Gulia S, Gupta S (2017). Reply to S. Rastogi et al. Journal of Global Oncology. 3(2): 184-185. Comment on Organization of chemotherapy and systemic therapy services in India: The devil lies in the details. [J Glob Oncol. 3(2): 182-183, 2017] PMID: 28722034
    47. Gupta S, Mukherjee S, Syed P, Pandala NG, Choudhary S, Singh VA, Singh N, Zhu H, Epari S, Noronha SB, Moiyadi A, Srivastava S (2017). Evaluation of autoantibody signatures in meningioma patients using human proteome arrays. Oncotarget. 8(35): 58443-58456. PMID: 28454087
    48. Gupta T, Dasgupta A, Epari S, Shirsat NV, Chinnaswamy G, Jalali R (2017). Extraneuraxial metastases in medulloblastoma: Is histology and molecular biology important? Journal of Neuro-oncology. 135(2): 419-421. PMID: 28755322
    49. Gusev GP, Govekar R, Gadewal N, Agalakova NI (2017). Understanding quasi-apoptosis of the most numerous enucleated components of blood needs detailed molecular autopsy. Ageing Research Reviews. 35: 46-62. PMID: 28109836
    50. Hudlikar RR, Venkadakrishnan V, Kaushal RK, Thorat RA, Kannan S, Ingle AD, Desai S, Maru GB, Mahimkar MB (2017). Polymeric black tea polyphenols (PBPs) inhibit benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung carcinogenesis potentially through down-regulation of p38 and Akt phosphorylation in A/J mice. Molecular Carcinogenesis. 56(2): 625-640. PMID: 27377358
    51. Jalali R, Gupta T, Goda JS, Goswami S, Shah N, Dutta D, Krishna U, Deodhar J, Menon P, Kannan S, Sarin R (2017). Efficacy of stereotactic conformal radiotherapy vs conventional radiotherapy on benign and low-grade brain tumors: A randomized clinical trial. JAMA Oncology.3(10):1368-1376. PMID: 28570730
    52. Joshi A, Noronha V, Patil VM, Chougule A, Bhattacharjee A, Kumar R, Goud S, More S, Ramaswamy A, Karpe A, Pande N, Chandrasekharan A, Goel A, Talreja V, Mahajan A, Janu A, Purandare N, Prabhash K (2017). Efficacy of second-line pemetrexed-carboplatin in EGFR-activating mutation-positive NSCLC: Does exon 19 deletion differ from exon 21 mutation? Chemotherapy Research Practice. PMID: 29201462
    53. Joshi H, Marulkar K, Gota V, Ramaa CS (2017). Hydroxy cinnamic acid derivatives aspartial PPARγ agonists: In silico Studies, synthesis and biological characterization against chronic myeloid leukemia cell line (K562). Anticancer Agents in Medicinal Chemistry. 17(4): 524-541. PMID: 27291250
    54. Kameswaran M, Gota V, Ambade R, Gupta S, Dash A (2017). Preparation and preclinical evaluation of 131 I-trastuzumab for breast cancer. J Labelled Computational Radiopharmaceuticals. 60(1): 12-19. PMID: 27813128
    55. Kavathiya K, Gurjar M, Patil A, Naik M, Noronha V, Joshi A, Gota V, Prabhash K (2017). A Comparative Pharmacokinetic study of 2 pemetrexed formulations in Indian adult chemonaive patients with adenocarcinoma stage III/IV non-small cell lung cancer. Clinical Pharmacology and Drug Delivery.6 (3): 234-239. PMID: 28371303
    56. Kelkar MG, Thakur B, Derle A, Chatterjee S, Ray P, De A (2017). Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer. Breast Cancer Research and Treatment.164(3): 603-615. PMID: 28528452
    57. Khan N, Lipsa A, Arunachal G, Ramadwar M, Sarin R (2017). Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort. Scientific Reports. 7(1): 2214. PMID: 28533537
    58. Lakshminarayanan N, Kumar A, Roy S, Pawar Y, Chaudhari P, Rajan MGR (2017). Improved method for preparing Ni (II) Complex of (S)-Tyrosine Schiff Base and its use in the automated synthesis of O-(2’-[18F] Fluoroethyl)-L-Tyrosine using solid-phase extraction purification. Applied Radiation and Isotopes. 127: 122-129. PMID: 28570917
    59. Lewis S, Murthy V, Mahantshetty U, Shrivastava SK. Incidental dose to pelvic nodes in bladder-only radiotherapy: Is it clinically relevant? Technology Cancer Research Treatment. 16(3): 382-387. PMID: 28168933
    60. Lewis S, Wadasadawala T, Rane P, Gupta S, Chakraborty S, Budrukkar A, Parmar V, Jalali R, Sarin R. Validation of Patient Satisfactory Survey( PSS) for outpatient care carried out in multi-disciplinary breast clinic. BAOJ Cancer Res Ther. 3:1, 035, 2017.
    61. Mahajan A, Rao VRK, Anantaram G, Polnaya AM, Desai S, Desai P, Vadapalli R, Panigrahi M. Clinical-radiological-pathological correlation of cavernous sinus hemangioma: Incremental value of diffusion-weighted imaging. World J Radiol. 9(8): 330-338, 2017. PMID: 28932362
    62. Mahajan A, Paul P, Sridhar E, Rangarajan V, Gupta T, Chinnaswamy G, Moiyadi A, Jalali R (2017). Extraneural metastases from desmoplastic medulloblastoma masquerading as lymphoma. Clinical Nuclear Medicine. 42(5): 354-357. PMID: 28263211
    63. Mahantshetty U, Kumar DP, Chadha P, Choudary R, Kembhavi S, Thakur M, Engineer R, Chopra S, Shrivastava S (2017). Transabdominal ultrasonography-defined optimal and definitive bladder-filling protocol with time trends during pelvic radiation for cervical cancer.Technology Cancer Research and Treatment. 16(6): 917-22. PMID: 28532243
    64. Mahantshetty U, Krishanty R, Hande V, Jamema S, Ghadi Y, Engineer R, Chopra S, Naidu L, Deshpande D, Shrivastava S (2017). Magnetic resonance image guided adaptive brachytherapy in locally advanced cervical cancer: An experience from a tertiary cancer centre in a low-middle income country setting. International Journal of Radiation Oncology Biology and Physics. 99(3): 608-617.
    65. Malik A, Sahu A, Singh SP, Deshmukh A, Chaturvedi P, Nair D, Nair S, CM Krishna. In vivo Raman spectroscopy-assisted early identification of potential second primary/recurrences in oral cancers: An exploratory study. Head Neck. 2216-2233, 2017. PMID: 28736959
    66. Mehrotra S, Deshpande G. All are equal, but some are more equal than others: Epigenetic regulation of germ line stem cell fate in drosophila melanogaster. Genes and Genetic System. 92(4):163- 172. PMID: 28674274
    67. Mhatre S, Wang Z, Nagrani R, Badwe R, Chiplunkar SV, Mittal B, Yadav S, Zhang H, Chung CC, Patil P, Chanock S, Dikshit R, Chatterjee N, Rajaraman P (2017). Common genetic variation and risk of gallbladder cancer in India: A case-control genome-wide association study. Lancet Oncology.18(4): 535-544. PMID: 28274756
    68. Mittra I, Samant U, Sharma S, Raghuram GV, Saha T, Tidke P, Pancholi N, Gupta D, Prasannan P, Gaikwad A, Gardi N, Chaubal R, Upadhyay P, Pal K, Rane B, Shaikh A, Salunkhe S, Dutt S, Mishra PK, Khare NK, Nair NK, Dutt A. (2017) Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation. Cell Death and Discovery. 3: 17015. PMID: 28580170
    69. Mittra I, Pal K, Pancholi N, Shaikh A, Rane B, Tidke P, Kirolikar S, Khare NK, Agrawal K, Nagare H, Nair NK (2017). Prevention of chemotherapy toxicity by agents that neutralize or degrade cell-free chromatin. Annals of Oncology. 28(9): 2119-2127. PMID: 28911066
    70. Moiyadi AV, Shetty P, Sridhar E. Periventricular glioblastomas and ependymal involvement interrogated using intraoperative fluorescence - A pathological correlative study. British Journal of Neurosurgery. 31(1): 107-112. PMID: 27648634
    71. Moiyadi AV, Shetty P (2017). Early experience with combining awake craniotomy and intraoperative navigable ultrasound for resection of eloquent region gliomas. Journal of Neurological Surgery Part A Central European Neurosurgery. 78(2): 105-112. PMID: 27367358
    72. Munnolli SS, Pujar SM (2017). Scientometric study of Indian cancer research based on Scopus database. COLLNET Journal Scientometrics and Information Management.
    73. Murthy V, Lewis S, Sawant M, Paul SN, Mahantshetty U, Shrivastava SK (2017). Incidental dose to pelvic nodal regions in prostate-only radiotherapy. Technology in Cancer Research and Treatment.16(2): 211-217. PMID: 27492806
    74. Murthy V, Gurram L, Kannan S, Gandhi M, Gupta T, Ghosh-Laskar S, Budrukkar A, Agarwal JP (2017). Elective nodal dose of 60gy or 50gy in head and neck cancers: A matched pair analysis of outcomes and toxicity. Advamces in Radiation Oncology. 2(3): 339-345. PMID: 29114601
    75. Murthy V, Calcuttawala A, Chadha K, D’ Cruz A, Krishnamurthy I, Nair S, Teni T, Pawar S, Talapatra K, Patil A, Chatterjee S, Swain M, Narayanan P, Ghadyalpatil N, Singhal M, Kurialose M, Prabhash K, Agarwal J, Parikh P (2017). Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations. South Asian Journal of Cancer. 6: 93-8. PMID: 28975111
    76. Nagrani R, Mhatre S, Rajaraman P, Chatterjee N, Akbari MR, Boffetta P, Brennan P, Badwe R, Gupta S, Dikshit R (2017). Association of Genome-Wide Association Study (GWAS) identified SNPs and risk of breast cancer in an Indian population. Scientific Reports. 7: 40963. PMID: 28098224
    77. Noronha V, Ostwal V, Ramaswamy A, Joshi A, Nair R, Banavali SD, Prabhash K (2017). Chicken pox infection in patients undergoing chemotherapy: A retrospective analysis from a tertiary care center in India. Journal of Infection and Public Health. 10(1): 8-13. PMID: 26970699
    78. Noronha V, Choughule A, Patil VM, Joshi A, Kumar R, Susan Joy, Philip D, Banavali S, Dutt A, Prabhash K (2017). Epidermal growth factor receptor exon 20 mutation in lung cancer: Types, incidence, clinical features and impact on treatment. Onco Targets and Therapy. 10: 2903-2908. PMID: 28652772
    79. Ostwal V, Harris C, Sirohi B, Goel M, Bal M, Kannan S, Shrikhande SV (2017). Role of adjuvant chemotherapy in T2N0M0 periampullary cancers. Asia Pacific Journal of Clinical Oncology. 13(5): e298-303. PMID: 28029222
    80. Patere SN, Pathak PO, Kumar Shukla A, Singh RK, Kumar Dubey V, Mehta MJ, Patil AG, Gota V, Nagarsenker MS (2017). Surface-modified liposomal formulation of amphotericin B: In vitro evaluation of potential against visceral leishmaniasis. AAPS PharmSciTech. 18(3) 710-720, PMID: 27222025
    81. Patil R, Sureshbabu SK, Chiplunkar SV (2017). Immunosuppressive role of gdT cells in cancer: The other side of the coin. Translational Cancer Research. 6 (Suppl. 1): S22-S25.
    82. Purandare NC, Puranik A, Shah S, Agrawal A, Gupta T, Moiyadi A, Shetty P, Shridhar E, Jalali R, Rangarajan V (2017). Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation? Nuclear Medicine Communications. 38(12): 1109-1116. PMID: 28922334
    83. Prabhu S, Goda JS, Mutalik S, Mohanty BS, Chaudhari P, Rai S, Udupa N, Rao BSS (2017). A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: Tumor-specific homing directed by nestin. Nanoscale. 9(30): 10919-10932. PMID: 28731079
    84. Qureshi SS, Kammer P, Kembhavi S (2017). Excision of retroperitoneal germ cell tumor in children: A distinct surgical challenge. Journal of Pediatric Surgery. 52(8): 1344-1347. PMID: 28111005
    85. Qureshi SS, Prabhu A, Bhagat M, Kembhavi S, Vora T, Chinnaswamy G, Ramadwar M, Laskar S, Talole S (2017). Re-excision after unplanned resection of non-metastatic non-rhabdomyosarcoma soft tissue sarcoma in children: Comparison with planned excision. Journal of Pediatric Surgery. 52(8): 1340-1343. PMID: 28132767
    86. Qureshi SS, Rekhi B, Kembhavi S (2017). Wandering pelvic mass: Rhabdomyosarcoma of the Meckel Diverticulum. The Journal of Pediatrics. 185: 249. PMID: 28284478
    87. Raghuram GV, Gupta D, Subramaniam S, Gaikwad A, Khare NK, Nobre M, Nair NK, Mittra I (2017). Physical shearing imparts biological activity to DNA and ability to transmit itself horizontally across species and kingdom boundaries. BMC Molecular Biology. 18(1): 21. PMID: 28793862
    88. Ramaswamy A, Ostwal V, Pinniti R, Kannan S, Bhargava P, Nashikkar C, Mirani J, Banavali S (2017). Gemcitabine-cisplatin versus gemcitabine-oxaliplatin doublet chemotherapy in advanced gallbladder cancers: a match pair analysis. Journal of Hepatobiliary Pancreatic Sciences. 24(5): 262-267. PMID: 28196310
    89. Rao S, Nandeesh BN, Arivazhagan A, Moiyadi AV, Yasha TC (2017). Psammomatoid juvenile ossifying fibroma: Report of three cases with a review of literature. Journal of Pediatric Neuroscience. 12(4): 363-366.
    90. Reddy D, Gupta S (2017). Histone variant H3.3 and its future prospects in cancer clinic. Journal of Radiation Cancer Research.8: 77-81.
    91. Reddy D, Khade B, Pandya R, Gupta S (2017). A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours. Clinical Epigenetics. 29: 30. PMID: 28360947
    92. Regan MM, Walley BA, Francis PA, Fleming GF, Láng I, Gómez HL, Colleoni M, Tondini C, Pinotti G, Salim M, Spazzapan S, Parmar V, Ruhstaller T, Abdi EA, Gelber RD, Coates AS, Goldhirsch A, Pagani O (2017). Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT. Annals of Oncology. 28(9): 2225-2232. PMID: 28911092
    93. Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS (2017). Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell. 171(2): 481-494, PMID: 28985567Roy R, Bhattacharjee A, Roy N, Dutta K, Shahid M, Misabh M, Gupta S, Husain M. (2017) A preliminary predictive model of post-transplant tumor recurrence in hepatisis B virus associated hepatocellular carcinoma-epidemiological and therapeutic implications. Gastroenterology and Hepatology International Journal. 2(4): 000133.
    94. Saha P, Regan MM, Pagani O, Francis PA, Walley BA, Ribi K, Bernhard J, Luo W, Gómez HL, Burstein HJ, Parmar V, Torres R, Stewart J, Bellet M, Perelló A, Dane F, Moreira A, Vorobiof D, Nottage M, Price KN, Coates AS, Goldhirsch A, Gelber RD, Colleoni M, Fleming GF (2017). Treatment efficacy, adherence, and quality of life among women younger than 35 years in the International Breast Cancer Study Group TEXT and SOFT adjuvant endocrine therapy trials. Journal of Clinical Oncology. 35(27): 3113-3122.PMID: 28654365
    95. Sahu A, Gera P, Pai V, Dubey A, Tyagi G, Waghmare M, Pagare S, Mahimkar MB, CM Krishna (2017). Raman exfoliative cytology for oral precancer diagnosis. Journal of Biomedical Optics. 22(11): 1-12. PMID: 29139244
    96. Shriyan B, Bansal B, Sanap P, Gota V (2017). Novel NUDT15 germline variant in acute lymphoblastic leukaemia – Increase susceptibility to mercaptopurine toxicity responsible for relapse and severe life-threatening sepsis: A case report. Pediatric Hematology Oncology Journal. 2(3): 65-67.
    97. Sali A, Epari S, Tampi C, Goel A (2017). Spindle cell oncocytoma of adenohypophysis: Review of literature and report of another recurrent case. Neuropathology. 37(6): 535-544. PMID: 28631277
    98. Sulkshane P, Teni T (2017). BH3 mimetic Obatoclax (GX15-070) mediates mitochondrial stress predominantly via MCL-1 inhibition and induces autophagy-dependent necroptosis in human oral cancer cells. Oncotarget. 8:60060-60079. PMID: 27507051
    99. Sawant S, Dongre H, Ahire C, Sharma S, Kannan S, Mahadik S, Chaukar D, Lukmani F, Patil A, D'Cruz A, Vaidya MM, Dongre P (2017). A nomogram for predicting the risk of neck node metastasis in pathologically node-negative oral cavity carcinoma. Oral Diseases. 23(8):1087-1098. PMID: 28580710
    100. Sable M, Pai TD, Shet T, Patil A, Dhanavade S, Desai SB (2017). Triple-negative breast cancer: A comprehensive study of clinical, histomorphological, and immunohistochemical features in Indian patients. International Journal of Surgical Pathology. 25(3): 230-237. PMID: 27612858
    101. Sahay A, Bal M, Patil A, Kane S, Pai P (2017). Follicular dendritic cell sarcoma of the larynx: Apropos a rare case with review of the literature. Turk Patoloji Dergisi. PMID: 28984342
    102. Shaik AB, Rao GK, Kumar GB, Patel N, Reddy VS, Khan I, Routhu SR, Kumar CG, Veena I, Shekar KC, Barkume M, Jadhav S, Juvekar A, Kode J, Pal-Bhadra M, Kamal A (2017). Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells. European Journal of Medicinal Chemistry. 139: 305-324. PMID: 28803046
    103. Shaikh R, Prabitha VG, Dora TK, Chopra S, Maheshwari A, Deodhar K, Rekhi B, Sukumar N, CM Krishna, Subhash N (2017). A comparative evaluation of diffuse reflectance and Raman spectroscopy in the detection of cervical cancer. Journal of Biophotonics. 10(2): 242-252. PMID: 26929106
    104. Sharda A, Gupta S (2017). Chromatin landscape: Re-shaping radiation biology and oncology. Journal of Radiation Cancer Res. 8: 121-22.
    105. Shenoy VS, Gude RP, Nikam Y, Murthy RSR (2017). In vitro cytotoxic potential of paclitaxel-encapsulated lipid-based drug delivery systems. Austin Journal of Lung Cancer Research. 2(1): 1011.
    106. Siddiqui MQ, Choudhary RK, Thapa P, Kulkarni N, Rajpurohit YS, Misra HS, Gadewal N, Kumar S, Hasan SK, Varma AK (2017). Structural and biophysical properties of h-FANCI ARM repeat protein. Journal of Biomolecular and Structural Dynamics. 35(14):3032-3042. PMID: 27686023
    107. Siddiqui MQ, Rajpurohit YS, Thapa PS, Maurya GK, Banerjee K, Khan MA, Panda P, Hasan SK, Gadewal N, Misra HS, Varma AK (2017). Studies of protein-protein interactions in Fanconi anemia pathway to unravel the DNA interstrand crosslink repair mechanism. International Journal of Biological Macromolecules. 104(Pt A): 1338-1344. PMID: 28684355
    108. Singh A, Gurav M, Dhanavade S, Shetty O, Epari S (2017). Diffuse glioma - rare homozygous IDH point mutation, is it an oncogenetic mechanism? Neuropathology. 37(6):582-585. PMID: 28782849
    109. Singh S, Chopra S, Engineer R, Paul S, Kannan S, Mohanty S, Swamidas J, Mahantshetty U, Ghosh J, Maheshwari A, Shylasree T, Kerkar R, Gupta S, Shrivastava S (2017). Dose-volume correlation of cumulative vaginal doses and late toxicity after adjuvant external radiation and brachytherapy for cervical cancer. Brachytherapy.16(4):855-861. PMID: 28495443
    110. Singh SK, Shirsat NV (2017). DDX3X, a frequent mutated gene in medulloblastoma, encoding a DEAD box family RNA helicase can be expressed successfully as a recombinant protein in bacteria as MBP-fusion protein. Journal of Bioscience Technology. 8(2): 813-820.
    111. Singh SP, Alam H, D’ mello C, Mamgain H, Vaidya MM, Dasari RR, Krishna CM (2017). Identification of morphological and biochemical changes in keratin-8/18 knock-down cells using Raman spectroscopy. Journal of Biophotonics. 10(10):1377-1384. PMID: 28067994
    112. Singh SV, Nigam A, Deogharkar A, Kazi S, Kshirsagar R, Goel A, Moiyadi A, Jalali R, Sridhar E, Shetty P, Gadewal N, Shirsat NV. Restoration of miR-30a expression inhibits growth, tumorigenicity of medulloblastoma cells accompanied by autophagy inhibition. Biochemical and Biophysical Research Communications. 491(4):946-952, 2017. PMID: 28757413
    113. Swain M, Upreti RR, Chopra S, Dandapani E, Engineer R, Shrivastava SK. Investigation of optimal strategy target generation for Liver Stereotactic Body Radiotherapy (SBRT). Austin Journal of Radiation Oncology and Cancer. 3(1): 1025, 2017.Tembhare P, Badrinath Y, Ghogale S, Subramanian PG (2017). Method for DNA Ploidy Analysis Along with Immunophenotyping for Rare Populations in a Sample using FxCycle Violet. Current Protocols in Cytometry. PMID: 28369766Thakur B, Ray P (2017). Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop. Journal of Experimental and Clinical Cancer Research. 36(1): 164. PMID: 29169370
    114. Thummuri D, Naidu VGM, Chaudhari P (2017). Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling. Journal of Molecular Medicine. 95(10): 1065-1076. PMID: 28674855
    115. Tiwari R, Sahu I, Soni BL, Sathe GJ, Datta KK, Thapa P, Sinha S, Vadivel CK, Dhaka B, Gowda H, Vaidya MM (2017). Quantitative phosphoproteomic analysis reveals system-wide signaling pathways regulated by site-specific phosphorylation on Keratin-8 in skin squamous cell carcinoma derived cell- line. Proteomics. PMID: 28176443
    116. Tyagi M, Reddy D, Gupta S (2017). Genomic characterization and dynamic methylation of promoter facilitates transcriptional regulation of H2A variants, H2A.1 and H2A.2 in various pathophysiological states of hepatocyte. International Journal of Biochemistry and Cell Biology. 85: 15-24, PMID: 28163185
    117. Upadhyay P, Gardi N, Desai S, Chandrani P, Joshi A, Dharvath B, Arora P, Bal M, Nair S, Dutt A (2017). Genomic characterization of tobacco/nut chewing HPV-negative early stage tongue tumors identify MMP10 as a candidate to predict metastases. Oral Oncology. 73: 56-64. PMID:28939077
    118. Upreti RR, Budrukkar A, Upreti U, Misra S, Wadasadawala T, Kohle S, Deshpande DD (2017). Change of target volume and its dosimetric impact during the course of accelerated partial breast irradiation using intraoperative multicatheter interstitial brachytherapy after open cavity surgery. Brachytherapy. 16(5): 1028-1034. PMID: 28600139
    119. Upreti RR, Budrukkar A, Wadasadawala T, Misra S, Gurram L, Pathak R, Deshpande DD (2017). Interobserver variations of target volume delineation and its impact on irradiated volume in accelerated partial breast irradiation with intraoperative interstitial breast implant. J Contemporary Brachytherapy. 9(2): 139-145. PMID: 28533802.
    120. Vats M, Mishra SK, Baghini MS, Chauhan DS, Srivastava R, De A (2017). Near infrared fluorescence imaging in nano-therapeutics and photo-thermal evaluation. International Journal of Molecular Sciences. 18(5): 924. PMID: 28452928
    121. Vira HJ, Bhat VG (2017). Epidemiology of NDM-1 and its variants in multidrug resistant gram-negative bacilli isolated from infection in cancer patients. Medicinal Chemistry (Los Angeles). 7: 368.
    122. Vishal SS, Tilwani S, Thorat R, Dalal SN (2017). Generation of mice with tissue specific transgene expression using sperm mediated gene transfer. International Journal of Pharma and Biosciences.8(2): 324-329.
    123. Wadasadawala T, Vadgaonkar R, Bajpai J (2017). Management of isolated loco-regional recurrences in breast cancer: A review of local and systemic modalities. Clinical Breast Cancer.17(7):493-502. PMID: 28278583
    124. Wadasadawala T, Jain S, Paul S, Phurailatpam R, Joshi K, Popat P, Tandon S, Alahari A, Sarin R (2017). First clinical report of helical tomotherapy with simultaneous integrated boost for synchronous bilateral breast cancer. British Journal of Radiology. 90(1077):20170152. PMID: 28707988
    125. Warawdekar UM, Parmar V, Prabhu A, Kulkarni A, Chaudhari M, Badwe RA (2017). A versatile method for enumeration and characterization of circulating tumour cells from patients with breast cancer. Journal of Cancer and Metastasis Treatment. 3: 23-33.
    • 2016
      1. Achrekar M, Murthy V, Kanan S, Shetty R, Nair M, Khattry N. Introduction of situation, background, assessment, recommendation into nursing practice: A prospective study. Asia Pac J Oncol Nurs. 3: 45-50, 2016. PMID: 27981137
      2. Agrawal S, Kelkar M, De A, Kulkarni AR, Gandhi MN. Surfactant free novel one-minute microwave synthesis, characterization and cell toxicity study of mesoporous strontium hydroxyapatite nanorods. RSC Adv. 6: 94921-94926, 2016.
      3. Arjun C, Mukherjee A, Bhatt J, Chaudhari P, Repaka KM, Venkatesh M, Samuel G. Studies on batch formulation of a kit for the preparation of the 99mTc-Ubiquicidin (29–41): An infection imaging agent. Appl Radiat Isot. 107: 8-12, 2016. PMID: 26405838
      4. Ballinger ML, Goode DL, Ray-Coquard I, James PA, Mitchell G, Niedermayr E, Puri A, Schiffman JD, Dite GS, Cipponi A, Maki RG, Brohl AS, Myklebost O, Stratford EW, Lorenz S, Ahn S-M, Ahn J-H, Kim JE, Shanley S, Beshay V, Randall RL, Judson I, Seddon B, Campbell IG, Young M-A, Sarin R, Blay J-Y, Seán, O'Donoghue I, Thomas DM. Monogenic and polygenic determinants of sarcoma risk: an international genetic study. Lancet Oncol. 17(9): 1261-1271, 2016. PMID: 27498913
      5. Barreto SG, Dutt A. To improve outcomes of gallbladder cancer we need to better understand it! Hepatobiliary Surg Nutr. 5(4): 379-381, 2016. PMID: 27500397
      6. Basak R, Nair NK, Mittra I. Cell-free nucleic acids as continuously arising endogenous DNA mutagens: A new proposal. Mut Res. 793-794: 15-21, 2016. PMID: 27768916
      7. Baumann BC, Bosch WR, Bahl A, Birtle AJ, Breau RH, Challapalli A, Chang AJ, Choudhury A, Daneshmand S, El-Gayed A, Feldman A, Finkelstein SE, Guzzo TJ, Hilman S, Jani A, Malkowicz SB, Mantz CA, Master V, Mitra A, Murthy V, Porten SP, Richaud PM, Sargos P, Efstathiou JA, Eapen LJ, Christodouleas JP. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys. 96(1): 78-86, 2016. PMID: 27511849
      8. Bhanushali PB, Badgujar SB, Tripathi MM, Gupta S, Murthy V, Krishnasastry MV, Puri CP. Development of glycan specific lectin based immunoassay for detection of Prostate Specific Antigen. Int J Biol Macromol. 86: 468-480, 2016. PMID: 26840176
      9. Bhargava A, Khare NK, Bunkar N, Lenka RK, Mishra PK. Role of mitochondrial oxidative stress on lymphocyte homeostasis in patients diagnosed with extra-pulmonary tuberculosis. Cell Biol Int. 40(2): 166-76, 2016.PMID: 26431927
      10. Bhattacharya S, Gupta S. A simple method to produce sub-nucleosome complexes of high purity in vitro. Adv. Biosci. Biotechnol. 7: 133-141, 2016.
      11. Bhattacharya S, Reddy D, Ingle A, Khade B, Gupta S. Histone H2A mono-ubiquitination and cellular transformation are inversely related in N-nitrosodiethylamine-induced hepatocellular carcinoma. Exp Biol Med. 241(16): 1739-44, 2016. PMID: 27190257
      12. Bhattacharya S, Reddy D, Reddy R, Sharda A, Bose K, Gupta S. Incorporation of a tag helps to overcome expression variability in a recombinant host. Biotechnol Rep. 11:62-69, 2016. PMID: 28352541
      13. Bhosale PG, Pandey M, Desai RS, Patil A, Kane S, Prabhash K, Mahimkar MB. Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol. 122(5): 609-618, 2016. PMID: 27765330
      14. Bunkar N, Bhargava A, Khare NK, Mishra PK. Mitochondrial anomalies: driver to age associated degenerative human ailments. Front Biosci (Landmark Ed.) 21: 769-793, 2016. PMID: 26709805
      15. Chakraborty S, Balogh L, Das T, Polyák A, Andócs G, Máthé D, Király R, Thuróczy J, Chaudhari PR, Jánoki GA, Jánoki G, Banerjee S, Pillai MR. Evaluation of 177Lu-EDTMP in dogs with spontaneous tumor involving bone: Pharmacokinetics, dosimetry and therapeutic efficacy. Curr Radiopharm. 9(1): 64-70, 2016. PMID: 25771374
      16. Chellayadhas JY, Achrekar MS, Bakshi G, Shetty R, Carvalho M. Development of booklet on male sexual dysfunction, its measures and assessing its impact on knowledge of patients with urological cancers. Asia Pac J Oncol Nurs. 3(4): 382-389, 2016. PMID: 28083556
      17. Choudhary RK, Vikrant, Siddiqui QM, Thapa PS, Raikundalia S, Gadewal N, Kumar NS, Hosur MV, Varma AK. Multimodal approach to explore the pathogenicity of BARD1, ARG 658 CYS, and ILE 738 VAL mutants. J Biomol Struct Dyn.34(7): 1533-44, 2016. PMID: 26307947
      18. Choudhary V, Gupta S. Comprehensive gene mutation profiling of breast tumors: Is it ready for prime time use? Curr Breast Cancer Rep. 8(2): 53-59, 2016.
      19. Chow L, Costa L, Teh B, Li D, Feng G, Guan X, Nair A, Zhu L, Sugimoto M, Dutt A, Toi M, Gupta S, Badwe R, Knapp S, Pillai MR, Kumar R. Cancer Genomics and Biology 2015 – Meeting Report. Genes Cancer 7(1-2): 1-6, 2016.
      20. Coyle C, Cafferty FH, Rowley S, MacKenzie M, Berkman L, Gupta S, Pramesh CS, Gilbert D, Kynaston H, Cameron D, Wilson RH, Ring A, Langley RE, On behalf of the, Add-Aspirin investigators. ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. Contemp Clin Trials. 51: 56-64, 2016. PMID: 27777129
      21. Dar AA, Pradhan TN, Kulkarni DP, Shah SU, Rao KV, Chaukar DA, D'Cruz AK, Chiplunkar SV Extracellular 2'5'Oligoadenylate synthetase 2 (OAS2) mediates TCR CD3-ζ chain downregulation via caspase-3 activation in oral cancer. Immunology 147(2): 251-264, 2016.PMID: 26595239
      22. Das P, Bansal A, Rao SN, Deodhar K, Mahantshetty U, Shrivastava SK, Sivaraman K, Mulherkar R. Somatic variations in cervical cancers in Indian patients. PLoS One. 11(11): e0165878, 2016. PMID: 27829003
      23. Desai S, Srambikkal N, Yadav HD, Shetake N, Balla MM, Kumar A, Ray P, Ghosh A, Pandey BN. Molecular understanding of growth inhibitory effect from irradiated to bystander tumor cells in mouse fibrosarcoma tumor model. PLoS One. 11(8): e0161662, 2016. PMID: 27561007
      24. Dhawan V, Magarkar A, Joshi G, Makhija D, Jain A, Shah J, Reddy BVV, Krishnapriya M, Róg T, Bunker A, Jagtapa A, Nagarsenker M. Stearylated cycloarginine nanosystems for intracellular delivery – simulations, formulation and proof of concept. RSC Adv. 6: 113538-113550, 2016.
      25. D''Mello C, Sawant S, Alam H, Gangadaran P, Tiwari R, Dongre H, Rana H,Barve S, Costea DE, Chaukar D, Kane S, Pant H, Vaidya MM. Vimentin mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cells. Int J Biochem Cell Biol. 70: 161-172, 2016. PMID: 26646105
      26. Dubey S, Janu A, Chaudhari S, Moiyadi AV. Navigable 3D-Ultrasound facilitates supra-radical resections beyond the contrast-enhancing boundaries in malignant gliomas. J Neurol Surg A Cent Eur Neurosurg. 77(4):372-375, 2016. PMID: 26807614
      27. Ganguly A, Bhattacharjee C, Bhave M, Kailaje V, Jain BK, Sengupta I, Rangarajan A, Bhattacharyya D. Perturbation of nucleo-cytoplasmic transport affects size of nucleus and nucleolus in human cells. FEBS Lett. 590(5): 631-643, 2016. PMID: 26813731
      28. Ghadyalpatil NS, Chopra S, Patil P, D'souza A, Saklani A. Gastrointestinal cancers in India: Treatment perspective. South Asian J Cancer. 5: 126-36, 2016. PMID: 27606298
      29. Ghosh-Laskar S, Yathiraj PH, Dutta D, Rangarajan V, Purandare N, Gupta T, Budrukkar A, Murthy V, Kannan S, Agarwal JP. Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results. Head Neck. Suppl. 1: E1481-87, 2016. PMID: 26561342
      30. Gohulkumar M, Kumar P, CM Krishna, Krishnakumar N. Evaluation of raman spectroscopy for prediction of antitumor response to silibinin and its nanoparticulates in DMBA-induced oral carcinogenesis. J Raman Spectroscopy. 47(4): 375-383, 2016.
      31. Gota P, Adegcke A, Gurjar M, Singh S, Nandave M, Hingorani L, Gota V. Comparision of the metabolic stability of solid lipid boswellia serrata particles versus plain boswellia serrata extract in human hepatocytes(HHL-17). Int J Pharmacut Chem Biol Sci. 6(1): 22-27, 2016.
      32. Gota V, Chinnaswamy G, Vora T, Rath S, Yadav A, Gurjar M, Veal G, Kurkure P. Pharmacokinetics and pharmacogenetics of 13-cis retinoic acid in Indian high-risk neuroblastoma patients. Cancer Chemother Pharmacol.78(4): 763-768, 2016. PMID: 27541143
      33. Gota V, Goda JS, Doshi K, Patil A, Sunderajan S, Kumar K, Varne M, Kunwar A, Jain VK, Priyadarshini I. Biodistribution and Pharmacokinetic Study of 3,3' Diseleno Dipropionic Acid (DSePA), A Synthetic Radioprotector, in Mice. Eur J Drug Metab Pharmacokinet. 41(6): 839-844, 2016. PMID: 26446594
      34. Gota V, Karanam A, Rath S, Yadav A, Tembhare P, Subramanian P, Sengar M, Nair R, Menon H. Population pharmacokinetics of Reditux™, a biosimilar Rituximab, in diffuse large B-cell lymphoma. Cancer Chemother Pharmacol. 78(2): 353-359, 2016. PMID: 27329361
      35. Gudi S, Ghosh-Laskar S, Agarwal JP, Chaudhari S, Rangarajan V, Paul SN, Upreti R, Murthy V, Budrukkar A, Gupta T. Interobserver variability in the delineation of gross tumour volume and specified organs-at-risk during intensity modulated radiation therapy for head and neck cancers and the impact of Fluoro-deoxy-glucose positron emission tomography/computed tomography on such variability at the primary site. J Med Imaging Radiat Sci. 2016.
      36. GuhaSarkar S, Pathak K, Sudhalkar N, More P, Goda JS, Gota V, Banerjee R. Synergistic locoregional chemoradiotherapy using a composite liposome-in-gel system as an injectable drug depot. Int J Nanomedicine. 11: 6435-6448, 2016. PMID: 27942215
      37. Gulia S, Khurana S, Shet T, Gupta S. Radiographically occult intrasinusoidal liver metastases leading to hepatic failure in a case of breast cancer. BMJ Case Rep. 2016. PMID: 26880826
      38. Gupta A, Punatar S, Gawande J, Bagal B, Mathew L, Bhat V, Kannan S, Khattry N. Hepatitis B-related serological events in hematopoietic stem cell transplant patients and efficacy of lamivudine prophylaxis against reactivation. Hematol Oncol. 34(3): 140-146, 2016. PMID: 25690950
      39. Gupta S. Breast cancer: Indian experience, data, and evidence. South Asian J Cancer. 5: 85-86, 2016. PMID: 2760628
      40. Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP. Systematic review and meta-analysis of conventionally fractionated concurrent chemoradiotherapy versus altered fractionation radiotherapy alone in the definitive management of locoregionally advanced head and neck squamous cell carcinoma. Clin Oncol. 28:50-61, 2016. PMID: 26454839
      41. Gupta T, Zade B, Upasani M, Master Z, Phurailatpam R, Kurkure P, Menon H, Goda JS, Jalali R. Helical tomotherapy-based craniospinal irradiation: mature outcomes of a prospective feasibility study. J Radiat Oncol. 5(2): 221-230, 2016.
      42. Gupta T. Resistance mechanisms in glioblastoma: finding opportunities in challenges. Trans Cancer Res. 5(suppl.4): S738-741, 2016.
      43. Gurram L, Wadasadawala T, Joshi K, Phurailatpam R, Paul S, Sarin R. Multi-catheter interstitial brachytherapy for partial breast irradiation: an audit of implant quality based on dosimetric evaluation comparing intra-operative versus post-operative placement. J Contemp Brachytherapy. 8(2): 116-121, 2016. PMID: 27257415
      44. Gurushankar K, Gohulkumar M, Kumar P, CM Krishna, Krishnakumar N. Raman spectroscopy detects biomolecular changes associated with nanoencapsulated hesperetin treatment in experimental oral carcinogenesis. Laser Phys Lett. 13: 035901, 2016.
      45. Inamdar SR, Eligar SM, Ballal S, Belur S, Kalraiya RD, Swamy BM. Exquisite specificity of mitogenic lectin from Cephalosporium curvulum to core fucosylated N-glycans. Glycoconj J. 33(1): 19-28, 2016. PMID: 26514868
      46. Iyer P, Barreto SG, Sahoo B, Chandrani P, Ramadwar MR, Shrikhande SV, Dutt A. Non-typhoidal Salmonella DNA traces in gallbladder cancer. Infect Agent Cancer. 11:12, 2016. PMID: 26941832
      47. Jadhav V, Ray P, Sachdeva G, Bhatt P.Biocompatible arsenic trioxide nanoparticles induce cell cycle arrest by p21WAF1/CIP1 expression via epigenetic remodeling in LNCaP and PC3 cell lines. Life Sci. 148: 41-52, 2016. PMID: 26883975
      48. Jagilinki BP, Choudhary RK, Thapa PS, Gadewal N, Hosur MV, Kumar S, Varma AK. Functional basis and biophysical approaches to characterize the C-terminal domain of human-ribosomal S6 Kinases-3. Cell Biochem Biophys. 74(3): 317-25, 2016. PMID: 27324042
      49. Jain AS, Makhija DT, Goel PN, Shah SM, Nikam Y, Gude RP, Jagtap AG, Nagarsenker MS. Docetaxel in cationic lipid nanocapsules for enhanced in vivo activity. Pharm Dev Technol. 21(1): 76-85, 2016. PMID: 25329444
      50. Jain D, Bajaj A, Athawale R, Shrikhande S, Goel PN, Nikam Y, Gude R, Patil S, Raut P. Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: Development, characterization and in vivo studies. Drug Deliv. 23(3): 999-1016, 2016. PMID: 25026415
      51. Jain DS, Bajaj AN, Athawale RB, Shrikhande SS, Pandey A, Goel P, Gude RP, Patil S, Raut P. Thermosensitive PLA based nanodispersion for targeting brain tumor via intranasal route. Mater Sci Eng C. 63(1): 411-421, 2016. PMID: 27040235
      52. Jalali R, Mittra I, Badwe R. Cancer research: In need of introspection. Lancet Oncol. 17(2): 140-141, 2016. PMID: 26868338
      53. Jalali R, Rishi A, Goda JS, Sridhar E, Gurav M, Sharma P, Moiyadi AV, Shetty P, Gupta T. Clinical outcome and molecular characterization of pediatric glioblastoma treated with postoperative radiotherapy with concurrent and adjuvant temozolomide: A single institutional study of 66 children. Neuro-Oncol Pract. 3(1): 39-47, 2016.
      54. Kakade PS, Budnar S, Kalraiya RD, Vaidya MM. Functional implications of O-GlcNAcylation dependent phosphorylation at proximal site on keratin 18. J Biol Chem. 291(23): 12003-13, 2016. PMID: 27059955
      55. Kannan A, Wells RB, Sivakumar S, Komatsu S, Singh KP, Samten B, Philley JV, Sauter ER, Ikebe M, Idell S, Gupta S, Dasgupta S. Mitochondrial Reprogramming Regulates Breast Cancer Progression. Clin Cancer Res. 22(13): 3348-60, 2016. PMID: 26888829."
      56. Kaur E, Sahu A, Hole AR, Rajendra J, Chaubal R, Gardi N, Dutt A, Moiyadi AV, CM Krishna, Dutt S. Unique spectral markers discern recurrent glioblastoma cells from heterogeneous parent population. Sci Rep. 6: 26538, 2016. PMID: 27221528
      57. Kaur E, Goda JS, Ghorai A, Salunkhe S, Shetty P, Moiyadi AV, Sridhar E, Mahajan A, Jalali R, Dutt S. Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome - A short report. Cell Oncol (Dordr). 2018. PMID: 30361826
      58. Kelkar MG, Senthilkumar K, Jadhav S, Gupta S, Ahn BC, De A.Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation. Sci Rep. 6: 19341, 2016. PMID: 26777440
      59. Khan SA, Amnekar R, Khade B, Barreto SG, Ramadwar M, Shrikhande SV, Gupta S. p38-MAPK/MSK1-mediated overexpression of histone H3 serine 10 phosphorylation defines distance-dependent prognostic value of negative resection margin in gastric cancer. Clin Epigenetics. 8:88, 2016. PMID: 27588146" Khariwala S, Garg A, Stepanov I, Gupta P, Ahluwalia J, Gota V, Chaturvedi P. Point-of-sale tobacco advertising remains prominent in Mumbai, India. Tob Regul Sci. 2(3): 230-238, 2016. PMID: 28217721
      60. Khattry N, Gupta A, Jain R, Gore A, Thippeswamy R, Jeevangi N, Kannan S, Nair R, Saikia T. LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: Retrospective multicenter analysis of toxicity and efficacy. Int J Hematol. 103(3): 292-298, 2016. PMID: 26729297
      61. Kulkarni P, Karanam A, Gurjar M, Dhoble S, Naik AB, Vidhun BH, Gota V. Effect of various anticoagulants on the bioanalysis of drugs in rat blood: Implication for pharmacokinetic studies of anticancer drugs. Springerplus. 5(1): 2102, 2016. PMID: 28053832
      62. Kumar A, Ghosh B, Poswal HK, Pandey KK, Jagannath, Hosur MV, Dwivedi A, Makde RD, Sharma SM. Protein crystallography beamline (PX-BL21) at Indus-2 synchrotron. J Synchrotron Radiat. 23 (Pt 2): 629-34, 2016. PMID: 26917153
      63. Kumar P, Bhattacharjee T, Ingle A, Maru G, CM Krishna. Raman spectroscopy of experimental oral carcinogenesis: Study on sequential cancer progression in hamster buccal pouch model. Technol Cancer Res Treat. 15(5): NP60-72, 2016. PMID: 26272064
      64. Kumar P, Bhattacharjee T, Pandey M, Hole A, Ingle A, CM Krishna. Raman spectroscopy in experimental oral carcinogenesis: Investigation of abnormal changes in control tissues. J Raman Spectrosc.47(11): 1318-1326, 2016
      65. Lakshminarayanan N, Kumar A, Roy S, Pawar Y, Chaudhari PR, Rajan M G R. Fully automated synthesis of O-(20-[18F]fluoroethyl)-L-tyrosine ([18F]FET) using solid phase extraction (SPE) purification with neutral alumina. J Radioanal Nucl Chem. 310(3): 991-999, 2016.
      66. Mahajan A, Engineer R, Chopra S, Mahanshetty U, Juvekar SL, Shrivastava SK, Desekar N, Thakur MH. Role of 3T multiparametric-MRI with BOLD hypoxia imaging for diagnosis and post therapy response evaluation of postoperative recurrent cervical cancers. Eur J Radiol Open. 3: 22-30, 2016. PMID: 27069975
      67. Malik A, Joshi P, Mishra A, Garg A, Mair M, Chakrabarti S, Nair S, Nair D, Chaturvedi P. Prospective study of the pattern of lymphatic metastasis in relation to the submandibular gland in patients with carcinoma of the oral cavity. Head Neck. 38(11): 1703-1707, 2016. PMID: 27232643
      68. Maru GB, Hudlikar RR, Kumar G, Gandhi K, Mahimkar MB. Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials.World J Biol Chem. 7(1): 88-99, 2016. PMID: 26981198
      69. Mir R, Pradhan SJ, Patil P, Mulherkar R, Galande S. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression. Oncogene. 35(13): 1679-91, 2016. PMID: 26165840
      70. Mirji G, Bhat J, Kode J, Banavali S, Sengar M, Khadke P, Sait O, Chiplunkar SV. Risk stratification of T-cell acute lymphoblastic leukemia patients based on gene expression, mutations and copy number variation. Leuk Res. 45: 33-39, 2016. PMID: 27070758
      71. Moiyadi AV, Shetty P. Direct navigated 3D ultrasound for resection of brain tumors: a useful tool for intraoperative image guidance. Neurosurg Focus. 40(3): E5, 2016. PMID: 26926063
      72. Moiyadi AV. Intraoperative ultrasound technology in neuro-oncology practice – Current role and future applications. World Neurosurg. 93:81-93, 2016. PMID: 27268318
      73. More SK, Chiplunkar SV, Kalraiya RD. Galectin-3-induced cell spreading and motility relies on distinct signaling mechanisms compared to fibronectin. Mol Cell Biochem. 416(1-2): 179-91, 2016. PMID: 27130204
      74. Mukhopadhyay A, Sehgal L, Bose A, Gulvady A, Senapati P, Thorat R, Basu S, Bhatt K, Hosing A, Balyan A, Borde L, Kundu T, Dalal SN. 14-3-3γ prevents centrosome amplification and neoplastic progression. Sci. Reports. 6: 26580, 2016. PMID: 27253419
      75. Murthy V, Masodkar R, Kalyani N, Mahantshetty U, Bakshi G, Prakash G, Joshi A, Prabhash K, Shrivastava SK. Clinical outcomes with dose-escalated adaptive radiotherapy for urinary bladder cancer: A prospective study. Int J Radiat Oncol Biol Phys. 94(1): 60-66, 2016. PMID: 26547385
      76. Murthy V, Rishi A, Gupta S, Kannan S, Mahanshetty U, Tongaonkar H, Bakshi G, Prabhash K, Bhanushali P, Shrivastava SK. Clinical impact of prostate specific antigen (PSA) inter-assay variability on management of prostate cancer. Clin Biochem. 49(1): 79-84, 2016. PMID: 26506115
      77. Murugan K, Ostwal V, Carvalho MD, D'Souza A, Achrekar MS, Govindarajan S, Gupta S. Self-identification and management of hand-foot syndrome (HFS): Effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer. Support Care Cancer. 24(6): 2575-81, 2016. PMID: 26715292
      78. Nagrani R, Mhatre S, Rajaraman P, Soerjomataram I, Boffeta P, Gupta S, Parmar V, Badwe R, Dikshit R. Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity. Eur J Cancer. 66: 153-161, 2016.PMID: 27573429
      79. Nawale KK, Vyas M, Kane S, Patil A. Metastatic tumors in the jaw bones: A retrospective clinicopathological study of 12 cases at tertiary cancer center. J Oral Maxillofac Pathol. 20: 252-5, 2016. PMID: 27601818
      80. Pai T, Shet T, Desai S, Patil A, Nair N, Parmar V, Gupta S, Budrukkar A, Sarin R, Badwe R. Impact of squamous differentiation in breast carcinoma. Int J Surg Pathol. 24(6): 483-489, 2016. PMID: 27076454
      81. Pantziarka P, Hutchinson L, André N, Benzekry S, Bertolini F, Bhattacharjee A, Chiplunkar SV, Duda D, Gota V, Gupta S, Joshi A , Kannan S, Kerbel R, Kieran M, Palazzo A, Parikh A, Pasquier E, Patil V, Prabhash K, Shaked Y, Sholler G, Sterba J, Waxman D, Banavali S. Next generation metronomic chemotherapy - report from the fifth biennial international metronomic and anti-angiogenic therapy meeting, 6- 8 May 2016, Mumbai. eCancermedicalscience. 2016. PMID: 27994645
      82. Parashurama N, Ahn BC, Ziv K, Ito K, Paulmurugan R, Willmann JK, Chung J, Ikeno F, Swanson JC, Merk DR, Lyons JK, Yerushalmi D, Teramoto T, Kosuge H, Dao CN, Ray P, Patel M, Chang YF, Mahmoudi M, Cohen JE, Goldstone AB, Habte F, Bhaumik S, Yaghoubi S, Robbins RC, Dash R, Yang PC, Brinton TJ, Yock PG, McConnell MV, Gambhir SS. Multimodality molecular imaging of cardiac cell transplantation: Part II. In vivo imaging of bone marrow stromal cells in swine with PET/CT and MR imaging. Radiology. 280(3): 826-36, 2016. PMID: 27332865
      83. Parashurama N, Ahn BC1, Ziv K, Ito K, Paulmurugan R, Willmann JK, Chung J, Ikeno F, Swanson JC, Merk DR, Lyons JK, Yerushalmi D, Teramoto T, Kosuge H, Dao CN, Ray P, Patel M, Chang YF, Mahmoudi M1, Cohen JE, Goldstone AB, Habte F, Bhaumik S, Yaghoubi S, Robbins RC, Dash R, Yang PC, Brinton TJ, Yock PG, McConnell MV, Gambhir SS. Multimodality molecular imaging of cardiac cell transplantation: Part I. reporter gene design, characterization, and optical in vivo imaging of bone marrow stromal cells after myocardial infarction. Radiology. 280(3): 815-825, 2016. PMID: 27332865
      84. Pasquier E, André N, Street J, Chougule A, Rekhi B, Ghosh J, Philip DS, Meurer M, MacKenzie KL, Kavallaris M, Banavali SD. Effective management of advanced angiosarcoma by the synergistic combination of propranolol and vinblastine-based metronomic chemotherapy: A bench to bedside Study. EBioMedicine. 6: 87-95, 2016. PMID: 27211551
      85. Pathak P, Dhawan V, Magarkar A, Danned R, Govindarajane S, Ghosh S, Steinigerg F, Chaudhari P, Gopale V, Bunker A, Rógd T, Fahrh A, Nagarsenker M. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation. Int J Pharmaceutics. 509(1-2): 149-58, 2016. PMID: 27231122
      86. Patil RA, Wadasadawala TA. Radiotherapy-induced depigmentation in breast cancer patients without prior history of vitiligo: A review. Oncobiol Targets 3: 9, 2016.
      87. Patil RS, Shah SU, Shrikhande SV, Goel M, Dikshit R, Chiplunkar SV. IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients. Int J Cancer. 139(4): 869-881, 2016. PMID: 27062572
      88. Patkar N, Ghodke K, Joshi S, Chaudhary S, Mascerhenas R, Dusseja S, Mahadik S, Gaware S, Tembhare P, Gujral S, Kabre S, Kadam-Amare P, Jain H, Dangi U, Bagal B, Khattry N, Sengar M, Arora B, Narula G, Banavali S, Menon H, Subramanian PG. Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: Not just missense mutations but insertions and deletions are also associated with TKI resistance. Leuk Lymphoma. 57(11): 2653-60, 2016. PMID: 26999421
      89. Patkar N, Joshi S, Chaudhary S, Mascerhenas R, Doshi H, Tembhare P, Gujral S, Subramanian PG. Development of a cost-effective 'duplexed' real-time PCR assay for minimal residual disease monitoring of chronic myeloid leukemia using locked nucleic acid probes. Int J Lab Hematol. 38(6): e102-e106, 2016. PMID: 27461906
      90. Phalke S, Chiplunkar SV. Cytokine Dynamics of γδ T Cells: A Double Edged Sword in Osteoclastogenesis. J Cytokine Biol. 1:3, 2016.
      91. Phurailatpam R, Upreti R, Nojin Paul S, Jamema SV, Deshpande DD. Characterization of commercial MOSFET detectors and their feasibility for in-vivo HDR brachytherapy. Phys Med. 32(1): 208-212, 2016. PMID: 26470807
      92. Pradhan L, Thakur B, Srivastava R, Ray P, Bahadur D. Assessing therapeutic potential of magnetic mesoporous nanoassemblies for chemo-resistant tumors. Theranostics 6(10): 1557-1572, 2016. PMID: 27446490
      93. Qureshi SS, Bhagat M, Laskar S, Kembhavi S, Vora T, Ramadwar M, Chinnaswamy G, Prasad M, Khanna N, Shah S, Talole S. Local therapy in non-metastatic primary Ewing sarcoma of the mandible and maxilla in children. Int J Oral Maxillofac Surg. 45(8): 938-944, 2016. PMID: 27026058
      94. Qureshi SS, Kammar P, Vora T, Kembhavi S,Ramadwar M. Intracranial extramedullary hematopoiesis masquerading as progressive metastasis in a child with stage 4 neuroblastoma: Utility of sulfur colloid scan. Pediatr Hematol Oncol J. 1(3): 69-71, 2016.
      95. Qureshi SS, Bhagat M, Singhal N, Tathe N, Kembhavi S, Laskar S, Ramadwar M, Yadav P. Clinical characteristics and treatment outcomes of primary and recurrent malignancy involving the salivary glands in children. Head Neck. 38(6): 852-856, 2016. PMID: 25917761.
      96. Qureshi SS, Rent EG, Bhagat M, D'Souza P, Kembhavi S, Vora T, Prasad M, Chinnaswamy G, Ramadwar M, Laskar S, Khanna N, Shah S, Talole S. Chyle leak following surgery for abdominal neuroblastoma. J Pediatr Surg. 51(9): 1557-60, 2016. PMID: 26656616."
      97. Ramteke MP, Patel KJ, Godbole M, Vyas M, Karve K, Choughule A, Prabhash K, Dutt A. CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons. F1000 Res. 4: 160, 2016. PMID: 27127615
      98. Raskar T, Khavnekar S, Hosur M.Time-dependent X-ray diffraction studies on urea/hen egg white lysozyme complexes reveal structural changes that indicate onset of denaturation. Sci Rep. 6:32277,2016. PMID: 27573790
      99. Raychaudhuri K, Chaudhary N, Gurjar M, D'Souza R, Limzerwala J, Maddika S, Dalal SN. 14-3-3σ loss leads to activation of the epithelial to mesenchymal transition due to the stabilization of c-Jun protein. J Biol Chem. 291(31): 16068-81, 2016. PMID: 27261462
      100. Reichardt P, Demetri GD, Gelderblom H, Rutkowski P, Im SA, Gupta S, Kang YK, Schöffski P, Schuette J, Soulières D, Blay JY, Goldstein D, Fly K, Huang X, Corsaro M, Lechuga MJ, Martini JF, Heinrich MC. Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial. BMC Cancer. 16(1): 22, 2016. PMID: 26772734
      101. Rekhi B, Upadhyay P, Ramteke MP, Dutt A. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes. Mod Pathol. 29(12): 1532-1540, 2016. PMID: 27562493
      102. Renier C, Do J, Reyna-Neyra A, Foster D, De A, Vogel H, Jeffrey SS, Tse V, Carrasco N, Wapnir I. Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy. Oncotarget. 7(34): 54811-54824, 2016. PMID: 27363025
      103. Sahu A, Deshmukh A, Hole AR, Chaturvedi P, CM Krishna. In vivo sub-site classification and diagnosis of oral cancers using Raman spectroscopy. J Innov Opt Health Sci. 9(5): 1650017, 2016.
      104. Sarate RM, Chovatiya GL, Ravi V, Khade B, Gupta S, Waghmare SK. Spla2 -IIA overexpression in mice epidermis depletes hair follicle stem cells and induce differentiation mediated through enhanced JNK/C-Jun activation. Stem Cells. 34(9): 2407-17, 2016. PMID: 27299855
      105. Sawant S, Dongre H, Singh AK, Joshi S, Costea DE, Mahadik S, Ahire C, Makani V, Dange P, Sharma S, Chaukar D, Vaidya MM. Establishment of 3D co-culture models from different stages of human tongue tumorigenesis: Utility in understanding neoplastic progression. PLoS One. 11(8): e0160615, 2016. PMID: 27501241
      106. Sawant S, Gokulan R, Dongre H, Vaidya MM, Chaukar D, Prabhash K, Ingle A, Joshi S, Dange P, Joshi S, Singh AK, Makani V, Sharma S, Jeyaram A, Kane S, D'Cruz A. Prognostic role of Oct4, CD44 and c-Myc in radio-chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice. Clin Oral Investig. 20(1): 43-56, 2016. PMID: 25914047
      107. Sengar M, Chorghe S, Jadhav K, Singh S, Laskar SG, Pai P, Aggarwal JP, D'Cruz A, Chaturvedi P, Deshpande M, Chaukar D, Budrukkar A, Gupta T, Murthy V, Kane S, Thakur M, Rangarajan V, Kannan S, Shet T, Kode J. Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urine. Head Neck. 38: Suppl 1:E1666-73, 2016. PMID: 26667883
      108. Shetty N, Joshi A, Noronha V, Dhumal S, Epari S, Prabhash K, Partil V. Extra-lymphatic filariasis at reconstructive surgery flap site recurrence of head and neck cancer. IDCases 3:8-9, 2016. PMID: 26793481
      109. Shindikar A, Singh A, Nobre M, Kirolikar S. Curcumin and resveratrol as promising natural remedies with nanomedicine approach for the effective treatment of triple negative breast cancer. J Oncology. 2016. PMID: 27242900
      110. Singh M, Singh SK, Thakur B, Ray P, Singh SK. Design and Synthesis of Novel Schiff base-benzothiazole hybrids as potential Epidermal Growth Factor Receptor (EGFR) inhibitors. Anticancer Agents Med Chem. 16(6): 722-39, 2016. PMID: 26443027
      111. Singh N, Hassan A, Bose K. Molecular basis of death effector domain chain assembly and its role in caspase-8 activation. FASEB J. 30(1): 186-200, 2016. PMID: 26370846
      112. Singh N, Senapati S, Bose K. Insights into the mechanism of human papillomavirus E2-induced procaspase-8 activation and cell death. Sci Rep. 6: 21408, 2016. PMID: 26906543
      113. Singh RK, Dhadve A, Sakpal A, De A, Ray P. An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population. Sci Rep. 6: 36612 2016. PMID: 27819360
      114. Som D, Tak M, Setia M, Patil A, Sengupta A, CM Krishna, Srivastava A, Parmar V, Nair N, Sarin R, Badwe R.A grid matrix-based Raman spectroscopic method to characterize different cell milieu in biopsied axillary sentinel lymph nodes of breast cancer patients.Lasers Med Sci. 31(1): 95-111,2016. PMID: 26552923
      115. Subramaniam S, Vohra I, Iyer A, Nair N , Mittra I. A paradoxical relationship between Resveratrol and copper (II) with respect to degradation of DNA and RNA. F1000 Research. 4: 1145, 2016. PMID: 27134724
      116. Tembhare P, Badrinath Y, Ghogale S, Patkar N, Dhole N, Dalavi P, Kunder N, Kumar A, Gujral S, Subramanian PG. A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping. Cytometry A.89(3): 281-91, 2016. PMID: 26671309
      117. Thakur B, Ray P. p53 loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance. Mol Oncol.10(8): 1283-95, 2016. PMID: 27401370
      118. Tiwari M, Murugan R, Tulsawani R, Gota V, Sarin R, Devi P, Tripathi R, Parimelazhagan T, Dwarakanath B, Agrawala P. Factors affecting radioprotective efficacy of ocimum sanctum (Tulsi) extract in mice. J Adv Med Pharmaceut Sci. 9(3): 1-12, 2016.
      119. Upadhyay P, Gardi N, Desai S, Sahoo B, Singh A, Togar T, Iyer P, Prasad R, Chandrani P, Gupta S, Dutt A. TMC-SNPdb: An Indian germline variant database derived from whole exome sequences. Database (Oxford). 2016. PMID: 27402678
      120. Upadhyay P, Nair S, Kaur E, Aich J, Dani P, Sethunath V, Gardi N, Chandrani P, Godbole M, Sonawane K, Prasad R, Kannan S, Agarwal B, Kane S, Gupta S, Dutt S, Dutt A. Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer. Oncotarget. 7(31):50437-50449, 2016. PMID: 27391340
      121. Vartak SV, Hegde M, Iyer D, Gaikwad S, Gopalakrishnan V, Srivastava M, Karki SS, Choudhary B, Ray P, Santhoshkumar TR, Raghavan SC. A novel inhibitor of BCL2, disarib abrogates tumor growth while sparing platelets, by activating intrinsic pathway of apoptosis. Biochem Pharmacol. 122: 10-22, 2016. PMID: 27693384
      122. Vira H, Bhat V, Chavan P. Diagnostic molecular microbiology and its applications: Current and future perspectives. Clin Microbiol Infect Dis. 2016.
      123. Wadasadawala T, Bajpai J. Internal mammary nodal irradiation: The jury is still out. Clin in Oncol. 1:1119, 2016.
      124. Wadasadawala T, Swain M, Bajpai J. Phyllodes tumor of the breast: Wolf inside the sheep’s skin! Oncobiol Targets. 3: 10, 2016.
      125. Yadav K, Nair D, Agarwal J, Chakrabarti S, Joshi S, Ingole P, Mishra A, Tathe N, Chaturvedi P. Prevalence of functional problems after oral cavity malignancy treatment at a tertiary center: Utilizing PSS HN (Performance Status Scale for Head and Neck) scale. J Maxillofac Oral Surg. 15(1): 38-44, 2016. PMID: 26929551
    • 2023
      1. Acharekar A, Bachal K, Shirke P, Thorat R, Banerjee A, Gardi N, Majumder A, Dutt S (2023). Substrate stiffness regulates the recurrent glioblastoma cell morphology and aggressiveness. Matrix Biology. 115: 107-127. PMID: 36563706

      2. Ambulkar R, Parab S, Vignesh B, Nagargoje V, Janu A, Parikh P, Moiyadi A. (2023) A prospective study to evaluate the use of surveillance venous ultrasonography to detect incidence of deep venous thrombosis following neurosurgical excision of brain tumors. Journal of Neurosciences in Rural Practice.14(2):252-257. PMID: 37181162

      3. Anjikar A, Jadhav P, Hole A, Panneerselvam R, Ingle A, Yamamoto T, Noothalapati H, CM Krishna (2023). Removal of hemolysis interference in serum Raman spectroscopy by multivariate curve resolution analysis for accurate classification of oral cancers. Sensors and Diagnostics. 2:390-97.

      4. Anwaar A, Varma AK, Baruah R (2023). In silico-based structural evaluation to categorize the pathogenicity of mutations identified in the RAD class of proteins. ACS Omega. 8(11):10266-10277.PMID: 36969410

      5. Arun B, Joshi M, Kakkar AK, Madki S, Ivaturi V, Chinnaswamy G, Banavali S, Gota V (2023). Bioequivalence study followed by model-informed dose optimization of a powder for oral suspension of 6-mercaptopurine. Pediatric Blood & Cancer.PMID: 38110844

      6. Asija S, Chatterjee A, Goda JS, Yadav S, Chekuri G, Purwar R. (2023). Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option. Frontiers in Immunology. PMID: 37006286

      7. Bagal S, Budukh A, Singh Thakur J, Dora T, Qayyumi B, Khanna D, Fernandes D, Chakravarti P, Singh R, Patil S, Dikshit R, Chaturvedi P. Head and neck cancer burden in India: an analysis from published data of 37 population-based cancer registries. Ecancer.17:1603. PMID: 37799939

      8. Bagal B, Sarma R, Dey S, Nayak L, Bonda A, Goda J, Khanna N, Dasgupta A, Kakoti S, Chatarjee A, Jain H, Epari S, Laskar S, Sengar M, Gupta T (2023). Lenalidomide following whole-brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy. British Journal of Haematology. 201(1):150-153. PMID: 36682363.

      9. Biswas D, Halder A, Barpanda A, Ghosh S, Chauhan A, Bhat L, Epari S, Shetty P, Moiyadi A, Ball GR, Srivastava S (2023). Integrated Meta-Omics Analysis Unveils the Pathways Modulating Tumorigenesis and Proliferation in High-Grade Meningioma. Cells. 12(20):2483.PMID: 37887327

      10. Ballinger ML, Pattnaik S, Mundra PA.... Puri A, Sarin R (2023). et al. Heritable defects in telomere and mitotic function selectively predispose to sarcomas. Science. 379(6629):253-260. PMID: 36656928.

      11. Banerjee A, Halder A, Jadhav P, Sarkar A, Hole A, Shastri J, Agrawal S, CM Krishna, Srivastava S (2023). SARS-CoV-2 severity classification from plasma sample using Confocal Raman spectroscopy. Journal of Raman Spectroscopy. 54(1): 124-132

      12. Barrios C, de Lima Lopes G, Yusof MM, Rubagumya F, Rutkowski P, Sengar M (2023). Barriers in access to oncology drugs - a global crisis. Nature Reviews Clinical Oncology. 20(1):7-15. PMID: 36380066

      13. Baviskar Y, Likonda B, Pant S, Mokal S, Pawar A, Dasgupta A, Chatterjee A, Gupta T. Short-course palliative hypofractionated radiotherapy in patients with poor-prognosis high-grade glioma: Survival and quality of life outcomes from a prospective phase II study. Clinical Oncology.35 (10):e573-e581. PMID: 37455146

      14. Bhatla N, Muwonge R, Malvi SG, Joshi S, Poli URR, Lucas E, Esmy PO, Verma Y, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Vashist S, Mishra G, Jadhav R, Siddiqi M, Anantharaman D, Panicker G, Butt J, Sankaran S, Kannan TPRA, Varghese R, Kartha P, Pillai MR, Waterboer T, Müller M, Sehr P, Unger ER, Sankaranarayanan R, Basu P. Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine. Human Vaccines Immunotherapeutics. 19(3):2289242. PMID: 38078840.

      15. Bindal A, Mittal P, Shinghal A, Scaria L, Prajapati K, Swamidas J, Gurram L, Berger D, Sturdza A, Chopra S (2023). Sigmoid dose accumulation and reporting for multifractionated brachytherapy for cervical cancer: Methodological development of sigmoid points through virtual endoscopic method. Brachytherapy. 22(3):325-333. PMID: 36882345

      16. Biswas S, Anadon CM, Conejo-Garcia JR (2023). Antibodies target intracellular oncodrivers through PIGR-mediated transcytosis. Genes & Immunity.PMID: 38092884.

      17. Biswas S, Mandal G, Anadon C, Chaurio R, Lopez-Bailon L, Nagy M, Mine J, Hänggi K, Sprenger K, Innamarato P, Harro C, Powers J, Johnson J, Fang B, Eysha M, Nan X, Li R, Perez B, Curiel T, Yu X, Rodriguez P, Conejo-Garcia J (2023). Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers. Immunity.56(11):2570-2583.e6 PMID: 37909039

      18. Boppana M, Sengar M, Jain H, Gurjar M, Ambotkar M, Gota V, Bonda A, Bagal B, Thorat J, Gokarn A, Nayak L, Shetty N, Baheti A, Mokal S, Kannan S, Shetty A, Eipe T (2023). A prospective study to evaluate the effect of therapeutic drug monitoring-based posaconazole prophylaxis on invasive fungal infection rate during acute myeloid leukemia induction therapy. Indian Journal of Hematology and Blood Transfusion

      19. Budrukkar A, Murthy V, Kashid S, Swain M, Rangarajan V, Ghosh-Laskar S, Kannan S, Kale S, Upreti R, Pai P, Pantvaidya G, Gupta T, Agarwal JP (2023). Intensity Modulated Radiation Therapy Alone Vs Intensity modulated radiation therapy and brachytherapy for T1-T2N0M0 oropharyngeal cancers: Results from A randomized controlled trial. International Journal of Radiation Oncology, Biology, Physics. S0360-3016(23)07854-9. PMID: 37660737

      20. Budukh A, Kadam P, Singh D, Thakur JS (2023). Innovative field methods for residence confirmation and updating follow-up status of cancer cases: Experience from rural cancer registry, Punjab, India. Clinical Epidemiology and Global Helath. 22: 101329.

      21. Butti R, Kapse P, Bhadauriya G, Ahmad S, Chaubal R, Parab P, Kadam R, Mahapatra SS, Shet T, Dutt A, Gupta S, Kundu GC(2023). Development and characterization of a patient derived orthotopic xenograft of therapy resistant breast cancer. Oncology Reports. 49(5): 99. PMID: 36999625

      22. Chakraborty N, Jain BK, Shembekar S, Bhattacharyya D (2023). ER exit sites (ERES) and ER-mitochondria encounter structures (ERMES) often localize proximally. FEBS Letters. 597(2):320-336. PMID: 36103135

      23. Chakraborty S, Baruah R, Mishra N, Varma AK (2023). In-silico and structure-based assessment to evaluate pathogenicity of missense mutations associated with non-small cell lung cancer identified in the Eph-ephrin class of proteins. Genomics and Informatics.21(3):e30.PMID: 37813626

      24. Chakraborty S, Shenoy PS, Mehrotra M, Phadte P, Singh P, Rekhi B, Ray P. Through the looking Glass: Updated insights on ovarian cancer diagnostics. Diagnostics. 13(4): 713. PMID: 36832201

      25. Chakravorty G, Ahmad S, Godbole MS, Gupta S, Badwe RA, Dutt A (2023). Deciphering the mechanisms of action of progesterone in breast cancer. Oncotarget. 14: 660-667.PMID: 37395734

      26. Chatterjee G, Patkar N (2023). United we stand, divided we fall. Multicentre standardization of measurable residual disease assessment in acute leukaemia is the way forward. British Journal of Haematology. 200(3):277-279 PMID: 36282207

      27. Chaubal K, Shetty D, Mohanty P, Walunj K, Tembhare P, Patkar N, Narula G (2023). B-cell acute lymphoblastic leukemia with t(5;9)(q22;q34.1) involving the SNX2 and ABL1. Atlas of Genetics and Cytogenetics in Oncology and Haematology.

      28. Chavan A, Shriyan B, Chavan P, Shirsat A, Gavhane U, Pillai B, Bhat V, Dhamne C, Gota V (2023). Covid antibody titers in cancer patients following vaccination with ChAdOx1 nCOV-19 vaccine. South Asian Journal of Cancer.

      29. Chavan P, Dey R, Castelino R, Kamble A, Poladia P, Bagal R, Jadhav M, Shirsat A, Chavan A, Dhumal S, Kumar S, Krishnamurty MN, Bhat V, Bhattacharjee A, Gota V (2023). Safety, immunogenecity and effectiveness of ChAdOx1 nCoV-19 vaccine during the second wave of pandemic in India: a real-world study. Drug Metabolism and Personalized Therapy. 38(3):227-236. PMID: 37098129.

      30. Chen Y, Li H, Janowczyk A, Toro P, Corredor G, Whitney J, Lu C, Koyuncu CF, Mokhtari M, Buzzy C, Ganesan S, Feldman MD, Fu P, Corbin H, Harbhajanka A, Gilmore H, Goldstein LJ, Davidson NE, Desai S, Parmar V, Madabhushi A (2023). Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer. NPJ Breast Cancer. 9(1):40. PMID: 37198173

      31. Chikhale V, Goswami N, Khan MA, Borah P, Varma AK (2023). Evaluation of pathogenicity and structural alterations for the mutations identified in the conserved region of the C‑terminal kinase domain of Human-Ribosomal S6 Kinase 1. ACS Omega. 8(18):16273-16283. PMID: 37179615

      32. Chilukuri S, Mallick I, Agrawal A, Maitre P, Arunsingh M, James FV, Kataria T, Narang K, Gurram BC, Anand AK, Utreja N, Dutta D, Pavamani S, Mitra S, Mallik S, Mahale N, Chandra M, Chinnachamy AN, Shahid T, Raghunathan MS, Kannan V, Mohanty SK, Basu T, Hotwani C, Panigrahi G, Murthy V (2023). Multi-institutional clinical outcomes of biopsy gleason grade group 5 prostate cancers treated with contemporary high-dose radiation and long-term androgen deprivation therapy. Clinical oncology. 35(7):454-462. PMID: 37061457

      33. Chopra S, Gupta A, Aoyama H, Wu HG, Mahmood H, Tharavichitkul E, Khine A, Gandhi A, Faruque GM, Cruz M, Kodrat H, Xue X, Abeysinghe P, Ho GF, Minjgee M, Tey J, Gao X (2023). Radiation Oncology Research in Asia: Current Status and a Peep into the future from the federation of Asian Organizations for Radiation Oncology. JCO Global Oncology.PMID: 37384859

      34. Chopra S, Mulani J, Mittal P, Singh M, Shinde A, Gurram L, Scaria L, Dheera A, Kolhe S, Rane P, Ghadi Y, Rath S, Ghosh J, Gulia S, Gupta S, Kinhikar R, Laskar S, Agarwal J (2023). Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic. Brachytherapy. 22(2): 125–131.PMID: 36585283

      35. Choudhary B, Chaudhary N, Shah M, Dwivedi N, Smitha PK, Das M, Dalal SN (2023). Lipocalin 2 inhibits actin glutathionylation to promote invasion and migration. FEBS Letters.597(8):1086-1097 PMID: 36650979

      36. Chougule A, Chandrani P, Noronha V, Pange P, Kale S, Nikam A, Nambiar K, Marchande D, Durve A, Gupta V, Jagtap V, Tiwrekar P, Menon N, Joshi A, Kaushal R, Pai T, Patil V, Dutt A, Banavali S, Prabhash K (2023). Real world evidence of EGFR targeted therapy in non-small cell lung cancer– a brief report of decade long single centre experience. JTO Clinical and Research Reports.

      37. Christie J, Anthony CM, Harish M, Mudartha D, Farooqee SBUD, Venkatraman P (2023). The interaction network of the proteasome assembly chaperone PSMD9 regulates proteostasis. FEBS Journal. 290(23):5581-5604. PMID: 37665644.

      38. Das CG, Kumar VG, Kode J (2023).Green nanotechnology approaches using Mesobacillus jeotgali ADCG SIST 4 strain synthesized gold nanoparticles for anticancer studies. Journal of Drug Delivery Science and Technology.

      39. Das L, Shekhar S, Chandrani P, Varma AK.(2023) In silico structural analysis of secretory clusterin to assess pathogenicity of mutations identified in the evolutionarily conserved regions.Journal of Biomolecular Structure & Dynamics.41(2):469-478. PMID: 34821197.

      40. Das S, Sakhare N, Kumar D, Mathur A, Mirapurkar S, Sheela M, Mohanty B, Chaudhari P, Chakraborty S. Design, characterization and evaluation of a new 99mTc-labeled folate derivative with affinity towards folate receptor. Bioorganic Medicinal Chemistry Letters. 86:129240. PMID: 36931350.

      41. Dubey S, Mishra N, Shelke R, Varma AK (2023). Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain. FEBS Journal. PMID: 38129745.

      42. Dwivedi P, Sawant V, Vajarkar V, Vatsa R, Choudhury S, Jha AK, Rangarajan V (2023). Analysis of image quality by regulating beta function of BSREM reconstruction algorithm and comparison with conventional reconstructions in carcinoma breast studies of PET CT with BGO detector. Nuclear Medicine Communications. 44(1):56-64. PMID: 36449665.

      43. Datta D, Dasgupta A, Chatterjee A, Sahu A, Bhattacharyya K, Meena L, Joshi K, Puranik A, Dev I, Moiyadi A, Shetty P, Singh V, Patil V, Menon N, Epari S, Sahay A, Gupta T (2023). Imaging-based patterns of failure following re-irradiation for recurrent/progressive high-grade glioma †. Journal of Personalized Medicine. 13(4): 685.PMID: 37109071

      44. Dey P, Gadewal N, De A (2023). Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer. International Journal of Biological Macromolecules. 242(Pt 2):124765. PMID: 37156315

      45. Dharavath B, Butle A, Pal A, Desai S, Upadhyay P, Rane A, Khandelwal R, Manavalan S, Thorat R, Sonawane K, Vaish R, Gera P, Bal M, D'Cruz AK, Nair S, Dutt A (2023). Role of miR-944/MMP10/AXL- axis in lymph node metastasis in tongue cancer. Communications Biology. 6(1):57. PMID: 36650344

      46. Dhumal S, Patil V, Parekh D, Noronha V, Menon N, Peelay Z, Nawale K, Prabhash K (2023). Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer. Lancet Regional Health - Southeast Asia. 12:100143. PMID: 37384062

      47. Dilli Batcha JS, Raju AP, Matcha S, Raj SEA, Udupa KS, Gota, V, Mallayasamy S (2023). Factors influencing pharmacokinetics of tamoxifen in breast cancer patients: A systematic review of population pharmacokinetic models. Biology. 12:51. PMID: 36671744

      48. D'Silva SZ, Singh M, Pinto AS (2023). NK cell defects: implication in acute myeloid leukemia. Frontiers in Immunology. 14: 1112059. PMID: 37228595

      49. D'Silva SZ, Tambe M, Pinto AS, Singh M (2023). Identification of the novel allele, HLA-C*06:02:38:02, in a Gujarati individual from India. HLA. 101(1):69-70. PMID: 36087312.

      50. D'Silva SZ, Tambe M, Pinto AS, Singh M (2023). Identification of the novel HLA-DQA1*01:01:01:11 and -DQA1*01:03:01:13 alleles in individuals from India. HLA. 101(3):296-297 PMID: 36394229.

      51. D'Silva SZ, Tambe M, Pinto AS, Singh M (2023). The novel HLA-B*52:01:01:23 allele in an individual from Uttar Pradesh, North India. HLA. 101(1):56-57. PMID: 36086925.

      52. Dubey S, Mishra N, Shelke R, Varma AK (2023). Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain. FEBS Journal. PMID: 38129745.

      53. Dutta RP, Kumar R, Tembhare PR, Bagal B, Swain RK, Hasan SK. Targeting transcriptional kinase of CDK7 halts proliferation of multiple myeloma cells by modulating the function of canonical NF-kB pathway and cell cycle regulatory proteins. Translational Oncology. 35:101729. PMID: 37369156

      54. Dwivedi P, Sawant V, Vajarkar V, Vatsa R, Choudhury S, Jha AK, Rangarajan V. Analysis of image quality by regulating beta function of BSREM reconstruction algorithm and comparison with conventional reconstructions in carcinoma breast studies of PET CT with BGO detector. Nuclear Medicine Communications. 44(1):56-64. PMID: 36449665.

      55. Ecker S, Kirisits C, Schmid M, De Leeuw AAC, Seppenwoolde Y, Knoth J, Trnkova P, Heilemann G, Sturdza A, Kirchheiner K, Spampinato S, Serban M, Jürgenliemk-Schulz IM, Chopra S, Nout R, Tanderup K, P¨otter R, Eder-Nesvacil N (2023). Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer. Radiotherapy and Oncology. 182:109524. PMID: 36764459

      56. Fields E, Chopra S, Ludwig M, Taunk N, Chino J (2023). Pivotal science from the 2022 International Gynecologic Cancer Society Meeting. International Journal of Radiation Oncology, Biology, Physics. 116(3): 473-478.

      57. Gandhi VV, Gandhi KA, Goda JS, Kumbhare LB, Gota V, Kunwar A (2023). Post-radiation treatment of 3,3'-diselenodipropionic acid augments cell kill by modulating DNA repair and cell migration pathways in A549 cells. IUBMB Life. 75(10):811-829. PMID: 37072689.

      58. Garg M, Gandhi K, Jadhav SM, Gurjar M, Gota V (2023). Effect of moderate malnutrition on the pharmacokinetics of etoposide and vincristine in freshly weaned rats. European Journal of Drug Metabolism and Pharmacokinetic 48(6):657-663.PMID: 37700116

      59. Gaur T, Poddutoori R, Khare L, Bagal B, Rashmi S, Patkar N, Tembhare P, Pg S, Shetty D, Dutt A, Zhang Q, Konopleva M, Platzbeckar U, Gupta S, Samajdar S, Ramchandra M, Khattry N, Hasan SK. Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax. J Exp Clin Cancer Res. 42(1):186. PMID: 37507802

      60. Gawali P, Saraswat A, Bhide S, Gupta S, Patel K (2023). Human solid tumors and clinical relevance of the enhanced permeation and retention effect: a 'golden gate' for nanomedicine in preclinical studies? Nanomedicine (Lond). 18(2):169-190PMID: 37042320

      61. Ghantasala S, Bhat A, Agarwal U, Biswas D, Bhattarai P, Epari S, Moiyadi A, Srivastava S (2023). Deep Proteome investigation of high-grade gliomas reveals heterogeneity driving differential metabolism of 5-Aminolevulinic acid. Neuro-Oncology Advances. 5(1): vdad065..PMID: 37358939

      62. Ghantasala S, Bhat A, Epari S, Moiyadi A, Srivastava S (2023). High-Grade Gliomas from Subventricular Zone: Proteomic Drivers of Aggressiveness Using Fluorescence-Guided Multiple Sampling. OMICS: A Journal of Integrative Biology. 27(12):598-606 PMID: 38055199.

      63. Gholap D, Dikshit R, Chaturvedi P, Chaturvedi A, Majrekar A, Mhatre S (2023). Exclusive use of different types of tobacco products, exposure to second hand tobacco smoke and risk of subtypes of head and neck cancer among Indian males. International Journal of Cancer. 152(3): 374-383.PMID: 36054453

      64. Ghosh Laskar S, Chaukar D, Deshpande M, Chatterjee A, Sinha S, Chakraborty S, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Pai P, Chaturvedi P, Pantvaidya G, Deshmukh A, Nair D, Nair S, Prabhash K, Swain M, Kumar A, Noronha V, Patil V, Joshi A, D'Cruz A (2023). Oral Cavity Adjuvant Therapy (OCAT) -A phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) vs concurrent CT-RT vs accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity. European Journal of Cancer. 181:179-187. PMID: 36669426

      65. Ghosh Laskar S, Sinha S, Gupta M, Karmakar S, Nivedha J M, Kannan S, Budrukkar A, Swain M, Kumar A, Gupta T, Murthy V, Chaukar D, Pai P, Chaturvedi P, Pantvaidya G, Nair D, Nair S, Thiagarajan S, Deshmukh A, Noronha V, Patil V, Joshi A, Prabhash K, Agarwal JP (2023). Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched-pair analysis. Head Neck. 45(5):1226-1236. PMID: 36912016.

      66. Giri P, Bharti A, Kode J, Begum R, Dwivedi M. Harmine and Kaempferol treatment enhances NFATC1 and FOXP3 mediated regulatory T-cells’ suppressive capacity in generalized vitiligo. International Immunopharmacology. 125(Part B):111174.PMID: 37951194

      67. Gohil D, Panigrahi GC, Gupta SK, Gandhi KA, Gera P, Chavan P, Sharma D, Sandur S, Gota V (2023). Acute and sub-acute oral toxicity assessment of 5-hydroxy-1,4-naphthoquinone in mice. Drug and Chemical Toxicology. 46(4): 795-708.PMID: 35899689.

      68. Gokarn A, Shenoy R, Punatar S, Mirgh S, Chichra A, Nayak L, Bonda A, Jindal N, Saroha M, Toshniwal A, Prayag P, Tripathi R, Kumar S, Bhat V, Biswas S, Khattry N (2023). Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants. Bone Marrow Transplantation. 58(2):209-211 PMID: 36310244.

      69. Gokarn A, Tembhare PR, Syed H, Sanyal I, Kumar R, Parab S, Khanka T, Punatar S, Kedia S, Ghogale SG, Deshpande N, Nikam Y, Girase K, Mirgh S, Jindal N, Bagal B, Chichra A, Nayak L, Bonda A, Rath S, Hiregoudar S, Poojary M, Saha S, Ojha S, Subramanian PG, Khattry N (2023). Long-term cryopreservation of peripheral blood stem cell harvest using low concentration (4.35%) dimethyl sulfoxide with methyl cellulose and uncontrolled rate freezing at -80°C: An effective option in Resource Limited Setting. Transplantation and Cellular Therapy. 29 (12): 777.e1-777.e8. PMID: 37678607

      70. Grover S, Lichter K, Likhacheva A, Jang J, Ning M, Robin T, Small W, Kudchadker R, Swamidas J, Chopra S, Rai B, Dutt Sharma S, Sharma D, Kuppusamy T, Yang R, Berger D, Mendez L, Glaser S, Erickson D, Chino J, Mourtada F, Abdel-Wahab M, Jhingran A, Simonds H, Mahantshetty U (2023). The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries. Brachytherapy. 22(6):716-727. PMID: 37704540

      71. Gulia S, Kannan S, Ghosh J, Rath S, Maheshwari A, Gupta S (2023). Secondary cytoreduction in platinum sensitive relapsed ovarian cancer: An individual patient level meta-analysis. International Journal of Gynecological Cancer. 33(9):1440-1447. PMID: 37567595

      72. Gupta D, Singh A, Gupta N, Mehra N, Bahuguna P, Aggarwal V, Krishnamurthy MN, Roy PS, Malhotra P, Gupta S, Kumar L, Kataki A, Prinja S(2023). Cost-effectiveness of the first line treatment options for metastatic renal cell carcinoma in India. JCO Global Oncology. PMID: 36795991.

      73. Gupta SK, Gohil D, Dutta D, Panigrahi GC, Gupta P, Dalvi K, Khanka T, Yadav S, Kaushal RK, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Tembhare PR, Hasan SK, Sandur SK, Hingorani L, Khattry N, Gota V (2023). Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect. International Immunopharmacology. 121: 110437. PMID: 37311352.

      74. Gupta T, Maheshwari G, Joshi K, Sawant P, Mishra A, Khairnar S, Patel P, Sinha S, Swain M, Budrukkar A, Ghosh-Laskar S, Agarwal JP (2023. Image-guidance triggered adaptive radiation therapy in head and neck squamous cell carcinoma: single-institution experience and implications for clinical practice. Journal of Medical Imaging and Radiation Sciences. 54(1):88-96. PMID: 36517346

      75. Gupta T, Selvarajan JMP, Kannan S, Menon N, Dasgupta A, Chatterjee A (2023). Updated systematic review and meta-analysis of extended adjuvant temozolomide in patients with newly diagnosed glioblastoma. Neuro-oncology Advances.13; 5(1):vdad086. PMID: 37638346

      76. Hande V, Chopra S, Polo A, Mittal P, Kohle S, Ghadi Y, Mulani A, Kinhikar R, Agarwal JP (2023). Transitioning India to advanced image based adaptive brachytherapy: A national impact analysis of upgrading National Cancer Grid cervix cancer guidelines. Lancet Regional Health- Southest Asia.16:100218. PMID: 37694176

      77. Handley KF, Mehta S, Martin AL, Biswas S, Maharaj K, Nagy MZ, Mine JA, Cortina C, Yu X, Sprenger K, Mandal G, Innamarato P, Powers JJ, Harro CM, Chaurio RA, Anadon CM, Shahzad MM, Flores I, Conejo-Garcia JR (2023) . Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma. Gynecologic Oncology. 173: 114-121. PMID: 37121178

      78. Harkenrider M, Fields E, Chopra S, Damast S, Kidd E, Chino J (2023). Recent key Studies in cancers of the uterine corpus and cervix: New updates in immunotherapy, the microbiome, bone density, quantifying lymphovascular invasion, and hypofractionated pelvic radiation therapy. International Journal of Radiation Oncology Biology Physics. 115(2): 269-275. PMID: 36621226

      79. Harro CM, Sprenger KB, Chaurio RA, Powers JJ, Innamarato P, Anadon CM, Zhang Y, Biswas S, Mandal G, Mine JA, Cortina C, Nagy MZ, Martin AL, Handley KF, Borjas GJ, Chen PL, Pinilla-Ibarz J, Sokol L, Yu X, Conejo-Garcia JR. Sézary Syndrome originates from heavily mutated hematopoietic progenitors. Blood Advances. 7(18): 5586-5602. PMID: 37531660

      80. Hegde MM, Sandbhor P, Aishwarya J, Gota V, Goda JS. Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects. Frontiers in Oncology. 13:1168454. PMID: 37483515

      81. Im SA, Gennari A, Park YH, Kim JH, Jiang ZF, Gupta S, Fadjari TH, Tamura K, Mastura MY, Abesamis-Tiambeng MLT, Lim EH, Lin CH, Sookprasert A, Parinyanitikul N, Tseng LM, Lee SC, Caguioa P, Singh M, Naito Y, Hukom RA, Smruti BK, Wang SS, Kim SB, Lee KH, Ahn HK, Peters S, Kim TW, Yoshino T, Pentheroudakis G, Curigliano G, Harbeck N (2023). Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer. ESMO Open. 8(3): 101541.PMID: 37178669

      82. Inchanalkar M, Srivatsa S, Ambatipudi S, Bhosale PG, Patil A, Schäffer AA, Beerenwinkel N, Mahimkar MB (2023). Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers. Clinical Epigenetics. 15(1): 93. PMID: 37245006

      83. Jadhav P, Pansare K, Hole A, Ingle A, Govekar R, CM Krisha (2023). Serum Raman Spectroscopy in experimental carcinogenesis hamster buccal pouch model: exploring early diagnostic capability. Journal of Raman Spectroscopy. 54(1): 37-46.

      84. Jain B, Christopher Dee E, Jain U, Chaturvedi P, Murthy V. (2023) The implications of rising alcohol-associated cancer burden: Considerations for the Indian context. Asia Pacific Journal of Clinical Oncology. 19(1):275-276 PMID: 35098671.

      85. Jha AK, Mthun S, Sherkhane U, Jaiswar V, Osong B, Purandare N, Kannan S, Prabhash K, Gupta S, Vanneste B, Rangarajan V, Dekker A, Wee L (2023). Systematic review and meta-analysis of prediction models used in cervical cancer.Artificial Intelligence in Medicine. 139:102549. PMID: 37100501

      86. Jindal N, C M, Mathew LJ, Kumbhalwar K, Patel K, Garg M, Mirgh S, Chichra A, Nayak L, Bonda A, Gokarn A, Punatar S, Bagal B, Khattry N (2023). Fertility outcomes in patients desiring conception following autologous stem cell transplantation for Hodgkin lymphoma using LACE conditioning. Bone Marrow Transplantation. PMID: 38102211

      87. Jindal N, Saroha M, Mirgh S, Chichra A, Nayak L, Bonda A, Gokarn A, Punatar S, Bagal B, Chavan P, Mathew LJ, Kanan S, Khattry N (2023). Relevance of vitamin D in patients undergoing HLA matched allogeneic stem cell transplant for acute leukemia. Transplant Immunology. 81:101925. PMID: 37648032.

      88. Joshi M, Dey P, De A (2023). Recent advancements in targeted protein knockdown technologies-emerging paradigms for targeted therapy. Exploration of Targeted Antitumor Therapy. 4(6):1227-1248. PMID: 38213543

      89. Joshi P, Bhattacharya K, Menon MB, Ghosh Laskar S, Joshi A, Patil V, Chaturvedi P. Malignant Minor Salivary gland neoplasms ofLarynx: Our Experience. Polish Journal of Otolaryngology. 77(5):1-7. PMID: 38032326.

      90. Joshi P, Waghmare S (2023). Molecular signaling in cancer stem cells of tongue squamous cell carcinoma: Therapeutic implications and challenges. World Journal of Stem Cells 15(5): 438-452. PMID: 37342225

      91. Joshi S, Anantharaman D, Muwonge R, Bhatla N, Panicker G, Butt J, Usha Rani Reddy Poli, Malvi S, Esmy P, Lucas E, Verma Y, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Divate U, Vashist S, Mishra G, Jadhav R, Siddiqi M, Sankaran S, Thiraviam Pillai Rameshwari Ammal Kannan, Kartha P, Shastri S, Sauvaget C, M. Radhakrishna Pillai, Waterboer T, Müller M, Sehr P, Unger E, Sankaranarayanan R, Basu P (2023). Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination. Vaccine. 41(1): 236-245. PMID: 36446654

      92. Joshi S, Ramarajan L, Ramarajan N, Lee SS, Deshpande O, Fernandes E, Engineer M, Srivastava G, Vanmali V, Kannan S, Hawaldar R, Nair N, Parmar V, Thakkar P, Chitkara G, Gupta S, Badwe R (2023). Effectiveness of a decision aid plus standard care in surgical management among patients with early breast cancer: A randomized clinical Trial. JAMA Network Open. 6(10):e2335941. PMID: 37782500

      93. Kandekar S, Punatar S, Khattry N Gokarn A, Jindal N, Mirgh S, Chichra A, Tembhare P, Rane P, Gawade J, Mathew L, Patil A, Chiplunkar S, Kode J.Low levels of CD26 on certain cellular subtypes of donor harvest is associated with better clinical outcomes post allogeneic stem cell transplantation through regulation of NF-κB pathway and pro-inflammatory cytokines.International Immunopharmacology. 125(Part A): 111054.PMID: 37890379

      94. Kapoor A, Noronha V, Patil V, Menon N, Joshi A, Kumar A, Singh AK, Mahajan A, Janu A, Kumar R, Pai T, Chougule A, Shetty O, Prabhash K (2023). Clinical Profile, Practice Pattern, and Outcomes with First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data from Resource-Constrained Settings. JTO Clinical and Research Reports. 4(1):100443. PMID: 36654881

      95. Khan MA, Varma AK (2023). In silico and structure-based assessment to classify VUS identified in the α-helical domain of BRCA2.Journal of Biomolecular Structure and Dynamics. 41(19):9879-9889 PMID: 36404616.

      96. Khanna D, Budukh A, Sharma P, Shruti T, Vishwakarma R, Sharma AN, Bagal S, Vikraman SM, Vaza Y, Anand A, Chaturvedi P, Pradhan S (2023). Role of verbal autopsy in cancer registration: A mixed-methods study from the population-based cancer registry of Northern India. Tropical Medicine and International Health. 28(8):629-640. PMID: 37430444.

      97. Khurud P, Gupta A, Krishnatry R, Panigrahi G, Phurailatpam RD, Menon S, Pal M, Bakshi G, Prakash G, Murthy V (2023). Optimizing Target Volume for Adjuvant Radiation Therapy in Penile Cancer. Practical Radiation Oncology. 13(3):e270-e277.PMID: 36460183.

      98. Kode J, Maharana J, Dar A, Mukherjee S, Gadewal N, Sigalapalli D, Kumar S, Panda D, Ghosh S, Keshry S, Mamidi P, Chattopadhyay S, Pradhan T, Kailaje V, Inamdar S, Gujjarwar V (2023).6-Shogaol exhibits anti-viral and anti-inflammatory activity in COVID-19-associated inflammation by regulating NLRP3 inflammasomes. ACS Omega. 8(2):2618-2628. PMID: 36687062

      99. Koppikar S, Oakin A, Babu KG, Lorusso D, Gupta S, We L-Y, Rajabto W, Harano K, Hong S-H, Malik RA, Strebel H, Aggarwal IM, Lai C-H, Dejthevaporn T, Tangjitgamol S, Cheng WF, Chay WY, Benavides D, Hashim NM, Moon YW, Yunokawa M, Anggraeni TD, Wei W, Curigalina G, Maheshwari A, Mahantshetty U, Sheshadri S, Peters S, Yoshino T, Pentheroudakis G (2023). Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer. ESMO Open. 8(1): 10074. PMID: 36696825

      100. Krishnatry R, Maitre P, Kumar A, Telkhade T, Bakshi G, Prakash G, Pal M, Joshi A, Menon S, Murthy V (2023). Utilising alternative cystoscopic schedules to minimise cost and patient burden after trimodality therapy for muscle-invasive bladder cancer. Cancer Medicine. 12(10):11305-11314. PMID:36965102

      101. Kumar A, Jha AK, Agarwal JP, Yadav M, Badhe S, Sahay A, Epari S, Sahu A, Bhattacharya K, Chatterjee A, Ganeshan B, Rangarajan V, Moyiadi A, Gupta T, Goda JS (2023). Machine-Learning-Based Radiomics for Classifying Glioma Grade from Magnetic Resonance Images of the Brain. Journal of Personalized Medicine.13 (6):920. PMID: 37373909

      102. Kumar Gupta S, Gohil D, Dutta D, Panigrahi GC, Gupta P, Dalvi K, Khanka T, Yadav S, Kumar Kaushal R, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Tembhare PR, Khizer Hasan S, Kumar Sandur S, Hingorani L, Khattry N, Gota V. Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect. International Immunopharmacology. 121:110437. PMID: 37311352

      103. Kumar M, Moiyadi A, Rangaraj N, Noronha S, Shetty P, Singh VK, Choudhari AK (2023). Implications of use of different intraoperative ultrasound modalities during glioma surgery – a comparative study of factors affecting outcomes. International Journal of Medical Informatics.177:105154. PMID: 37506442

      104. Kumbhalwar K, Punatar S, Gokarn A, Nayak L, Chichra A, Mirgh S, Jindal N, Mathew L, Khattry N (2023). Lenalidomide with or without dexamethasone for relapsed or refractory Hodgkin lymphoma post autologous stem cell transplant. Blood Cell Therapy. 6(3):95-103. PMID: 38146353

      105. Kuru D, Kumar AK, Chaturvedi P (2023). Barriers in quest for cancer care access in two states of northeast India. The International Journal of Health Planning and Management. ;38(5):1396-1408. PMID: 37270797

      106. Lall S, Bhat V, Biswas S, Joshi A, Janu A (2023). Delftia acidovorans: An unusual pathogen from an adenocarcinoma lung patient with pleural effusion. Journal of Global Infectious Diseases. 15(3): 121-123. PMID: 37800087

      107. Laskar SG, Chaukar D, Deshpande M, Chatterjee A, Sinha S, Chakraborty S, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Pai P, Chaturvedi P, Pantvaidya G, Deshmukh A, Nair D, Nair S, Prabhash K, Swain M, Kumar A, Noronha V, Patil V, Joshi A, DCruz A. Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity. European Journal of Cancer. 181:179-187. PMID: 36669426.

      108. Leung K, McLeod M, Torode J, Ilbawi A, Chakowa J, Bourbeau B, Sengar M, Booth CM, Gralow JR, Sullivan R, Aggarwal A(2023). Quality indicators for systemic anticancer therapy services: a systematic review of metrics used to compare quality across healthcare facilities. European Journal of Cancer. 195:113389. PMID: 37924649.

      109. Madhugiri V, Venkatesan S, Dutt A, Moiyadi AV, Shetty P, Gupta T, Epari S, Jalali R, Sasidharan GM, Kumar VR, Ganesh S, Ramesh A, Prabhu A, Dutt A (2023). An analysis of eosinophil and basophil based indices in patients with glioblastoma and their correlation with survival. World Neurosurgery. 170:e292-e300. PMID: 36368458

      110. Madkaiker D, Hiregoudar SS, Chavan P, Ojha S, Mendes J, Shastry S (2023). 'Ironing out the risk': Assessing the effect of plateletpheresis donation frequency on iron stores in South-Asian male donors. Vox Sanguinis. 18(11):921-929. PMID: 37772675

      111. Mahadik P, Patwardhan S (2023). ECM stiffness-regulated exosomal thrombospondin-1 promotes tunneling nanotubes-based cellular networking in breast cancer cells. Archives of Biochemistry and Biophysics.742:109624.PMID: 37146866

      112. Mahantshetty U, Kashid S, Mulye G, Gurram L, Engineer R, Chopra S, Ghosh J, Gulia S, Gupta S, Ghadi Y, Dheera A, Kohle S, Kadam S, Menon S, Deodhar K, Maheshwari A, Shylasree TS, Lewis S, Kalyani N, Shrivastava SK (2023). Reirradiation with advanced brachytherapy techniques in recurrent GYN cancers. Brachytherapy. 22(6):753-760. PMID: 37716821

      113. Mailankody S, Bajpai J, Budukh A, Swaminathan R, Dikshit R, Dhimal M, Perera S, Tshomo U, Bagal S, Bhise M, Chaturvedi P, Banavali S, Gupta S, Badwe R, Trama A. (2023) Epidemiology of rare cancers in India and South Asian countries-remembering the forgotten. Lancet Regional Health - Southeast Asia. 12:100168. PMID: 37384065

      114. Majumdar S, Sharma N, Sengar M, Thorat J, Nayak L, Bonda A, Bagal B, Rajendra A, Sethi A, Jain H (2023). A phase II study to evaluate the efficacy of low-dose rasburicase (1.5mg) in adolescent and adult acute leukemia and high-grade lymphomas with tumor lysis syndrome. Leukemia and Lymphom 64(3):628-638. PMID: 36891578

      115. Mani S, Chatterjee A, Dasgupta A, Shirsat N, Epari S, Chinnaswamy G, Gupta T (2023). WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? Oncotarget. 14: 105-110. PMID: 36749287.

      116. Mehta D, Shaikh S, Mohanty B, Chaudhari P, Waghmare SK (2023). Secretory phospholipase (sPLA2-IIA) regulates breast cancer stem cells differentiation and metastatic potential. Biochemical and Biophysical Research Communication. 677:98-104. PMID: 37566923.

      117. Mittal N, Patil A, Singhal P, Bal MM, Rane SU, Thiagarajan S(2023). Histoplasmosis of the Head and Neck Region Mimicking Malignancy: A Clinic-Pathological Predicament. Turkish Journal of Pathology 39(2):133-139. PMID: 35989588.

      118. Mittal P, Chopra S, Kamrava M, Vashistha R, Konrad S, Senapati S, Pradhan S, Reddy VA, Sharma DN, Engineer R, Sarin R, Budrukkar A, Ghoshal S, Shrivastava SK, Agarwal JP, Sturdza AE (2023). Brachytherapy training in India: Results from the GEC-ESTRO-India survey. Brachytherapy.22(4):562-569. PMID: 37193616.

      119. Mohanty P, Shetty D, Patkar N (2023). t(4;11) (p14;q23),KMT2A::PDS5A, in a case of pediatric B acute lymphoblastic leukemia (B-ALL). Atlas of Genetics and Cytogenetics in Oncology and Haematology.

      120. Mohanty SK, Wadasadawala T, Sen S, Khan PK (2023). Socio-economic variations of breast cancer treatment and discontinuation: a study from a public tertiary cancer hospital in Mumbai, India. BMC Womens Health. 23(1):113. PMID: 36935486

      121. Mohite A, Rangarajan V, Goda J, Chugh S, Agrawal A, Sengar M. (2023). Metabolic tumor parameters complement clinicopathological factors in prognosticating advanced stage Hodgkin Lymphoma. Asia Oceania Journal of Nuclear Medicine & Biology. 11(2):111-121 PMID: 37324230

      122. Moiyadi A, Jain K, Shetty P, Singh VK, Radhakrishnan K, Rane P, Velayutham P (2023). Baseline neurocognitive dysfunction is ubiquitous in intrinsic brain tumors– results from a large Indian cohort of patients and analysis of factors associated with domain-specific dysfunction. World Neurosurgery: X. 19:100210. PMID: 37251242

      123. Moiyadi A, Shetty P, Singh V, Yeole U (2023). Intraoperative navigated three dimensional-ultrasound guidance improves resection in gliomas as compared to standard two-dimensional ultrasound – Results from a comparative cohort study. World Neurosurgery. 180:e233-e242. PMID: 37739176

      124. Mujawar A, Phadte P, Palkina KA, Markina NM, Mohammad A, Thakur BL, Sarkisyan KS, Balakireva AV, Ray P, Yamplosky I, De A (2023). Triple reporter assay: A non-overlapping luciferase assay for the measurement of complex macromolecular regulation in cancer cells using a new mushroom luciferase-luciferin pair. Sensors (Basel). 23(17): 7313. PMID: 37687774

      125. Mundhe D, Mishra R, Basu S, Dalal S, Kumar S, Teni T (2023). ΔNp63 overexpression promotes oral cancer cell migration through hyperactivated Activin A signaling. Experimental Cell Research. 431(1):113739. PMID: 37567436

      126. Murthy V, Maitre P, Singh M, Pal M, Arora A, Pujari L, Kapoor A, Pandey H, Sharma R, Gudipudi D, Joshi A, Prabhash K, Noronha V, Menon S, Mehta P, Bakshi G, Prakash G (2023). Study protocol of the Bladder Adjuvant RadioTherapy (BART) trial: A randomised phase III trial of adjuvant radiotherapy following cystectomy in bladder Cancer. Clinical Oncology.35(9):e506-e515.PMID: 37208232

      127. Nag S, Dikshit R, Desai S, Mane A, Mhatre S, Neve R, Gurav M, Bhosale N, Perumal P, Kembhavi Y, Jethwa D, Badwe R, Gupta S (2023). Risk factors for the development of triple-negative breast cancer versus non-triple-negative breast cancer: a case-control study. Scientific Reports.13(1):13551. PMID: 37599285

      128. Nair N, Ali B, Siddique S, Maheshwari A, Bajpai J, Parmar V, Gulia S, Chitkara G, Joshi S, Hawaldar R, Badwe R. Patient-related awareness of impact of cancer-directed therapy on fertility in young women diagnosed of breast cancer. South Asian Journal of Cancer.

      129. Nair N, Das A, Shet T, Kirti K, Hawaldar R, Desai S, Parmar V, Joshi S, Badwe RA (2023). Accuracy of intraoperative frozen section analysis of lymph nodes in women undergoing axillary sampling for treatment of breast cancer: Single institution audit. Clinical Breast Cancer.23(7):e420-e423.PMID: 37460382

      130. Nair NS, Kothari B, Gupta S, Kanann S, Vanmali V, Hawaldar R, Tondare A, Siddique S, Parmar V, Joshi S, Badwe RA (2023). Validation of PREDICT Version 2.2 in a Retrospective Cohort of Indian Women with Operable Breast Cancer. JCO Global Oncology. PMID: 38085062.

      131. Nath A, Mathur P, Sudarshan KL, Kaur Rajput G, Mascarenhas L, Arora RS, Seth R, Kumar Dixit S, Chinnaswamy G, Banipal RPS, Bhutia TW, Kumar Bodal V, Budukh A, Kumar Chaudhary N, Vijay CR, Shikha Das D, Gundeti S, Harris C, Hazarika M, Natha Jondhale S, Gunaseelan K, Khamo V, Konjengbam R, Kumar A, Saroj Kumar DM, Majumdar G, Malik S, Mandal S, Najmi AM, Mohan Kumar C, Kumar Pandey A, Pandya S, Pareek P, Pautu JL, Surya Rao V, Ramesh C, Rawal M, Radhakrishnan N, Radhakrishnan V, Shah A, Singh SB, Singh V, Singh P, Sundriyal D, Swaminathan R, Avinash T, Priya Kumari T, Tawsik S, Tiwari L. An assessment of childhood cancer care services in India - gaps, challenges and the way forward. Lancet Regional Health - Southeast Asia.16:100235. PMID: 37694177

      132. Natu A, Pedgaonkar A, Gupta S (2023). Mitochondrial dysfunction and chromatin changes with autophagy-mediated survival in doxorubicin resistant cancer cell lines. Biochemical and Biophysical Research Communications. 648:1-10. PMID: 36724554

      133. Nautiyal A, Jha AK, Konuparamban A, Mithun S, Srichandan T, Puranik A, Gala K, Shetty N, Kulkarni S, Rangarajan V (2023). A dosimetric comparison of systemic peptide receptor radionuclide therapy and intra-arterial peptide receptor radionuclide therapy in patients with liver dominant gastroenteropancreatic neuroendocrine tumours. Nuclear Medicine Communications. 44(7):585-595. PMID: 37038926.

      134. Navarange SS, Bane SM, Mehta D, Shah S, Gupta S, Waghmare SK (2023). Epithelial-to-mesenchymal transition status correlated with ultrastructural features, and TP53 mutation in patient-derived oral cancer cell lines. Molecular Biology Reports. 50(10):8469-8481. PMID: 37639153

      135. Nehra P, Singh Chauhan A, Malhotra P, Kumar L, Singh A, Gupta N, Mehra N, Mathew A, Kataki AC, Gupta S, Prinja S (2023).Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in India. The Lancet Regional Health - Southeast Asia. 13: 100201. PMID: 37383548

      136. Noronha V, Rao AR, Ramaswamy A, Kumar A, Pillai A, Dhekale R, Krishnamurthy J, Kapoor A, Gattani S, Sehgal A, Kumar S, Castelino R, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Chitre A, Narasimhan PN, Banerjee J, Gota V, Banavali S, Badwe R, Prabhash K. (2023) The current status of geriatric oncology in India. Ecancer. 17:1595. PMID: 37799956

      137. Oak S, Karajgikar O, Teni T (2023). Curcumin mediates selective aggregation of mutant p53 in cancer cells a promising therapeutic strategy. Biochemical and Biophysical Research Communications. 677:141-148.PMID: 37586212

      138. Oike T, Kakoti S, Sakai M, Matsumura A, Ohno T, Shibata A. Analysis of the relationship between LET, γH2AX foci volume and cell killing effect of carbon ions using high-resolution imaging technology. Journal of Radiation Research. 64(2):335-344. PMID: 36621883

      139. Ostwal V, Ramaswamy A, Bhargava P, Srinivas S, Mandavkar S, Chaugule D, Peelay Z, Baheti A, Tandel H, Jadhav V, Shinde S, Jadhav S, Gota V, Mittra I (2023). A pro‑oxidant combination of resveratrol and copper reduces chemotherapy‑related non‑haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single‑arm study (RESCU III study). Medical Oncology. 40:17.PMID: 36372825

      140. Pagdhune A, Kashyap R, SivaPerumal P, Balachandar R, Viramgami A, Sarkar K (2023). Occupational exposure of vehicular emissions and cardiorespiratory risk among urban metropolitan bus drivers: A cross-sectional comparative study. Work.75(4):1309-1318 PMID: 36744353

      141. Panda TR, Manikandan M, Vaidya SP, Chhatar S, Sinha S, Mehrotra M, Chakraborty S, Gadre S, Duari P, Ray P, Patra M (2023). The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity. Angewandte Chemie .62(38):e20230395. PMID: 37314332

      142. Parui AL, Bose K (2023). Purification of hetero-oligomeric protein variants using a modified tandem affinity purification approach. STAR Protocols. 4(1): 102036. PMID: 36853657

      143. Patil A, Diwakar H, Sawant J, Kurian N, Yadav S, Rane S, Bameta T, Sethi A (2023). Efficient quality control of whole slide pathology images with human-in-the-loop training. Journal of Pathology Informatics. PMID: 37089617

      144. Patil V, Noronha V, Menon N, Mathrudev V, Bhattacharjee A, Nawale K, Parekh D, Banavali S, Prabhash K (2023). Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation–a randomised trial. Lancet Regional Health - Southeast Asia. 12:100162. PMID: 37384061

      145. Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A, Nawale K, Jogdhankar S, Tambe R, Dhumal S, Sawant R, Alone M, Karla D, Peelay Z, Pathak S, Balaji A, Kumar S, Purandare N, Agarwal A, Puranik A, Mahajan A, Janu A, Kumar Singh G, Mittal N, Yadav S, Banavali S, Prabhash K(2023). Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study. Journal of Clinical Oncology. 41(2):222-232.PMID: 36265101

      146. Patnam N, Trivedi K, Janu A, Kaushal RK, Kulkarni S, Ankathi SK (2023). Cross-sectional imaging review of common to uncommon lung cancer mimickers in a tertiary care oncology center. Acta Radiologica. 64(10):2731-2747. PMID: 37592920

      147. Pattanaik S, Gota V, Tripathi SK, Kshirsagar NA (2023). Therapeutic drug monitoring in India: A SWOT analysis. British Journal of Clinical Pharmacology. 89(11):3247-3261. PMID: 37259249

      148. Paul S, Gupta T, Purandare N, Joshi K, Ghosh-Laskar S, Budrukkar A, Swain M, Sinha S, Kumar A, Joshi A, Prabhash K, Nair S, Rangarajan V, Agarwal JP (2023). Diagnostic performance of response assessment FDG-PET/CECT in HNSCC treated with definitive Radio (chemo)therapy using NI-RADS. Otolaryngology- Head and Neck Surgery. 169(4):938-947. PMID: 36856038

      149. Pelizzola M, Tanderup K, Chopra S, Jürgenliemk-Schulz IM, Nout R, Kirchheiner K, Spampinato S (2023). Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis. Acta Oncologica. 62(11):1479-1487. PMID: 37906286.

      150. Phurailatpam R, Sah MK, Wadasadawala T, Khan A, Palottukandy J, Gayake U, Jain J, Sarin R, Pathak R, Krishnamurthy R, Joshi K, Swamidas J (2023). Can knowledge based treatment planning of VMAT for post-mastectomy locoregional radiotherapy involving internal mammary chain and supraclavicular fossa improve performance efficiency? Frontiers in Oncology. 13:991952. PMID: 37114138

      151. Pinto AS, Tambe M, D'Silva SZ, Singh M (2023). Identification of the novel HLA-DQB1*06:01:01:04 allele in an individual from Western India. HLA. 101(1):90-91. PMID: 36086916.

      152. Pinto AS, Tambe M, D'Silva SZ, Singh M (2023). Identification of the novel HLA-C*12:02:47 allele in an individual from Maharashtra, India. HLA. 101(1):74-75. PMID: 36161710

      153. Pinto AS, Tambe M, D'Silva SZ, Singh M (2023). Identification of the novel HLA-DQA1*01:01:01:10 allele in an individual from Orissa, India. HLA. 101(2):190-191. PMID: 36181697

      154. Pinto AS, Tambe M, D'Silva SZ, Singh M(2023)Identification of the novel HLA-DQB1*06:01:01:04 allele in an individual from Western India. HLA. 101(1):90-91. PMID: 36086916

      155. Poon D, Yuan J, Yang B, Kerkmeijer L, Kishan A, Murthy V, Zapaetero A, Wong O (2023). Magnetic resonance imaging–guided focal boost to intraprostatic lesions using external beam radiotherapy for localized prostate cancer: A systematic review and meta-analysis. European Urology Oncology. 6 (2): 116-127.

      156. Pramesh CS, Sengar M, Patankar S, Chinnaswamy G, Gupta S, Vijayakumar M, Sood S, Sathe AN, Radhakrishnan V, Ganesan P, Mallavarapu KM, Badwe RA. A National Cancer Grid pooled procurement initiative, India. Bulletin of World Health Organization. 101(9):587-594. PMID: 37638358;

      157. Prinja S, Dixit J, Gupta N, Dhankhar A, Kataki AC, Roy PS, Mehra N, Kumar L, Singh A, Malhotra P, Goyal A, Rajsekar K, Krishnamurthy MN, Gupta S (2023). Financial toxicity of cancer treatment in India: towards closing the cancer care gap. Frontiers in Public Health. 11:1065737. PMID: 37404274

      158. Priyadharshn Selvarajan JM, Epari S, Sahu A, Dasgupta A, Chatterjee A, Gupta T (2023) . Pearls & Oy-sters: Primary diffuse leptomeningeal melanocytosis: A diagnostic conundrum. Neurology. PMID: 36878703

      159. Puja R, Dutta S, Bose K (2023). Elucidating the interaction of C-terminal domain of Vaccinia-Related Kinase 2A(VRK2A) with B-cell lymphoma-extra Large(Bcl-xL) to decipher its anti-apoptotic role in cancer. Biochemical Journal. 480(22):1871-1885. PMID: 37943248.

      160. Raj S, Kattepur A, Shylasree TS, Mishra G, Patil A, Pimple S, Noronha S, Pramesh CS (2023). Novel educational training of para medical professionals in cervical cancer screening. Gynecologic Oncology Reports. 48:101241. PMID: 37520786

      161. Rajak J, Tambe M, D'Silva SZ, Singh M (2023). Identification of the novel HLA-DPA1*02:82 allele in a Punjabi individual. HLA. 101(1):94-95. PMID: 36073256.

      162. Rajak J, Tambe M, D'Silva SZ, Singh M (2023). Identification of the HLA-B*15:665 and HLA-C*12:02:02:23 alleles in individuals from the South Asia. HLA. 102(5):625-626.. PMID: 37551036.

      163. Rajendra A, Sengar M, Bonda VNA, Jain H, Nayak L, Thorat J, Shet T, Epari S, Laskar S, Aggarwal A, Rangarajan V, Gujral S, Bagal B, Kakoti S, Salvi O (2023). Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL). Leukemia Lymphoma. PMID: 37602660

      164. Ramaswamy A, Bhargava P, Srinivas S, Kannan S, Bhandare M, Chaudhari V, Mantri A, Kapoor A, Das S, Booma N, Chaugule D, Shrikhande SV, Ostwal V (2023). Perioperative modified FLOT versus EOX in locally advanced resectable gastric and gastro-oesophageal junction adenocarcinoma: Results of a matched-pair analysis. Journal of Gastrointestinal Cancer. 54(3):820-828. PMID: 36242748

      165. Rauniyar S, Pansare K, Sharda A, Singh S, Saha P, CM Krishna, Gupta S (2023). Raman spectroscopy revealed cell passage-dependent distinct biochemical alterations in radiation-resistant breast cancer cells. ACS Omega. 8: 5522-5532. PMID: 36816694

      166. Raveendran V, R GR, P T A, Bhasi S, C P R, Kinhikar RA (2023). Moving towards process-based radiotherapy quality assurance using statistical process control. Physica Medica. 112:102651.PMID: 37562233.

      167. Ravichandran G, Harijan D, Ganapathy N, Prabusankar G, De A, Rengan K (2023). The multifaceted role of degradable cobalt nanoparticles: Dual-target starvation and intracellular acidification engendering LC3-associated whole-cell autophagy. ACS Materials Letters. 5, 10, 2726–2738.

      168. Rekhi B, Bal M, Dharavath B, Dutt A, Pai P (2023. A rare case of a low-grade inflammatory leiomyosarcoma/histiocyte-rich rhabdomyoblastic tumor in the neck of an adolescent male. Turkish Journal of Pathology.PMID: 35642345

      169. Rekhi B, Dave V, Butle A, Dutt A (2023). Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center. Annals of Diagnostic Pathology. 66: 152174. PMID: 37356274

      170. Saha P, Sawant S, Deshmukh A, Hole A, CM Krishna (2023). Serum Raman spectroscopy: Prognostic applications in oral cancers. Head Neck. 45(5):1244-1254. PMID: 36919570.

      171. Sahu A, Patnam N, Goda JS, Epari S, Sahay A, Mathew R, Choudhari A, Desai S, Dasgupta A, Chatterjee A, Pratishad P,Shetty P, Moiyadi A, Gupta T (2023). Multiparametric magnetic resonance imaging correlates of isocitrate dehydrogenase mutation in WHO high-Grade astrocytomas. Journal of Personalized Medicine. 13(1): 72. PMID: 36675733

      172. Sali AP, Prakash G, Murthy V, Joshi A, Shah A, Desai SB, Menon S (2023). Updates in staging of penile cancer: The evolution, nuances, and issues. Human Pathology. 133:76-86. PMID: 35714835.

      173. Sandbhor P, Goda J, Mohanty B, Gera P, Yadav S, Chekuri G, Chaudhari P, Dutt S, Banerjee R (2023). Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model. Drug Delivery and Translational Research. 13(2):608-626. PMID: 36245060.

      174. Sawant P, Perera S, Jayanthi KGN, Ziyad AIA, Saoba S, Ervik M, Mery L, Bray F, Dikshit R, Budukh A (2023). Application of Rupantaran software to Sri Lankan hospitals: an innovative tool developed to merge population-based cancer registry data into CanReg5. Ecancermedicalscience. 17:1553.PMID: 37377679

      175. Scheltes D, Mohanty S, Smits G, Steen-Banasik E, Murthy V, Hoskin P (2023). Improving quality of life with brachytherapy for urological malignancies. Clinical Oncology. 35(8):516-523. PMID: 36764876

      176. Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT, Nout R, Nesvacil N, de Leeuw A, Pötter R, Kirisits C; EMBRACE Collaborative Group (2023). Risk factors for local failure following chemoradiation and magnetic resonance image-guided brachytherapy in locally advanced cervical cancer: Results from the EMBRACE-I Study. Journal of Clinical Oncology. 41(10):1933-1942 PMID: 36599120

      177. Sengar M, Jain H, Shet T, Sridhar E, Gota V, Rangarajan V, Laskar SS, Alahari A, Thorat J, Agarwal A, Sharma N, Gupta H, Kannan S, Kumar S, Nayak L, Menon H, Gujral S, Bagal B (2023). Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas. British Journal of Haematology. 200(4):429-439. PMID: 36323643.

      178. Setia P, Bargir UA, Shanmukhaiah C, Jodhawat N, Gaikwad P, Vedpathak D, Dutta S, Kulkarni R, Kambli P, Dalvi A, Shinde S, Gupta M, Nambiar N, Sawant S, Shelar S, Dhawale A, Mohanty M, Yadav RM, Bose K, Madkaikar M (2023). Expanding the clinical phenotype of FADD deficiency with a novel mutation and its role in Fas-mediated apoptotic pathway. British Journal of Haematology. 202(2):e11-e15. PMID: 37199216

      179. Shabrish S, Chandrakasan S, Madkaikar M (2023). NK cell defects: diagnosis and treatment. Frontiers in Immunology. 14:1323793. PMID: 38022628

      180. Shabrish S, Pal K, Khare N, Satsangi D, Pilankar A, Jadhav V, Shinde S, Raphael N, Sriram G, Lopes R, Raghuram G, Tandel H, Mittra I (2023). Cell-free chromatin particles released from dying cancer cells activate immune checkpoints in human lymphocytes: Implications for cancer therapy. Frontiers in Immunology.

      181. Shaikh MR, Singh B, Halder R, Singh R, Shaikh MR, Agarwal N, Bansal N, Ahmed R, Mirgh SP, Bhurani D (2023). FLAG based v/s Standard 3 + 7 induction therapy in treatment naïve Acute Myeloid Leukemia: Time to think "beyond anthracyclines". Leukemia Research. 132:107346. PMID: 37467566

      182. Shaikh ZM, Bhatia N, Aradhye P, Anbarasu A, Gawde J, Thorat R, Mahimkar MB (2023). Thearubigins/Polymeric black tea polyphenols (PBPs) do not prevent benzo[a]pyrene (B[a]P) induced lung tumors in A/J mice. American Journal of Translational Research. 15(9):5826-5834.PMID: 37854224

      183. Sharma D, Pawar SN, Sulkshane P, Waghole R, Yasser M, Pawar SS, Kannan S, Chaudhary N, Kalwar A, Patil R, Nair S, Dalal SN, Teni T (2023). Elevated translationally controlled tumour protein promotes oral cancer progression and poor outcome. Journal of Oral Pathology and Medicine. 52(9):849-859. PMID: 37573872.

      184. Shenoy R, Rao AR, Rane P, Noronha V, Kumar A, Pillai A, Pathak S, Gattani S, Sehgal A, Kumar S, Castelino R, Dhekale R, Krishnamurthy J, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajam P, Timmanpyati S, Nokala M, Chitra A, Kapoor A, Gota V, Banavali S, Prabhash K, Ramaswamy A. Validation of the Onco-MPI in predicting short-term mortality in older Indian patients with cancer. Journal of Geratric Oncology. 14(6): 101550. PMID: 37327761

      185. Shrivastav G, Datta D, Wadasadawala T, Rane P, Panda S, Pathak R, Scaria L, Krishnamurthy R, Sarin R. (2023). Clinical audit of breast cancer patients treated with helical tomotherapy for irradiation of the internal mammary chain. Journal of Radiotherapy in Practice.22:E23.

      186. Shruti T, Khanna D, Khan A, Dandpat A, Tiwari M, Singh AG, Mishra A, Shetty A, Birur P, Chaturvedi P (2023). Status and determinants of early detection of oral premalignant and malignant lesions in India. Cancer Control.PMID: 36809192

      187. Singh A, Shetty D, Patil J, More M, Chatterjee G, Rajpal S, Patkar NV, Subramanian PG, Gujral S, Tembhare PR (2023). Acute basophilic leukemia in a patient with down syndrome: A case report and review of literature. International Journal of Laboratory Hematology. 45(6):972-978. PMID: 37334558

      188. Singh B, Patnaik C, Bahadur R, Gandhi M, De A, Srivastava R (2023). Synthesis and degradation mechanism of renally excretable gold core-shell nanoparticles for combined photothermal and photodynamic therapy. Nanoscale. 15(3):1273-1288. PMID: 36541678.

      189. Singh C, Karunakaran P, Yanamandra U, Jindal N, Kumar S, Saini N, Jandial A, Jain A, Lad D, Prakash G, Khadwal A, Kumar N, Naseem S, Ahluwalia J, Varma N, Varma S, Malhotra P (2023). Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic Leukemia treated with Arsenic Trioxide and All-Trans Retinoic Acid. Leukemia Research. 134:107392. PMID: 37774447

      190. Singh C, Yanamandra U, Karunakaran P, Jindal N, Kumar SR, Saini N, Jandial A, Jain A, Das C, Lad D, Prakash G, Khadwal A, Naseem S, Das R, Varma N, Varma S, Malhotra P (2023). Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre study. British Journal of Haematology. 201(2):249-255. PMID: 36529704.

      191. Sinha S, Pandey S, Salins S, Salins N, Deodhar J, Gupta T, Laskar S, Budrukkar A, Swain M, Kumar A, Murthy V, Nair S, Nair D, Joshi P, Chaturvedi P, Menon N, Patil V, Joshi A, Noronha V, Prabhash K, Agarwal J(2023). Psycho-oncology/supportive care in head–neck cancers patients undergoing radiation therapy: A randomized controlled trial. South Asian Journal of Cancer.

      192. Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia M, Miranda-Filho A, Ferlay J, Parkin D, Ranganathan R, Piñeros M, Znaor A, Mery L, Joko-Fru Y, Dikshit R, Sankaranarayanan R, Swaminathan R, Bray F (2023).Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncology. 24 (1): 22-32. PMID: 36603919

      193. Spampinato S, Tanderup K, Lindegaard JC, Schmid MP, Sturdza A, Segedin B, Jürgenliemk-Schulz IM, De Leeuw A, Bruheim K, Mahantshetty U, Chargari C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Wiebe E, Villafranca E, Van Limbergen E, Pieters BR, Tee Tan L, C H W Lutgens L, Hoskin P, Smet S, Pötter R, Nout R, Chopra S, Kirchheiner K EMBRACE Collaborative Group (2023) Appendix. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors. Radiotheray and Oncology. 181:109501. PMID: 36720348.

      194. Spohn S, Draulans C, Kishan A, Spratt D, Ross A, Maurer T, Tilki D, Berlin A, Blanchard P, Collins S, Bronsert P, Chen R, Pra A, Meerleer G, Eade T, Haustermans K, Hölscher T, Höcht S, Ghadjar P, Davicioni E, Heck M, Kerkmeijer L, Kirste S, Tselis N, Tran P, Pinkawa M, Pommier P, Deltas C, Schmidt-Hegemann N, Wiegel T, Zilli T, Tree A, Qiu X, Murthy V, Epstein J, Graztke C, Gao X, Grosu A, Kamran S, Zamboglou C (2023). Genomic classifiers in personalized prostate cancer radiotherapy approaches – A systematic review and future perspectives based on international consensus. International Journal of Radiation Oncology, Biology Physics. 116(3):503-520.PMID: 36596346

      195. Srinivasan S, Prasad M, Parambil BC, Shrimal A, Gollamudi VRM, Subramani V, Ramadwar M, Khanna N, Baheti AD, Gala K, Patil V, Laskar S, Qureshi S, Chinnaswamy G (2023). Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach. Pediatric Blood Cancer. 70(7):e30302 .PMID: 37046413.

      196. Srinivasan S, Ramanathan S, Kumar S, Peyam S, Radhakrishnan V (2023). Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis. Annals of Hematology. 102(8): 2165-2179. PMID: 37154889

      197. Syamprasad NP, Rajdev B, Jain S, Panda S, Rao Puppala E, Chaudhari P, Rao Vaidya J, Kumar GJ, Naidu VGM (2023). Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis. International Immunopharmacology.119: 110145. PMID: 37044030

      198. Tambe M, D'Silva SZ, Parsaniya B, Pinto AS, Singh M (2023) Identification of HLA-C*03:599 novel allele variant in two South Indian individuals in a Brahmin family. HLA. 101(1):66-67. PMID: 36088573.

      199. Tambe M, D'silva SZ, Pinto AS, Parsaniya B, Singh M (2023). Identification of the novel allele, HLA-A*02:11:01:06, in two North Indian individuals in a Kshatriya family. HLA. 101(1): 43-44. PMID: 36087311

      200. Tambe M, D'Silva SZ, Pinto AS, Singh M (2023). Characterization of the novel HLA-B*58:01:01:19 allele by next-generation sequencing. HLA. 101(2):173-174. PMID: 36239076

      201. Thomas M, Agarwal V, DeSouza A, Joshi R, Mali M, Panhale K, Salvi OK, Ambulkar R, Shrikhande S, Saklani A(2023). Enhanced recovery pathway in open and minimally invasive colorectal cancer surgery: a prospective study on feasibility, compliance, and outcomes in a high-volume resource limited tertiary cancer center. Langenbeck's Archives of Surgery 408(1):99. PMID: 36811742

      202. Tiwari M, Pandey A, Rautham A, Chavan P, Bhat V (2023). Implementation of a quality management system in accordance with ISO15189 - Evaluation of accredited versus non-accredited resource limited medical laboratories in several Indian states. European Chemical Bulletin. 12 (S3):3867 – 3873.

      203. Tongaonkar A, Simha V, Menon N, Noronha V, Bakshi G, Murthy V, Menon S, Sable N, Krishnantry R, Popat P, Palak P, Prakash G, Agarwal A, Jadhav B, Prabhash K, Joshi A. Management of testicular tumours in patients with undescended testes— a challenging but rewarding task: experience from a tertiary care cancer centre in India. ecancermedicalscience.17: 1521. PMID: 37113713

      204. Trivedi B, Chawathey SA, Pinjari AN, Kataria KK. Intraoperative diagnosis of bilateral upper limb arteriovenous fistulae in a child: A case report. A &A Practice. 17(12):e01738. PMID: 38099715.

      205. Trivedi V, Noronha V, Sreekanthreddy P, Desai S, Poojary D, Varghese L, Gowda P, Butle A, Mishra R, Bal M, Mittal N, Rane S, Kane S, Basu S, Patil V, Menon N, Singh AK, Chaturvedi P, Chandrani P, Choughule A, Veldore V, Prabhash K, Dutt A. Association of Cutibacterium acnes with human thyroid cancer. Frontiers in Endocrinology (Lausanne). 14:1152514. PMID: 38027096

      206. Uthale A, Anatram A, Sulkshane P, Degani M, Teni T (2023). Identification of bicyclic compounds that act as dual inhibitors of Bcl-2 and Mcl-1. Molecular Diversity. 27:1359–1374 (2023) PMID: 35909144

      207. Vahabi M, Shahil-Feroz A, Lofters A, Wong JP, Prakash V, Pimple S, Anand K, Mishra G (2023). Surviving the Storm: The Impact of COVID-19 on Cervical Cancer Screening in Low- and Middle-Income Countries. Healthcare. 11(23):3079. PMID: 38063647

      208. Vengurlekar V, Shetty O, Gurav M, Bapat P, Karnik N, Wagh G, Epari S, Rekhi B, Ramadwar M, Desai S. BRAF V600E Mutations and Beyond: A Molecular Perspective of Melanoma from a Tertiary Cancer Referral Center of India. South Asian Journal of Cancer. 12(4):359-370. 1760759. PMID: 38130275

      209. Venkatesulu B, Liauw SL, Joshi M, Brian Baumann B, Yoo R, Roupret M, Choudhury A, Efstathiou J, Murthy V, Sargos P, Solanki A (2023). Multidisciplinary management and radiotherapy recommendations for clinically and pathologically node-positive bladder cancer. Seminars in Radiation Oncology. 33 (1): 35-50. PMID: 36517192

      210. Verghese G, Lennerz JK, Ruta D, Ng W, Thavaraj S, Siziopikou KP, Naidoo T, Rane S, Salgado R, Pinder SE, Grigoriadis A (2023). Computational pathology in cancer diagnosis, prognosis, and prediction - present day and prospects. Journal of Pathology. 260(5):551-563. PMID: 37580849

      211. Verghese G, Li M, Liu F, Lohan A, Kurian NC, Meena S, Gazinska P, Shah A, Oozeer A, Chan T, Opdam M, Linn S, Gillett C, Alberts E, Hardiman T, Jones S, Thavaraj S, Jones JL, Salgado R, Pinder SE, Rane S, Sethi A, Grigoriadis A (2023). Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies. Journal of Pathology. 260(4):376-389. PMID: 37230111

      212. Verma T, Natu A, Khade B, Gera P, Gupta S. An increase in polyadenylation of histone isoforms, Hist1h2ah and Hist2h3c2, is governed by 3'-UTR in de-differentiated and undifferentiated hepatocyte. Experimental Biology and Medicine (Maywood). PMID: 37021545.

      213. Vesprini D, Pathmanathan A, Murthy V. Elective nodal irradiation: Old game, new sport. International Journal of Radiation Oncology, Biology, Physics. 17(3): 610-612.PMID: 37739608

      214. Wadasadawala T, Datta D, Puchali N, Rane P, Sen S, Mohanty S, Gupta S, Sarin R, Parmar V (2023). Prospective Study of Incidence and Impact of Comorbidities on Breast Cancer Survival from India. Asian Pacific Journal of Cancer Prevention. 24(11):3805-3814. PMID: 38019238

      215. Wadasadawala T, Mohanty SK, Sen S, Khan PK, Pimple S, Mane JV, Sarin R, Gupta S, Parmar V (2023). Health-Related Quality of Life (HRQoL) Using EQ-5D-5L: Value set derived for Indian breast cancer ccohort. Asian Pacific Journal Cancer Prevention. 24(4):1199-1207. PMID: 37116141

      216. Wadasadawala T, Patil R, Carlton J, Verma S, Umesh N, Rane P, Sarin R, Pathak R, Bajpai J, Nair N, Shet T, Kaur R (2023). Long-term outcomes and prognostic factors in elderly patients with breast cancer: single-institutional experience. Ecancermedicalscience. 17:1542. PMID: 37377682

      217. Wilson BE, Booth CM, Suvillian R, Aggarwal A, Sengar M, Jacob S, Bray F, Barton MB, Pearson S-A (2023). Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement. Lancet Oncology. 24(6): 682-690. PMID: 37269845

      218. Yadav S, Mittal N, Rane SU, Bal M, Patil A, Ankathi SK, Nair D. Nonsalivary Primary Adenocarcinomas of the Base of Tongue. Archives of Pathology & Laboratory Medicine. 147(11):1278-128 2023 PMID: 36602895.

      219. Zhong AY, Lui AJ, Katz MS, Berlin A, Kamran SC, Kishan AU, Murthy V, Nagar H, Seible D, Stish BJ, Tree AC, Seibert TM (2023). Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation. Radiation Oncology. 18(1):188. PMID: 37950310.
    • 2024
      1. Ambulkar R, Solanki SL, Salunke B, Ps P, Gholap S, Desouza AL, Bakshi SG, Agarwal V (2024). A randomised comparison of transverse abdominal plane block versus thoracic epidural analgesia on postoperative opioid consumption for colorectal enhanced recovery after surgery programme (OPIATE study). Journal of Perioperative Practice.

      2. Ambatipudi S, Inchanalkar M, Mahimkar MB. (2024) Role of DNA methylation-based mitotic ageing indices in oral cancer development and recurrence. Oral Diseases.30(5):2929-2939. PMID: 37846052.

      3. Ambulkar R, Kunte AR, Sarangi A, Nair S, Negussie T, Lima I, Tara M. Long-term sustainability of peri-operative infection control practices: Implementation of "Clean Cut," a checklist-based quality improvement program in India. Surgical Infections. PMID: 38957964.

      4. Anand A, Khanna D, Singh P, Singh A, Pandey A, Budukh A, Pradhan S (2023). Evaluation of medical certification of cause of death in tertiary cancer hospitals in northern India. Health Information Management Journal. 53(2):121-128. PMID: 36680503

      5. Anjikar A, Iwasaki K, Paneerselvam R, Hole A, CM Krishna, Noothalapati H, Dutt S, Yamamoto T (2024). Discernable machine learning methods for Raman micro-spectroscopic stratification of mitoxantrone-induced drug-resistant cells in acute myeloid leukemia. Journal of Raman Spectroscopy.

      6. Aradhye P, Jha S, Saha P, Raghavendra S. Patwardhan R, Noothalapati H, CM Krishna, Patwardhan S (2024). Distinct spectral signatures unfold ECM stiffness-triggered biochemical changes in breast cancer cells. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 311: 123994. PMID: 38354672

      7. Arun B, Joshi M, Kakkar AK, Madki S, Ivaturi V, Chinnaswamy G, Banavali S, Gota V (2024). Bioequivalence study followed by model-informed dose optimization of a powder for oral suspension of 6-mercaptopurine. Pediatric Blood & Cancer. 71(3): e30813.PMID: 38110844

      8. Baliga S, Abou-Foul AK, Parente P, Szturz P, Thariat J, Shreenivas A, Nankivell P, Bertolini F, Biau J, Blakaj D, Brennan S, Brunet A, De Oliveira TB, Burtness B, Maseda AC, Chow VL, Chua ML, de Ridder M, Garikipati S, Hanai N, Ho FCH, Huang SH, Kiyota N, Klinghammer K, Kowalski LP, Kwong DL, McDowell LJ, Merlano MC, Nair S, Economopoulou P, Overgaard J, Psyrri A, Tribius S, Waldron J, Yom SS, Mehanna H. (2024) Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database. European Journal of Cancer. 203:114038. PMID: 38579517

      9. Barua SA, Choudhary RK, Gawde J, Mishra N, Varma AK (2024). Structural dynamics of clinically-reported VUS in the BARD1 ARD-BRCT region to predict the molecular basis of alterations. Journal of Biomolecular Structure and Dynamics.42(11):5475-5484. PMID: 37418175

      10. Bathla P, Mujawar A, De A, Sandanaraj B (2024). Development of noninvasive activity-based protein profiling-bioluminescence resonance energy transfer platform technology enables target engagement studies with absolute specificity in living systems. ACS Pharmacology & Translational Science

      11. Bhardwaj P, Arora B, Saxena S, Singh S, Palkar P, Goda J, Banerjee R (2024). Paper-based point of care diagnostics for cancer biomarkers. Sensors and Diagnostics. 3: 504-535.

      12. Biswas C, Shetty PM, Sahu A, Velayutham P, Singh V, Shah K, Moiyadi AV (2024). Factors affecting the extent of resection and neurological outcomes following transopercular resection of insular gliomas. Acta Neurochirurgica. 166(1):244. PMID: 38822919

      13. Biswas S, Anadon CM, Conejo-Garcia JR (2024). Antibodies target intracellular oncodrivers through PIGR-mediated transcytosis. Genes & Immunity. 25(1):85-86. PMID: 38092884.

      14. Budukh A, Dora T, Sancheti S, Singh V, Goel A, Bagal S, Kaur A, Manchanda I, Kaur G, Gulia A, Chaturvedi P, Badwe R (2024). Outcome of early detection approach in control of breast, cervical, and oral cancer: Experience from a rural cancer center in India. International Journal of Cancer. PMID: 38642029.

      15. Chakraborty A, Mitra A, Sahu S, Tawate M, Lad S, Kamaldeep, Rakshit S, Upadhye Bannore T, Gaikwad S, Dhotre G, Ray MK, Damle A, Basu S, Banerjee S (2024). Intricacies in the preparation of patient doses of [177Lu]Lu-Rituximab and [177Lu]Lu-Trastuzumab using low specific activity [177Lu]LuCl3: Methodological Aspects. Molecular Imaging and Biology. 26(1):61-80. PMID: 37673943

      16. Chakravarti P, Patel K, Budukh A, Khanna D, Chaturvedi P, Pradhan S, Dikshit R, Badwe R (2024). Cancer screening uptake by women from India’s largest state Uttar Pradesh: District-wise analysis from the fifth round of National Family Health Survey (2019–2021). Ecancermedicalscience

      17. Charnalia M, Chopra S, Mulani J, Popat P, Rath S, Thomeer M, Mittal P, Gupta A, Boere I, Gupta S, Nout RA (2024). RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials. International Journal of Gynecological Cancer. PMID: 38649234.

      18. Chatterjee G, Dhende P, Raj S, Shetty V, Ghogale S, Deshpande N, Girase K, Patil J, Kalra A, Narula G, Dalvi K, Dhamne C, Moulik NR, Rajpal S, Patkar NV, Banavali S, Gujral S, Subramanian PG, Tembhare PR (2023). 15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challenges. European Journal of Haematology. 112(1):122-136.PMID: 37706583

      19. Chatterjee S, Ganguly A, Bhattacharyya D (2024). Reprogramming nucleolar size by genetic perturbation of the extranuclear Rab GTPases Ypt6 and Ypt32. FEBS Letters.598 (3): 283-301. PMID: 37994551.

      20. Chaubal R, Gardi N, Joshi S, Pantvaidya G, Kadam R, Vanmali V, Hawaldar R, Talker E, Chitra J, Gera P, Bhatia D, Kalkar P, Gurav M, Shetty O, Desai S, Krishnan NM, Nair N, Parmar V, Dutt A, Panda B, Gupta S, Badwe R (2024). Surgical tumour resection deregulates Hallmarks of Cancer in resected tissue and the surrounding microenvironment. Molecular Cancer Research. PMID: 38394149.

      21. Chaudhari N, Choudhary BS, Shivashankar A, Manna S, Ved K, Shaikh S, Khanna S, Barr J, Dani J, Verma N (2024). EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI. bioRxiv.

      22. Chichra A, Nayak L, Kothari R, Kalantri S, Bonda A, Gokarn A, Punatar S, Mirgh S, Jindal N, Bagal B, Kannan S, Mathew L, Khattry N. Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis. International Journal of Hematology. 119(1):71-79. PMID: 37952243.

      23. Chopra S, Bosse T, Horeweg N, Deodhar K, Menon S, Rafael T, Pai V, Rijstenberg L, Kemenade F, Kannan S, Mahantshetty U, Segedin B, Huang F, Bruheim K, Perez M, Rai B, Tan L, Giannakopoulus N, Schmid M, Tanderup K, Pötter R, Nout R (2024). Biomarker expression and impact on clinical outcomes in an international study of chemoradiation and MRI-based image-guided brachytherapy for locally advanced cervical cancer: BIOEMBRACE. International Journal of Radiation Oncology, Biology, Physics

      24. Choudhary BS, Chaudhary N, Vijan A, Mandal D, Pilankar L, Gawand S, Khan B, Shivashankar A, Doloi R, Joshi N, Das M, Dalal SN (2024). LCN2 promotes focal adhesion formation and invasion by stimulating Src activation. bioRxiv.

      25. Colaco V, Goswami N, Goel VK, Srivastava SK, Lalrohlua P, Senthil Kumar N, Borah P, Baruah R, Varma AK (2024). In silico and structure-based evaluation of deleterious mutations identified in human Chk1, Chk2, and Wee1 protein kinase. Journal of Cellular Biochemistry. 125(1):89-99. PMID: 38047473.

      26. Dalal N, Dandia H, Ingle A, Tayalia P (2024). Surface-modified injectable poly(ethylene-glycol) diacrylate-based cryogels for localized gene delivery. Biomedical Physics & Engineering Express. 10(4) PMID: 38772344.

      27. Deshmukh V, Chiplunkar S, Sardeshmukh S, Patil T, Shinde J, Gupta V, Gujar S, Sardeshmukh N, Pathak S, Chavan S, Pradhan T, Godbole J (2024). Selective adjuvant ayurvedic treatment modulates immune response and oxidative stress in patient with carcinoma of pyriform fossa, undergoing radiotherapy: A case study. Complementary Medicine Research.

      28. Dandia HY, Pillai MM, Sharma D, Suvarna M, Dalal N, Madhok A, Ingle A, Chiplunkar SV, Galande S, Tayalia P (2024). Acellular scaffold-based approach for in situ genetic engineering of host T-cells in solid tumor immunotherapy. Military Medical Research.PMID: 38173045

      29. Das RP, Gandhi KA, Singh BG, Gota V, Kunwar A (2024). Preparation of protein nanoparticles using diselenide functionalized gelatin for redox responsive release of doxorubicin. Journal of Drug Delivery Science and Technology. 92:105281.

      30. Desai S, Ahmad S, Bawaskar B, Rashmi S, Mishra R, Lakhwani D, Dutt A. Singleton mutations in large-scale cancer genome studies: uncovering the tail of cancer genome. NAR Cancer. 6(1):zcae010. PMID: 38487301

      31. Deshpande A, Varghese R, Pal K (2024). On-demand male contraceptives: gazing at the long road ahead. International Journal of Impotence Research. 36(4):450-451.PMID: 37165198

      32. Dharavath B, Butle A, Chaudhary A, Pal A, Desai S, Chowdhury A, Thorat R, Upadhyay P, Nair S, Dutt A (2024). Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implications. NPJ Precision Oncology. 8(1):63. PMID: 38438481.

      33. Digholkar G, Varghese R, Pal K, Sharma R (2024). Adipose-derived stem cells: an upcoming novel therapeutic in the management of Erectile dysfunction post radical prostatectomy in prostate cancer patients.International Journal of Impotence Research.PMID: 38443556

      34. Dixit J, Gupta N, Kataki A, Roy P, Mehra N, Kumar L, Singh A, Malhotra P, Gupta D, Goyal A, Rajsekar K, Krishnamurthy MN, Gupta S, Prinja S (2024). Health-related quality of life and its determinants among cancer patients: evidence from 12,148 patients of Indian database. Health and Quality of Life Outcomes. 22(1):26

      35. Dorff T, Kashid SR, Murthy V, Lombardo R, De Nunzio C (2024). Prostatectomy in oligometastatic prostate cancer: a call for high-quality evidence.Prostate Cancer and Prostatic Diseases.PMID: 38643307.

      36. Dwivedi P, Kumar Jha A, Mithun S, Sawant V, Vajarkar V, Chauhan M, Choudhury S, Rangarajan V (2024). Dose estimation in patients from different protocols of 18F-FDG PET/CT studies and analysis of optimization strategies. Radiation Protection Dosimetry.

      37. Eekers D, Zegers C, Ahmed K, Amelio D, Gupta T, Harrabi S, Kazda T, Scartoni D, Seidel C, Shih H, Minniti G (2024). Controversies in neuro-oncology: focal proton versus photon radiation therapy for adult brain tumors. Neuro-Oncology Practice.

      38. Giri S, Harindranath S, Mohan BP, Jearth V, Varghese J, Kozyk M, Kale A, Sundaram S. Adverse events with endoscopic ultrasound-guided gastroenterostomy for gastric outlet obstruction-A systematic review and meta-analysis. United European Gastroenterology Journal. 12(7):879-890.

      39. Gadewal N, Natu A, Sen S, Rauniyar S, Bastikar V, Gupta S (2024). Integrative epigenome-transcriptome analysis unravels cancer-specific over-expressed genes potentially regulating immune microenvironment in clear cell renal cell carcinoma.Biochimica et Biophysica Acta (BBA) - General Subjects. 1868(5): 130596. PMID: 38471632

      40. Gundavda KK, Patkar S, Kannan S, Varty GP, Nandy K, Shah T, Polusany K, Solanki SL, Kulkarni S, Shetty N, Gala K, Ostwal V, Ramaswamy A, Bhargava P, Goel M (2024). Realizing textbook outcomes following liver resection for hepatic neoplasms with development and validation of a predictive nomogram. Annals of Surgical Oncology.

      41. Gaikwad P, Hole A, Saxena V, Choudhary S, Nath B, CM Krishna, Mukhopadhyaya R (2024). Vibrational spectroscopic detection of radiation-induced structural changes in Chironomus hemoglobin. Biochemistry and Biophysics Reports. 38: 101721.

      42. Gardi NL, Chaubal R, Parab P, Pachakar S, Kulkarni SS, Shet T, Joshi S, Kembhavi Y, Chandrani P, Quist J, Kowtal P, Grigoriadis A, Sarin R, Govindrajan R, Gupta S (2024). Natural history of germline BRCA1 mutated and BRCA wild-type triple-negative breast cancer. Cancer Research Communications PMID: 38315150.

      43. Garg M, Gandhi K, Gera P, Jadhav S, Mohanty B, Gurjar M, Sandupatla B, Gala R, Chaudhari P, Prasad M, Chinnaswamy G, Gota V (2024). Implications of chronic moderate protein-deficiency malnutrition on doxorubicin pharmacokinetics and cardiotoxicity in early post-weaning stage. Life Sciences. 350:122765. PMID: 38830506

      44. Gaur T, Ali A, Sharma D, Gupta SK, Gota V, Bagal B, Platzbeckar U, Mishra R, Dutt A, Khattry N, Mills K, Hassan Md., Sandur S, Hasan SK (2024). Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia. Cellular Signalling. 14: 111004.PMID: 38048856

      45. Ghosh-Laskar S, Sinha S, Kumar A, Samanta A, Mohanty S, Kale S, Khan F, Salins S, Murthy V (2024). Reducing salivary toxicity with adaptive radiotherapy (ReSTART): A randomized controlled trial comparing conventional IMRT to adaptive IMRT in head and neck squamous cell carcinomas. Clinical Oncology.36(6):353-361. PMID: 38575432

      46. Ghosh S, Goda J, Chatterjee A, Shetty P,Sahay A, Dasgupta A, Epari S, Sahu A, Singh V, Gupta T, Moiyadi A, Jalali R. Clinical outcomes following surgery and radiation therapy in a real world setting. World Neurosurgery. 181:e809-e819. PMID: 37923012.

      47. Gohil D, Gandhi K, Gupta SK, Gera P, Yadav S, Patwardhan R, Checker R, Sharma D, Khattry N, Sandur S, Gota V (2024). Immunomodulation by juglone alleviates acute graft-versus-host disease without compromising the graft-versus-leukaemia activity in mice. British Journal of Pharmacology. PMID: 38584000

      48. Guha A, Halder S, Shinde S, Gawade J, Munnolli S, Talole S, Goda J (2024). How does deep learning/ machine learning perform in comparison to radiologists in distinguishing Glioblastomas (or grade IV Astrocytomas) from Primary CNS lymphomas?: A meta-analysis and systematic review. Clinical Radiology.79(6):460-472. PMID: 38614870

      49. Gupta SK, Gohil D, Momin MB, Yadav S, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Hingorani L, Khattry N, Gota V (2024). Withania somnifera extract mitigates experimental acute graft versus host disease without abrogating graft versus leukemia effect. Cell Transplantation. 33:9636897241226573. PMID: 38258793.

      50. Gupta T, Chatterjee A (2024). Existing and evolving landscape of medulloblastoma: Towards optimization and personalization. Diagnostics. 14(6): 598.

      51. Gupta T, Mani S, Chatterjee A, Dasgupta A, Epari S, Chinnaswamy G (2024). Risk-stratification for treatment de-intensification in WNT-pathway medulloblastoma: finding the optimal balance between survival and quality of survivorship. Expert Review of Anticancer Therapy.24(7):589-598. PMID: 38761170

      52. Hande V, Ranjan N, Chopra S, Sinha S, Mittal P, Gupta A, Maheshwari A, Gupta S (2024). Longitudinal costs of image-guided intensity-modulated radiation therapy versus three-dimensional conformal radiation: Lessons from phase III PARCER trial for shaping resource-stratified guidelines in low- and middle-income countries. JCO Global Oncology. PMID: 38484193

      53. Huck C, Achard V, Maitre P, Murthy V, Zilli T (2024). Stereotactic body radiation therapy for prostate cancer after surgical treatment of prostatic obstruction: Impact on urinary morbidity and mitigation strategies. Clinical and Translational Radiation Oncology. 45: 100709.

      54. Jadhav P, Hole A, Sivaprasad M, Viswanath K, Sahay M, Sahay R, Reddy GB, CM Krishna (2024). Raman spectroscopy analysis of plasma of diabetes patients without and with retinopathy, nephropathy, and neuropathy. Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy. 304:123337. PMID: 37703793

      55. Jadhav PA, Hole A, Ingle A, Govekar R, Noothalapati H, Krishna CM (2024). Serum Raman spectroscopy: Evaluation of tumour load variations in experimental carcinogenesis. Journal of Biophotonics. PMID: 38229194.

      56. Jaganmurugan R, Arora A, chandankhede U, Prakash G, Bakshi G, Joshi A, Menon S, Murthy V, Pal M (2024). Prognostic significance of lymph node density in pathological Node positive urothelial carcinoma of the bladder -Upfront surgery and post neoadjuvant chemotherapy cohorts. Clinical Genitourinary Cancer. 22(2):385-393. PMID: 38245435

      57. Jain Y, Agrawal A, Joshi A, Menon S, Gagan P, Murthy V, Purandare N, Shah S, Puranik A, Choudhury S, Shukla V, Dev I, Kumar P, Noronha V, Rangarajan V (2024). Can 18F FDG PET/CT metabolic parameters be used to noninvasively differentiate between different histopathological subtypes and Fuhrman grades of renal cell cancer? Nuclear Medicine Communications.45(7):601-611.PMID: 38686492

      58. James ND, Tannock I, N'Dow J, Feng F, Gillessen S, Ali SA, Trujillo B, Al-Lazikani B, Attard G, Bray F, Compérat E, Eeles R, Fatiregun O, Grist E, Halabi S, Haran Á, Herchenhorn D, Hofman M, Jalloh M, Loeb S, MacNair A, Mahal B, Mendes L, Moghul M, Moore C, Morgans A, Morris M, Murphy D, Murthy V, Nguyen PL, Padhani A, Parker C, Rush H, Sculpher M, Soule H, Sydes MR, Tilki D, Tunariu N, Villanti P, Xie LP (2024). The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet.403(10437):1683-1722. PMID: 38583453

      59. Jindal N, C M, Mathew LJ, Kumbhalwar K, Patel K, Garg M, Mirgh S, Chichra A, Nayak L, Bonda A, Gokarn A, Punatar S, Bagal B, Khattry N (2024. Fertility outcomes in patients desiring conception following autologous stem cell transplantation for hodgkin lymphoma using LACE conditioning. Bone Marrow Transplantation. 59: 417–418. PMID: 38102211.

      60. Joshi P, Bavaskar M, Shetty R, Singh A, Nair S, Chaturvedi P. Local flap reconstructions in oral cavity defects: An insight from 104 Cases. Rambam Maimonides Medical Journal. 15(3: e0012.

      61. Joshi R, Goswami D, Saha P, Hole A, Mandhare P, Wadke R, Murthy P, Borgohain S, CM Krishna, Kapoor S (2024). Serum Raman spectroscopy: Unearthing the snapshot of distinct metabolic profile in patients with Congenital Heart Defects (CHDs). Heliyon.

      62. Juthani R, Punatar S, Mittra I (2024). New light on chemotherapy toxicity and its prevention. BJC Reports. 2:41

      63. Kadam S, Jadhav P, Singh R, Hole A, Sawardekar S, CM Krishna, Barage S (2024). Raman spectroscopic characterization of local rice germplasm from konkan region of Maharashtra. Food Analytical Methods.

      64. Kumar P, Shanbhag N, Chaudhari P, Mohanty B, Thakur R, Gopalkrishnan MS (2024). Radiolabeling and preclinical evaluation of technetium-99m labeled colistin. Applied Radiation and Isotopes

      65. Kafle Dahal U, Dhimal M, Budukh A, Khadka K, Poudel S, Baral G, Gyanwali P, Jha AK, Chapagain S (2024). Burden of tobacco-related cancers in urban, semi-urban and rural setting of Nepal: Findings from population-based cancer registries 2019. PLoS One. 19(5): e0300271. PMID: 38805435

      66. Kashid S, Gurram L, Pullan S, Chopra S, Mittal P, Ghadi Y, Dheera A, Scaria L, Kolhe S, Kadam S, Ghosh J, Rath S, Gupta S, Mahantshetty U (2024). Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data. Brachytherapy. PMID: 38641455

      67. Kekatpure V, Subramaniam N, Sunny S, Nambiar S, Sarah T, Vasudevan V, Rao A, Murali A, Kolur T, Krishnamurthy A, Kantharia R, Nair SV, Thankappan K, M N B, Kumar R, Balasubramanian S, Toprani R, Agrawala S, Battoo AJ, Bakshi J, Babu S, Shah S, Trivedi N, Selvam S, Kannan R, Kumar A, Suresh A, Pillai V, Chaturvedi P, Iyer S, Kuriakose MA. Two by Two Factorial Design using Metformin and Curcumin for Second Primary Head and Neck Cancer Prevention Trial. Asian Pacific Journal of Cancer Prevention. 25(6):1935-1943. PMID: 38918654.

      68. Ketkar M, Desai S, Rana P, Thorat R, Epari S, Dutt A, Dutt S (2024). Inhibition of PERK mediated UPR acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma. Neuro Oncology. PMID: 39021199.

      69. Khanna D, Sharma P, Budukh A, Vishwakarma R, Sharma AN, Bagal S, Tripathi V, Maurya VK, Chaturvedi P, Pradhan S. Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry. BMC Cancer. 2024 Mar 6;24(1):308. PMID: 38448839.

      70. Koli S, Shetty S (2024). Ribosomal dormancy at the nexus of ribosome homeostasis and protein synthesis. Bioessays. 46(7): e230024. PMID: 38769702.

      71. König C, Ivanisenko N, Hillert-Richter L, Namjoshi D, Natu K, Espe J, Reinhold D, Kolchanov N, Ivanisenko V, Kähne T, Bose K, Lavrik I (2024). Targeting type I DED interactions at the DED filament serves as a sensitive switch for cell fate decisions. Cell Chemical Biology.

      72. Kumar A, Sonkusare L, Noronha V, Deodhar J, Rao A, Kumar S, Castellino R, Gattani S, Dhekale R, Krishnamurthy J, Mahajan S, Daptadar A, Ansari N, Vagal M, Gota V, Mahajan P, Nookala M, Chitre A, Banavali S, Prabhash K, Ramaswamy A. (2024) An analysis of psychological problems in older Indian patients with cancer. Journal of Geriatric Oncology. 15(4):101744. PMID: 38538494

      73. Kumar S, Castelino R, Rao A, Gattani S, Kumar A, Pillai A, Sehgal A, Rane P, Ramaswamy A, Dhekale R, Krishnamurthy J, Banavali S, Badwe R, Prabhash K, Noronha V, Gota V (2024). Performance of potentially inappropriate medications assessment tools in older Indian patients with cancer. Cancer Medicine.13(1):e6797. PMID: 38183404

      74. Laibl S, André F, Bachelot T...Guarneri V, Gupta S...Harbeck N on behalf of the ESMO Guidelines Committe (2024). Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 35(2):159-182. PMID: 38101773

      75. Lonare A, Raychaudhuri K, Shah S, Madhu G, Sachdeva A, Basu S, Thorat R, Gupta S, Dalal SN (2024). 14-3-3σ restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer. International Journal of Cancer.

      76. Lokhande M, Kannusamy S, Oak A, Cheulkar S, Chavan S, Mishra V, Gode P, Thakadiyil AS, Mendhe S, Kadam S, Balasubramaniam G, Chaturvedi P, Dikshit R (2024). A hospital-based study of survival in oral cancer patients of Tata Memorial Hospital, Mumbai. Ecancermedicalscience. 18:1669. PMID: 38439812

      77. Mailankody S, Godkhindi VM, Udupa K, Pai A, Budukh A, Noronha V, Prabhash K, Rajaraman S. A glimpse into the Epidemiology of Geriatric Cancers in India: Report from the Indian Population Based Cancer Registries. Asian Pacific Journal of Cancer Prevention. 25(6):2011-2022.PMID: 38918663.

      78. Maitre P, Maheshwari G, Sarkar J, Singh P, Kannan S, Dutta S, Phurailatpam R, Raveendran V, Prakash G, Menon S, Joshi A, Pal M, Arora A, Murthy V. (2024). Late urinary toxicity and QOL with pelvic radiotherapy for high-risk prostate cancer: Dose-effect relations in the POP-RT randomized phase III trial. International Journal of Radiation Oncology Biology Physics. PMID: 38552989

      79. Mani S, Chatterjee A, Dasgupta A, Shirsat N, Pawar A, Epari S, Sahay A, Sahu A, Moiyadi A, Prasad M, Chinnaswamy G, Gupta T (2024). Clinico-Radiological Outcomes in WNT-Subgroup Medulloblastoma. Diagnostics (Basel). 14(4):358. PMID: 38396397

      80. Manikandan M, Chhatar S, Dey S, Panda TR, Chakraborty S, Ray P, Patra C, Patra M (2024). Analysis of antiangiogenic potential and cell death mechanism of a kinetically inert platinum antitumor agent. ACS Medicinal Chemistry Letters. 15(9): 1482-1490.

      81. Murli D, Smriti V, Yadav S, Trivedi B, Qureshi SS (2024). Desmoid Fibromatosis of the oesophagus creating an oesophageal diverticulum in a 2-year-old girl. African Journal of Paediatric Surgery . 21(3):210-212

      82. Moirangthem R, Hosseini B, Patil A, George G, Manjrekar A, Doibale P, Golapkar S, Panse N, Krishnatreya M, Mishra A, Singh A, Chaturvedi A, Chaturvedi P, Dikshit R, Olsson A, Mhatre S (2024). Occupations and the risk of buccal mucosa cancer in Indian men: A multi-centre case-control study. Cancer Epidemiology. 92:102644.

      83. Manikandan M, Chhatar S, Gadre S, Paul S, Vaidya SP, Khatri S, Duari P, Kode J, Ingle A, Kolthur-Seetharam U, Patra M (2023). Improving in vivo tumor accumulation and efficacy of platinum antitumor agents by electronic tuning of the kinetic lability. Chemistry- A European Journal. 30(4): e202302720. PMID: 37888749.

      84. McLeod M, Torode J, Leung K, Bhoo-Pathy N, Booth C, Chakowa J, Gralow J, Ilbawi A, Jassem J, Parkes J, Mallafré-Larrosa M, Mutebi M, Pramesh CS, Sengar M, Tsunoda A, Unger-Saldaña K, Vanderpuye V, Yusuf A, Sullivan R, Aggarwal A (2024). Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study. Lancet Oncology. 25(2):e63-e72.PMID: 38301704

      85. Mhatre SS, Bragg F, Panse N, Judge PK, Manjrekar A, Burrett JA, Patil S, Davey Smith G, Kotkar L, Relton CL, Doibale P, Gadhave B, Chaturvedi P, Sherliker P, Jha P, Lewington S, Dikshit R (2024). Cohort Profile: Indian study of healthy ageing (ISHA-Barshi). International Journal of Epidemiology. 53(4): dyae079.

      86. Mirian C, Jensen LR, Juratli TA, Maier AD, Torp SH, Shih HA, Morshed RA, Young JS, Magill ST, Bertero L, Stummer W, Spille DC, Brokinkel B, Oya S, Miyawaki S, Saito N, Proescholdt M, Kuroi Y, Gousias K, Simon M, Moliterno J, Prat-Acin R, Goutagny S, Prabhu VC, ...Jensen R, Gupta T...et al. The importance of considering competing risks in recurrence analysis of intracranial meningioma. Journal of Neurooncology. 166(3):503-511. PMID: 38336917.

      87. Mishra N, Dubey S, Kumari A, Khan MA, Kuligina ES, Preobrazhenskaya EV, Romanko AA, Yadav LR, Sarin R, Imyanitov EN, Varma AK (2024). Structural implications of amyloidogenic rare variants Ser282Leu and Gln356Arg identified in h-BRCA1. Proteins. 92(4):540-553. PMID: 38037760.

      88. Mishra SV, Banerjee A, Sarkar D, Thangarathnam V, Bagal B, Hasan SK, Dutt S (2024). DNA-PKcs mediated transcriptional regulation of TOP2β drives chemoresistance in acute myeloid leukemia. Journal of Cell Science. PMID: 38240344

      89. Mittra I (2024). Exploiting the damaging effects of ROS for therapeutic use by deactivating cell-free chromatin: The alchemy of resveratrol and copper. Frontiers in Pharmacology.

      90. Mohamad O, Zamboglou C, Zilli T, Murthy V, Aebersold D, Loblow A, Guckenberger M, Shelan M (2023). Safety of ultra-hypofractionated pelvic nodal irradiation in the definitive management of prostate cancer: Systematic review and meta-analysis. International Journal of Radiation Oncology, Biology, Physics. 118(4):998-1010.PMID: 37863241

      91. Mohanty S, Patil D, Joshi K, Gamre P, Mishra A, Khairnar S, Kakoti S, Nayak L,Punatar S, Jain J, Phurailaptam R, Goda J (2024). Dosimetric impact of voluntary Deep Inspiration Breath Hold (DIBH) in mediastinal hodgkin lymphomas: A comparative evaluation of three different Intensity Modulated Radiation Therapy (IMRT) delivery methods using voluntary DIBH and free breathing techniques. Cancers. 16(4): 690. PMID: 38398081

      92. Moharir S, Akotkar L, Aswar U, Kumar D, Gawade B, Pal K, Rane R (2024). Improved pharmacokinetic and pharmacodynamic profile of deuterium-reinforced tricyclic antidepressants doxepin, dosulepin, and clomipramine in animal models. European Journal of Drug Metabolism and Pharmacokinetics. PMID: 38172422

      93. Mujawar A, Dimri S, Palkina KA, Markina NM, Sarkisyan KS, Balakireva AV, Yampolsky IV, De A (2024). Novel BRET combination for detection of rapamycin-induced protein dimerization using luciferase from fungus Neonothopanusnambi. Heliyon10(4): e25553. PMID: 38384550

      94. Multani K, Velayutham P, Moiyadi A (2024). Utility of multimodal Intraoperative Neuromonitoring (IONM) For excision of filum terminale ependymoma in close proximity to Conus. World Neurosurgery. 189:53-54. PMID: 38796147

      95. Nair S, Bavaskar M, Abhishek PT, Singhavi H, Singh A, Shetty R, Joshi P (2024). Surgical management of patients with distant metastasized adenoid cystic carcinoma of the head and neck. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.PMID: 38834502

      96. Nair S, Singhvi H, Joshi K, Shetty R, Joshi P, Ghosh-Lashkar S, Chaturvedi P (2024). Oncological safety and feasibility of posterior marginal mandibulectomy vis-à-vis anterior marginal mandibulectomy in oral cancers. South Asian Journal of Cancer.

      97. Noronha V, Shah M, Pillai A, Menon N, Ramaswamy A, Ostwal V, Rao A, Kumar A, Dhekale R, Shetake A, Mahajan S, Daptardar A, Sonkusare L, Vagal M, Mahajan P, Timmanpyati S, Gota V, Niyogi D, Badwe R, Prabhash K (2024). Geriatric Assessment-guided therapy modification and outcomes in patients with non-metastatic gastroesophageal cancer: A retrospective cohort study. ESMO Gastrointestinal Oncology. 6: 100093.

      98. Nair SM, Sahu A, Dasgupta A, Puranik A, Gupta T (2024). Post-ictal changes presenting as late pseudoprogression on MRI and PET in a patient with diffuse glioma: Case report and brief literature review. The Neuroradiology Journal. 37(2):229-233.PMID: 37002537

      99. Natu A, Verma T, Khade B, Thorat R, Gera P, Dhara S, Gupta S (2024). Histone acetylation: A key determinant of acquired cisplatin resistance in cancer. Clinical Epigenetics. 16:8. PMID: 38172984

      100. Natu K, Dutta S, Bose K (2024). cFLIP – An interacting partner and a novel substrate for pro-apoptotic serine protease HtrA2. Biochemistry and Biophysics Reports. 38: 101682

      101. Ndarukwa S, Flores JA, Rosenblatt E, Berger D, Akbarov K, Hedden N, Chopra S, Hande V, Rubio AP (2024). Brachytherapy Workflow Practices: Analysis of Different Workflow Scenarios in Patients with Cervical Cancer and Impact on IGBT Implementation-An IAEA Study. JCO Global Oncology. PMID: 38386958.

      102. Nguyen NP, Karlsson UL, Page BR, Chirila ME, Vinh-Hung V, Gorobets O, Arenas M, Mohammadianpanah M, Javadinia SA, Giap H, Kim L, Dutheil F, Murthy V, Mallum AA, Tlili G, Dahbi Z, Loganadane G, Blanco SC, Bose S, Natoli E, Li E, Morganti AG (2024). Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group. Frontiers in Oncology. 14:1371752

      103. Nikam S, Gota V, Gupta P, Puntambekar N, Singh A, Chaturvedi P, Villalta P, Hatsukami D, Ahluwalia J, Basu S, Khariwala S, Stepanov I(2024). Variability in addictive and carcinogenic potential of smokeless tobacco products marketed in Mumbai, India: A surveillance study. Lancet Regional Health - Southeast Asia.

      104. Nofal M, Zhuang A, Gebeyehu N, ...Alito T, Ambulkar R. etal. (Clean Cut Investigation Group) (2024). An observational cohort study on the effects of extended postoperative antibiotic prophylaxis on surgical-site infections in low- and middle-income countries. British Journal of Surgery. 111(1): znad438. PMID: 38198157"

      105. Noronha V, Dhanawat A, Patil VM, Menon N, Singh AK, Chaturvedi P, Pai P, Chaukar D, Laskar SG, Prabhash K (2024). Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice. Oral Oncology. 148:106633. PMID: 37988838.

      106. Noronha V, Kapu V, Joshi A, Menon N, Singh A, Prakash G, Menon S, Sable N, Murthy V, Pal M, Arora A, Kumar S, Banavali S, Prabhash K (2024). Clinical profile and outcomes of carcinoma penis patients receiving systemic therapy at an Indian tertiary care centre: A retrospective observational study. Clinical Genitourinary Cancer.

      107. Noronha V, Patil V, Chaturvedi P, Mathrudev V, Menon N, Bhattacharjee A, Singh A, Peelay Z, Chakraborty S, Jadhav M, Alone M, Bhagyavant P, Kolkur M, Srinivas S, Das S, Roy S, Mandal T, Dsouza H, Saha S, Rai R, Srikanth A, Shah D, Khan A, Muthuluri H, Kumar A, Agarwal A, Rajpurohit A, Goli V, Sekar A, Mantri A, Kanteti A, Majumdar S, Khaddar S, Shenoy R, Elamarthi P, Rathnaswamy N, Kashyap L, Abraham G, Booma N, Simha V, Chaukar D, Pai P, Nair S, Laskar S, Nawale K, Naidu P, Salian S, Shelar P, Raulo R, Dhumal S, Prabhash K (2024).Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer. European Journal of Cancer. 200: 113560. PMID: 38306841

      108. Ostwal V, Ramaswamy A, Mandavkar S, Bhargava P, Naughane D, Sunn SF, Srinivas S, Kapoor A, Mishra BK, Gupta A, Sansar B, Pal V, Pandey A, Bonda A, Siripurapu I, Muddu VK, Kannan S, Chaugule D, Patil R, Parulekar M, Dhanawat A, Trikha M, Ghosh J, Noronha V, Menon N, Patil V, Prabhash K, Olver I (2024). Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial. JAMA Network Open. 7(8): e2426076.

      109. Pandya RK, Jijo A, Cheredath A, Uppangala S, Salian SR, Lakshmi VR, Kumar P, Kalthur G, Gupta S, Adiga SK (2024). Differential sperm histone retention in normozoospermic ejaculates of infertile men negatively affects sperm functional competence and embryo quality. Andrology.12(4):881-890. PMID: 37801310.

      110. Patil B, Chavan N, Gota V, Bhaskar V, Kulkarni P. Development and validation of a bioanalytical technique entitled 5-fluorouracil (5FU) used in therapeutic drug monitoring. Research Journal of Pharmacy and Technology. 17(5): 2345-51.

      111. Pant B, Goda J, Gota V (2024). Drug development in LMICs: could the emerging Indian model usher the southeast Asian region? The Lancet Regional Health - Southeast Asia. 29: 100464. Augustine S, Hole A, Sooraj KP, Saini M, Deshmukh A, Gota V, Chaturvedi P, Ranjan M, CM Krishna (2024). Ion beam-induced nanoripples patterns for SERS based saliva analysis to detect oral cavity cancer. Radiation Effects and Defects in Solids.

      112. Patwardhan RS, Gohil D, Singh B, Kumar BK, Purohit V, Thoh M, Checker R, Gardi N, Gota V, Kutala VK, Patwardhan S, Sharma D, Sandur SK (2024). Mitochondrial-targeted curcumin inhibits T-cell activation via Nrf2 and inhibits graft-versus-host-disease in a mouse model. Phytotherapy Research. PMID: 38281735.

      113. Phadte P, Bishnu A, Dey P, M M, Mehrotra M, Singh P, Chakrabarty S, Majumdar R, Rekhi B, Patra M, De A, Ray P (2024). Autophagy-mediated ID1 turnover dictates chemo-resistant fate in ovarian cancer stem cells. Journal of Experimental and Clinical Cancer Research. 43(1):222.

      114. Polusany K, Karun H, Rane S, Thiagarajan S (2024). Does the use of intraoperative frozen section of bone marrow from the cut end of the mandible help assess the adequacy of bone margins following mandibulectomy for oral cancer? Journal of Surgical Oncology.129(8):1501-1506. PMID: 38685722

      115. Prabhash K, Saldanha E, Patil V, Bal M, Reddy P S, Sanjeev A, Kumar R, Poojary D, Noronha V, Menon N, Mittal N, Trivedi V, Nambiar K, Mishra R, Tanwar N, Malhotra R, Pange P, Gupta V, Veldore VH, Chougule A, Chaturvedi P, Dutt A, Chandrani P (2024). RET alterations differentiate molecular profile of medullary thyroid cancer. JCO Precision Oncology. 8:e2300622. PMID: 38754058

      116. Qureshi S, Reddy S, Smriti V, Baheti A, Shah S, Channaswamy G, Prasad M, Parambil B, Gollamudi V, Panjwai P, Ramadwar M, Amin N, Kembhavi S (2024). Impact of surgical timing (primary, delayed, or second look) on surgical morbidity and outcomes in Malignant Germ Cell Tumor of the Ovary in children. Journal of Pediatric Surgery

      117. Raghuram GV, Pal K, Sriram G, Khan A, Joshi R, Jadhav V, Shinde S, Shaikh A, Rane B, Kangne H, Mittra I. Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes. PLoS One. 19(2): e0298042. PMID: 38346047.

      118. Raghuram GV, Tripathy BK, Avadhani K, Shabrish S, Khare NK, Lopes R, Pal K, Mittra I (2024). Cell-free chromatin particles released from dying cells inflict mitochondrial damage and ROS production in living cells. Cell Death Discovery. PMID: 38225229.

      119. Rahman MM, Rahman MS, Islam MR, Gilmour S, Haruyama R, Budukh A, Shankar A, Mishra G, Mehrotra R, Matsuda T, Inoue M, Abe SK (2024). Regional variations and inequalities in testing for early detection of breast and cervical cancer: evidence from a nationally representative survey in India. Journal of Epidemiology. Dizendorf E, Chopra S, Mittal P, Gupta A, Nout R, Sturdza A, Chargari C, Tanderup K, Tharavichitkul E, Tatli H, Jeeva M, Jain J, Panda S, Upreti RR, Ghadi Y, Bhavke A, Kohle S, Bhajbhuje R, Agarwal JP. Gynecological brachytherapy hybrid training: The Tata Memorial Centre and BrachyAcademy experience. Brachytherapy.

      120. Ramaswamy A, Bhargava P, Srinivas S, Kapoor A, Mishra BK, Gupta A, Mandavkar S, Kannan S, Chaugule D, Patil R, Parulekar M, Nashikkar C, Ankathi SK, Kaushal RK, Naughane D, Daddi A, Mer N, Shetty N, Ostwal V (2024). Bevacizumab erlotinib switch maintenance in chemo-responsive advanced gallbladder and cholangiocarcinoma (BEER BTC): A multicenter, open-label, randomized, phase II trial. Journal of Clinical Oncology.

      121. Rai A, Patwardhan R, Jayakumar S, Pachpatil P, Das D, Panigrahi G, Gota V, Sandur S (2024). Clobetasol propionate, a Nrf-2 inhibitor, sensitizes human lung cancer cells to radiation-induced killing via mitochondrial ROS-dependent ferroptosis. Acta Pharmacologica Sinica. PMID: 38480835

      122. Rajak J, Firfire A, Tambe M, D'Silva SZ, Singh M (2024). Identification of the novel HLA-C*01:02:01:74Q and -C*15:02:01:63 alleles in individuals from Madhya Pradesh. HLA. 103(6): e15565. PMID: 38887852.

      123. Rajak J, Firfire A, Tambe M, D'Silva SZ, Singh M (2024). Identification of the HLA-B*15:679 and HLA-C*15:02:01:61 alleles in individuals from eastern India. HLA. 103(6): e15563. PMID: 38887196

      124. Ramaswamy A, Chaudhari V, Srinivas S, Bhargava P, Kannan S, Agarwal A, Seshadri RA, Talwar V, Goel S, Goel V, Singh S, Kayal S, Rebala P, Rao GV, Prajapati B, Parikh D, Kothari J, Kadamapuzha JM, Ramesh H, Kapoor D, Chaudhary A, Gupta A, Sekar A, Misra S, Vishnoi JR, Soni S, Varshney VK, Bairwa SK, Ghosh J, Lavingia V, Bhandare M, Shrikhande SV, Ostwal V (2024). Adjuvant therapy may improve overall survival in high-risk periampullary adenocarcinomas patients - A match-pair analysis from a multi-institutional cohort study (The MIPPAP study). HPB (Oxford). PMID: 39019675.

      125. Ranade M, Epari S, Shetty O, Dhanavade S, Chavan S, Sahay A, Sahu A, Shetty P, Moiyadi A, Singh V, Dasgupta A, Chatterjee A, Kannan S, Gupta T (2024). CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization. Journal of Neuro-oncology. PMID: 38265748.

      126. Ranganathan S, Dee EC, Debnath N, Patel TA, Jain B, Murthy V. Access and barriers to genomic classifiers for breast cancer and prostate cancer in India. International Journal of Cancer. 154(8): 1335-1339. PMID: 37962056.

      127. Rao A, Noronha V, Ramaswamy A, Kumar A, Pillai A, Gattani S, Sehgal A, Kumar S, Castelino R, Dhekle R, Krishnamurthy J, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Chitre A, Kapoor A, Gota V, Banavali S, Badwe R, Prabhash K (2023). Correlation of the geriatric assessment with overall survival in older patients with cancer. Clinical Oncology. 36(1): e61-e71PMID: 37953073

      128. Rao AR, Noronha V, Ramaswamy A, Kumar A, Pillai A, Sehgal A, Castelino R, Dhekale R, Jagtap P, Tripathi V, Satamkar S, Krishnamurthy J, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Chitre A, Kapoor A, Gota V, Banavali S, Badwe RA, Prabhash K. Assessing frailty in older Indian patients before cancer treatment: Comparative analysis of three scales and their implications for overall survival. Journal of Geriatric Oncology. 15(3):101736. PMID: 38428186.

      129. Reddy BRC,Musale D, Kadam D, Lanjekar K, Ogale G, Bhise M, Gore S, Chaturvedi P, Dikshit R, Budukh A (2024). Challenges faced by tobacco quitline services during the COVID-19 pandemic. Journal of Substance Use. 29(3): 376-381.

      130. Roy Moulik N, Keerthivasagam S, Pandey A, Agiwale J, Hegde K, Chatterjee G, Dhamne C, Prasad M, Chichra A, Srinivasan S, Mohanty P, Jain H, Shetty D, Tembhare P, Patkar N, Narula G, Subramanian PG, Banavali S (2024). Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort. British Journal of Haematology. 204(4):1249-1261. PMID: 38098201

      131. Roy S, Mehta D, Paradkar A, Chovatiya G, Waghmare SK (2024). Dab2 (Disabled-2), an adaptor protein, regulates self-renewal of hair follicle stem cells. Communications Biology. 7(1): 525. PMID: 38702433

      132. Sandhbhor P, Palkar P, Bhat P, Bhat S, John G, Goda J (2024). Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy. Nanoscale

      133. Sengupta S, Biswas M, Gandhi KA, Gupta SK, Gera PB, Gota V, Sonawane A (2024). Preclinical evaluation of engineered L-asparaginase variants to improve the treatment of Acute Lymphoblastic Leukemia. Translational Oncology. PMID: 38412663.

      134. Solanki S, Salunke B, Gangakhedkar G, Ambulkar R, Kuberkar D, Bhatt A (2024). Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy- A systematic review. European Journal of Surgical Oncology.

      135. Shetty T, Joshi P, Talole S, Nair S, Chaturvedi P (2024). Factors affecting drain output in oral carcinoma. Journal of Maxillofacial and Oral Surgery.

      136. Shinde U, De A, Godse R, Rathod M, Thorat R, Sharma N, Ansari M, Singh K (2024). Efficacy evaluation of carboplatin -etoposide Co-loaded PLGA microparticles for subconjunctival chemotherapy in retinoblastoma. Journal of Drug Delivery Science and Technology. 92: 105333.

      137. Shivshankar S, Mhamane S, Budukh AM (2024). Representation of Indian and Chinese cancer registries from 1964 to 2017 in Cancer Incidence in Five Continents: Growing burden but low coverage. International Journal of Cancer. PMID: 38357961.

      138. Shivshankar S, Sarade M, Bhojane S, Kolekar S, Patil S, Budukh A. Quality assessment of a rural population-based cancer registry (PBCR) at Ratnagiri, Maharashtra, India for the years 2017-18. Ecancermedicalscience. 18:1672. PMID: 38439807

      139. Srinivasan S, Bolous NS, Batra A, Bharti S, Singh N, Shaikh T, Yadav A, Kanwar V (2024). Cost-effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India. Pediatric Blood and Cancer.

      140. Shruti T, Sharma P, Budukh A, Khanna D (2024). Electronic nicotine delivery system: a narrative review on growing threat to tobacco control and health of the young Indian population. International Journal of Adolescent Medicine and Health. PMID: 38369380

      141. Singh A, Patil J, Ghogale SG, Deshpande N, Girase K, Shetye N, Rajpal S, Chatterjee G, Patkar N, Jain D, Epari S, Shet T, Gujral S, Subramanian PG, Tembhare PR (2024). Utility of leukocyte-associated immunoglobulin-like receptor-1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B-cell non-Hodgkin lymphoma. Cytometry B Clinical Cytometry

      142. Singh A, Sullivan R, Bavaskar M, Shetty R, Joshi P, Nair S, Gupta S, Chaturvedi P, Badwe R (2024). A prospective health economic evaluation to determine the productivity loss due to premature mortality from oral cancer in India. Head Neck. 46(6):1263-1269. PMID: 38622958.

      143. Singh AG, Bavaskar M, Sharin F, Singhavi H, Shetty R, Joshi P, Nair S (2024). The Trans-facial approach for simultaneous resection and reconstruction of retromolar trigone tumors: A pilot study. Journal of Maxillofacial and Oral Surgery.

      144. Singh AG, Chaturvedi P. (2024) Areca nut and oral cancer. Oral Diseases. PMID: 38566541

      145. Singh M, Maitre P, Krishnan A, Adsul K, Sarath MS, Chauhan H, Bishnu P, Phurailatpam R, Singh P, Kamble D, Bakshi G, Pal M, Arora A, Misra A, Prakash G, Murthy V (2024). Late urinary toxicity after extreme or moderate hypofractionated prostate radiotherapy in patients with prior transurethral resection of prostate (TURP). International Journal of Radiation Oncology, Biology,Physics.

      146. Singh S, Mohammad N, Pal K, Pawar V, Saxena S, Khanna P (2024). Sonochemical synthesis of silver nanoparticles using orange juice: Cytotoxic behaviour and applications. Hybrid Advances.6:100220.

      147. Sinha S, Kumar A, Maheshwari G, Mohanty S, Joshi K, Shinde P, Gupta D, Kale S, Phurailatpam R, Swain M, Budrukkar A, Kinhikar R, Ghosh-Laskar S (2024). Development and validation of single-optimization knowledge-based volumetric modulated arc therapy model plan in nasopharyngeal carcinomas. Advances in Radiation Oncology. 9 (1): 101311. PMID: 38260222

      148. Soares A, Bourlon MT, Wong A, Joshi A, Jardim D, Korbenfeld E, Karak FE, Orlandi F, Sze H, Ansari J, Zarba J, Mansour MA, Manneh R, Thirumulai R, Tsai YC, Morsi WA, Powles T. Management of metastatic urothelial carcinoma in Emerging Markets (EM): An expert opinion. Clinical Genitourinary Cancer. PMID: 38228413.

      149. Srinivasan S, Dhamne C, Patkar N, Chatterjee G, Moulik NR, Chichra A, Pallath A, Tembhare P, Shetty D, Subramanian PG, Narula G, Banavali S (2023). KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1. Pediatric Blood Cancer. 71(2): e30791. PMID: 38014874.

      150. Srinivasan S, Keerthivasagam S, Kumar S, Puri A (2024). ASO Author Reflections: Utilizing surveillance imaging techniques for detecting recurrences in patients with extremity sarcomas. Annals of Surgical Oncology. 31(3):2063-2064.PMID: 37851198

      151. Swain M, Budrukkar A, Murthy V, Pai P, Kanoja A, Ghosh-Laskar S, Dushmukh A, Pantvaidya G, Kannan S, Patil V, Noronha V, Prabhash K, Sinha S, Kumar A, Gupta T, Agarwal J (2024). Contralateral nodal relapse in well lateralized oral cavity cancers treated uniformly with ipsilateral surgery and adjuvant radiotherapy with or without concurrent chemotherapy: A retrospective study. Clinical Oncology. PMID: 38365518

      152. Talati VP, Karn V, Gadewal N, Bastikar VA (2024). Mechanistic influence of discreet conformation of human telomerase linker region. Journal of Biomolecular Structure and Dynamics. PMID: 38319038.

      153. Thakur R, Kumar M, Kumar A, Joshi RK, Maheshwari D, Km AM, Venkataswamy M, Mohanty B, Chaudhari P, Mohan HK, Kumar P (2024). Synthesis, preclinical toxicity, and biodistribution of [18F]AVT-011 to assess the P-Glycoprotein function. Cancer Biotherapy and Radiopharmaceuticals.

      154. Tamuli B, Sharma S, Patkar M, Biswas S (2024). Key players of immunosuppression in epithelial malignancies: Tumor-infiltrating myeloid cells and γδ T cells. Cancer Reports. 7(5): e2066. PMID: 38703051

      155. Tembhare PR, Sriram H, Khanka T, Gawai S, Bagal B, Ghogale SG, Deshpande N, Girase K, Patil J, Hasan SK, Shetty D, Ghosh K, Chatterjee G, Rajpal S, Patkar NV, Jain H, Punatar S, Gokarn A, Nayak L, Mirgh S, Jindal N, Sengar M, Khattry N, Subramanian PG, Gujral S. Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant. Hemasphere.8(4): e63. PMID: 38566804

      156. Thorat J, Bhat S, Sengar M, Baheti A, Bothra S, Bhaskar M, Tandon SP, Biswas SK, Salunke GV, Karimundackal G, Tiwari VK, Pramesh CS, Sharma N, Kapu V, Eipe T, Bagal BP, Nayak L, Bonda A, Janu A, Shetty A, Jain H (2024). Clinical utility of stepwise bronchoalveolar lavage fluid analysis in diagnosing and managing lung infiltrates in leukemia/lymphoma patients with febrile neutropenia. JCO Global Oncology. PMID: 38301183.

      157. Trivedi KH, Guha A, Thakur M, Mahajan A, Bhole P, Gupta T. (2024) External validation of the Brain Tumour Reporting and Data System (BT-RADS) in the multidisciplinary managementof post-treatment gliomas. Polish Journal of Radiology. 89: e148-e155. PMID: 38550961

      158. Vaish R, Hawaldar R, Gupta S, Dandekar M, Shah S, Chaukar D, Pantvaidya G, Deshmukh A, Chaturvedi P, Pai P, Nair D, Nair S, Thakur M, Ghosh-Laskr S, Agarwal JP, D'Cruz A (2024). N0 neck trial: Does Intensification of Follow-up (ultrasound + Physical Examination) Influence Outcomes in Early-stage Oral Cancer? European Jounral of Cancer.204: 114064.PMID: 38705028

      159. Varghese R, Pal K, Gota V, Islam MF (2024). Colonic probiotic insufflation: clinical proposal for an economical game-changer for restoration of the gut microbiome in colorectal cancer and beyond. International Journal of Surgery. 110(5): 2515-2519. PMID: 38348859

      160. Verma A, Patel R, Mahale A, Thorat RV, Rath SL, Sridhar E, Moiyadi A, Srivastava S (2024). Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing. OMICS: A Journal of Integrative Biology.28(2):59-75. PMID: 38320249.

      161. Wadasadawala T, Mohanty S, Sen S, Kanala T, Maiti S, Puchali N, Gupta S, Sarin R, Parmar V (2024). Out-of-pocket payment and financial risk protection for breast cancer treatment: prospective study from India. The Lancet Regional Health- Southeast Asia.

      162. Yeole U, Shetty P, Singh V, Moiyadi A.(2024) Pattern of use of intraoperative ultrasound in surgery for brain tumors influences outcomes in glial tumors. British Journal of Neurosurgery. 38(5):1052-1061. PMID: 34927516

      163. Uchinami Y, Dasgupta A, Nishioka K, Handoko, Goda JS, Kim JW, Zaid RM, Kai Yun O, Mehmood H, Chitapanarux I, Chopra S, Aoyama H. Patterns of Care for Brain Metastases in Asia: A real-world survey conducted by the federation of asian organizations for radiation oncology. JCO Global Oncology. 10:e2400222

    • 2015
      1. Agarwal AK, Srinivasan N, Godbole R, More SK, Budnar S, Gude RP, Kalraiya RD. Role of tumor cell surface lysosome-associated membrane protein-1 (LAMP1) and its associated carbohydrates in lung metastasis. J Cancer Res Clin Oncol.141(9): 1563-1574, 2015. PMID: 25614122
      2. Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, Budrukkar A, Mittra I, Gupta S. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: An open-label randomised controlled trial. Lancet Oncol. 16:1380-1388, 2015. PMID: 26363985
      3. Basu S, Thorat R, Dalal SN.MMP7 is required to mediate cell invasion and tumor formation upon Plakophilin3 loss. PLoS One. 10(4): e0123979, 2015. PMID: 25875355
      4. Bendale K, Desai S, Patil A, Chaudhari P,Talekar S, Gaikwad R, Chaudhari D. Giant cavernous splenic haemangioma in a dog. Companion Animal 201(11): 600-603, 2015.
      5. Bhargava S, Malhotra H, Rathore OS, Malhotra B, Sharma P, Batra A, Sharma A, Chiplunkar SV. Anti-leukemic activities of alcoholic extracts of two traditional Indian Medicinal Plants. Leuk Lymphoma 56(11): 3168-3182, 2015. PMID: 25772975
      6. Bhat V, Joshi A, Sarode R, Chavan P. Cytomegalovirus infection in the bone marrow transplant patient. World J Transplant. 5(4): 287-291, 2015. PMID: 26 722656
      7. Bhat VG, Chavan P, Chital N, Poladia P. The external quality assessment scheme (EQAS): Experiences of a medium sized accredited laboratory. Clin Chim Acta. 445: 61-63, 2015. PMID: 25882227
      8. Bhat VG, Chavan P, Ojha S, Nair PK. Challenges in the laboratory diagnosis and management of dengue infections. Open Microbiol J. 9: 33-37, 2015. PMID: 4676044
      9. Bhattacharjee T, Khan A, Kumar P, Ingle AD, Maru G, CM Krishna. Raman spectroscopy of serum: A study on ‘pre’ and ‘post’ breast adenocarcinoma resection in rat models. J Biophotonics. 8(7): 575-583, 2015. PMID: 25044732
      10. Bhattacharjee T, Khan A, Maru G, Ingle A, CM Krishna. Preliminary Raman spectroscopic study of urine: Diagnosis of breast cancer in animal models. Analyst 140: 456-466, 2015. PMID: 254296666
      11. Bhattacharjee T, Maru G, Ingle A, Krishna CM. Transcutaneous in vivo Raman spectroscopy of breast tumors and pretumors. J Raman Spect. 46(11):1053-1061, 2015.
      12. Bhattacharjee T, Tawde S, Hudlikar R, Mahimkar M, Maru GB, Ingle A, CM Krishna. Ex vivo Raman spectroscopic study of breast metastatic lesions in lungs in animal models. J Biomed Opt. 20(8): 085006, 2015. PMID: 26295177
      13. Bhattacharjya S, Roy KS, Ganguly A, Sarkar S, Panda CK, Bhattacharyya D, Bhattacharyya NP, Roychoudhury S. Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death. Mol Cancer. 14:42, 2015. PMID: 25743594
      14. Bodini M, Ronchini C, Giacò L, Russo A, Melloni GE, Luzi L, Sardella D, Volorio S, Hasan SK, Ottone T, Lavorgna S, Lo-Coco F, Candoni A, Fanin R, Toffoletti E, Iacobucci I, Martinelli G, Cignetti A, Tarella C, Bernard L, Pelicci PG, Riva L.The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.Blood 125(4): 600-605, 2015. PMID: 25499761
      15. Bukhari AB, Dutta S, De A. Image guidance in stem cell therapeutics: Unfolding the blindfold.Curr Drug Targets. 16(6): 658-671, 2015. PMID: 25483223
      16. Cardoso-Avila PE, Pichardo-Molina JL, CM Krishna, Castro-Beltran R. Photochemical transformation of silver nanoparticles by combining blue and green irradiation. J Nanopart Res. 17:160, 2015.
      17. Chandrani P, Kulkarni V, Iyer P, Upadhyay P, Chaubal R, Das P, Mulherkar R, Singh R, Dutt A. NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome. Br J Cancer. 112: 1958-1965, 2015. PMID: 25973533
      18. Chandrani P, Upadhyay P, Iyer P, Tanna M, Shetty M, Raghuram GV, Oak N, Singh A, Chaubal R, Ramteke M, Gupta S, Dutt A. Integrated genomics approach to identify biologically relevant alterations in fewer samples. BMC Genomics. 16(1): 936, 2015. PMID: 26572163
      19. Chatterjee S, Thaker N, De A. Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells. Breast Cancer (Dove Med Press). 7: 251-265, 2015. PMID: 26355636
      20. Chaudhari AD, Gude RP, Kalraiya RD, Chiplunkar SV. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice. Mol Immunol.68(2) Part A : 300-311, 2015. PMID: 26442663
      21. Chaudhari PR, Vaidya MM.Versatile hemidesmosomal linker proteins: structure and function. Histol Histopathol. 30(4): 425-34, 2015. PMID: 25421866
      22. Chopra S, Dora T, Engineer R, Mechanery S, Agarwal P, Kannan S, Ghadi Y, Swamidas J, Mahantshetty U, Shrivastava S. Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity. Brachytherapy. 14(6): 881-888, 2015. PMID: 26409708
      23. Chopra S, Krishnatry R, Dora T, Kannan S, Thomas B, Sonawone S, Engineer R, Paul S, Phurailatpam R, Mahantshetty U, Shrivastava S. Predictors of late bowel toxicity using three different methods of contouring in patients undergoing postoperative radiation for cervical cancer. Br J Radiol. 88(1055): 20150054 PMID: 26394195
      24. Dange MC, Agarwal AK, Kalraiya RD. Extracellular galectin-3 induces MMP9 expression by activating p38 MAPK pathway via lysosome-associated membrane protein-1 (LAMP1). Mol Cell Biochem. 404(1-2): 79-86, 2015. PMID: 25739356
      25. D'Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R; Head and Neck Disease Management Group. Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. N Engl J Med. 373: 521-529, 2015. PMID: 26027881
      26. Delahaye-Sourdeix M, Anantharaman D, Timofeeva MN, Gaborieau V, Chabrier A, Vallée MP, Lagiou P, Holcátová I, Richiardi L, Kjaerheim K, Agudo A, Castellsagué X, Macfarlane TV, Barzan L, Canova C, Thakker NS, Conway DI, Znaor A, Healy CM, Ahrens W, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Fabianova E, Mates IN, Bencko V, Foretova L, Janout V, Curado MP, Koifman S, Menezes A, Wünsch-Filho V, Eluf-Neto J, Boffetta P, Fernández Garrote L, Polesel J, Lener M, Jaworowska E, Lubiński J, Boccia S, Rajkumar T, Samant TA, Mahimkar MB, Matsuo K, Franceschi S, Byrnes G, Brennan P, McKay JD. A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer. J Natl Cancer Inst. 107(5): djv037, 2015. PMID: 25838448
      27. Delahaye-Sourdeix M, Oliver J, Timofeeva MN, Gaborieau V, Johansson M, Chabrier A, Wozniak MB, Brenner DR, Vallée MP, Anantharaman D, Lagiou P, Holcátová I, Richiardi L, Kjaerheim K, Agudo A, Castellsagué X, Macfarlane TV, Barzan L, Canova C, Thakker NS, Conway DI, Znaor A, Healy CM, Ahrens W, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Fabianova E, Mates IN, Bencko V, Foretova L, Janout V, Curado MP, Koifman S, Menezes A, Wünsch-Filho V, Eluf-Neto J, Boffetta P, Garrote LF, Serraino D, Lener M, Jaworowska E, Lubiński J, Boccia S, Rajkumar T, Samant TA, Mahimkar MB, Matsuo K, Franceschi S, Byrnes G, Brennan P, McKay JD. The 12p13.33/RAD52locus and genetic susceptibility to squamous cell Cancers of upper aerodigestive tract. PLoS One 10(3): e0117639.PMID: 25793373
      28. Devadas SK, Bhat V, Khattry N. Subcutaneous infection caused by Blastoschizomyces capitatus post allogeneic hematopoietic transplant and its successful treatment with voriconazole. Transpl Infect Dis. 17(4): 588-592, 2015. 2015. PMID: 26012493
      29. Fuji S, Mori T, Khattry N, Cheng J, Do YR, Yakushijin K, Kohashi S, Fukuda T, Kim S-W. Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality. Bone Marrow Transplant.50(1): 100-105, 2015.PMID: 25285803
      30. Gaikwad SM, Thakur B, Sakpal A, Singh RK, Ray P. Differential activation of NF-κB signaling is associated with Platinum and Taxane resistance in MyD88 deficient epithelial ovarian cancer cells. Int J Biochem Cell Biol. 61:90-102,2015. PMID: 25681684
      31. Gambhir L, Checker R, Sharma D, Thoh M, Patil A, Degani M, Gota V, Sandur SK. Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occuring steroidal lactone withaferin a. Toxicol Appl Pharmacol.289(2): 297-312, 2015. PMID: 26408225
      32. Garg R, Dolas S, Maru GB. Dietary curcumin modulates phenobarbital-and acetone- induced CYP450 2B1 and 2E1 isozymes in mice. BAOJ Cancer Res Ther. 2015.
      33. Goda J, Lewis S, Agarwal A, Epari S, Churi S, Padmavati A, Gupta T, Shetty P, Moiyadi A, Jalali R. Impact of oligodendroglial component in glioblastoma (GBM-O): Is the out come favourable than glioblastoma? Clin Neurol Neurosurg. 135: 46-53, 2015. PMID: 26038275
      34. Goel PN, Singh SP, Krishna CM, Gude RP. Investigating the effects of pentoxifylline on human breast cancer cells using raman spectroscopy. J Innov Opt Health Sci. 2015.
      35. Gupta T, Hotwani C, Kannan S, Master Z, Rangrajan V, Murthy V, Budrukkar A, Ghosh –Laskar S, Agarwal JP. Prospective longitudinal assessment of parotid gland function using dynamic quantitative pertechnate scintigraphy and estimation of dose–response relationship of parotid- sparing radiotherapy in head-neck cancers. Rad Oncol. 2015. PMID: 25889705
      36. Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP. Concomitant chemo-radiotherapy (CT-RT) versus altered fractionation radiotherapy (AF-RT) in the radiotherapeutic management of loco-regionally advanced head & neck squamous cell carcinoma (HNSCC): An adjusted indirect comparison meta-analysis. Head Neck 37(5): 670-676, 2015. PMID: 24596112
      37. Gupta T, Shirsat N, Jalali R. Molecular subgrouping of medulloblastoma: impact upon research and clinical practice. Curr Pediatr Rev. 11(2): 106-119, 2015. PMID: 26133181
      38. Gurjar M, Raychaudhuri K, Dalal SN. Loss of desmosomal protein plakophilin 3 does not induce the epithelial mesenchymal transition. J Biosci Tech. 6(1): 647-652, 2015.
      39. Harmalkar M, Upraity S, Kazi S, Shirsat NV. Tamoxifen-Induced cell death of malignant glioma cells is brought about by oxidative-stress-mediated alterations in the expression of BCL2 family members and is enhanced on miR-21 Inhibition. J Mol Neurosci.57(2): 197-202, 2015. PMID: 26109525
      40. Hotwani C, Chopra S, Moirangthem N, Mohanty S, Paul SN, Engineer R, Mahantshetty U, Shrivastava SK. Impact of lymphoceles on organ at risk doses in patients undergoing adjuvant pelvic radiation for carcinoma cervix. Int J Cancer Ther Oncol. 3(2): 3220, 2015.
      41. Jagilinki BP, Gadewal N, Mehta H, Mahadik H, Vikrant, Pandey A, Sawant U, Wadegaonkar PA, Goyal P, Kumar S, Varma AK. Conserved residues at the MAPKs binding interfaces that regulate transcriptional machinery. J Biomol Struct Dyn. 33(4): 852-60, 2015. PMID: 24739067
      42. Kameswaran M, Pandey U, Dhakan C, Pathak K, Gota V, Vimalnath KV, Dash A, Samuel G. Synthesis and preclinical evaluation of 177Lu-CHX-A”-DTPA-Rituximab as a radioimmunotherapeutic agent for non-hodgkin's lymphoma. Cancer Biother Radiopharm. 30(6): 240-246, 2015. PMID: 26066665
      43. Kaur E, Rajendra J, Jadhav S, Sridhar E, Goda J, Moiyadi A, Dutt S. Radiation induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence. Carcinogenesis.36(6):685-695, 2015.PMID: 25863126
      44. Khachane PV, Jain AS, Dhawan VV, Joshi GV, Date AA, Mulherker R, Nagarsenker MS. Cationic Nanoemulsions As Potential Carriers For Intracellular Delivery. 2015. Saudi Pharm J. 23: 188-194, 2015. PMID: 25972740
      45. Khan MB, Sathe N, Chavan R, Juvekar A. In Vitro Evaluation of anti-cancer activity of kukkutnakhi guggual on breast cancer. Int Ayurvedic Med J. 3(11): 3146-3155, 2015.
      46. Khan SA, Reddy D, Gupta S. Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment? World J Biol Chem. 6(4): 333-345, 2015. PMID: 26629316
      47. Kumar CS, Gadewal N, Mohammed SM. Seminal role of deletion of amino acid residues in H1-S2 and S-loop regions in eukaryotic β-tubulin investigated from docking and dynamics perspective. J Theor Biol. 378: 79-88, 2015. PMID: 25956360
      48. Kumar CS, Jena L, Mohod K, Daf S, Varma AK. Virtual screening for potential inhibitors of high-risk human papillomavirus 16 E6 protein. Interdiscip sci. Comput Life Sci.7(2): 136-42, 2015. PMID: 25663107
      49. Kumar S, Jena L, Sahoo M, Kakde M, Daf S, Varma AK. In Silico Docking to explicate interface between plant-originated inhibitors and E6 oncogenic protein of highly threatening human papillomavirus 18. Genomics Inform 13(2): 60-67, 2015. PMID: 26175664
      50. Lewis S, Pal M, Bakshi G, Ghadi YG, Menon S, Murthy V, Mahantshetty U. High-dose-rate brachytherapy - a novel treatment approach for primary clear cell adenocarcinoma of male urethra. J Contemp Brachytherapy. 7(3): 248-51, 2015. PMID: 26207115
      51. Mancini M, Hasan SK, Ottone T, Lavorgna S, Ciardi C, Angelini DF, Agostini F,Venditti A, Lo-Coco F. Two novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia. J Mol Diagn. 17(2): 179-84, 2015. PMID: 25554589
      52. Mansara PP, Deshpande RA, Vaidya MM, Kaul-Ghanekar R. Differential ratios of omega fatty acids (AA/EPA+DHA) modulate growth, lipid peroxidation and expression of tumor regulatory MARBPs in breast cancer cell lines MCF7 and MDA-MB-231. PLoS One. 10(9): e0136542 2015. PMID: 26325577
      53. Mathur A, Sharma AK, Murhekar VV, Mallia MB, Pawade S, Sarma HD, Chaudhari P, Sachdev SS, Banerjee S. Syntheses and biological evaluation of ⁹⁹ᵐTc-HYNIC-fatty acid complexes for myocardial imaging. RSC Adv. 5: 93374-93385, 2015.
      54. Mishra PK, Bunkar N, Raghuram GV, Khare NK, Pathak N, Bhargava A. Epigenetic dimension of oxygen radical injury in spermatogonial epithelial cells. Reprod Toxicol. 52: 40-56, 2015. PMID: 25687723
      55. Mishra PK, Raghuram GV,Bunkar N, Bhargava A, Khare NK.Molecular bio-dosimetry for carcinogenic risk assessment in survivors of bhopal gas tragedy. Int J Occup Med Environ Health. 28(6), 2015. PMID: 26294196
      56. Mishra R, Palve V, Kannan S, Pawar S, Teni T. High expression of survivin and its splice variants survivin ΔEx3 and survivin 2B in oral cancers. Oral Surg Oral Med Oral Pathol Oral Radiol. 120(4): 497-507, 2015. PMID: 26346910
      57. Mittra I. Circulating nucleic acids: a new class of physiological mobile genetic elements. F1000Res. 4: 924, 2015. PMID: 26664710
      58. Moiyadi AV, Sridhar E. δ-Aminolevulinic acid-induced fluorescence unmasks biological intratumoral heterogeneity within histologically homogeneous areas of malignant gliomas. Acta Neurochir (Wien). 157(4): 617-619, 2015. PMID: 255577752
      59. Moiyadi AV. Impact of navigable ultrasound: How much credit should we give to the "Navigable" component? J Neurol Surg A Cent Eur Neurosurg. 76(2): 177-178, 2015. PMID: 25594813
      60. Moiyadi AV. Intraoperative assistive technologies-the way ahead. Neurosurg Rev. 38(3): 593-94, 2015. PMID: 25862667
      61. Moiyadi AV. Linear intraoperative ultrasound probes and phased-array probes: two sides of the same coin. Acta Neurochir. 157(6): 957-958 2015. PMID: 25762190
      62. Molli PR, Pradhan MB, Ingle AD, Naik NR. Preclinical model for identification of therapeutic targets for CML offers clues for handling imatinib resistance. Biomed Pharmacother. 73:160-170, 2015. PMID: 26211598
      63. More SK, Srinivasan N, Budnar S, Bane S, Upadhya A, Thorat R, Ingle A, Chiplunkar SV, Kalraiya RD. N-glycans and metastasis in galectin-3 transgenic mice. Biochem Biophys Res Commun. 460: 302-307, 2015. PMID: 25791476
      64. Nakka KK, Chaudhary N, Joshi S, Bhat J, Singh K, Chatterjee S, Malhotra R, De A, Santra MK, Dilworth FJ, Chattopadhyay S. Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68. Proc Natl Acad Sci. 112(26): PMID: 26080397
      65. Nath S, Chowdhury A, Dey S, Roychoudhury A, Ganguly A, Bhattacharyya D, Roychoudhury S. Deregulation of Rb-E2F1 axis causes chromosomal instability by engaging the transactivation function of Cdc20-APC/C complex. Mol Cell Biol.35(2): 356-369, 2015. PMID: 25368385
      66. Padul V, Epari S, Moiyadi A, Shetty P, Shirsat NV. ETV/Pea3 family transcription factor-encoding genes are overexpressed in CIC-mutant oligodendrogliomas. Genes Chromosomes Cancer. 54(12): 725-33, 2015. PMID: 26357005
      67. Panwalkar P, Moiyadi A, Goel A, Shetty P, Goel N, Sridhar E, Shirsat N. MiR-206, a cerebellum enriched miRNA is downregulated in all medulloblastoma subgroups and Its overexpression Is necessary for growth inhibition of medulloblastoma cells. J Mol Neurosci. 56(3): 673-680, 2015. PMID: 25859932
      68. Pathak PO, Nagarsenker MS, Barhate CR, Padhye SG, Dhawan VV, Bhattacharyya D, Viswanathan CL, Steiniger F, Fahr A. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: Synthesis , characterization, and proof of concept of hepatospecific delivery. Carbohydr Res.408:33-43, 2015. PMID: 25841057
      69. Patil RS, Bhat SA, Dar AA, Chiplunkar SV. The Jekyll and Hyde story of IL17 producing γδT (Tγδ17) cells. Front Immunol. 2015. PMID: 25699053
      70. Patkar N, Subramanian PG, Deshpande P,Ghodke K, Tembhare, P, Mascarenhas R, Muranjan A, Chaudhary S, Bagal B, Gujral S, Sengar M, Menon H.MYD88 Mutant Lymphoplasmacytic Lymphoma / Waldenstroms Macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart. Leuk Lymphoma.56(2): 420-425,2015. PMID: 24828863
      71. Phalke SP, Chiplunkar SV. Activation status of γδ T cells dictates their effect on osteoclast generation and bone resorption. Bone Rep.3: 95-103, 2015.
      72. Prashar V, Bihani SC, Ferrer JL, Hosur MV. Structural basis of why nelfinavir resistant D30N mutant of HIV-1 protease remains susceptible to saquinavir. Chem Biol Drug Des. 86(3): 302-308, 2015.PMID: 25487655
      73. Qureshi SS, Bhagat M, Kembhavi S, Vora T, Ramadwar M, Chinnaswamy G, Prasad M, Khanna N, Laskar S. Benign liver tumors in children: outcomes after resection. Pediatr Surg Int. 31(12): 1145-9, 2015. PMID: 26263875.
      74. Qureshi SS, Bhagat M, Kembhavi S, Vora T, Ramadwar M, Talole S. PRETEXT II-III multifocal hepatoblastoma: significance of resection of satellite lesions irrespective of their disappearance after chemotherapy. Pediatr Surg Int. 31(6): 573-9, 2015. PMID: 25904441
      75. Rao KD, Sahoo NK, Krishna CM. Perspectives of optical coherence tomography imaging and Raman spectroscopy in cancer diagnosis. Biomed Spectrosc Imaging. 4: 35-55, 2015.
      76. Rath S, Sahu A, Gota V, Martinez-Torres PG, Pichardo- Molina JL, CM Krishna. Raman spectroscopy for detection of Imatinib in plasma: A proof of concept. J Innov Opt Health Sci. 2015.
      77. Ravindran G, Sawant SS, Hague A, Kingsley K, Devaraj H. Association of differential β-catenin expression with Oct-4 and Nanog in oral squamous cell carcinoma and their correlation with clinicopathological factors and Prognosis. Head Neck 37(7): 982-993, 2015. PMID: 24700702
      78. Ray P, De A, Yaghoubi S, Khanna A. Application of adult stem cells in medicine. Stem Cell Int 2015: 258313,2015. PMID: 26346753
      79. Raychaudhuri K, Gurjar M, Dalal SN. Plakophilin3 and Plakoglobin recycling are differently regulated during the disassembly of desmosomes. J Biosci. Tech. 6(1): 634-642, 2015.
      80. Rengan AK, Bukhari AB, Pradhan A, Malhotra R, Banerjee R, Srivastava R, De A. In Vivo Analysis of Biodegradable Liposome Gold Nanoparticles as Efficient Agents for Photothermal Therapy of Cancer. Nanoletters .15(2):842-848, 2015. PMID: 25554860
      81. Sahu A, Dhoot S, Singh A, Sawant SS, Nandakumar N, Talathi-Desai S, Garud M, Pagare S, Srivastava S, Nair S, Chaturvedi P, CM Krishna. Oral cancer screening: serum Raman spectroscopic approach. J Biomed Optics. 20(11):115006, 2015. PMID: 26580700
      82. Sahu A, Nandakumar N, Sawant S, Krishna CM.Recurrence prediction in oral cancers: a serum Raman spectroscopy study. Analyst. 140(7):2294-301, 2015. PMID: 25619332
      83. Sahu A, Sawant S, Talathi-Desai S, Krishna CM. Raman spectroscopy of serum: A study on oral cancers. J Biomed Spectr Imag .4(2): 171-187, 2015. 2015.
      84. Sahu A, Tawde S, Pai V, Chaturvedi P, Nair S, CM Krishna. Raman spectroscopy and cytopathology of oral exfoliated cells for oral cancer diagnosis. Anal Methods. 7: 7548-7559, 2015.
      85. Sanganeria P, Sachar S, Chandra S, Bahadur D, Ray P, Khanna A. Cellular internalization and detailed toxicity analysis of protein-immobilized iron oxide nanoparticles. J Biomed Mater Res Part B 103(1): 125-134, 2015 PMID: 24788586
      86. Shah SM, Ashtikar M, Jain AS, Makhija DT, Nikam Y, Gude RP, Steiniger F, Jagtap AA, Nagarsenker MS, Fahr A. LeciPlex, invasomes, and liposomes: A skin penetration study. Int J Pharmaceut 490(1-2): 391-403, 2015. PMID: 26002568
      87. Sharma AK, Bhattacharya S, Khan SA, Khade B, Gupta S. Dynamic alteration H3 serine 10 phosphorylation is G1- phase specific during ionization radiation induced DNA damage response in human cell. Mutat Res Fundam Mol Mech Mutagen.773:83-91, 2015. PMID: 25847424
      88. Sharma AK, Khan SA, Sharda A, Reddy DV, Gupta S. MKP1 phosphatase mediates G1-specific dephosphorylation ofH3Serine10P in response to DNA damage. Mutat Res. 778: 71-79, 2015. PMID: 26111828
      89. Sharma S, Ray S, Mukherjee S, Moiyadi A, Sridhar E, Srivastava S. Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. Proteomics 15(2-3): 394-407, 2015. PMID: 25413884
      90. Shetake NG, Kumar A, Gaikwad S, Ray P, Desai S, Ningthoujam RS, Vatsa RK, Pandey BN. Magnetic nanoparticle-mediated hyperthermia therapy induces tumour growth inhibition by apoptosis and Hsp90/AKT modulation. Int J Hyperthermia. 31(8): 909-919, 2015. PMID: 26416812
      91. Shete H, Sable S, Tidke P, Selkar N, Pawar Y, Chakraborty A, De A, Vanage G, Patravale V. Mono-guanidine heterolipid based SMEDDS : A promising tool for cytosolic delivery of antineoplastics. Biomaterials. 57: 116-132, 2015. PMID: 25916500
      92. Shrikhande SS, Jain DS, Athavale RB, Bajaj AN, Goel P, Kamran Z, Nikam Y, Gude RP. Evaluation of anti-metastatic potential of Cisplatin polymeric nanocarriers on B16F10 melanoma cells original. Saudi Pharm J. 23(4): 341-351, 2015.
      93. Singh N, Kanthaje S, Bose K. Equilibrium dissociation and unfolding of human papillomavirus E2 transactivation domain. Biochem Biophys Res Commun.463(4)496-503, 2015.PMID: 26091566
      94. Suhane T, Laskar S, Advani S, Roy N, Varunan S, Bhattacharyya D, Bhattacharyya S, Bhattacharyya MK. Both charged linker region and ATPase domain of Hsp90 are essential for Rad51 dependent DNA repair. Eukaryot Cell. 14(1): 64-77, 2015. PMID: 25380755
      95. Suryavanshi S, Sharma D, Checker R, Thoh M, Gota V, Sandur SK, Sainis KB. Amelioration of radiation induced hematopoietic syndrome by an antioxidant chlorophyllin through increased stem cell activity and modulation of haematopoiesis . Free Radic Biol Med. 85: 56-70, 2015.PMID: 25872101
      96. Sutradhar S, Yadav V, Sridhar S, Sreekumar L, Bhattacharyya D, Ghosh SK, Paul R, Sanyal K. A Comprehensive model to predict mitotic division in budding yeasts. Mol Biol Cell. 26(22): 3954-3965, 2015. PMID: 26310442
      97. Syed P, Gupta S, Choudhary S, Pandala NG, Atak A, Richharia A, Kp M, Zhu H, Epari S, Noronha SB, Moiyadi A, Srivastava S. Autoantibody profiling of glioma serumsamples to identify biomarkers using human proteome arrays. Sci Rep. 2015. PMID: 26370624
      98. Thakur B, Chatterjee S, Chaudhury S, Ray P. Molecular imaging of therapeutic potential of reporter probes. Curr Drug Targets. 16(6):645-57, 2015.PMID: 25537653
      99. Thota RS, Ambardekar M, Likhate P. Conscious sedation for middle ear surgeries: A comparison between fentanyl-propofol and fentanyl-midazolam infusion. Saudi J Anaesth. 9(2): 117-21, 2015. PMID: 25829896
      100. Thummuri D, Jeengar MK, Shrivastava SK, Nemani H, Ramavat RN, Chaudhari P, Naidu VGM. Thymoquinone prevents RANKL-induced osteoclastogenesisactivation and osteolysis in an in vivo model of inflammation bysuppressing NF-KB and MAPK Signalling. Pharmacol Res. 99: 63-73, 2015. PMID: 26022736
      101. Upasani MN, Chopra S, Engineer R, Mahantshetty U, Medhi S, Mehta Z, Shrivastava S. Internal Target Volume for posthysterectomy vaginal recurrences of cervical cancers during image guided radiotherapy. Br J Radiol. 88(1054): 20140783, 2015. PMID: 26248870
      102. Vallam KC, Bhagat M, Shankhdhar VK, Qureshi SS. Recurrent abdominal wall dermatofibrosarcoma protuberans in a child: a challenging reconstruction. Springerplus. 4:331. 2015. PMID: 26180751
      103. Venkitaraman R, Lorente D, Murthy V, Thomas K, Parker L, Ahiabor R, Dearnaley D, Huddart R, De Bono J, Parker C.A Randomised Phase 2 Trial of Dexamethasone Versus Prednisolone in Castration-resistant Prostate Cancer.Eur Urol. 67(4): 673-679, 2015. PMID: 25457497
      104. Warawdekar UM, Kowtal P. Molecular pathways to therapeutics: Paradigms and challenges in oncology meeting report: Carcinogenesis 2015. J Carciogen. 14(1): 4, 2015. PMID: 26085817
      105. Warawdekar UM, Sirajuddin MM, Pramesh CS, Mistry RC.An approach of selecting appropriate markers from the primary tumor to enable detection of circulating tumor cells in patients with non-small cell lung cancer.J BUON.20(3): 782-90, 2015. PMID: 26214631
      106. Winn DM, Lee YC, Hashibe M, Boffetta P, Agudo A, Ahrens W, Bencko V, Benhamou S, Boccia S, Bosetti C, Brennan P, Brenner H, Cadoni G, Castellsague X, Chen C, Conway D, Curado MP, D'Souza G, Maso LD, Daudt AW, De Ruyck K, Diergaarde B, Eluf- Neto J, Fabianova E, Fernandez L, Franceschi S, Gillison M, Haddad RI, Hayes R, Healy C, Herrero R, Hofmann J, Holcátová I, Hung R, Kelsey K, Kjaerheim K, Koifman S, La Vecchia C, Lacko M, Lagiou P, Lazarus P, Levi F, Li G, Lissowska J, Liu G, Luce D, Macfarlane T, Mahimkar M, Mates D, Matsuo K, McClean M, Menezes A, Menvielle G, Merletti F, Moysich K, Muscat J, Olshan A, Pawlita M, Peters WH, Ramroth H, Rozek L, Rudnai P, Schantz S, Schwartz S, Serraino D, Shangina O, Simonato L, Smith E, Stucker I, Sturgis EM, Szeszenia-Dabrowska N, Thomson P, Vaughan T, Vilensky M, Wolf G, unsch-Filho VW, Yu G, Zaridze D, Zatonski W, Zevallos JP, Zhang ZF, Zheng TZ, Znaor A. The INHANCE consortium: toward a better understanding of the causes and mechanisms of head and neck cancer. Oral Dis. 21(6): 685-693, 2015. PMID: 25809224
      107. Yadav LR, Rai S, Hosur MV, Varma AK. Functional assessment of intrinsic disorder central domains of BRCA1. J Biomol Struct Dyn. 33(11): 2469-78, 2015. PMID : 25616417
      108. Yogi K, Sridhar E, Goel N, Jalali R, Goel A, Moiyadi A, Thorat R,Panwalkar P, Khire A, Dasgupta A, Shetty P, Shirsat NV. MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1. Oncoscience. 2(4): 334-348, 2015. PMID: 26097868
    • 2014
      1. Adhikary A, Chakraborty S, Mazumdar M, Ghosh S, Mukherjee S, Manna A, Mohanty S, Nakka KK, Joshi S, De A, Chattopadhyay S, Sa G, Das T. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: Dual role of SMAR1 in breast cancer cells. J Biol Chem. 289: 25431- 25444, 2014. PMID: 25086032
      2. Agarwal AK, Gude RP, Kalraiya RD. Regulation of melanoma metastasis to lungs by cell surface Lysosome Associated Membrane Protein- 1 (LAMP1) via galectin-3, Biochem. Biophys. Res. Commun.449(3): 332-337, 2014. PMID: 24845565
      3. Agarwal AK, Kalraiya RD. Glycosylation regulates the expression of Lysosome Associated Membrane Protein-1 (LAMP1) on the cell surface. J Biosci Tech. 5(3): 556-563, 2014.
      4. Aggarwal A, Chopra S, Paul SN, Engineer R, Srivastava SK. Evaluation of internal target volume in patients undergoing image guided intensity modulated adjuvant radiation for gastric cancers. Br J Radiol. 87(1033):20130583. PMID: 24288401
      5. Anantharaman D, Chabrier A, Gaborieau V, Franceschi S, Herrero R, Rajkumar T, Sawant T, Mahimkar MB, Brennan P, Mckay JD. Genetic Variants in Nicotine Addiction and Alcohol Metabolism Genes, Oral Cancer Risk and the Propensity to Smoke and Drink Alcohol: A Replication Study in India. PLoS ONE 9(2): e88240, 2014. PMID: 24505444
      6. Athawale RB, Jain DS, Singh KK, Gude RP. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung. Biomed Pharmacother. 68(2): 231-240, 2014. PMID: 24560352
      7. Balakrishnan B, Indap MM, Singh SP, Chilkapati MK, Chiplunkar SV.Turbomethanol extract inhibits bone resorption through regulation of T cell function. Bone 58:114-125, 2014. PMID: 24140785
      8. Balakrishnan B,Chiplunkar SV,Indap MM.Methanol Extract of Euchelus asper prevents bone resorption in ovariectomised mice model. J Osteoporosis 2014. PMID: 24995144
      9. Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mæhle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, Asperen C, Vasen H,. Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A, Skytte A, Lam J, Taylor L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Blanco I, Salinas M, Cook J, Rosario DJ, Buys S, Conner T, Ausems MG, Ong K, Hoffman J, Domchek S, Powers J, Teixeira MR, Maia S, Foulkes WD, Taherian N, Ruijs M, Helderman-van den Enden AT, Izatt L, Davidson R, Adank MA, Walker L, Schmutzler R, Tucker K, Kirk J, Hodgson S, Harris M , Douglas F, Lindeman GJ, Zgajnar J, Tischkowitz M, Clowes VE, Susman R, Cajal T, Patcher N, Gadea N, Spigelman A, van Os T, Liljegren Al, Side L, Brewer C, Brady AF, Donaldson A, Stefansdottir V, Friedman E, Chen-Shtoyerman R, Amor DJ, Copakova L, Barwell J, Giri VN, Murthy V, Nicolai N, Teo S,Greenhalgh L,Strom S, Henderson A, McGrath J, Gallagher D, Aaronson N, Ardern-Jones A, Bangma C, Dearnaley D, Costello P, Eyfjord J, Rothwell J, Falconer A, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Kote-Jarai Z, Lubinski J, Melia AU, McKinley J, Mitra AV, Moynihan C, Rennert G, Suri M, Wilson P, Killick E, The IMPACT Collaborators, Moss S, Eeles RA. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the Initial screening round of the IMPACT study. Eur Urol.66: 489-499, 2014. PMID: 24484606
      10. Barreto SG, Dutt A, Chaudhary A. A genetic model for gallbladder carcinogenesis and its dissemination. Ann Oncol. 1086-1097, 2014. PMID: 24705974
      11. Behl I, Kukreja L, Deshmukh A, Singh SP, Mamgain H, Hole AR, CM Krishna. Raman mapping of oral buccal mucosa: a spectral histopathology approach. J Biomed Opt. 19(12): 126005, 2014. PMID: 25478870
      12. Behl I, Mamgain H, Deshmukh A, Kukreja L, Hole AR, CM Krishna. Raman microspectroscopic study of oral buccal mucosa. Proc. SPIE. 8940, Optical Biopsy XII, 89400D. (March 17, 2014)
      13. Bhargava A,Bunkar N, Khare NK, Mishra PK, Mishra DK. Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: from biology to translational medicine. Nanomedicine 9(14): 2187-2202, 2014. PMID: 25405796
      14. Bhat V, Kelkar R, Biswas S, Natarajan G. Ventilator-associated pneumonia: Survey of infection control practices in intensive care units of 15 tertiary care hospitals in Mumbai. Am J Infect Control. 42 : 935-940, 2014. PMID: 25087150
      15. Bhattacharjee T, Kumar P, Maru G, Ingle A, Krishna CM.Swiss bare mice: a suitable model for transcutaneous in vivo Raman spectroscopic studies of breast cancer. Laser Med Sci.29(1): 325-333, 2014. PMID: 23708992
      16. Bhave M, Papanikou E, Iyper P, Pandya K, Jain BK, Ganguly A, Sharma C, Pawar K, Austin II J, Day KJ, Rossanese OW, Glick BS, Bhattacharyya D. Golgi enlargement in Arf-depleted yeast cells is due to altered dynamics of cisternal maturation. J Cell Sci. 127(pt1): 250-257,2014. PMID:24190882
      17. Biswas NK, Das S, Maitra A, Sarin R, Majumder PP. Somatic mutations in arachidonic acid metabolism pathway genes enhance oral cancer post-treatment disease-free survival. Nat Commun.5: 5835, 2014. PMID: 25517499
      18. Chatterjee S, De A. Applications of lentiviral vectors in molecular imaging. Front Biosci (Landmark Ed). 19: 835-853,2014. PMID: 24896320
      19. Chaudhury S, Thakur B, Chatterjee S, Ray P. Molecular imaging aided improvement in drug discovery and development. Curr Biotech. 3(3): 218-237, 2014.
      20. Chavan P, Chauhan B, Joshi A, Ojha S, Bhat V. Differential diagnosis of thrombocytopenia in hematopoietic stem cell transplant patients. J Hematol Thromb Dis. 2(6), 2014.
      21. Chopra S, Dora T, Chinnachamy AN, Thomas B, Kannan S, Engineer R, Mahantshetty U, Phurailatpam R,Paul SN, Shrivastava SK. Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: Results from a prospective study.Int J Radiat Oncol Biol Phys. 88(3): 630-635, 2014. PMID: 24521678
      22. Chopra S, Patidar A, Dora T, Moirangthem N, Paul SN, Engineer R, Mahantshetty U, Shrivastava SK.Vaginal displacement during course of adjuvant radiation for cervical cancer: Results from a prospective IG-IMRT study. Br J Radiol. 87(1042): 20140128, 2014. PMID: 25135439
      23. Choughule A, Sharma R, Trivedi V, Thavamani A, Noronha V, Joshi A, Desai S, Chandrani P, Sundaram P, Utture S, Jambhekar N, Gupta S, Aich J, Prabhash K, Dutt A. Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer. Br J Cancer.111: 2203-2204, 2014. PMID: 25117816
      24. Dange MC, Srinivasan N, More SK, Bane SM, Upadhya A, Ingle AD, Gude RP, Mukhopadhyaya R, Kalraiya RD. Galectin-3 expressed on different lung compartments promotes organ specific metastasis by facilitating arrest, extravasation and organ colonization via high affinity ligands on melanoma cells. Clin Exp Metastasis.31(6): 661-673, 2014. PMID: 24952269
      25. Daniel A, Prakasarao A, David B, Joseph L, CM Krishna, Koteeswaran D, Ganesan S. Raman mapping of oral tissues for cancer diagnosis. J Raman Spectrosc.45(7): 541-549, 2014.
      26. Dar AA, Patil RS, Chiplunkar SV. Insights into the realtionship between toll like receptors and gamma delta T cell responses. Front Immunol. 5(2): Art 366, 2014. PMID: 25132835
      27. Dhamne H, Chande AG, Mukhopadhyaya R. Lentiviral vector platform for improved erythropoietin expression concomitant with shRNA mediated host cell elastase down regulation, Plasmid 71:1-7, 2014 PMID: 24325878
      28. Dhawan VV, Joshi GV, Jain AS, Nikam YP, Gude RP, Mulherkar R, Nagarsenkar MS. Apoptosis induction and anti-cancer activity of LeciPlex formulations. Cell Oncol. 37:339-351, 2014. PMID: 25204961
      29. Goel PN, Gude RP. Pentoxifylline regulates the cellular adhesion and its allied receptors to 4 extracellular matrix components in breast cancer cells.Biomed Pharmacother 68: 93-99, 2014. PMID: 24269001
      30. Gogoi D, Dar AA, Chiplunkar SV.Involvement of Notch in activation and effector functions of γδ T cells. J Immunol. 192(5):2054-62, 2014. PMID: 24489102
      31. Gore M and Govekar R. Preliminary assessment on choice of matrix based on hydrophobicity/hydrophilicity of proteins in analysis by MALDI-Tof-Tof mass spectrometry. Bionano Frontier. 7(2): 7-9, 2014.
      32. Gota V, Kavathiya K, Doshi K, Gurjar M, Damodaran SE, Noronha V, Joshi A, Prabhash K. High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy. Cancer Management Res. 6: 261-265, 2014. PMID: 24940080
      33. Gupta P, Giri J, Srivastav S, Chande AG, Mukhopadhyaya R, Das PK, Ukil A. Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response. FASEB J.28(4): 1756-68, 2014. PMID: 24391131
      34. Gupta T, Mohanty S, Kannan S, Jalali R. Prospective longitudinal assessment of sensorineural hearing loss with hyperfractionated radiation therapy alone in patients with average-risk medulloblastoma. Neuro –Oncol Pract. 1(3): 86-93, 2014.
      35. Gupta T, Nair V, Jalali R.Stem cell niche irradiation in glioblastoma: providing a ray of hope? CNS Oncol. 3(5):367-76, 2014. PMID: 25363009
      36. Jain AS, Goel PN, Shah SM, Dhawan VV, Nikam Y, Gude RP, Nagarsenker MS. Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: In vitro and in vivo evaluation. Biomed Pharmacother. 68: 429-438, 2014. PMID: 24721327
      37. Jain D, Athavale RB, Bajaj A, Shrikhande S, Goel P, Nikam Y, Gude R. Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles. DARU J Pharmceu Sci22(1): 18, 2014. PMID: 24410831
      38. Jindal A, Mathur A, Pandey U, Sarma HD, Chaudhari P, Dash A. Development of 68 Ga-labeled fatty acids for their potential use in cardiac metabolic imaging. J Labelled Comp Radiopharm. 57(7): 463-469, 2014. PMID: 24966158
      39. Joh J, Jenson JB, Ingle AD, Sundberg JP, Ghim SJ. Searching for the initiating site of the major capsid protein to generate virus-like particles for a novel laboratory mouse papillomavirus. Exp Mol Pathol. 96: 155-161, 2014. PMID: 24389228
      40. Joshi NN, Bhat S, Hake S, Kale M, and Kannan S. Opposing effects of pro- and anti-inflammatory cytokine gene polymorphisms on the risk for breast cancer in western Indian women: a pilot study. Int J of Immunogenet. 41(3): 242-249, 2014. PMID: 2416486
      41. Joshi NN, Kannan S, Kotian N, Bhat S, Kale M, Hake S. Interleukin 6 -174G>C polymorphism and cancer risk: Meta-analysis reveals a site dependent differential influence in Ancestral North Indians. Human Immunol. 75(8) : 901-908, 2014. PMID: 24994460
      42. Kaur E, Gupta S, Dutt S. Clinical implications of MTA proteins in human cancer. Cancer Metastasis Rev. 33(4): 1017-1024, 2014. PMID: 25374266
      43. Khan SA, Tyagi M, Sharma AK, Barreto SG, Sirohi B, Ramadwar M, Shrikhande SV, Gupta S. Cell-type specificity of β-actin expression and its clinicopathological correlation in gastric adenocarcinoma. World J Gastroent. 20(34): 12202-12211, 2014. PMID: 25232253
      44. Khan TH, Srivastava N, Srivastava A, Sareen A, Mathur RK, Chande AG, Musti KV, Roy S, Mukhopadhyaya R, Saha B. SHP-1 plays a crucial role in CD40 signaling reciprocity. J Immunol. 193(7): 3644-3653, 2014.. PMID: 25187664
      45. Kumar G, Tajpara P, Bukhari AB, Ramchandani AG, De A, Maru GB. Dietary curcumin post-treatment enhances the disappearance of B(a)P-derived DNA adducts in mouse liver and lungs. Toxicol Rep. 1: 1181-1191, 2014. PMID: 19817699
      46. Kumar S, Jena L, Galande S, Daf S, Mohod K, Varma AK. Elucidating molecular interactions of natural inhibitors with HPV-16 E6 oncoprotein through docking analysis. Genomics Inform. 12(2): 64-70, 2014. PMID: 25031569
      47. Kumar S, Jena L, Galande S, Daf S, Varma AK. Molecular docking explains atomic interaction between plant-originated ligands and oncogenic E7 protein of high risk human papillomavirus type 16. Int J BIO Aut, 315-324, 2014.
      48. Lo-Coco F, Hasan SK. Understanding the molecular pathogenesis of acute promyelocytic leukemia. Best Pract Res Clin Haematol. 27(1):3-9, 2014. PMID: 24907012
      49. Maiers M, Halagan M, Joshi S, Ballal HS, Jagannatthan L, Damodar S, Srinivasan P, Narayan S, Khattry N, Malhotra P, Minz RW, Shah SA, Rajagopal R, Cereb N, Yang SY, Parekh S, Mammen J, Daniels D, Weisdorf D. HLA match likelihoods for Indian patients seeking unrelated donor transplantation grafts: a population-based study, Lancet Haematol. 1(2): e57-e63, 2014.
      50. Manjappa AS, Goel PN, Gude RP, Murthy RSR. Anti-neuropilin antibody Fab′ fragment conjugated liposomal docetaxel for active targeting of tumours. J Drug Target. 22(8): 698-711, 2014. PMID: 24766186
      51. Manoharan Y, Kanniyappan U, Vadivel J, Prakasa Rao A, Ganesan B, Dornadula K, Munusamy B D, Krishna CM, Ganesan S. Fluorescence spectroscopic characterization of salivary metabolites of oral cancer patients. J. Photochem. Photobiol. B, 130: 153-160, 2014. PMID: 24333763
      52. Mishra PK, Raghuram GV, Jain D, Jain SK, Khare NK, Pathak N. Mitochondrial oxidative stress induced epigenetic modifications in pancreatic epithelial cells. Int J Toxicol.33(2): 116-129, 2014.PMID: 24563415
      53. Moiyadi A, Shetty P.Navigable Intraoperative Ultrasound and Fluorescence-Guided Resections Are Complementary in Resection Control of Malignant Gliomas: One Size Does Not Fit All. J Neurol Surg A Cent Eur Neurosurg.75(6): 434-441, 2014 . PMID: 24971685
      54. Moiyadi A, Syed P, Srivastava S. Fluorescence-guided surgery of malignant gliomas based on 5-aminolevulinic acid: paradigm shifts but not a panacea. Nat Rev Cancer.14(2): 146, 2014. PMID: 24457418
      55. Moiyadi AV. Objective assessment of intraoperative ultrasound in brain tumors. Acta Neurochir (Wien).156(4): 703-704, 2014. PMID: 24499993
      56. Murthy V, Narang K, Ghosh-Laskar S, Gupta T, Budrukkar A, Agrawal JP. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials. Head Neck. 36(11):1573-80, 2014.
      57. Nagraj J, Chatterjee S, Pal T, Sakpal AS, Gota V, Ramaa CS, Ray P. A novel series of di-fluorinated propanedione derivatives synergistically augment Paclitaxel mediated caspase 3 activation in ovarian cancer cells.J Cancer Res Ther. 10(3):701-709, 2014. PMID: 25313764
      58. Nair PK, Bhat VG, Vaz MK. Prosthetic joint infections- a clinico-microbiological perspective: Review article. World J Clin Infect Dis. 4(3): 9-15, 2014.
      59. Nanaware P, Ramteke M, Somavarapu AK, Venkatraman P. Discovery of multiple interacting partners of gankyrin, a proteasomal chaperone and an oncoprotein –Evidence for a common hot spot site at the interface and its functional relevance. Proteins. 82(7): 1283-1300, 2014. PMID: 24338975
      60. Noronha V, Patil VM, Joshi A, Krishna MV, Dhumal S, Juvekar S, Pai P, Chatturvedi P, Chaukar DA, Agarwal JP, Ghosh S, Murthy V, D’cruz A, Prabhash K. Induction chemotherapy in technically unresectable locally advanced carcinoma of maxillary sinus. Chemother Res Pract. 2014. PMID: 24900922
      61. Palve V, Mallick S, Ghaisas G, Kannan S, Teni T. Overexpression of Mcl-1L splice variant is associated with poor prognosis and chemoresistance in oral cancers. PLoS One 9(11): e111927, 2014. PMID: 25409302
      62. Pandey R, Mehrotra D, Kowtal P, Mahdi AA, Sarin R. Mitochondrial DNA from archived tissue samples kept in formalin for forensic odontology studies. J Oral Biol Craniofac Res.4(2): 109-113, 2014. PMID: 25737927
      63. Pandey R, Mehrotra D, Mahdi AA, Sarin R, Kowtal P. Additional cytosine inside mitochondrial C-tract D-loop as a progression risk factor in oral precancer cases. J Oral Biol Craniofac Res. 4(1): 3-7, 2014. PMID: 25737911
      64. Panwar H, Raghuram GV, Jain D, Ahirwar AK, Khan S, Jain SK, Pathak N, Banerjee S, Maudar KK, Mishra PK. Cell cycle deregulation by methyl isocyanate: Implications in liver carcinogenesis. Environ Toxicol. 29(3): 284-297, 2014. PMID: 22223508
      65. Patel K, Patil A, Mehta M, Gota V, Vavia P. Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: Preparation, characterization and antitumor activity, Int J Pharmaceut. 472(1-2): 214-223, 2014. PMID: 24954663
      66. Patel K, Tyagi M, Monpara J, Vora L, Gupta S, Vavia P. Arginoplexes: an arginine-anchored nanoliposomal carrier for gene delivery. J Nanopart Res.16:2345, 2014.
      67. Patil T, Kowtal PK, Nikam A, Barkume MS, Patil A, Kane SV, Juvekar AS, Mahimkar MB, Kayal J. Establishment of a tongue squamous cell carcinoma cell line from Indian gutka chewer. J Oral Oncol 2014.
      68. Pawar S, Mahantshetty U, Deodhar K, Teni T. A simple cost-effective modification improves the quality of immunocytochemical staining in cervical scrape samples characterized by presence of excess mucus. J Histotechnol. 37(1): 3-8,2014. PMID: 25620823
      69. Prabhakar V, Balasubramanian R, Sathe P, Krishna CM, Juvekar A. In vitro anticancer activity of monosubstituted chalcone derivatives. Int J Tumour Ther. 3(1): 1-9, 2014.
      70. Pramesh CS, Badwe RA, Borthakur BB, Chandra M, Raj EH, Kannan T, Kalwar A, Kapoor S, Malhotra H, Nayak S, Rath GK, Sagar TG, Sebastian P, Sarin R, Shanta V, Sharma SC, Shukla S, Vijayakumar M, Vijaykumar DK, Aggarwal A, Purushotham A, Sullivan R. Delivery of affordable and equitable cancer care in India. Lancet Oncol. 15(6): e223-e233, 2014. PMID: 24731888
      71. Qureshi SS, Kembhavi S, Ramadwar M, Chinnaswamy G, Laskar S, Talole S, Desai S, Khanna N, Vora T, Kurkure P. Outcome and morbidity of surgical resection of primary cervical and cervicothoracic neuroblastoma in children: a comparative analysis. Pediatr Surg Int. 30(3) : 267-73, 2014. PMID: 24264427
      72. Ramteke MP, Shelke P, Ramamoorthy V, Kumar A, Gautam AKS, Nanaware PP, Karanam S, Mukhopadhyay S, Venkatraman P. Identification of a novel ATPase activity in 14-3-3 proteins- evidence from enzyme Kinetics, structure guided modeling and mutagenesis studies. FEBS Lett. 588(1): 71-78, 2014. PMID: 24269678
      73. Ranjan A, Bane SM, Kalraiya RD. Glycosylation of the laminin receptor (α3β1) regulates its association with tetraspanin CD151: Impact on cell spreading, motility, degradation and invasion of basement membrane by tumor cells. Exp Cell Res. 322(2):249-64, 2014. PMID: 24530578
      74. Ranjan A, Kalraiya RD. Invasive potential of melanoma cells correlates with the expression of MT1-MMP and regulated by modulating its association with motility receptors via N-Glycosylation the receptor. Biomed Res Int. 2014. PMID: 25180193
      75. Reddy D, Bhattacharya S,Gupta S. Histone Chaperones: Functions beyond nucleosome deposition. Advances in Bioscience and Biotechnology. 5: 546-556, 2014.
      76. Rengan AK, Jagtap M, De A, Banerjee R, Srivastava R. Multifunctional gold coated thermo-sensitive liposomes for multimodal imaging and photo-thermal therapy of breast cancer cells. Nanoscales. 6(2): 916-923,2014. PMID: 24281647
      77. S Rubina, Sathe P, Dora TK, Chopra S, Maheshwari A, CM Krishna. In vivo Raman spectroscopy of cervix cancers. Proc. SPIE. 8940, Optical Biopsy XII, 89400E. (March 17, 2014)
      78. Sahu A, Shah N, Mahimkar M, Garud M, Pagare S, Nair S, CM Krishna. Raman spectroscopy and oral exfoliative cytology. Proc. SPIE 8926, Photonic Therapeutics and Diagnostics X, 89262N (March 4, 2014)
      79. Sahu A, Talathi S, Sawant S, CM Krishna. Classification of oral cancers using raman spectroscopy of serum. Proc. SPIE 8939, Biomedical Vibrational Spectroscopy VI: Advances in Research and Industry, 89390E (March 4, 2014).
      80. Sahu I, Sangith N, Ramteke M,Gadre R, Venkatraman P. A novel role for the Proteasomal Chaperone PSMD9 and hnRNPA1 in enhancing IκBα degradation and NF-κB activation – Functional Relevance of predicted PDZ domain-motif interaction. FEBS J 281(11) : 2688-2709, 2014. PMID: 247207
      81. Sangith N, Srinivasaraghavan K, Sahu I, Desai A, Medipally S, Somavarappu AK, Verma C, Venkatraman P. Discovery of novel interacting partners of PSMD9, a proteasomal chaperone: Role of an unusual and versatile PDZ-domain motif interaction and identification of putative functional modules, FEBS Open Bio 571-583, 2014. PMID: 25009700
      82. Savanur MA, Eligar SM, Pujari R, Chen C, Mahajan P, Borges A, Shastry P, Ingle A, Kalraiya RD, Swamy BM, Rhodes JM, Yu LG, Inamdar SR.Sclerotium rolfsii lectin induces stronger inhibition of proliferation in human breast cancer cells than normal human mammary epithelial cells by induction of cell apoptosis. PLoS One.9(11): e110107, 2014. PMID: 24364905
      83. Sawant SS, Vaidya MM, Chaukar DA, Alam H, Dmello C, Gangadaran P, Kannan S, Kane S, Dange P, Dey N, Ranganathan K, D’cruz AK. Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas. Oral Dis 20(5): 453,465, 2014. PMID: 23865921
      84. Sawant SS, Vaidya MM, Chaukar DA, Gangadaran P,Singh A,Rajadhyax S, Kannan S, Padmavathi A, Kane S, Pagare S, Kannan R, D’cruz AK. Clinicopathological features and prognostic implications of loss of K5 and gain of K1, K8 and K18 in oral potentially malignant lesions and squamous cell carcinomas: Immunohistochemical analysis. Edorium Journal of Tumor Biology. 2014
      85. Sehgal L, Mukhopadhyay A, Rajan A, Khapre N, Sawant M, Vishal SS, Bhatt K, Ambatipudi S, Antao N, Alam H, Gurjar M, Basu S, Mathur R, Borde L, Hosing AS, Vaidya MM, Thorat R, Samaniego F, Kolthur-Seetharam U, Dalal SN. 14-3-3γ meditated transport of plakoglobin to the cell border is required for the initiation of desmosome assembly in vitro and in vivo. J Cell Sci.127(pt10): 2174-2188, 2014.
      86. Shah SM, Goel P, Jain AS, Pathak PO, Padhye SG, Govindarajan S, Ghosh SS, Chaudhary P, Gude RP, Gopal V, Nagarsenker MS. Liposomes for targeting hepatocellular carcinoma: Use of conjugated arabinogalactan as targeting ligand. Int J Pharm. 477(1-2): 128-139, 2014. PMID: 25311181
      87. Shaikh R, Dora TK, Chopra S, Maheshwari A, Deodhar K, Rekhi B, CM Krishna. In Vivo Raman spectroscopy of human uterine cervix: exploring the utility of vagina as an internal control. J Biomed Opt. 2014. PMID: 25104415
      88. Shankar R, Qureshi SS, Sugoor P, Kembhavi S, Yadav PS, Mukta R. Colossal squamous cell carcinoma of the face in a child with Xeroderma Pigmentosum. J Indian Assoc Pediatr Surg. 19(3): 185-186, 2014. PMID: 25197203
      89. Sharma S, Punjabi V, Zingde SM, Gokhale SM.A comparative protein profile of Mammalian erythrocyte membranes identified by mass spectrometry. J Membr Biol. 247(11):1181-9, 2014. PMID: 25150706
      90. Sharma S, Ray S, Moiyadi A, Sridhar E, Srivastava S. Quantitative proteomic analysis of meningiomas for the identification of surrogate protein markers. Sci Rep. 4: 7140, 2014. PMID: 25413266
      91. Shastri SS, Mittra I, Mishra GA, Gupta S, Dikshit R, Singh S, Badwe RA. Effect of VIA screening by primary health workers: Randomized controlled study in Mumbai, India. J Natl Cancer Inst. 106:(3): dju009. PMID: 24563518
      92. Shenoy M, Hole AR, Shridhar E, Moiyadi AV, CM Krishna. Raman spectroscopy of gliomas: An exploratory study. Proc. SPIE 8928, Optical Techniques in Neurosurgery, Neurophotonics, and Optogenetics, 892808 (March 5, 2014)
      93. Shivakumar T, Nair S, Gupta T, Kannan S. Concurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinoma. Cochrane Database Syst Rev. 1: CD010906, 2014.
      94. Singh N, D'Souza A, Cholleti A, Sastry MG, Bose K. Dual regulatory switch confers tighter control on HtrA2 proteolytic activity. FEBS J. 281(10): 2456-2470, 2014. PMID: 24698088
      95. Singh RK, Gaikwad SM, Jinager A, Chaudhury S, Maheshwari A, Ray P. IGF-1R inhibition potentiates cytotoxic effects of chemotherapeutic agents in early stages of chemoresistant ovarian cancer cells. Cancer Lett.354: 254-262, 2014.(PMID: 25157649
      96. Singh SP, Krishna CM. Raman spectroscopy of oral tissues: Correlation of spectral and biochemical markers. Proc. SPIE 8926, Photonic Therapeutics and Diagnostics X, 89262O (March 4, 2014).
      97. Singh SP, Krishna CM. Raman spectroscopy of oral tissues: correlation of spectral and biochemical markers. Analytical Methods. 6: 8613-8620, 2014.
      98. Sinha RK, Bojjireddy N, Kanojia D, Subrahmanyam G. Type II PtdIns 4-kinase β associates with CD4–p56lck complex and is involved in CD4 receptor signaling. Mol Cell Biochem. 2014. 395(1-2): 231-9, 2014.PMID: 24972704
      99. Somavarapu AK, Balakrishnan S, Gautam AK, Palmer DS, Venkatraman P. Structural interrogation of phosphoproteome identified by mass spectrometry reveals allowed and disallowed regions of phosphoconformation. BMS Struct. Biol. 14:9, 2014. PMID: 24618394
      100. Soni BL, Marimuthu A, Pawar H, Sawant SS, Borges A, Kannan R, Pandey A, Ingle AD, Harsha HC, Vaidya MM. Quantitative proteomic analysis of different stages of rat lingual carcinogenesis. Clin Commun Oncol. 1: 2, 2014.
      101. Stupp R, Hegi ME, Gorlia T, Erridge SC , Perry J, Hong Yong, Aldape, Benoit Lhermitte Kenneth D , Pietsch T, Grujicic D, Steinbach JP, Wick W, Tarnawski R, Nam D, Hau P, Weyerbrock A, Taphoorn MJB, Shen C, Rao N, Thurzo L, Herrlinger U, Gupta T, Kortmann R, Adamska K, McBain C, Brandes AA, Tonn JC, Schnell O, Wiegel T, Kim CY, Nabors LB, Reardon DA, van den Bent MJ, Hicking C, Markivskyy A, Picard M, Weller M, for the European Organisation for Research and Treatment of Cancer (EORTC), the Canadian Brain Tumor Consortium, and the CENTRIC study team, Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 15: 1100-1108, 2014. PMID: 25163906
      102. Sullivan R, Badwe RA, Rath GK, Pramesh CS, Shanta V, Digumarti R, D'Cruz A, Sharma SC, Viswanath L, Shet A, Vijayakumar M, Lewison G, Chandy M, Kulkarni P, Bardia MR, Kumar S, Sarin R, Sebastian P, Dhillon PK, Rajaraman P, Trimble EL, Aggarwal A, Vijaykumar DK, Purushotham AD. Cancer research in India: national priorities, global results. Lancet Oncol. e213-e222, 2014. PMID: 24731887
      103. Sundberg JP, Stearns TM, Joh J, Proctor M, Ingle A, Silva KA, Dadras SS, Jenson AB, Ghim SJ. Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas. PLoS One. 9(12): e113582, 2014. PMID: 25474466
      104. Thakur B, Chatterjee S, Chaudhury S, Ray P. Molecular imaging of therapeutic potential of Reporter probes.Curr Drug Targets. 2014. PMID: 25537653
      105. Thompson BA, Spurdle AB, Plazzer JP, Greenblatt MS, Akagi K, Al-Mulla F, Bapat B, Bernstein I, Capellá G, den Dunnen JT, du Sart D, Fabre A, Farrell MP, Farrington SM, Frayling IM, Frebourg T, Goldgar DE, Heinen CD, Holinski-Feder E, Kohonen-Corish M, Robinson KL, Leung SY, Martins A, Moller P, Morak M, Nystrom M, Peltomaki P, Pineda M, Qi M, Ramesar R, Rasmussen LJ, Royer-Pokora B, Scott RJ, Sijmons R, Tavtigian SV, Tops CM, Weber T, Wijnen J, Woods MO, Macrae F, Genuardi M; on behalf of InSiGHT; The InSiGHT collaborators are as follows:, Castillejo A, Sexton A, Chan AK, Viel A, Blanco A, French A, Laner A, Wagner A, van den Ouweland A, Mensenkamp A, Payá A, Betz B, Redeker B, Smith B, Espenschied C, Cummings C, Engel C, Fornes C, Valenzuela C, Alenda C, Buchanan D, Barana D, Konstantinova D, Cairns D, Glaser E, Silva F, Lalloo F, Crucianelli F, Hogervorst F, Casey G, Tomlinson I, Blanco I, Villar IL, Garcia-Planells J, Bigler J, Shia J, Martinez-Lopez J, Gille JJ, Hopper J, Potter J, Soto JL, Kantelinen J, Ellis K, Mann K, Varesco L, Zhang L, Le Marchand L, Marafie MJ, Nordling M, Tibiletti MG, Kahan MA, Ligtenberg M, Clendenning M, Jenkins M, Speevak M, Digweed M, Kloor M, Hitchins M, Myers M, Aronson M, Valentin MD, Kutsche M, Parsons M, Walsh M, Kansikas M, Zahary MN, Pedroni M, Heider N, Poplawski N, Rahner N, Lindor NM, Sala P, Nan P, Propping P, Newcomb P, Sarin R, Haile R, Hofstra R, Ward R, Tricarico R, Bacares R, Young S, Chialina S, Kovalenko S, Gunawardena SR, Moreno S, Ho SL, Yuen ST, Thibodeau SN, Gallinger S, Burnett T, Teitsch T, Chan TL, Smyrk T, Cranston T, Psofaki V, Steinke-Lange V, Barbera VM.Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet 46(2): 107-117, 2014. PMID: 24362816
      106. Tyagi M, Khade B, Khan SA, Ingle A, Gupta S. Expression of histone variant, H2A.1 is associated with the undifferentiated state of hepatocyte. Exp Biol Med. 239(10): 1335-1339, 2014. PMID: 24764240
      107. Upraity S, Shaikh S, Padul V, Shirsat NV. miR-224 expression increases radiation sensitivity of glioblastoma cells. Biochem Bophys Res Commun.448(2): 225-230, 2014. PMID: 24785373
      108. Varghese F, Bukhari AB, Malhotra R, De A.IHC Profiler: An open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One. 9(5):e96801,2014. PMID: 24802416
      109. Vikrant , Sawant UU, Varma AK. Role of MERIT40 in stabilization of BRCA1 complex: a protein-protein interaction study. Biochem Biophys Res Commun. 446(4): 1139-44, 2014. PMID: 24667604
      110. Vikrant, Nakhwa P, Badgujar DC, Kumar R, Rathore KK, Varma AK.Structural and functional characterization of the MERIT40 to understand its role in DNA repair.J Biomol Struct Dyn.32(12): 2017-2032,2014. PMID: 24125081
      111. Vora L, Tyagi M, Patel K, Gupta S, Vavia P.Self-assembled nanocomplexes of anionic pullulan and polyallylamine for DNA and pH-sensitive intracellular drug delivery. J Nanopart Res.2014
      112. Wirth MD, Burch JB, Hébert JR, Kowtal P, Mehrotra-Kapoor A, Steck SE, Hurley TG, Gupta PC, Pednekar MS, Youngstedt SD, Zhang H, Sarin R. Case–Control Study of Breast Cancer in India: Role of PERIOD3 Clock Gene Length Polymorphism and Chronotype. Cancer Invest. 32(7): 321-329, 2014.. PMID: 24903750
      113. Yadav LR, Biswal MN, Vikrant, Hosur MV, Varma AK. Tetrameric ZBRK1 DNA binding domain has affinity towards cognate DNA in absence of Zinc ions. BBRC 450(1): 283-288, 2014. PMID: 24924633
      114. Yarnold J, Offersen BV, Olivotto I, Poortmans P, Sarin R. Radiotherapy for breast cancer, the TARGIT-A trial. Lancet 383(9930) : 1717-1718, 2014. PMID: 24835613
      115. Yaseer M, Shaikh R, Krishna CM, Teni T. Raman spectroscopic study of radioresistant oral cancer sublines established by fractionated ionizing radiation. PLoS ONE 9(5): e97777. PMID: 24841281
    • 2013
      1. Ambatipudi S, Bhosale P, Heath E, Pandey M, Kumar G, Kane S, Patil A, Maru GB, Desai RS, Watt FM, Mahimkar MB. Downregulation of keratin 76 expression during oral carcinogenesis of human, hamster and mouse . PLoS One. 8(7): e70688, 2013. PMID: 23936238
      2. Arjmand F, Sayeed F, Parveen S, Tabassum S, Juvekar AS, Zingde SM. Design and synthesis of (S)– and (R)– enantiomers of [4–(2–hydroxy–1–phenylethylimino) pent-2-ol]dimethyltin(IV) and 2,2-dimethyl-4-phenyl-1,3,2-oxazastannolidine: In vitro antitumor activity against human tumor cell lines and in vivo assay of (S)–enantiomers. Dalton Trans. 42: 3390-3401, 2013. PMID: 23250651
      3. Badgujar DC, Sawant U, Vikrant, Yadav L, Hosur MV, Varma AK. Preliminary crystallographic studies of BRCA1 BRCT–ABRAXAS complex. Acta Cryst. F69: 1401-1404, 2013. PMID: 24316840
      4. Bejugam PR, Kuppili RR, Singh N, Gadewal N, Chaganti LK, Sastry M, Bose K. Allosteric regulation of serine protease HtrA2 through novel non-canonical substrate binding pocket. PLoS One. 8(2):e55416, 2013. PMID: 23457469
      5. Bhargava A, Mishra D, Banerjee S, Mishra PK. Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research. J Drug Target. 21(2): 126-136, 2013 PMID: 23061479
      6. Bhargava A, Mishra D, Khan S, Varshney SK, Banerjee S, Mishra PK. Assessment of tumor antigen-loaded solid lipid nanoparticles as an efficient delivery system for dendritic cell engineering. Nanomedicine. 8(7): 1067-1084, 2013. PMID: 23311961
      7. Bhattacharjee T, Maru GB, Ingle A, CM Krishna. Transcutaneous in vivo Raman spectroscopic studies in a mouse model: evaluation of changes in the breast associated with pregnancy and lactation. J Biomed. Opt. 18(4): 047004
      8. Bhattacharjee T, Maru GB, Ingle A, CM Krishna. Transcutaneous in vivo Raman spectroscopy: Detection of age-related changes in mouse breast. Vib Spectrosc. 67: 80-86, 2013.
      9. Chaganti LK, Kuppili RR, Bose K. Intricate structural coordination and domain plasticity regulate activity of serine protease HtrA2. FASEB J. 27(8): 3054-66, 2013. PMID: 23608143
      10. Chandarana RC, Vikrant, Varma AK, Saran A, Coutinho EC,D'souza J. Over-expression, purification and isotopic labeling of a tag-less human glucose-dependent insulinotropic polypeptide (hGIP). 3Biotech 2013.
      11. Chande A, Raina S, Dhamne H, Kamat RH, Mukhopadhyaya R.Multiple platforms of a HIV-2 derived lentiviral vector for expanded utility. Plasmid. 69: 90-5, 2013. PMID: 23159456
      12. Chandrashekhar C, Pons B, Muller CD, Tounsi N, Mulherkar R, Zuber G. Oligobenzylethylenimine enriches linear polyethylenimine with a pH-sensitive membrane disruptive property and leads to enhanced gene delivery activity. Acta Biomater. 9(2): 4985-4993, 2013. PMID: 23000009
      13. Chatterjee S, Malhotra R, Varghese F, Bukhari AB, Patil A, Budrukkar A, Parmar V, Gupta S, De A. Quantitative immunohistochemical analys is reveals association between sodium iodide symporter and estrogen receptor expression in breast cancer. PLoS One. 8(1): e54055, 2013. PMID: 23342072
      14. Chinnachamy AN, Chopra S, Krishnatry R, Kannan S, Thomas B, Mahantshetty U, Engineer R, Shrivastava SK. Evaluation of interobserver and interscale agreement in assessing late bowel toxicity after pelvic radiation in patients with carcinoma of the cervix. Jpn J Clin Oncol. 43(5): 508-514, 2013. PMID: 23515269
      15. Chopra S, Shukla P, Paul SN, Engineer R, Phurailatpam R, Swamidas J, Mahantshetty U, Shrivastava SK. Evaluation of quality indices during multifractionated pelvic interstitial brachytherapy for cervical cancer. Brachytherapy. 12(2): 156-161,2013. PMID: 23182042
      16. Choudhary I, Chimanpure V, Patil A, Mukhopadhyaya R, Paranjape R, Bhattacharya J. Single step detection of HIV-1 proviral DNA and housekeeping β-actin gene from dried blood spots by a monoplex polymerase chain reaction. J Virol Methods. 187(1): 203-206, 2013. PMID: 23085628
      17. Chougule A, Prabhash K, Noronha V, Joshi A, Thavamani A, Chandrani P, Upadhyay P, Utture S,Desai S, Jambhekar N, Dutt A. Frequency of EGFR mutations in 907 lungadenocarcioma patients of Indian ethnicity. PLoS ONE. 8(10): e76164,2013. PMID: 24124538
      18. Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R. Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet.381(9869):805-816, 2013. PMID: 23219286
      19. De A, Jasani A, Arora R, Gambhir SS. Evolution of BRET biosensors from live cell to tissue-scale in vivo imaging. Front Mol Struct Endocrinol.4: 131, 2013. PMID: 24065957
      20. Dhumale P, Nikam Y, Gude R. Pentoxifylline: A potent inhibitor of angiogenesis via blocking STAT3 signaling in B16F10 melanoma. Int J Tumor Ther. 2(1): 1-9, 2013.
      21. Eligar SM, Pujari R, Savanur SM, Nagre NN, Barkeer S, Ingle A, Kalraiya RD, Swamy BM, Shastry P, Inamdar SR. Rhizoctonia bataticola lectin (RBL) induces apoptosis in human ovarian cancer PA-1 cells and suppresses tumor growth in vivo. J Glycobiol. S1, 2013.
      22. Engineer R, Mohandas KM, Shukla PJ, Shrikhande SV, Mahantshetty U, Chopra S, Goel M, Mehta S, Patil P, Ramadwar M, Deodhar K, Arya S, Shrivastava SK. Escalated radiation dose alone vs. concurrent chemoradiation for locally advanced and unresectable rectal cancers: results from phase II randomized study. Int J Colorectal Dis. 28(7):959-966, 2013. PMID: 23358929
      23. Fulzele A, Malgundkar SA, Govekar RB, Patil A, Kane SV, Chaturvedi P, D’Cruz AK, Zingde SM. Proteomic profile of keratins in cancer of gingivo buccal complex: Consolidating insights for clinical applications. J Proteomics. 91c: 242-258, 2013. PMID: 23876858
      24. Gaikwad S, Gunjal L, Junutula AR, Astanehe A, Gambhir SS, Ray P. Non-invasive imaging of phosphoinositide-3-kinase-catalytic-subunit-alpha (PIK3CA) promoter modulation in small animal models. PLoS One. 8(2): e55971, 2013. PMID: 23393606
      25. Goel P, Tailor P, Chande AG, Basu A, Mukhopadhyaya R. An infectious HHV-6B isolate from a healthy adult with chromosomally integrated virus and a reporter based relative viral titer assay. Virus Res. 173(2): 380-385, 2013,PMID: 23454489
      26. Goel PN, Gude RP. Curbing the focal adhesion kinase and its associated signalling events by pentoxifylline in MDA-MB-231 human breast cancer cells. Eur J Pharmacol. 714:432-441, 2013. PMID: 23872375
      27. Gupta T, Upasani M, Master Z, Patil A, Phurailatpam R, Nojin S, Kannan S, Godasastri J, Jalali R. Assessment of three-dimensional set-up errors using megavoltage computed tomography (MVCT) during Image-guided intensity-modulated radiation therapy (IMRT) for craniospinal irradiation (CSI) on helical tomotherapy (HT). Technol Cancer Res Treat. 2013 PMID: 24325133
      28. Gupta T, Wadasadawala T, Phurailatpam R, Paul SN, Murthy V, Budrukkar A, Ghosh-Laskar S, Nair D, Pai P, Chaturvedi P, Agarwal J. Early clinical outcomes in midline sinonasal cancers treated with helical tomotherapy-based image-guided intensity-modulated radiation therapy. Int J Head Neck Surg. 4(1): 6-12, 2013.
      29. Gupta T, Mohanty S, Moiyadi A, Jalali R. Factors predicting temozolomide induced clinically significant acutehematologic toxicity in patients with high-grade gliomas: A clinical audit. Clin Neurol Neurosurg. 115: 1814-1819, 2013. PMID:23764039
      30. Hussain T, Kotnis A, Sarin R, Mulherkar R. Genetic susceptibility to multiple primary neoplasms in the upper aero-digestive tract: Genotype score and phenotype correlation. Cancer Lett. 332(1): 46-54, 2013. PMID: 23348701
      31. Ingle AD, Ahire SD. Checking the genetic integrity of laboratory mice with the help of conventional methods. Res Animals. 1(1): 47-55, 2013.
      32. Ingle AD, Hosetti BB. Therapeutic response of human occipital, breast and oral cavity tumors to paclitaxel in NOD SCID mice. Int J Biopharm Res. 02(01): 39-46, 2013.
      33. Iyer S, Dange PP, Alam H, Sawant SS, Ingle AD, Borges AM, Shirsat NV, Dalal SN, Vaidya MM. Understanding the role of keratins 8 and 18 in neoplastic potential of breast cancer derived cell lines. PLoS One. 8(1): e53532, 2013. PMID: 23341946
      34. Jadhav J, Juvekar A, Kurane R, Salunkhe R, Rashinkar G. Remarkable Anti-Breast Cancer Activity of Ferrocene Tagged Multi-functionalized 1,4- Dihydropyrimidines. Eur J Med Chem. 65: 232-239, 2013. PMID: 23711834
      35. Jain DS, Athawale RB, Bajaj AN, Shrikhande SS, Goel PN, Nikam Y, Gude RP. Poly lactic acid (PLA) nanoparticles sustain the cytotoxic action oftemozolomide in C6 Glioma cells. Biomed Aging Pathol. 3(4): 201-208, 2013.
      36. Jain D, Athawale R, Bajaj A, Shrikhande S, Goel PN, Gude RP. Studies on stabilization mechanism and stealth effect of Poloxamer 188 onto PLGA nanoparticles. Colloids Surf B Biointerfaces. 109: 59-67, 2013. PMID: 23608470
      37. Jain AS.Shah SM, Nagarsenker MS, Nikam Y, Gude RP, Steiniger F, Thamm J, Fahr A. Lipid colloidal carriers for improvement of anticancer activity of orally delivered Quercetin: formulation, characterization and establishing in vitro - in vivo advantage. J Biomed. Nanotechnol. 9: 1230-1240, 2013. PMID: 23909137
      38. Jaiswal AK, Dhumal RV, Ghosh S, Chaudhari P, Nemani H, Soni VP, Vanage GR,Bellare JR. Bone healing evaluation of nanofibrous composite scaffolds in rat calvarial defects: A comparative study. J Biomed Nanotechnol 9: 2073-2085, 2013. PMID: 24266262
      39. Jamema S, Mahantshetty U, Tanderup K, Malvankar D, Sharma S, Engineer R, Chopra S, Shrivastava SK, Deshpande DD. Inter-application variation of dose and spatial location of D2cm3 volumes of OARs during MR image based cervix brachytherapy. Radiother Oncol.107: 58-62, 2013. PMID: 23453543
      40. Kamran MZ, Gude RP. Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway. Biomed Pharmcother. 67(5): 399-405,2013. PMID: 23639230
      41. Kamran MZ, Patil P, Gude RP. Role of STAT3 in cancer metastasis and translational advances. Biomed Res Int. 2013 PMID: 24199193
      42. Kamran MZ, Patil P, Shirsath K, Gude RP. Tyrosine kinase inhibitor AG490 inhibits proliferation, migration and disrupts actin organization of cancer cells. J Environ Pathol Toxicol Oncol, 32(4): 361-371, 2013. PMID: 24579787
      43. Kembhavi SA, Qureshi S, Vora T, Chinnaswamy G, Laskar S, Ramadwar M, Arora B. Understanding the principles in management of Wilms' tumour: Can imaging assist in patient selection? Clin Radiol. 68(7):646-53, 2013. PMID: 23352764
      44. Kembhavi S, Deshpande S, Qureshi S. Paediatric renal tumors with subcapsular fluid sign: is it specific for Rhabdoid tumors? OMICS J Radiology 2: 128, 2013.
      45. Kumar S, Jena L, Daf S, Mohod K, Goyal P, Varma AK. hpvPDB: An online proteome reserve for human papillomavirus. Genome Inform. 11(4): 289-291, 2013. PMID: 24465243
      46. Kunder R, Jalali R, Sridhar E, Moiyadi A, Goel N, Goel A, Gupta T, Krishnatry R, Kannan S, Kurkure P, Deopujari C, Shetty P, Biyani N, Korshunov A, Pfister SM, Northcott PA, Shirsat NV.: Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas. Neuro Oncol. 15(12):1644-1651,2013. PMID: 24203893
      47. Maitra A, Biswas NK, Amin K, Kowtal P, Kumar S, Das S, Sarin R, Majumder PP, Bagchi I, Bairagya BB, Basu A, Bhan MK, Chaturvedi P, Das D ,D’Cruz A, Dhar R, Dutta D, Ganguli D, Gera P, Gupta T, Mahapatra S, Mujawar MHK, Mukherjee S, Nair S, Nikam S, Nobre M, Patil A, Patra S, Rama-Gowtham M, Rao TS, Roy B , Roychowdhury B, Sarkar D, Sarkar S, Sarkar –Roy N, Sutradhar D. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat Commun. 2013. PMID: 24292195
      48. Malhotra G, Asopa RV, Sridhar E. Unusual case of isolated paraseller metastasis from carcinoma of thyroid. Clin Nucl Med. 38(2): 145-148, 2013. PMID: 23334134
      49. Mallick S, Agarwal J, Kannan S, Pawar S, Kane S, Teni T.Bcl-xL protein: Predictor of complete tumor response in patients with oral cancer treated with curative radiotherapy. Head Neck 35(10): 1448-53, 2013.PMID: 22987535
      50. Manjappa AS, Goel PN, Vekataraju MP, Rajesh KS, Makwana K, Ukawla M, Nikam Y, Gude RP, Murthy RSR. Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond. Pharm Res. 30(10): 2675-93,2013. PMID:23756759
      51. Mishra DK, Dhote V, Mishra PK. Transdermal immunization: biological framework and translational perspectives. Expert Opin Drug Deliv. 10(2): 183-200, 2013. PMID: 23256860
      52. Moiyadi A, Pai PS, Nair D, Pal P, Shetty P, Agarwal J, Budrukar . Dural involvement in Skull base tumors - Accuracy of preoperative radiological evaluation and intraoperative assessment. J Craniofac Surg 24(2): 526-30, 2013. PMID: 24036675
      53. Moiyadi AV, Shetty PM, Mahajan A, Udare A, Sridhar E. Usefulness of three-dimensional navigable intraoperative ultrasound in resection of brain tumors with a special emphasis on malignant gliomas. Acta Neurochir. 155(12):2217-2225, 2013.
      54. Munnolli SS, Pujar SM. Beyond traditional citations: Leap on clouds to capture virtual metrics. J Scient. Res. 2(2) : 157-158, 2013.
      55. Noronha V, Prabhash K, Thavamani A, Chougule A,Purandare N, Joshi A, Sharma R, Desai S, Jambekar N, Dutt A, Mulherkar R. EGFR mutations in Indian lung cancer patients: Clinical correlation and outcome to EGFR targeted therapy. PLoS One. 8(4): e61561, 2013. PMID: 23620765
      56. Paleja B, Anand A, Chaukar D, D’cruz A, Chiplunkar SV. Decreased functional response to toll like receptor ligands in patients with oral cancer. Hum Immunol. 74(8): 927-938, 2013 PMID: 23628388
      57. Nxasana N, Baba K, Bhat VG, Vasaikar SD. Prevalence of intestinal parasites in primary school children of Mthatha, Eastern Cape Province, South Africa. Ann Med Health Sci Res. 3(4):511-516, 2013.
      58. Panwar H, Jain D, Khan S, Pathak N, Raghuram GV, Bhargava A, Banerjea S, MIshra PK. Imbalance of mitochondrial-nuclear cross talk in isocyanate mediated pulmonary endothelial cell dysfunction. Redox Biol. 1(1): 163-171, 2013. PMID: 24024149
      59. Parmar V, Hawaldar R, Nair NS, Shet T, Vanmali V, Desai S, Gupta S, Rangrajan V, Mittra I, Badwe RA. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer. The Breast. 22: 1081-86,2013. PMID:23948301
      60. Patel K, Patil A, Mehta M, Gota V, Vavia P. Medium chain triglyceride (MCT) rich, paclitaxel loaded self nanoemulsifying preconcentrate (PSNP): A safe and efficacious slternative to taxol®. J Biomed Nanotechnol 9: 1-11, 2013. PMID: 24266255
      61. Pranay A, Shukla S, Kannan S, Malgundkar SA, Govekar RB, Patil A, Kane SV, Chaturvedi P, D’Cruz AK, Zingde SM.Prognostic utility of autoantibodies to α-enolase and Hsp70 for cancer of the gingivo-buccal complex using immunoproteomics. Proteomics Clin Appl. 7(5-6): 392-402, 2013. PMID: 23161576
      62. Qureshi SS, Kembhavi S, Vora T, Ramadwar M, Laskar S, Talole S, Kurkure P. Prognostic factors in primary nonmetastatic ewing sarcoma of the rib in children and young adults. J Paed Surg. 48(4): 764-770, 2013. PMID: 23583131
      63. Rajasekran R, Aruna P, Koteeswaran K, Padmanabhan L, Muthuvelu K, Rai RR, Thamilkumar P, Krishna CM, Ganesan S. Characterisation and diagnosis of cancer by native fluorescence spectroscopy of human urine. Photochem Photobiol 89(2): 483-91,2013. PMID: 22971002
      64. Rathod S, Gupta T, Ghosh-Laskar S, Murthy V, Budrukkar A, Agarwal J.Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. Oral Oncol. 49:634-642, 2013. PMID: 23562564
      65. Ray S, Moiyadi A, Srivastava S. Biorepositories for cancer research in developing countries. Nat Rev Clin Oncol. 10:434-436, 2013. PMID:23836317
      66. Rekha MR, Pal K, Bala P, Shetty M. Mittra I, Bhuvaneshwar GS, Sharma CP. Pullulan-histone antibody nanoconjugates for the removal of chromatin fragments from systemic circulation. Biomaterials. 34(27): 6328-6338, 2013.PMID: 23746856
      67. S Rubina, Maheswari AK, Deodhar K, Rekhi B, Krishna CM. Raman spectroscopic study on classification of cervical cell specimens. Vib Spectrosc 68: 115-121, 2013
      68. S Rubina, Vidyasagar MS, Krishna CM. Raman spectroscopic study on prediction of treatment response in cervical cancers. J Innov Opt Health Sci. 6(2) , 2013.
      69. Sahu A, Sawant SS, Mamgain H, Krishna CM. Raman spectroscopy of serum: an exploratory study for detection of oral cancers. Analyst. 138(14): 4161-74, 2013. PMID: 23736856
      70. Sahu A, Dalal K, Naglot S, Aggarwal P, Krishna CM. Serum based diagnosis of asthma using raman spectroscopy: An early phase pilot study. PLoS One. 2013. PMID:24250817
      71. Salot S, Gude RP.:MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines. Eur J Cancer. 49:492-499, 2013. PMID: 22841503
      72. Sawant RB, Marathe AN. Pooled platelet product using the acrodose plus system: Evaluation of feasibilty, safety and efficacy.Transfus Apher Sci. 49(3): 535-538,2013. PMID: 24080148
      73. Selvaa Kumar C, Gadewal N, Mohammed SMM. Identification of leads from marine seaweeds against human β- tubulin. Lett Drug Des Discov. 10: 67-74, 2013.
      74. Shah S, Pal A, Gude RP, Devi S. A novel approach to prepare etoposide-loaded poly(N-vinyl caprolactam-co-methylmethacrylate) copolymeric nanoparticles and their controlled release studies. J Appl Polym Sci. 127(6): 4991-4999, 2013.
      75. Sharma AJ, Mansukh A, Varma A, Gadewal N, Gupta S. Molecular modeling of differentially phosphorylated serine 10 and acetylated iysine 9/14 of histone H3 regulates their interactions with 14-3-3ζ, MSK1, and MKP1. Bioinform Biol Insights 7: 271-288, 2013 PMID: 24027420
      76. Sharma S, Zingde SM, Gokhale SM. Identification of Human Erythrocyte Cytosolic Proteins Associated with Plasma Membrane During Thermal Stress. J Membr Biol. 246(8): 591-607,2013. PMID:23774970
      77. Shenoy V, Gude RP, Murthy RS. In vitro anticancer evaluation of 5-fluorouracil lipid nanoparticles using B16F10 melanoma cell lines. Int Nano Lett. 3:36, 2013.
      78. Shete H, Chatterjee S, De A, Patravale V. Long chain lipid based tamoxifen nlc. Part ii: Pharmacokinetic, biodistribution and in vitro anticancer efficacy studies. Int J Pharmaceutics. 454(1)584-592,2013. PMID: 23535344
      79. Shukla P, Engineer R, Chopra S, Shrivastava SK. Endobiliary stent: Marker for patient alignment in image-guided radiotherapy in pancreatic and periampullary cancers. J Gastrointest Cancer. 44(4): 393-397, 2013.PMID: 23733213
      80. Singh SP, Sahu A, Deshmukh A, Chaturvedi P, CM Krishna. In vivo Raman spectroscopy of oral buccal mucosa: A study on malignancy associated changes (MAC)/cancer field effects (CFE). Analyst. 138:4175-4182, 2013. PMID: 23392131
      81. Sinha RK, Bojjireddy N, Kulkarni D, Ratheesh A, Chiplunkar SV, Gude R, Subrahmanyam G. Type II phosphatidylinositol 4-kinase β is an integral signaling component of early T cell activation mechanisms. Biochimie. 95(8): 1560-66, 2013.PMID: 23619705
      82. Somani R, Chiplunkar SV, Vetale SP, Makhija DT, Shirodkar PY. Evaluation of apoptosis inducing activity of an oxadiazole based potential anticancer compound. Int J Pharmtech Res. 5(3): 1233-1240, 2013
      83. Thomas A, Mahantshetty U, Kannan S, Deodhar K, Shrivastava SK, Kumar-Sinha C and Mulherkar R. Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease. Cancer Medicine. 2(6): 836-848, 2013. PMID: 24403257
      84. Thorat R, Ahire S, Ingle A. Re-establishment of a breeding colony of immunocompromised mice through revival of cryopreserved embryos. Lab Anim (NY). 42(4):131-4, 2013.PMID: 23511082
      85. Vikrant, Kumar R, Yadav LR, Nakhwa P, Waghmare SK, Goyal P, Varma AK. Structural and functional implication of RAP80 ΔGlu81 mutation. PLoS One 8(9): e72707, 2013. PMID: 24039796
      86. Waghmare SK, Tumbar T. Adult hair follicle stem cells do not retain the older DNA strands in vivo during normal tissue homeostasis. Chromosome Res. 21(3): 203-12, 2013.PMID: 23681654
      1. Dahara, R, Jain, B, Bhattacharyya, D. (2023). Visualizing Reversible Cisternal Stacking in Budding Yeast Pichia pastoris. In: Wang Y, Lupashin VV, Graham TR. (Eds) Golgi. Methods in Molecular Biology, vol 2557. New York, Humana. (ISBN: 978-1-0716-2638-2)
    • 2022
      1. Acharya S, Bose R, Bose K. "Purification of Difficult Proteins." In: Bose K. (ed.) Textbook on Cloning, Expression and Purification of Recombinant Proteins. Singapore; Springer, 2022. Pp. 249-278. (ISBN: 978-981-16-4986-8)

      2. Bose R, Bose K. "A Brief Introduction to Recombinant DNA Technology." In: Bose K. (ed.) Textbook on Cloning, Expression and Purification of Recombinant Proteins. Singapore; Springer, 2022. Pp. 1-12. ( ISBN 978-981-16-4986-8)

      3. Chakraborty A, Puja R, Bose K. "Protein Purification by Ion Exchange Chromatography." In: Bose K. (Ed.) Textbook on Cloning, Expression and Purification of Recombinant Proteins. Singapore; Springer, 2022. Pp.173-198. (ISBN: 978-981-16-4986-8)

      4. Chatterjee A, Maitre M, Dasgupta A, Sridhar E, Gupta T. "Multidisciplinary Management of Medulloblastoma: Consensus, Challenges, and Controversies". In: Dey A, Malhotra A, Garg N. (Eds) Medulloblastoma. Methods in Molecular Biology, vol 2423. New York; Humana, 2022. Pp. 215-235. (ISBN 978-1-0716-1951-3)

      5. Deshmukh S, Kulkarni R, Bose K. (2022) "Transformation and Protein Expression." In: Bose K. (ed.) Textbook on Cloning, Expression and Purification of Recombinant Proteins.Springer, Singapore; Springer, 2022. Pp. 83-114. (ISBN: 978-981-16-4986-8)

      6. Dutta S, Bose K. "Protein Purification by Affinity Chromatography." In: Bose K. (ed.) Textbook on Cloning, Expression and Purification of Recombinant Proteins. Singapore; Springer, 2022. Pp. 141-171. (ISBN: 978-981-16-4986-8)

      7. Ketkar M, Dutt S. (2022). Epigenetic regulation towards acquired drug resistance in cancer. In: Kundu TK, Das C. (Eds) Metabolism and epigenetic regulation: Implications in cancer. Subcellular Biochemistry, vol 100. Springer, Cham.

      8. Kulkarni R, Bose R, Bose K. "Selection of Cloning and Expression Plasmid Vectors." In: Bose K. (Ed.) Textbook on Cloning, Expression and Purification of Recombinant Proteins. Singapore; Springer, 2022. Pp. 57-81. ( ISBN: 978-981-16-4986-8)

      9. Kulkarni R, Bose K. "Protein Purification by Reversed Phase Chromatography and Hydrophobic Interaction Chromatography." In: Bose K. (Ed.) Textbook on Cloning, Expression and Purification of Recombinant Proteins. Singapore; Springer, 2022. Pp. 221-247.

      10. Kumar S, Gupta S, Maurya AP, Singh R, Nigam S. (2022). Hormonal and Targeted Treatments in Breast Cancer. In: Sharma, SC, Mazumdar, A, Kaushik R. (Eds.) Breast Cancer. Springer, Singapore. Pp. 443–463.

      11. Kummari R, Bose K. Gel Filtration Chromatography." In: Bose K. (Ed.) Textbook on Cloning, Expression and Purification of Recombinant Proteins. Singapore; Springer, 2022. Pp. 199-219. (ISBN: 978-981-16-4986-8)

      12. Kummari R, Puja R, Bose K. "Protein Quantitation and Detection." In: Bose K. (Ed.) Textbook on Cloning, Expression and Purification of Recombinant Proteins. Singapore; Springer, 2022.

      13. Kunder R, Shirsat NV. (2022) Real-Time PCR Assays on Formalin-Fixed, Paraffin-Embedded Medulloblastomas. In: Dey A, Malhotra A, Garg N. (Eds) Medulloblastoma. Methods in Molecular Biology, vol 2423. New York; Humana. (ISBN 978-1-0716-1952-0)

      14. Mehta D, Waghmare SK. (2022) "Emerging Metabolic Regulation of Redox Status in Cancer Stem Cells Progression and Metastasis". In: Chakraborti S. (Eds) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Singapore; Springer.

      15. Pansare K, CM Krishna. “Monitoring Therapeutic Response in Cancers: A Raman Spectroscopy Approach” In: Rahman A, Ozkan S (Eds.). Recent Advances in Analytical Techniques. Vol. 5, Bentham Science Publishers, 2022. Pp. 192-275. (ISBN: 978-9815036947)

      16. Panwalkar P, Khire A, Shirsat NV. (2022) Quantification of microRNAs in Cells and Tissues Using Stem-Loop RT PCR and qPCR. In: Dey A, Malhotra A, Garg N. (Eds) Medulloblastoma. Methods in Molecular Biology, vol 2423. New York; Humana. (ISBN 978-1-0716-1952-0)

      17. Panwalkar P, Khire A. Shirsat NV. (2022) Validation of microRNA Target Genes Using Luciferase Reporter assay and Western Blot Analysis. In: Dey A., Malhotra A., Garg N. (Eds) Medulloblastoma. Methods in Molecular Biology, vol 2423. New York; Humana. (ISBN 978-1-0716-1952-0)

      18. Parui A, Singh N, Dutta S, Bose K. (2022)Role of conserved regulatory loop residues in allosteric propagation of serine protease HtrA2. Biochemical and Biophysical Research Communications. 594: 63-68.

      19. Parui AL. Chaganti LK, Kulkarni R, Bose K. "Cloning and Gene Manipulation." In: Bose K. (ed.) Textbook on Cloning, Expression and Purification of Recombinant Proteins. Springer, Singapore; Springer, 2022. Pp. 13-56. (ISBN: 978-981-16-4986-8)

      20. Sarangi SS, Gupta S, Kataki AC. (2022). Principles of Chemotherapy, Targeted Therapy, and Immunotherapy in Gynaecological Malignancies. In: Kataki AC, Barmon D. (Eds) Fundamentals in Gynaecologic Malignancy. Springer; Singapore.Pp. 77-97. ( ISBN 978-9811958595)

      21. Sarkar D, Dutt S. (2022) ROS Signaling in Brain Tumor. In: Chakraborti S. (Eds) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Springer, Singapore. ISBN (978-981-16-1247-3-242-1)

      22. Shetty D, Dave U. "Intellectual Disability: A Challenge to Genetic Counselling" Chapter 11, Part II- Genetic Counseling; Section 2- Genetic Counseling in Development Disabilities.In: Dave U (Ed), Shetty D (Co-Ed) Genetic Counseling: Clinical and laboratory Approach. 1st Edition. New Delhi; Jaypee Brothers Medical Publishers (P) Ltd., 2022. Pp. 131-149. (ISBN 978-93-5465-212-7).

      23. Shetty D. " Pedigree Charting and Inheritance: Essential for Genetic Counseling" Chapter 3, Part I- Basics of Genetics. In: Dave U (Ed), Shetty D (Co-Ed) Genetic Counseling: Clinical and laboratory Approach. 1st Edition. New Delhi; Jaypee Brothers Medical Publishers (P) Ltd., 2022. Pp. 34-41. (ISBN 978-93-5465-212-7).

      24. Singh M, D’Silva S. "Genetic counseling for HLA typing for finding a donor for Hematopoietic Stem Cell Transplantation". In: Chapter 33, Part II- Genetic Counseling; Section 9- Genetic Counseling in Cancer In: Dave U (Ed), Shetty D (Co-Ed) Genetic Counseling: Clinical and laboratory Approach. 1st Edition. New Delhi; Jaypee Brothers Medical Publishers (P) Ltd., 2022. Pp. 417-424. (ISBN 978-93-5465-212-7).

      25. Singh N, Bose K. "Introduction to Recombinant Protein Purification." In: Bose K. (ed.) Textbook on Cloning, Expression and Purification of Recombinant Proteins. Singapore; Springer, 2022. Pp. 115-140. (ISBN: 978-981-16-4986-8)

      26. Talukdar A, Kataki AC, Banavali S, Ghosh J. (2022). Cancer: Infection and Vaccines. In: Kataki AC, Barmon D. (Eds) Fundamentals in Gynaecologic Malignancy. Singapore; Springer. Pp. 37-46.( ISBN 978-9811958595)

      27. Yogi K, Thorat R, Shirsat NV. (2022) In Vivo Tumorigenicity Assays Using Subcutaneous and Orthotopic Xenografts in Immunodeficient Mice. In: Dey A, Malhotra A, Garg N. (eds) Medulloblastoma. Methods in Molecular Biology, vol 2423. New York; Humana. (ISBN 978-1-0716-1952-0)
    • 2021
      1. Kulkarni P, Mehta P, Shriyan B, Gawit K, Gota V, Ghante M. (2021) "Pharmacokinetics, Pharmacodynamics, and Toxicology Aspects of Immunotherapeutics". In: Sawarkar SP, Nikam VS, Syed S. (Eds.) Immunotherapy – A Novel Facet of Modern Therapeutics. Singapore Springer, 2021. Pp. 195-214. (ISBN: 978-981-15-9037-5)
      2. Thorat R. "Assisted Reproductive Technologies (ARTs) in the Laboratory Mouse. In: Nagarajan P, Gudde R, Srinivasan R. (Ëds.) Essentials of Laboratory Animal Science: Principles and Practices. Singapore; Springer, 2021. Pp. 679-707. ( ISBN 978-981-16-0987-9)
      3. Chaudhari P. (2021). Preclinical Imaging of Laboratory Rodents. In Nagarajan P, Ramachandra SG, Suresh R (Eds.) Essentials of Laboratory Animal Science: Principles and Practices. Singapore; Springer, 2021. Pp 607-630. (ISBN 978-981-16-0987-9)
      4. Gupta C, Uthale A, Teni T, Ambre P, Coutinho E. "Emerging Polymer-Based Nanomaterials for Cancer Therapeutics". In: Saravanan M, Barabadi H. (Eds.) Cancer Nanotheranostics. Nanotechnology in the Life Sciences. Cham: Springer, 2021. (ISBN: 978-3-030-74329-1)
      5. Shabrish S, Madkaikar M. "Comprehensive evaluation of NK cells and its utility in the diagnosis of NK cell defects" In: Duncan LT (Ed.) Advances in Health and Disease. Volume 46, New York; Nova Science Publishers, 2021. Pp. 103-154. (ISBN 978-1-68507-266-7).
      6. Martins S, Salvi P, Lavuri S, Srivastava M, Shalini Sakthivel S, Barman M, Chand K, Singh M, Sonkar S, Bhukya P. "Therapeutic Approaches to Employ Monoclonal Antibody for Cancer Treatment." In: Kumar S, Rizvi M and Verma S (Eds.) Handbook of Research on Advancements in Cancer Therapeutics. Hershey, PA: IGI Global, 2021. Pp. 42-88. (ISBN:978-1-7998-6530-8)
      7. Attri S, Sharma S, Sharma U, Srivastava M, Sonkar S, Meenakshi Singh M, Bhukya P. "Use of Lipids, Polymers, and Peptides for Drug Delivery and Targeting to Cancer Cells or Specific Organs. In: Kumar S, Rizvi M and Verma S (Eds.) Handbook of Research on Advancements in Cancer Therapeutics. Hershey, PA: IGI Global, 2021. Pp. 276-289. (ISBN:978-1-7998-6530-8)
      8. Ravichandiran N, Barman M, Lavuri S, Srivastava M, Sakthivel S, Singh M, Chand K, Sonkar S, Bhukya P. "Precision Medicine in Cancer." In: Kumar S, Rizvi M and Verma S (Eds.) Handbook of Research on Advancements in Cancer Therapeutics. Hershey, PA: IGI Global, 2021. Pp. 433-466. (ISBN:978-1-7998-6530-8)
      9. Shalini S, Srivastava M, Barman M, Ravichandiran N, Martins S, Singh M, Chand K, Sonkar S, Bhukya P. "Cancer Stem Cells and Advanced Novel Technologies in Oncotherapy." In Handbook of Research on Advancements in Cancer Therapeutics. ." In: Kumar S, Rizvi M and Verma S (Eds.) Handbook of Research on Advancements in Cancer Therapeutics. Hershey, PA: IGI Global, 2021. Pp. 486-513. (ISBN:978-1-7998-6530-8)
      10. Rashi R, Bhukya P, Barman M, Singh M, Chand K, Sonkar S, Srivastava M. "Cancer: Clinical Trial Design and Principles." In Handbook of Research on Advancements in Cancer Therapeutics. ." In: Kumar S, Rizvi M and Verma S (Eds.) Handbook of Research on Advancements in Cancer Therapeutics. Hershey, PA: IGI Global, 2021. Pp. 627-638. (ISBN:978-1-7998-6530-8)
      11. Barman M, Srivastava M, Singh M, Fakhri K, Chand K, Sonkar S, Bhukya P. "Utilization of Bio-Imaging in Cancer Studies.” In: Kumar S, Rizvi M and Verma S (Eds.) Handbook of Research on Advancements in Cancer Therapeutics. Hershey, PA: IGI Global, 2021. Pp. 534-540. (ISBN:978-1-7998-6530-8)
      12. Munnolli SS. Ethical challenges in open science: Researchers' perspective. In; Pujar SM, Munnolli SS, Babu R (Eds.) Open Scholarship and Libraries, Sunstar Publishers: Banglore, 2021. Pp. 291-298.
    • 2020
      1. Roy G, Bhattacharjee A, Khan I. “Biostatistics in Clinical Oncology." In: Masood N, Shakil Malik S. (Eds.) Essentials of Cancer Genomic, Computational Approaches and Precision Medicine. Singapore: Springer, 2020. Pp. 365-378. (ISBN: 978-981-15-1066-3)    
      2. Shah S, Rashid M, Verma T, Gupta S. "Chromatin, Histones, and Histone Modifications in Health and Disease". In: Forero DA, Patrinos GP (Eds.) Genome Plasticity in Health and Disease. Translational and Applied Genomics. San Diego: Academic Press, 2020. Pp. 109-135. (ISBN:978-0-12-817819-5
      3. Bhat S, Sureshbabu S, Philip S, Chiplunkar S. “Impact of Epigenetic Modifiers on the Immune System.” In: Kabelitz D, Jaydeep Bhat (Eds.) Translational Epigenetic. Volume 16: Epigenetics of the Immune System. London: Academic Press, 2020. Pp. 315-352. (ISBN: 978-012-817964-2)
    • 2019
      1. Akshay S, Basu S, Chakraborty S, Sundararajan R, Venkatraman P. “Functional Significance Checking in Noisy Gene Regulatory Networks.” In: Schiex T., de Givry S. (Eds) Principles and Practice of Constraint Programming. CP 2019. Lecture Notes in Computer Science, vol 11802. Cham: Springer, 2019. Pp. 767-785. (ISBN: 978-3-030-30047-0)
      2. Bose A, Dalal SN. “Centrosome amplification and tumorigenesis: Cause or effect?” In: Kloc M. (Ed.) The Golgi Apparatus and Centriole. Results and Problems in Cell Differentiation: Volume 67. Cham: Springer, 2019. Pp. 413-440. (ISBN: 978-3-030-23173-6)
      3. Tembhare PR, Gujral S, Krishnamurthy H. “Measurement of Predictive Cancer Biomarkers by Flow Cytometry.” In: Badve S., Kumar G. (Eds) Predictive Biomarkers in Oncology. Switzerland: Springer, 2019. Pp. 119-129. ( ISBN: 978-3-319-95227-7)
      4. Ingle AD. “Alternatives and Refinement for Animal Experimentation in Cancer Research.” In: Kojima H, Seidle T, Spielmann H. (Eds) Alternatives to Animal Testing. Singapore: Springer, 2019. Pp. 69-75. (ISBN: 978-981-13-2446-8)
      5. Kumar P, CM Krishna. “Optical Techniques: Investigations in Oral Cancers. (2019) In: Panta P (Ed). Oral Cancer Detection: Novel Strategies and Clinical Impact. Switzerland: Springer International Publishing, 2019. Pp. 167-187. (ISBN: 978-3-319-61255-3)
      6. Panta P, Chih-W, Kumar P, Tuan--Shu H, Sheng-Lung H, Kumar P, CM Krishna, Rao KD, John R. “Optical Coherence Tomography: Emerging In Vivo Optical Biopsy Technique for Oral Cancers.” Panta P (Ed). Oral Cancer Detection: Novel Strategies and Clinical Impact. Switzerland: Springer International Publishing, 2019. Pp. 211-237. (ISBN: 978-3-319-61255-3)
      7. Sharda A, Amnekar RV, Natu A, Sukanya, Gupta S. “Histone posttranslational modifications: Potential role in diagnosis, prognosis, and therapeutics of cancer.” In: Sharma S (Ed.) Prognostic Epigenetics. Vol.15, Translational Epigenetics. London: Academic Press, 2019. Pp. 351-373. (ISBN: 978-0-12-814259-2)
      8. Parui AL, Bose K. “Cancer Biology and Its Treatment Modalities: A Brief Historical Perspective. “ In: Bose K, Chaudhari P. (Eds.) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Singapore: Springer, 2019. Pp. 1-11. (ISBN: 978-981-329-815-6)
      9. Wagh AR, Bose K. “Apoptosis in Cancer Cell Signaling and Current Therapeutic Possibilities.” In: Bose K, Chaudhari P. (Eds.) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Singapore: Springer, 2019. Pp.113-129. (ISBN: 978-981-329-815-6)
      10. Mansuri MS, Mehrotra S. “Emerging Epigenetic Targets and Their Implications in Cancer Therapy.” In: Bose K, Chaudhari P. (Eds.) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Singapore: Springer, 2019. Pp. 157-188. (ISBN: 978-981-329-815-6)
      11. Dhumal A, Bendale K, Chaudhari P. “Preclinical Animal Models for Cancer Research and Drug Discovery.” In: Bose K, Chaudhari P. (Eds.) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Singapore: Springer, 2019. Pp. 229-254. (ISBN: 978-981-329-815-6)
      12. Doshi J, Dutta S, Bose K. “Analysing Cancer Signalling Pathways: A Structural Bioinformatics Approach.” In: Bose K, Chaudhari P. (Eds.) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Singapore: Springer, 2019. Pp. 271-293. (ISBN: 978-981-329-815-6)
      13. Zingde SM. “Proteomics for Cancer: Approaches and Challenges.” In: Bose K, Chaudhari P. (Eds) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Singapore: Springer, 2019. Pp. 343-368. (ISBN: 978-981-329-815-6)
      14. Kumar P, Singh B, Chaudhari P, Jose J, Butler A, Prebble H, Moghiseh M and the MARS Collaboraion. “Preclinical Non-invasive Imaging in Cancer Research and Drug Discovery: An Overview.” In: Bose K, Chaudhari P. (Eds) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Singapore: Springer, 2019. Pp. 419-469. (ISBN: 978-981-329-815-6)
      15. Bhatia DR, Rath S, Gupta S. “New Emerging Molecules in Cancer Research Which Hold Promise in Current Era.” In: Bose K, Chaudhari P. (Eds) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. Singapore: Springer, 2019. Pp. 539-583. (ISBN: 978-981-329-815-6)
      16. Mishra GA, Pimple SA. “ Prevention of Cancer.” In: Sanchetee S (Ed) A Textbook of Clinical Oncology in the Indian Context. 2019, Vol I , Pp. 111-125.
    • 2018
      1. Dhadve A, Thakur B, Ray P. “Construction of Dual Modality Optical Reporter Gene Constructs for Bioluminescent and Fluorescent Imaging”. In: Dubey P(Ed.). Methods in Molecular Biology: Volume 1790. Reporter Gene Imaging: Methods and Protocols. New York: Humana Press, 2018. PP. 13-27. (ISBN 978-1-4939-7860-1)
      2. Dhadve A, Thakur B, Ray P.” Dual Modality Imaging of Promoter Activity as a Surrogate for Gene Expression and Function.” In: Dubey P(Ed.). Methods in Molecular Biology: Volume 1790. Reporter Gene Imaging: Methods and Protocols. New York: Humana Press, 2018.PP. 1-12. (ISBN 978-1-4939-7860-1)
      3. Pujar SM, Munnolli SS. Mundgod MB. “Sharing Economy and Libraries”. In: Sangam SL, Bankapur VM. (Eds.) Libraries in Sharing Economy. Agra: Current Publications, 2018. 1-10.
      4. Rathod M, Mal A, De A. Reporter-Based BRET Sensors for Measuring Biological Functions In Vivo. In: Dubey P(Ed.). Methods in Molecular Biology: Volume 1790. Reporter Gene Imaging: Methods and Protocols. New York: Humana Press, 2018. PP. 51-74. (ISBN 978-1-4939-7860-1)
    • 2017
      1. Coleman-Vaughan C, Mal A, De A, McCarthy J. “The γ-Secretase Protease Complexes in Neurodegeneration, Cancer and Immunity”. In: Chakraborti S, Dhalla N (Eds.) Pathophysiological Aspects of Proteases. Singapore: Springer Nature, 2017. Pp. 1-41. (ISBN 978-981-10-6140-0)
      2. Gujral S, Tiwari M. “Reporting the Results”. In: Sood SK, Mukherjee R, Sood S. Assuring Quality and Competence: A Guide for Medical Laboratories Seeking Accredation to ISO 15189. Noida: Sumeet Sood, 2017. Pp.182-188.
      3. Gujral S, Tiwari M. “Release of Results”. In: Sood SK, Mukherjee R, Sood S. Assuring quality and competence: A Guide for Medical Laboratories Seeking Accredation to ISO 15189. Noida: Sumeet Sood, 2017. Pp. 189-196.
      4. Misra P, Bunkar N, Jain S, Khare N, Pathak N.” Bhopal (1984): Cancer Risk Among Survivors and Opportunities for Translational Environmental Health Research”. In: Brimblecombe P(Ed.) Air Pollution Episodes. Singapore: World Scientific, 2017. Pp.101-127.
      5. Nair J, Dutt S. “Preclinical Orthotopic Murine Xenograft Models in Glioblastoma" In, Brain Tumor. Avid Science, 2017. Pp. 2-33.
      6. Parui A, Kakoli Bose. “Caspases: Regulatory Mechanisms and Their Implications in Pathogenesis and Therapeutics”. In: Chakraborti S, Dhalla N (Eds.) Pathophysiological Aspects of Proteases. Singapore: Springer Nature, 2017. Pp. 423-488. (ISBN 978-981-10-2512-9)
      7. Wagh A, Bose. K "Emerging Roles of Mitochondrial Serine Protease HtrA2 in Neurodegeneration". In: Chakraborti S, Dhalla N (Eds) Proteases in Physiology and Pathology. Singapore: Springer, 2017. Pp.325-353. (ISBN 978-981-10-2512-9)
    • 2023
      1. Dahara, R, Jain, B, Bhattacharyya, D. (2023). Visualizing Reversible Cisternal Stacking in Budding Yeast Pichia pastoris. In: Wang Y, Lupashin VV, Graham TR. (Eds) Golgi. Methods in Molecular Biology, vol 2557. New York, Humana. (ISBN: 978-1-0716-2638-2)

      2. Moiyadi A, Shetty P, Velayutham P, Singh VK, Jain K. (2023). Intraoperative Mapping and Monitoring Techniques for Intra-Axial Brain Tumors. In: Shah A, Goel A, Kato Y. (Eds) Functional Anatomy of the Brain: A View from the Surgeon’s Eye. Springer, Singapore.(ISBN: 978-981-99-3411-9)

      3. Verma N. (2023). Who Dictates and When: Genetic and Epigenetic Dictatorships in Breast Cancer Response and Resistance to Ttherapy. In: Garg M, Sethi G, Pandey A. (Eds.) Transcription and Translation in Health and Disease. Academic Press. Pp. 49-73. (ISBN: 9780323995214)


      4.  
    • 2024
      1. Anchan S, Shaikh Z, Kumari A, Thorat R. (2024). Animal Models in Cancer Research: Revolutionizing the Field of Oncology. In: Vijayakumar Sreelatha H, Patel S, Nagarajan P. (eds) Animal Models in Research. Springer, Singapore. Pp.363-378. (ISBN: 978-981-97-0047-9)

      2. Arunadevi R, Zacharioudaki A, Thorat R, Shenoy SJ, Vijayakumar Sreelatha H. (2024). Basic Techniques to Facilitate Small Animal Experimentation. In: Vijayakumar Sreelatha H, Patel S, Nagarajan P. (eds) Animal Models in Research. Springer, Singapore. Pp. 77-128. (ISBN: 978-981-97-0047-9)

      3. Bhat KV, Jain H. (2024). Pediatric Myeloproliferative Disorders/Myelodysplastic Syndromes/Overlap Syndromes. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore.Pp.359-365.

      4. Bonda A, Khattry N. (2024). Hematopoietic Stem Cell Transplantation. In: Badwe RA., Gupta S, Shrikhande SV, Laskar, S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp. 367-375.

      5. Dikshit R, Budukh A. (2024). Cancer Registration in India. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp.229 -238.

      6. Epari, S., Narula, G. (2024). Histiocytic and Dendritic Cell Neoplasms. In: Badwe, R.A, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer, Singapore. Pp. 319-330.

      7. Ghosh J, Maheshwari A, Rekhi B, Thakkar (Popat) PB, Rath S, Kannan RA (2024). Non-Epithelial Ovarian Cancers. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp. 847-855.

      8. Ghosh J, Maheshwari A, Rekhi B, Thakkar(Popat) P, Damani A, Poddar P, Mahantshetty U (2024).Epithelial Ovarian Cancer. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp.821-846.

      9. Gota V, Nookala Krishnamurthy M, Patil A, Nehra J, Mehta PR (2024). Clinical Pharmacology in Oncology. In: Badwe RA,Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp.199-212.

      10. Gulia S, Talreja V, Ghosh J, Gupta S, Bajpai J. (2024). Gestational Trophoblastic Disease. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp.809-820.

      11. Joshi A, Dholakia K, Bakshi G. (2024). Adrenocortical Carcinoma. In: Badwe RA, Gupta S, Shrikhande SV, Laskar, S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp. 679-685.

      12. Joshi, A., Shrirangwar, S., Kataria, P., Goel, A., Pande, N. (2024). Testicular Cancer. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore,Pp. 751-761.

      13. Mehrotra M, Phadte P, Shenoy P, Chakraborty S, Gupta S. Ray P. (2024). Drug-Resistant Epithelial Ovarian Cancer: Current and Future Perspectives. In: Schatten, H. (eds) Cell and Molecular Biology of Ovarian Cancer. Advances in Experimental Medicine and Biology, Vol .1452. Springer, Cham, Pp. 65-96. (ISBN: 978-3-031-58310-0)

      14. Moiyadi A, Singh V, Tonse R, Jalali R. (2024). Central Nervous System (CNS) Tumors. In: Badwe RA, Gupta S, Shrikhande, SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore. Pp. 379-404

      15. Nair S, Wadasadawala T, Thakkar P, Kembhavi S, Bajpai J, Gulia S, Pathak R, Turkar S, Badwe R (2024). Breast Cancer.In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, PP.451-470.

      16. Patkar N, Nathany S, Gudapati P, Mehta A, Chatterjee G, Kodgule R, Tembhare P, Subramanian PG, Gujral S (2024). Oncological Hematopathology. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp.71-87.

      17. Pimple SA, Mishra GA. (2024). Cancer Screening in India. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp.239-250.

      18. Prakash G, Gupta AM, Sood S, Murthy V. (2024). Urinary Bladder Cancer. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp. 687-706.

      19. Punatar S, Shetty D. (2024). Adult Myeloproliferative Disorders/Myelodysplastic Syndromes/Overlap Syndromes. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp. 283-290.

      20. Sarin R. (2024). Hereditary Cancers. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, 1031-1045.

      21. Shylasree TS, Chopra S, Bansal R, Bhattacharjee A, Bajpai J. (2024). Vulvar and Vaginal Cancers. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp.795-808.

      22. Sirohi B, Khobragade K, Patkar S, Ramaswamy A, Mondal M, Chopra S, D'Souza M, Goel M (2024). Biliary Tract Cancer. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp.517-533.

      23. Singh B, Dutt S. (2024). Role of Cancer Stem Cells in Maintenance of Tumor Heterogeneity in Brain Tumors. In: Pathak S, Banerjee A (Eds.) Cancer Stem Cells and Signaling Pathways. Academic Press, Pp: 165-184. (ISBN: 978-0-443-13212-4).

      24. Tembhare P, Sastri GJ, Bagal B. (2024). Plasma Cell Dyscrasias. In: Badwe RA, Gupta S, Shrikhande SV, Laskar, S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer, Singapore, Pp. 291-305.

      25. Thota RS, Jain P. (2024). Pain Management. In: Badwe RA, Gupta S, Shrikhande SV, Laskar S. (Eds) Tata Memorial Centre Textbook of Oncology. Springer; Singapore, Pp.983-993.

    • 2016
      1. Dimri Shalini, Soumya Basu, and Abhijit De. ""Use of BRET to Study Protein-Protein Interactions In Vitro and In Vivo."" Methods in Molecular Biology. Ed. Iain J. McEWAN. Vol. 1443. New York: Springer, 2016. 57-78.
      2. Divatia JV, Amol Kothekar. “Liberation from Mechanical Ventilation”. In, Mehta Y, Sharma J, Gupta MK (Eds.) Textbook of Critical Care Including Trauma and Emergency Care New Delhi: Jaypee Brothers, 2016, 195-201
      3. Gupta Sharbani, Vimala Ashok Mani, Arunashu Talukdar, Kunal Sehgal, C S Pramesh, Aliasgar Moiyadi and Sanjeeva Srivastava.” Exigencies of Biomarker Research in the Developing World: A Focus on the Dearth of Biobanking Resources”. In Srivastava S (Ed). Biomarker Discovery in the Developing World: Dissecting the Pipeline for Meeting the Challenges. New Delhi: Springer India, 2016. 1-7.
      4. Gupta Sharbani, Sandipan Ray, Arunashu Talukdar, Kunal Sehgal, Aliasgar Moiyadi and Sanjeeva Srivastava. “Geographic Pervasiveness of Cancer: Prospects of Novel Biomarker and Therapeutic Research in Developing Countries using OMICS approaches”. In Srivastava S (Ed). Biomarker Discovery in the Developing World: Dissecting the Pipeline for Meeting the Challenges. New Delhi: Springer India, 2016. 9-17.
      5. Kothekar Amol, JV Divatia.”Fiberoptic Intubation”. In, Gurjar M (Ed.). Manual of ICU Procedures. New Delhi: Jaypee Brothers, 2016, 49-61.
      6. Kothekar Amol, Janarthanan S, JV Divatia. “Infection in Immunocompromised Hosts”. In, Mehta Y, Sharma J, Gupta MK (Eds.). Textbook of Critical Care Including Trauma and Emergency Care. New Delhi: Jaypee Brothers, 2016, 819-25.
      7. Moiyadi Aliasgar V, Geirmund Unsgård. "Navigable ultrasound, 3D ultrasound and fusion imaging in neurosurgery" Intraoperative Ultrasound (IOUS) in Neurosurgery. Ed. Francesco Prada, Luigi Solbiati, Alberto Martegani, Francesco DiMeco. Switzerland. Springer International Publishing, 2016. 135-145.
      8. Myatra Sheila N, Amol Kothekar. “Oncological Emergencies”. In, Rungta N, Pande R, Munjal M. (Eds.) Critical Care. New Delhi: Jaypee Brothers Medical Publishers, 2016, 498 -508
      9. Shetty P, AliAsgar V Moiyadi. ""Clinical ultrasound: Historical aspects."" Intraoperative Ultrasound (IOUS) in Neurosurgery. Ed. Francesco Prada, Luigi Solbiati, Alberto Martegani, Francesco DiMeco. Switzerland. Springer International Publishing, 2016. 3-8.
      10. Yadav Lumbini R, Pankaj Thapa, Lipi Das and Ashok K Varma. "Structureomics in Systems-Based Drug Discovery". In Singh S (Ed). Systems Biology Application in Synthetic Biology. New Delhi: Springer India, 2016. 33-51.
    • 2009
      1. Chaudhari P. and Phurailatpam R., Institutional Radiological Safety Guidelines, ACTREC p. 1-22 (2009)
    • 2015
      1. Acharya S, Raja Reddy Kuppili, Lalith K Chaganti, Kakoli Bose.” Proteases in Apoptosis: Ptotocols and methods.” Proteases in Apoptosis: Pathways, Protocols and Translational Advances. Ed. Kakoli Bose. Switzerland. Springer International Publishing, 2015. 143-202 .
      2. Agarwal, Jai Prakash, Tejapl Gupta, Rahul Krishanty, Amit Joshi, and Mitali Dandekar. "Larynx and Hypopharynx." UICC Manual Of Clinical Oncology. Ed. Brian O'Suvilian, James D. Brierley, Anil K. D'Cruz, Martin F. Fey, Raphael Pollock, Jan B. Vermorken, and Shao Hui Huang. 9th ed. Oxford: Wiley-Blackwell, 2015.
      3. Chaganti LK, Nitu Singh, Kakoli Bose. “Cathepsins and HtrAs : Multitasking ptoteases in programmed cell death. “Proteases in Apoptosis: Pathways, Protocols and Translational Advances. Ed. Kakoli Bose. Switzerland. Springer International Publishing, 2015. 95-141. .
      4. Chaudhari P.“Precilinical animal model and non-invasive imaging in apoptosis.” Proteases in Apoptosis: Pathways, Protocols and Translational Advances. Ed. Kakoli Bose. Switzerland. Springer International Publishing, 2015. 203-237.
      5. Ghosh Laskar, Sarbani, Navin B. Mummudi, Vedang Murthy, and Gauri Pantvaidya. "Head and Neck Unknown Primary." UICC Manual of Clinical Oncology. Ed. Brian O'Sullivan, James D. Brierley, Anil K. D'Cruz, Martin F. Fey, Raphael Pollock, Jan B. Vermorken, and Shao Hui Huang. 9th ed. Oxford: Wiley-Blackwell, 2015 .
      6. Jamema, SV, Siji N. Paul, Reena Devi, Kishore Joshi, Ashwini Budrukkar, S. Laskar, S. G. Laskar, Umesh Mahantshetty, Mayur Sawant, Pooja Moundekar, and D. D. Deshpande. "Impact of In-homogenity Corrected Dose Calculation of Clinical Brachytherapy Sites." World Congress on Medical Physics and Biomedical Engineering, June 7-12, 2015, Toronto, Canada. Ed. David A. Jaffray. Vol. 51. Switzerland. Springer International Publishing, 2015. 463-66 .
      7. Kuppili R, Kakoli Bose. “Calpains and Granzymes: Non- caspase proteases in cell death.” Proteases in Apoptosis: Pathways, Protocols and Translational Advances. Ed. Kakoli Bose. Switzerland. Springer International Publishing, 2015. 53-94 .
      8. Munnolli SS, Shyam Prasad Pujar. “The Impact of Indian Cancer Research in Social Media: A Study Using Altmetric Explorer” Emerging Trends and Issues in Scientometrics, Informetrics and Webometrics. Ed. P.K. Jain, D.C. Kar, Kretschmer, H and P. Babbar. New Delhi, Ane Books Pvt. Ltd. 2015, 511-518 .
      9. Singh Nitu, Kakoli Bose.” Apoptosis: Pathways , Molecules and Beyond.” Proteases in Apoptosis: Pathways, Protocols and Translational Advances. Ed. Kakoli Bose. Switzerland. Springer International Publishing, 2015. 1-30 .
      10. Tyagi M, Khan SA, Bhattacharya S, Reddy D, Sharma AK, Khade B, Gupta S.Techniques to access histone modifications and variants in cancer. Methods Mol Biol. 1238: 251-72, 2015.
    • 2004
      1. Chaudhari, P., Balogh L. and Samuel A. Nonhuman Primates in Nuclear Medicine Research, in National Center for Primate Breeding and Research: Vision, Challenges and Opportunities, Editor’s: CP Puri and NK Ganguly, Indian Council of Medical Research, p. 503-514 (2004)
    • 2013
      1. Amin N, Patil V, B Trivedi. " Burns." Objective Anesthesia Review. A Comprehensive Textbook for the Examinees, By, A. Kulkarni, J. V. Divatia, Vijaya P. Patil, and R. P. Gehdoo. New Delhi: Jaypee, 2013.165-180.
      2. Gehdoo R,J Divatia, B Trivedi. ". Proximal fracture femur " Objective Anesthesia Review. A Comprehensive Textbook for the Examinees, By, A. Kulkarni, J. V. Divatia, Vijaya P. Patil, and R. P. Gehdoo. New Delhi: Jaypee, 2013. 205-210.
      3. Munnolli, Satish S. “Challenges for Libraries and Professionals in 21st Century: The Way Forward”. Ed. S L Sangam, B S Biradar and S M Pujar. Recent Trends in Library and Information Science: A Way forward for the future. Bangalore: LIS Academy International, 2013. 158-166.
      4. Myatra S , B Trivedi, Kothekar A. " Cardiopulmonary Resuscitation " Objective Anesthesia Review. A Comprehensive Textbook for the Examinees, By, A. Kulkarni, J. V. Divatia, Vijaya P. Patil, and R. P. Gehdoo. New Delhi: Jaypee, 2013. 416-425.
      5. Ranganathan, P, B Trivedi. " Intercostal drain " Objective Anesthesia Review. A Comprehensive Textbook for the Examinees, By, A. Kulkarni, J. V. Divatia, Vijaya P. Patil, and R. P. Gehdoo. New Delhi: Jaypee, 2013. 85-87.
      6. Ranganathan, P, B Trivedi. "Pneumonectomy." Objective Anesthesia Review. A Comprehensive Textbook for the Examinees, By, A. Kulkarni, J. V. Divatia, Vijaya P. Patil, and R. P. Gehdoo. New Delhi: Jaypee, 2013. 63-72.
    • 2014
      1. Chandrani, Pratik, and Amit Dutt. ""Domain Specific Targeting of Cancer."" Ed. Rakesh Kumar. Nuclear Signaling Pathways and Targeting Transcription in Cancer. New York: Springer, 2014. 299-310. Cancer Drug Discovery and Development.
      2. De, Abhijit. "Bioluminescence." eLS. Chichester: John Wiley & Sons Ltd., 2014.
      3. De, Abhijit, Rohit Arora, and Akshi Jasani. "Engineering Aspects of Bioluminescence Resonance Energy Transfer Systems. Ed. Weibo Cai. Engineering in Translational Medicine Part II London: Springer, 2014. 257-300.
      4. Maru, Girish B., G Kumar, S. Ghantasala, and P. Tajpara. ""Polyphenol-Mediated In Vivo Cellular Responses during Carcinogenesis."" Polyphenols in Human Health and Disease. Ed. Ronald Ross Watson, Victor R. Preedy, and Sherma Zibadi. Vol. 87. Amsterdam: Academic, 2014. 1141-179.
      5. Maru GB, Gandhi K, Ramchandani A, Kumar G. The role of inflammation in skin cancer. Adv Exp Med Biol. 816: 437-69, 2014.
      6. Sarin, Rajiv. "Genetics and Cancer." Practical Clinical Oncology. Ed. Praful Desai. New Delhi: Jaypee Brothers Medical (P), 2014. 84-97.
      7. Sehgal, Lalit, Abul Usmani, Sorab N. Dalal, and Subeer S. Majumdar. "Generation of transgenic mice by exploiting spermatogonial stem cells In vivo." Ed. Shree Ram Singh and Vincenzo Coppola. Mouse Genetics: Methods and Protocol. New York: Springer, 2014. 327-37. Methods in Molecular Biology. Vol. 1194.
      8. Singh, Ram K., Snehal M. Gaikwad, Subhoshree Chatterjee, and Pritha Ray. "Stem Cells: The Holy Grail of Regenerative Medicine." Ed. Weibo Cai. Engineering in Translational Medicine. Part I. London: Springer, 2014. 19-69
      9. Moiyadi AV. “Intraoperative Ultrasound in Neurosurgical Oncology” Scope and Utility. Tumors of the Central Nervous system . Ed. E Hayat. Netherlands. Springer, 2014. 149-158.
    • 2022
      1. Kode J, Pradhan T, Kailaje V. This is how phytochemical from dietary resource exerts innate immunity by regulating lung inflammasome. Science as Art. NIH-FDA IIG Newsletter pg. 7. November 2022. Image.
      2. Training Manual on Tobacco Cessation for Dental Professionals. 2022. Tobacco Cessation in Dental Settings. Reference Manual for Dental Professionals. National Resource Centre for Oral Health and Tobacco Cessation. MAIDS, New Delhi. Ed. Mohanty V. 2022. Experts: Swasticharan L, Jhanjee S, Mishra GA, Gupta R, Kshetrimayum N, Chhatwal GS, Saha S, Khattar P, Mathur VP, Mohanty U, Misra S, Kumar N.
      3. Gupta RP, Lakshman N, Kumar A, Srivastava A, Shukla A, Basile A, Thukral A, Nehra A, Urooj A, Singh BP, Nath B, Mishra G et al. Women’s health guideline. Health Parliament, October 28, 2022.
    • 2020
      1. CM Krishna (2020). Raman theranostic solutions for low cost settings. Biophotonics World.
      2. Prabha Sakshi Hindi News Paper online (India Science Wire): Title: कैंसर उपचार में मददगार हो सकते हैं समुद्री शैवाल आधारित नैनो कंपोजिट, http://vigyanprasar.gov.in/isw/Seaweed-based-nano-composites-may-be-helpful-in-cancer-treatment-hindi.html, published on 29th June, 2020.
      3. CSIR Press Release: Title: कैंसर उपचार में मददगार हो सकते हैं समुद्री शैवाल आधारित नैनो कंपोजिट, https://pib.gov.in/PressReleseDetailm.aspx?PRID=1634802, published on 27th June, 2020.
      4. Vigyan Prasar News (India Science Wire): Title: कैंसर उपचार में मददगार हो सकते हैं समुद्री शैवाल आधारित नैनो कंपोजिट, http://vigyanprasar.gov.in/isw/Seaweed-based-nano-composites-may-be-helpful-in-cancer-treatment-hindi.html, published on 26th June, 2020.
      5. Red seaweed polysaccharide inhibits growth of cancer cells, News Article in Nature India, 2020. doi:10.1038/nindia.2020.88 published online 27 May 2020.
    • 2016
      1. CM Krishna, Raman theranostics in cancer: challenges and perspectives, Kiran, ILA News Bulletin, 27: 5-13, 2016.
      2. Kulkarni A, Wadasadawala T, Parkar J. Linguistic validation of the reconstruction module of BREAST-Q questionnaire in Marathi: A new patient-reported outcome instrument for breast reconstructive surgery. PRO Newsletter, PP. 1-8, January 2016.
      3. Mahalakshmi H, Venkatraman P. Quanternary structure of proteins by DLS and allied light scattering techniques. Spinco Biotech Cutting Edge. PP. 9-13, January 2016.
      4. Tibdewal A, Wadasadawala T, Kulkarni A, Parkar J. Linguistic validation of the reconstruction module of BREAST-Q questionnaire in Hindi: A new patient-reported outcome instrument for breast reconstructive surgery. PRO Newsletter, PP. 1-9, February 2016.
    • 2015
      1. Mahalakshi Harish, Venkatraman P. DLS and its applications in structural biology of proteins. Spinco Biotech Cutting Edge. PP. 42-45, November 2015.
    • 2014
      1. Tyagi M, Khan SA, Gupta S. Histone post-translational modifications as biomarks in cancer: Dream or reality? Proteomics Society, India (PSI) News Letter 2(1): 7-10, 2014.
    • 2013
      1. Chiplunkar SV. Immunity and nutrition - A link ? Find out more. Perspectives: Nutrition and Immune Health. 4(1): 4-10, 2013.
      2. CM Krishna: Raman spectroscopy: A sleeping giant awakened. IWSA News Letter 41(3): 5-7, 2013.
    • 2023
      1. Das A, Kumar VG, Kode J (2023). Deep blue remedies- Roadmap from ocean to clinic unveiling marine bioactive compounds as potential immunomodulatory agents for improved therapeutics. Immuneconnect. 1:104-108.
    • 2020
      1. Munnolli SS. "Role of Librarians in Changing Dimensions of Publications and Research Ethics." In: Shivaram BS, G Mahesh (Eds.), Proceedings of the 3rd LIS Academy Virtual Conference on Reinventing Excellence in Librarianship. Banglore: Sunstar Publisher, 2020. Pp.217-228.
    • 2019
      1. Pujar SM, Munnolli SS, Mundgod MB. “Google scholar as an alternate tool for citation analysis.” In: Munnolli SS, Mundgod MB, Pujar SM, Gawali PB, Savanur SK (Eds.), Proceedings of the 8th National Conference of Institute of Scientometrics on Scholarly Communication and Scientometrics. Navi Mumbai: ACTREC, 2019. Pp. 19-25. (ISBN: 978-93-5391-919-1
      2. Raul MA, Munnolli SS. “Tools and techniques for enhancing the research impact: An overview.” In: Munnolli SS, Mundgod MB, Pujar SM, Gawali PB, Savanur SK (Eds.) Proceedings of the 8th National Conference of Institute of Scientometrics on Scholarly Communication and Scientometrics. Navi Mumbai: ACTREC, 2019. Pp. 39-47. (ISBN: 978-93-5391-919-1)
      3. Gawali PB, Munnolli SS. “Scientometrics: Credit score challenges.” In: Munnolli SS, Mundgod MB, Pujar SM, Gawali PB, Savanur SK (Eds.). Proceedings of the 8th National Conference of Institute of Scientometrics on Scholarly Communication and Scientometrics. Navi Mumbai: ACTREC, 2019. Pp. 195-197. (ISBN: 978-93-5391-919-1)
      4. Raul MA, Belapurkar SS, Patil AD, Munnolli SS. “Library, technology and services: Innovative approch for e-alert service in ACTREC.” In: Shivram BS, Mulla KR, Byrappa A (Eds.) Proceedings of the 2nd LIS Academy National Conference on Innovations in Libraries Bangalore: LIS Academy, 2019. Pp. 185-193. (ISBN: 978-81-941320-0-4)
    • 2017
      1. Munnolli SS, Shamprasad M Pujar. Altmetrics on Altmetrics! A study of top 100 Articles on Altmetrics. In: Sangam SL, Hosamani SS, Anand TB, Shivaram BS (Eds.) Proceedings of 6th International Conference of Institute of Scientometrics on Information for All: Scientometrics, Infographics, Social Medica & Public Libraries. Bengaluru: LIS Academy, 15-24.
    • 2014
      1. Munnolli SS, Pujar SM. Impact of highly cited Indian Cancer research papers on altmetric explorer : An exploratory study. 72-80. Third National Conference on Scientometrics, Big Data Analytics (BDA) and Libraries May 31, 2014.
      • 2013
        1. Bhutani G, Dwarakanath TA, Lagoo KD, Moiyadi A, Venkata PPK. Neuro-registration and navigation unit for surgical manipulation.Proceedings of the 1st International and 16th National Conference on Machines and Mechanisms (iNaCoMM2013), IIT Roorkee, India, Dec 18-20 2013.
      • 2022
        1. Bose K (Editor). Textbook on Cloning, Expression and Purification of Recombinant Proteins. Singapore; Springer, 2022. (ISBN 978-981-16-4986-8)

        2. Dave U (Ed), Shetty D (Co-Ed) Genetic Counseling: Clinical and laboratory Approach. 1st Edition. New Delhi; Jaypee Brothers Medical Publishers P) Ltd., 2022. (ISBN 978-93-5465-212-7).
      • 2021
        1. Bhattacharjee A. Bayesian Approches in Oncology Using R and OpenBUGS. 1st ed. Florida: CRC Press, 2021. (ISBN: 978-0-367-35050-5)
        2. Pujar SM, Munnolli SS, Babu R (Eds.) Open Scholarship and Libraries, Sunstar Publishers: Banglore, 2021.
      • 2019
        1. Bose K, Chaudhari P. (Eds.) Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach. 1st ed. Singapore: Springer, 2019. (ISBN: 978-981-329-815-6)
      • 2015
        1. Bose K. Proteases in Apoptosis: Pathways, Protocols and Translational Advances. Ed. Kakoli Bose. Switzerland. Springer International Publishing, 2015.
        2. Bhattacharjee, Tanmoy and C M Krishna. Raman Spectroscopy: Applications in Breast Cancer Management. Vol. SLO7, SPIE Book Press, 2015. [E-Book]
      • 2019
        1. Munnolli SS, Mundgod MB, Pujar SM, Gawali PB, Savanur SK (Eds.) Proceedings of the 8th National Conference of Institute of Scientometrics on Scholarly Communication and Scientometrics. Navi Mumbai: ACTREC, 2019. (ISBN: 978-93-5391-919-1)
      • 2016
        1. Munnolli Satish S “Scientometric Dimensions of The Central Nervous System(CNS) Cancer Research in India”. In, Mallikarjun Angadi, Munnolli Satish S, Shah Truptee , Prbakaran R, Kumar Praveen K, Kanamadi Satish (Eds). TIFR BOSLA National Conference on Future Librarianship (Proceedings). Mumbai, Imperial Publications. 2016. 224-232.
        2. Raul Mugdha A, Swati S Belapurkar , Satish S Munnolli. “Marketing of Library Resources and Services: New challenges and opportunities”. In, Mallikarjun Angadi, Munnolli Satish S, Shah Truptee , Prbakaran R, Kumar Praveen K, Kanamadi Satish (Eds). TIFR BOSLA National Conference on Future Librarianship (Proceedings). Mumbai, Imperial Publications. 2016. 374-380.
      • 2019
        1. Mishra GA, Pimple SA (2019)- Training module on cancer awareness for prevention and early detection of breast and uterine cervix cancer. (ISBN: 978-93-82963-30-1).
        2. Mishra GA, Pimple SA (2019) - Prashikshanpustika stana ani garbhashay mukhkark rogachya pratibandha ani lavkar nidaanasathi jagrukta. (978-93-82963-31-8).
        3. Mishra GA, Pimple SA (2019)- Prashikshanpustika stan aur garbhashayke cancer ki roktham aur shighrah nidan keliye jagrukta. ( ISBN: 978-93-82963-32-5).
        4. Mishra GA, Pimple SA (2019)- Training module on tobacco cessation counseling for female tobacco users. (ISBN: 978-93-82963-33-2).
        5. Mishra GA, Pimple SA (2019)- Prashikshanpustika tambhaku sevan karnarya mahilanna vyasanmukt karnyasathi margadarshan. (ISBN: 978-93-82963-34-9).
        6. Mishra GA, Pimple SA (2019)- Prashikshanpustika tambhaku upyogkarta mahilaonko tambhaku muktikeliye margdarshan. (ISBN: 978-93-82963-35-6).
        7. Mishra GA, Pimple SA (2019)- Practical training module about health awareness on hazards of tobacco use. ( ISBN: 978-93-82963-36-3).
        8. Mishra GA, Pimple SA (2019)- Prashikshanpustika tambhakuchy dhokyanbabat aarogyavishayak jagrukta. (ISBN: 978-93-82963-37-0).
        9. Mishra GA, Pimple SA (2019)- Prashikshanpustika tambhakusevan se hone vale khatron ke bare mein swasthya jagrukta. (ISBN: 978-93-82963-38-7).
        10. Mishra GA, Pimple SA (2019)- Training module to create awareness among children about ill effects of tobacco use. (ISBN: 978-93-82963-39-4).
        11. Mishra GA, Pimple SA (2019)- Prashikshanpustika tambhakuchya dushparinamanbabat mulanmadhye jagrukta. (ISBN: 978-93-82963-40-0).
        12. Mishra GA, Pimple SA (2019)- Prashikshanpustika tambhakuke dushprabhavke Vishay mein bachonmein jagrukta. (ISBN: 978-93-82963-41-7).
        13. Pimple SA, Mishra GA (2019) - Training Atlas of cervical pre cancers and cancer. (ISBN: 978-93-82963-27-1).
        14. Pimple SA, Mishra GA (2019) - Prashikshan chitrasanchpustika: Garbhashay mukhkark rogachi purvavastha aani karkrog. (ISBN: 978-93-82963-42-4).
        15. Pimple SA, Mishra GA (2019) - Prashikshan chitrasanchpustika: Garbhashay mukhkark rogki purvavastha aur karkrog. (ISBN: 978-93-82963-43-1).
        16. Pimple SA, Mishra GA (2019) - Training atlas of early detection of breast cancers. (ISBN: 978-93-82963-29-5).
        17. Pimple SA, Mishra GA (2019) - Prashikshan chitrasanchpustika: stanachya karkarogache lavkar nidan. (ISBN: 978-93-82963-46-2)
        18. Pimple SA, Mishra GA (2019) - Prashikshan chitrasanchpustika: stan ke karkarog ka jald nidan. (ISBN: 978-93-82963-47-9).
        19. Pimple SA, Mishra GA (2019) - Training atlas of oral pre cancers. (ISBN: 978-93-82963-28-8).
        20. Pimple SA, Mishra GA (2019) - Prashikshan chitrasanch pustika: tondachya karkarogachi purvavastha. (ISBN: 978-93-82963-44-8).
        21. Pimple SA, Mishra GA (2019) - Prashikshan chitrasanchpustika: muhke karkarog ki purvavastha. (ISBN: 978-93-82963-45-5).
        22. Pimple SA, Mishra GA (2019) - Guide book for preventive oncology services. (ISBN: 978-93-82963-48-6).
        23. Pimple SA, Mishra GA (2019) - MargdarshakPustika: karkrog pratibandh vibhag seva. (ISBN: 978-93-82963-49-3).
        24. Pimple SA, Mishra GA (2019) - MargdarshakPustika: karkrog pratibandh vibhag sevaen. (ISBN: 978-93-82963-50-9).
      Back to Top